data_2n4i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n4i _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 121.216 0.423 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.791 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 1.1 p90 -157.85 146.88 19.52 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.68 178.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.924 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.5 HG23 ' HE1' ' A' ' 125' ' ' PHE . 2.7 t -100.44 148.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.816 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 151.84 41.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.764 0.316 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.03 -127.74 9.33 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.56 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.35 178.76 6.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.07 74.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 136' ' ' THR . . . 119.27 84.23 0.89 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.712 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.05 81.62 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.75 2.3 . . . . 0.0 111.002 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.25 127.69 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.44 142.3 35.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.46 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 113' ' ' VAL . . . -152.19 172.09 16.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.476 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.69 140.02 51.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.767 ' HG ' HG22 ' A' ' 140' ' ' ILE . 2.2 mt -61.55 133.76 56.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.933 0.397 . . . . 0.0 111.107 -174.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.75 -16.42 8.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.918 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.74 -148.8 15.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.182 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -101.31 130.76 47.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.688 HD13 HG22 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -104.3 110.98 23.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.305 175.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.71 106.11 18.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 0.0 109.89 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 1.5 mm? -94.09 128.09 40.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.65 122.12 37.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.547 ' HB3' ' HE2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -126.83 141.12 51.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.461 176.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.601 ' HG3' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -115.15 130.71 56.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -127.79 154.7 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.07 0.462 . . . . 0.0 110.843 -178.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -125.15 83.66 60.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.951 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.791 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -93.99 164.39 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.511 2.807 . . . . 0.0 112.987 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.83 -14.85 10.99 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.765 2.31 . . . . 0.0 111.875 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -116.5 -172.84 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.115 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.3 -11.63 48.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 110.432 178.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.681 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 68.06 7.72 6.03 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.072 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.489 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 1.5 tm0? -58.22 -46.74 85.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.182 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.44 5.08 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.06 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.681 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -80.31 166.22 21.55 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -176.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 77' ' ' ARG . 3.1 mt-10 -105.29 142.8 34.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.59 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HD13 HD22 ' A' ' 96' ' ' LEU . 2.7 tt -137.37 144.49 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.162 0.506 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -127.86 116.76 20.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.615 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -130.74 58.1 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -170.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.5 170.51 18.43 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.638 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' CZ ' ' HA ' ' A' ' 117' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.47 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 85' ' ' GLU . 2.4 m170 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.365 0.126 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 85' ' ' GLU . 6.1 tp 176.1 127.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.973 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.12 138.24 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -137.49 139.62 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -163.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.0 t0 66.82 0.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.437 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.38 4.19 57.37 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 140.92 41.21 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.437 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 169.71 17.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.769 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.912 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 2.6 ttt -132.47 120.89 22.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.966 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.28 -40.57 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.535 ' HA3' ' HE1' ' A' ' 82' ' ' MET . . . -73.84 -10.87 80.84 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.93 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -93.96 -25.98 17.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 42.37 68.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.852 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 94' ' ' THR . 6.5 tp -66.06 -12.29 14.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.267 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -13.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -62.77 -35.21 79.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.834 0.349 . . . . 0.0 110.609 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 21.79 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.479 HG23 ' NH1' ' A' ' 93' ' ' ARG . 0.4 OUTLIER 54.8 -149.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.441 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.46 28.28 4.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.354 0.597 . . . . 0.0 110.645 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.51 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -100.49 35.57 2.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.475 -178.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -120.41 126.12 49.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.922 -175.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -136.33 99.89 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -88.24 100.1 12.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.238 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.11 99.93 0.72 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.885 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.05 -7.65 26.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.159 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -30.83 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.497 0.665 . . . . 0.0 109.99 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.26 -17.87 79.68 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.98 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 57' ' ' ALA . 3.6 tt -61.03 -29.81 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -171.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.494 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -69.53 -15.6 70.86 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.395 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 -4.58 28.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.944 0.402 . . . . 0.0 109.982 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . 89.83 20.72 42.33 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.945 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.601 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -130.28 132.54 45.96 Favored 'General case' 0 C--O 1.22 -0.477 0 O-C-N 122.507 -0.408 . . . . 0.0 111.11 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.66 132.28 69.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 121.763 -0.586 . . . . 0.0 109.75 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -125.25 103.17 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 0.0 111.5 -176.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB2' HD11 ' A' ' 96' ' ' LEU . 2.0 tp -91.69 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.802 0.334 . . . . 0.0 110.621 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 106.31 18.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.14 131.33 62.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.51 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -96.3 137.56 35.19 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.904 -176.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 t30 76.05 74.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.513 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.688 HG22 HD13 ' A' ' 45' ' ' LEU . 12.1 p -81.98 146.97 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.79 168.45 13.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.525 0.202 . . . . 0.0 111.325 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -77.39 -8.15 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.146 0.498 . . . . 0.0 111.643 -173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -35.3 12.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -72.76 -25.4 61.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.53 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -78.11 24.3 0.25 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.87 -108.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.428 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.87 116.2 23.25 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.393 -0.475 . . . . 0.0 109.898 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.616 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -74.37 141.1 45.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.925 178.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.11 105.65 17.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.403 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.7 t -98.68 117.22 32.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.05 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 53.0 t -132.33 124.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.676 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -110.34 135.91 50.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.97 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -123.75 104.8 9.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.444 . . . . 0.0 110.622 178.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.676 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 19.7 t70 -93.07 81.86 4.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.147 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.75 -100.83 0.58 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.694 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -95.75 -10.99 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -93.07 154.92 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.607 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 50.8 p90 -151.26 146.73 26.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.89 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 1.9 mm-40 -139.71 160.37 40.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.885 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' HG2' HG21 ' A' ' 124' ' ' VAL . 2.1 mt-10 -126.46 154.24 43.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -173.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 140.71 14.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.496 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -108.48 107.14 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.541 HG21 ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -95.04 102.03 13.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.055 -176.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.3 116.71 13.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 118' ' ' ASP . 1.3 t -86.53 150.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.164 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.02 112.57 8.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.182 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.767 HG22 ' HG ' ' A' ' 41' ' ' LEU . 47.9 mm -76.33 110.66 11.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.889 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.946 0.311 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -152.71 149.18 28.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.896 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -143.15 170.63 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 132' ' ' GLU . 84.9 t -96.88 147.89 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.182 175.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.13 136.6 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.55 78.52 1.16 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.582 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -135.41 115.89 13.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' O ' HG21 ' A' ' 136' ' ' THR . 45.7 mp0 -77.19 -44.77 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.07 111.59 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.716 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.63 62.55 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.53 2.154 . . . . 0.0 110.332 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.36 104.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.953 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.99 123.1 37.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.426 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.69 167.15 15.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.634 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.35 139.95 46.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.06 126.39 27.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.933 0.397 . . . . 0.0 110.621 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 85.98 -9.78 67.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.993 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.76 -164.78 39.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.2 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.74 133.01 48.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.49 115.53 24.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.385 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.3 mt-10 -99.42 112.95 25.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.01 0.433 . . . . 0.0 110.004 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 47' ' ' LEU . 10.3 mt -95.6 128.07 42.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.269 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.8 OUTLIER -123.99 123.05 39.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.36 -179.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.682 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -117.55 140.42 49.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -128.7 134.15 48.39 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.164 0.29 . . . . 0.0 111.062 -173.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -127.32 164.85 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -80.56 104.94 3.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 7.4 Cg_exo -72.15 114.81 4.09 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.143 2.562 . . . . 0.0 113.551 -170.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 52' ' ' SER . 98.8 Cg_endo -87.89 -13.24 3.96 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 111.067 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -171.5 3.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.478 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.461 ' HG3' ' OE1' ' A' ' 58' ' ' GLN . 4.8 pm0 -68.02 -7.75 31.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.484 0.183 . . . . 0.0 111.479 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' HG12 ' A' ' 101' ' ' ILE . . . 75.51 -33.77 0.24 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.461 ' OE1' ' HG3' ' A' ' 56' ' ' GLN . 10.1 pt20 -51.74 -39.79 59.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.93 15.02 3.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.562 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ptm -92.9 160.87 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.733 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.987 ' HB3' HD12 ' A' ' 75' ' ' LEU . 71.9 mt-10 -87.2 131.22 34.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -132.26 135.57 57.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.049 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -119.15 117.58 29.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.872 172.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.515 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -126.3 63.8 1.25 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' HE1' HG13 ' A' ' 87' ' ' ILE . 89.5 m-85 -148.93 154.71 39.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.611 -170.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.213 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.987 HD12 ' HB3' ' A' ' 61' ' ' GLU . 1.5 tp -113.08 130.81 56.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.52 ' HE2' ' HD2' ' A' ' 98' ' ' LYS . 52.5 t80 -126.24 152.85 45.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -141.96 143.33 33.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.04 113.2 4.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.328 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 122.45 16.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.401 0.62 . . . . 0.0 111.141 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.99 161.32 30.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.949 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -167.59 163.03 14.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.759 0.314 . . . . 0.0 110.622 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -12.04 61.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.981 0.419 . . . . 0.0 110.63 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.05 -35.87 79.51 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.029 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -76.68 -41.24 46.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.18 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 tp 21.54 72.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 124.754 1.283 . . . . 0.0 112.373 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.923 HG12 ' HB ' ' A' ' 94' ' ' THR . 14.9 tt -58.8 -23.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.235 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -13.72 59.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.956 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.93 -17.98 60.47 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.815 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.71 -71.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.086 -0.245 . . . . 0.0 110.706 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.0 t -134.84 -67.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.675 0.274 . . . . 0.0 110.817 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -168.98 -63.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.197 0.522 . . . . 0.0 110.25 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -101.0 98.61 9.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.921 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.923 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -130.58 115.05 16.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.536 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -126.7 133.65 50.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.81 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.81 104.53 14.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.97 0.414 . . . . 0.0 110.603 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.52 121.74 25.59 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.756 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -107.87 -4.71 17.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.413 -172.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -62.73 -35.81 80.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 110.959 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.41 -17.79 74.72 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.732 HG12 ' HB2' ' A' ' 57' ' ' ALA . 1.2 tt -62.09 -26.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 122.718 -0.283 . . . . 0.0 111.457 -173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.26 -17.37 63.78 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.801 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.63 5.65 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.229 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 89.23 23.66 33.94 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.123 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.5 OUTLIER -128.72 133.62 48.21 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 117.54 0.67 . . . . 0.0 111.475 -178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -115.04 132.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 O-C-N 121.761 -0.587 . . . . 0.0 109.629 175.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -114.12 103.26 10.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.187 0.518 . . . . 0.0 111.512 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 87' ' ' ILE . 22.9 tp -93.56 111.22 22.85 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.182 0.515 . . . . 0.0 110.264 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.55 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -88.08 107.41 18.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.807 178.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.525 HG13 ' HG ' ' A' ' 108' ' ' LEU . 63.5 mt -110.92 127.3 68.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.922 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -106.23 143.14 34.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.596 0.236 . . . . 0.0 110.832 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.426 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m120 68.35 55.72 0.51 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.636 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.831 HG21 HD11 ' A' ' 140' ' ' ILE . 4.5 p -65.88 152.2 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.39 152.39 39.08 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 112.39 -173.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.97 -17.45 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.212 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.47 -38.75 71.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.885 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -96.92 7.74 45.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.226 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.493 ' HA ' HD13 ' A' ' 140' ' ' ILE . 17.2 t70 -55.55 24.88 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 0.0 113.351 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -97.65 -132.66 7.58 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 120.788 -1.195 . . . . 0.0 112.194 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 127.57 43.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.443 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.701 ' CE2' ' HB ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -90.19 161.84 15.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.598 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -103.02 119.06 38.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.623 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -102.34 116.11 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 16.2 t -129.56 117.47 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.265 -176.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.682 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 17.4 m-30 -107.61 128.68 54.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.8 mtpt -122.55 104.9 9.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.44 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 6.2 t70 -91.63 73.94 5.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.525 0.678 . . . . 0.0 109.714 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.29 -83.05 1.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.96 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -116.82 -27.7 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.524 0.202 . . . . 0.0 111.457 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -89.67 125.78 35.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -126.32 150.56 48.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.896 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -132.12 145.38 51.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.877 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 124' ' ' VAL . 33.9 tt0 -132.35 126.39 33.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.388 . . . . 0.0 110.708 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -129.6 143.72 50.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.333 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -102.39 113.89 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.182 0.515 . . . . 0.0 110.191 176.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.619 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -105.65 147.23 28.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.726 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 150.35 28.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.828 0.347 . . . . 0.0 111.655 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.701 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 14.1 p -122.74 131.28 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.97 103.75 11.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.795 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.831 HD11 HG21 ' A' ' 113' ' ' VAL . 1.4 mp -73.41 124.51 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.444 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.611 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 CA-C-O 121.104 0.377 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.472 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -136.45 134.8 38.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.104 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.5 OUTLIER -150.47 161.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.373 0.42 . . . . 0.0 110.175 174.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 31' ' ' ASN . 75.5 t -92.31 145.07 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.491 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.464 ' N ' HG12 ' A' ' 30' ' ' VAL . 8.5 t-20 -67.94 162.5 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.85 62.95 2.41 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.294 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 122.78 19.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -83.75 -48.73 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.541 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 106.55 72.35 0.81 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.397 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.98 72.48 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.753 2.302 . . . . 0.0 110.919 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG13 HD11 ' A' ' 45' ' ' LEU . 3.3 t -85.89 103.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 -176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.74 139.39 33.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.45 171.39 14.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.774 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.62 154.25 28.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 130.48 42.54 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.451 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.64 8.62 86.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.205 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.97 -158.73 32.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.016 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -102.65 130.21 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.178 0.513 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HB2' HG22 ' A' ' 113' ' ' VAL . 8.6 tp -116.24 110.6 18.99 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.918 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tt0 -105.96 110.54 22.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 4.7 mt -95.8 128.43 42.67 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.67 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -121.55 125.4 46.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.583 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.3 140.23 50.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.85 130.83 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.103 0.477 . . . . 0.0 111.426 -172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.23 165.56 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.627 -176.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.582 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -117.54 82.41 15.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.714 169.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HA ' ' HE1' ' A' ' 28' ' ' PHE . 97.8 Cg_endo -89.86 141.83 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.027 2.485 . . . . 0.0 113.082 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.27 1.24 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.632 2.221 . . . . 0.0 112.646 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -151.97 -174.44 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.257 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -76.88 -18.55 58.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.272 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 61.45 34.97 17.89 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 170.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -64.6 -36.84 85.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.378 0.608 . . . . 0.0 109.56 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' A' ' 78' ' ' ASP . 49.9 t-80 -79.92 -2.67 44.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.094 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 127' ' ' ASP . 3.9 ttm -69.47 141.48 53.97 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.03 0.443 . . . . 0.0 111.396 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.81 116.95 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.927 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -116.44 147.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.338 0.589 . . . . 0.0 111.21 -174.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.739 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -128.56 137.22 51.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.241 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.447 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -151.81 42.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 30.6 m-85 -134.18 158.39 43.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.176 -168.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.032 0.444 . . . . 0.0 110.308 177.858 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 1.2 m-70 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.228 0.537 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -161.9 136.22 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.345 -171.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -103.37 109.28 20.85 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -116.52 130.18 56.6 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.486 -168.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 59' ' ' HIS . 16.4 t0 58.41 20.22 7.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.353 0.597 . . . . 0.0 111.684 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 22.93 58.25 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.885 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.51 139.18 50.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 110.815 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.81 169.98 17.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.176 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.513 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.27 135.11 49.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.924 0.393 . . . . 0.0 110.697 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.522 ' HA ' HD11 ' A' ' 86' ' ' ILE . 78.4 m-85 -87.5 -2.43 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.073 0.464 . . . . 0.0 110.981 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.46 -18.89 63.22 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -108.83 -40.73 4.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.542 0.21 . . . . 0.0 110.6 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 83' ' ' PHE . 31.5 mm 65.86 85.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.698 0.761 . . . . 0.0 111.435 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.544 HD13 HG21 ' A' ' 94' ' ' THR . 2.1 tp -67.8 -20.54 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 0.0 109.692 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -14.02 7.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.696 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -69.44 -22.52 63.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 178.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -74.88 -36.93 62.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.504 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.813 HG12 ' HG2' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 65.65 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.796 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.813 ' HG2' HG12 ' A' ' 91' ' ' VAL . 5.9 mm-40 66.25 -151.11 0.22 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.911 0.484 . . . . 0.0 110.416 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.47 109.28 22.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.156 0.503 . . . . 0.0 110.991 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.65 HG22 HG12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.77 95.36 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.524 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 4.7 tp10 -104.63 108.15 19.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.959 0.409 . . . . 0.0 110.675 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD13 HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -91.96 96.48 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.13 105.33 3.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.85 -8.71 20.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.952 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.56 -39.75 61.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.514 ' HA2' ' OE2' ' A' ' 103' ' ' GLU . . . -62.77 -18.66 59.72 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.543 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -58.61 -25.8 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 117.16 0.48 . . . . 0.0 111.833 -174.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 56' ' ' GLN . . . -63.9 -23.39 67.46 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.561 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.514 ' OE2' ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -105.84 -5.17 19.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.21 42.79 6.12 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.872 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.77 132.6 34.98 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.293 -0.533 . . . . 0.0 110.585 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.488 HG23 ' CZ ' ' A' ' 125' ' ' PHE . 14.0 m -121.67 133.18 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.03 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 103.46 9.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 96' ' ' LEU . 35.2 tp -92.86 110.25 21.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.476 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.735 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -88.95 105.79 17.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.35 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.65 HG12 HG22 ' A' ' 94' ' ' THR . 12.5 mt -112.46 119.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -94.55 140.08 30.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 74.26 67.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.056 0.848 . . . . 0.0 111.134 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.617 HG22 ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -62.02 133.36 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.994 174.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.77 149.44 24.48 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.59 -22.45 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.717 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -75.03 -37.07 61.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -89.74 2.26 55.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.631 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.5 t0 -58.47 27.09 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.94 0.896 . . . . 0.0 112.913 168.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -104.86 -147.43 16.4 Favored Glycine 0 N--CA 1.448 -0.539 0 O-C-N 121.399 -0.813 . . . . 0.0 112.29 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -100.96 120.3 39.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.7 0.286 . . . . 0.0 110.834 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.81 146.24 35.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 110.894 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.489 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 86.4 t60 -99.6 103.45 15.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.336 -177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 46.7 t -106.0 130.88 53.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 23.2 t -144.56 137.29 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 49' ' ' CYS . 17.0 m-85 -115.62 110.97 19.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.571 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -118.01 105.25 11.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 0.0 111.223 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.514 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 19.3 t0 -112.77 99.86 8.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 0.0 109.988 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.35 -103.6 2.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.233 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -112.57 -24.6 9.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.463 0.173 . . . . 0.0 111.274 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.74 129.66 36.63 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.788 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.571 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 23.5 p90 -137.4 127.77 26.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.283 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -112.34 136.36 51.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.942 177.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -110.1 146.87 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.857 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.513 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 7.1 t-80 -149.16 127.1 11.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.15 110.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.912 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.541 HG23 ' HA3' ' A' ' 35' ' ' GLY . 53.4 m -122.11 111.96 17.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.247 -177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.791 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.6 pt-20 -88.25 150.22 23.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.306 0.574 . . . . 0.0 111.867 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 118' ' ' ASP . 8.2 p -97.52 151.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.42 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -122.49 90.83 3.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.923 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' A' ' 118' ' ' ASP . 19.5 mt -76.66 107.32 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.516 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.463 -0.294 0 CA-C-O 121.028 0.345 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.566 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 4.9 p90 -78.58 164.94 24.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.787 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -128.63 173.85 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 111.673 -176.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG23 ' HE2' ' A' ' 125' ' ' PHE . 82.6 t -89.87 142.26 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.241 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.46 175.62 5.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.709 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.05 -113.47 3.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.772 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.48 176.87 9.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.73 -49.16 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.1 73.03 1.07 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.99 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.16 89.52 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.402 2.068 . . . . 0.0 110.494 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.89 129.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -174.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.8 mm? -88.98 128.34 35.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.02 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' A' ' 113' ' ' VAL . . . -133.99 169.71 16.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 128.96 54.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.665 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -62.59 123.91 19.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.73 -9.48 77.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.242 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.85 -171.45 35.73 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.847 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.33 137.35 33.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 tp -111.94 112.92 24.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.926 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -104.78 108.44 19.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.948 177.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.0 OUTLIER -96.61 127.95 43.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.514 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.47 123.87 50.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -121.58 140.73 51.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 1.0 OUTLIER -123.04 131.22 53.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 164.71 14.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.367 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.53 99.13 2.55 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 5.2 Cg_endo -83.76 121.1 2.82 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.162 2.575 . . . . 0.0 113.515 -167.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.02 -6.83 13.18 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.465 2.11 . . . . 0.0 110.356 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -165.62 -179.06 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.972 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.505 ' O ' HG23 ' A' ' 101' ' ' ILE . 2.2 pm0 -72.41 -17.24 61.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.535 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.49 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 58.34 30.16 19.18 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.408 0.623 . . . . 0.0 111.098 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -52.31 -58.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.612 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -96.03 26.61 4.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.84 167.68 11.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -97.14 149.97 21.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.685 0.278 . . . . 0.0 110.983 -172.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.425 HG23 HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -137.23 146.67 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.408 0.623 . . . . 0.0 112.195 -178.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.64 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mmm-85 -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -143.33 53.49 1.35 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HZ ' ' CD1' ' A' ' 76' ' ' TYR . 39.6 m-85 -136.46 154.72 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -166.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.593 ' HB2' ' CE1' ' A' ' 121' ' ' TYR . 4.2 ttp180 . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.981 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.467 ' HA ' ' CD ' ' A' ' 85' ' ' GLU . 31.1 m-70 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.96 0.41 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.04 124.83 1.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.587 -172.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.522 ' CD1' ' HZ ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -108.02 112.4 24.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -119.08 143.96 46.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 68.48 -2.72 1.53 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.319 0.58 . . . . 0.0 110.729 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 9.47 52.11 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.728 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -134.17 167.59 20.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.04 151.9 23.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 164.13 12.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.65 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -22.7 63.81 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.55 -28.64 69.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.478 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.467 ' CD ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -86.85 -42.33 13.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.629 ' O ' HG21 ' A' ' 86' ' ' ILE . 7.5 tp 43.7 90.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.663 1.227 . . . . 0.0 112.61 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.414 HG12 ' HB ' ' A' ' 94' ' ' THR . 3.8 tp -65.39 -12.45 13.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.308 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -14.45 60.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.234 0.54 . . . . 0.0 109.78 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.1 -21.51 54.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.173 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -61.86 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 ' CG1' ' H ' ' A' ' 92' ' ' GLU . 2.1 p -169.72 -71.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.285 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.43 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 177.85 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 109.887 -177.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -76.88 105.7 8.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.883 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.497 HG22 HG12 ' A' ' 110' ' ' ILE . 25.8 m -152.55 107.49 3.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 131.33 55.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.879 0.371 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -99.51 112.81 24.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.868 0.366 . . . . 0.0 110.177 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.41 105.76 10.95 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.954 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' HD13 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -100.32 1.78 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.456 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.6 -28.5 69.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 110.2 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.04 -17.46 78.31 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.548 HD13 ' HG2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -59.05 -28.29 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.88 0.34 . . . . 0.0 111.454 -173.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.12 -16.98 67.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.751 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -103.47 -4.26 24.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.516 0.326 . . . . 0.0 110.246 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 92.31 20.13 36.44 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.851 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -129.08 133.0 47.49 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 117.142 0.471 . . . . 0.0 111.511 -178.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.73 132.73 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -120.71 108.71 14.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.613 -177.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 64' ' ' TRP . 11.1 tp -91.96 121.67 33.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.289 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.788 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.545 HD11 HD21 ' A' ' 108' ' ' LEU . 38.3 mt -112.59 127.77 69.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.699 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 112' ' ' ASN . 31.4 t80 -83.48 122.61 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 32.6 t30 80.13 119.36 0.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.071 0.857 . . . . 0.0 111.68 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.575 HG13 ' HB1' ' A' ' 39' ' ' ALA . 7.1 p -117.9 134.59 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.412 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.5 p -103.78 171.27 7.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 112.007 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -67.06 -14.14 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.499 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.404 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 13.7 t0 -81.38 -34.02 31.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.455 ' HA ' ' CD ' ' A' ' 66' ' ' ARG . 32.6 m-20 -72.3 -24.84 61.39 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.014 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.56 -3.66 0.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.697 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.69 -132.12 1.71 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.813 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.486 ' HB2' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -106.62 127.12 53.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.105 0.479 . . . . 0.0 111.542 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-85 -90.37 148.48 22.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -106.19 113.66 27.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.781 0.324 . . . . 0.0 110.141 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 4.5 t -103.4 116.21 31.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.128 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.64 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 8.8 t -132.31 113.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.698 ' HE2' HG23 ' A' ' 30' ' ' VAL . 34.7 m-85 -93.27 136.09 33.87 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 126' ' ' LYS . 11.8 mtpp -121.01 102.97 8.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 33.9 t70 -99.05 74.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.548 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.15 -96.94 0.34 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.905 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.89 -27.83 17.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.67 0.271 . . . . 0.0 111.601 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.68 148.46 22.6 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.34 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -146.18 150.34 35.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.46 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.676 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -143.38 132.84 23.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.008 177.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -114.48 121.93 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 109.949 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.05 148.15 50.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -93.29 133.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.153 0.501 . . . . 0.0 110.772 -176.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -128.79 102.38 6.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.63 138.51 38.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 46.0 t -95.48 142.72 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.83 100.78 5.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.7 mt -81.83 97.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.682 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.55 ' CB ' ' HB3' ' A' ' 130' ' ' PHE . 4.0 Cg_exo . . . . . 0 N--CA 1.459 -0.551 0 N-CA-C 110.991 -0.426 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.76 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 13.4 p90 -140.67 160.55 39.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.75 172.35 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.582 . . . . 0.0 112.123 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.61 147.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.78 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 26.3 t30 -99.2 167.74 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.735 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.16 128.14 45.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.0 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -112.47 176.62 4.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.752 0.311 . . . . 0.0 110.518 -175.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HG2' HD21 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -73.53 -12.3 60.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.009 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 -132.35 11.02 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.567 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 55.5 Cg_endo -71.5 97.68 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.328 2.018 . . . . 0.0 111.513 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.78 113.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.1 mt -95.59 96.2 8.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.606 -175.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -127.4 170.84 12.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.885 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -97.38 145.35 26.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.777 0.322 . . . . 0.0 110.239 -170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.661 ' HB2' HG21 ' A' ' 140' ' ' ILE . 0.9 OUTLIER -70.71 142.65 51.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.13 -173.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.16 -8.07 72.44 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.698 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.12 -167.98 35.98 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.237 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.26 134.59 33.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.285 0.564 . . . . 0.0 110.412 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.936 ' HG ' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -106.05 111.0 23.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.289 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 96.89 6.8 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.63 129.22 42.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.879 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -107.49 128.94 54.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.11 140.26 50.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.672 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -125.96 129.72 49.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.597 0.237 . . . . 0.0 110.758 -175.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 HD23 ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -129.69 165.49 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.564 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.71 83.45 48.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.071 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HD3' HD23 ' A' ' 51' ' ' LEU . 86.6 Cg_endo -95.02 162.73 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.305 2.67 . . . . 0.0 113.107 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -88.44 37.45 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.947 2.431 . . . . 0.0 111.612 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -160.32 177.34 10.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.048 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.88 2.12 55.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.038 0.447 . . . . 0.0 109.817 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 62.28 24.77 14.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.907 172.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -67.81 -24.21 65.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 109.858 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -104.0 17.11 24.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.472 ' HA ' ' HB3' ' A' ' 127' ' ' ASP . 18.6 ttm -76.2 118.95 19.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 110.985 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.529 ' CG ' ' HB3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -78.67 98.88 6.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -111.22 140.48 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 111.336 -172.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.874 ' HB3' HG13 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.33 118.93 13.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -114.19 63.24 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 81.0 m-85 -136.01 151.28 49.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.604 -168.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.584 HH21 ' HB3' ' A' ' 116' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.63 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -146.71 152.24 38.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.693 -175.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.19 128.85 42.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.634 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.52 128.96 34.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -175.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.6 t70 62.25 15.08 7.25 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.463 0.649 . . . . 0.0 111.269 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.422 ' HA2' ' HE2' ' A' ' 98' ' ' LYS . . . 82.47 20.19 62.61 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.975 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.3 154.27 49.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.025 0.441 . . . . 0.0 111.065 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -132.22 139.03 48.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.916 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -177.8 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -67.09 -23.81 65.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.58 -53.36 5.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.047 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 75' ' ' LEU . 16.4 pm0 -93.15 15.31 15.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.543 0.337 . . . . 0.0 111.777 -175.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 83' ' ' PHE . 2.4 tt -42.58 121.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.712 0.768 . . . . 0.0 112.303 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.574 HD12 HD11 ' A' ' 108' ' ' LEU . 14.3 tt -72.75 -36.42 52.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.792 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.557 ' N ' HG21 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -61.69 -13.97 27.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -71.48 -12.42 61.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.534 -177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE1' ' HD1' ' A' ' 65' ' ' PHE . 1.3 t80 -58.76 -60.74 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -64.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -161.44 -91.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.921 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.459 ' H ' ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -72.1 111.78 7.63 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.617 HG22 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -140.91 90.8 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.054 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.01 127.08 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.095 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.477 HD23 ' HD3' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -97.65 100.5 11.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 110.951 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 9.3 mp -73.08 110.98 7.77 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.758 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HD3' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -101.14 -4.71 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.703 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.63 -29.33 67.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.272 0.558 . . . . 0.0 111.07 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.31 -17.94 77.07 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.829 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.528 HG12 ' HB3' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -59.54 -26.37 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -170.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -21.93 67.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.793 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.62 5.03 26.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 0.0 110.206 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 83.3 31.47 27.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.109 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.672 ' HG3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -123.78 132.25 53.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.16 0.48 . . . . 0.0 110.89 179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -121.32 132.79 69.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -120.02 105.04 10.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.309 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.574 HD11 HD12 ' A' ' 87' ' ' ILE . 7.0 tp -94.43 118.18 31.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.353 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -95.14 106.21 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.927 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.617 HG12 HG22 ' A' ' 94' ' ' THR . 65.4 mt -117.35 130.28 72.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.402 ' CG ' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER -91.0 134.53 34.42 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.465 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.8 t30 73.58 81.55 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.098 0.874 . . . . 0.0 112.237 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 140' ' ' ILE . 8.4 p -82.09 140.81 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.992 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -117.65 176.51 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.974 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.42 -14.25 18.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.243 0.544 . . . . 0.0 110.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.584 ' HB3' HH21 ' A' ' 66' ' ' ARG . 30.3 t70 -80.58 -24.56 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.692 ' HB2' HG21 ' A' ' 113' ' ' VAL . 4.3 m-20 -86.13 -20.27 28.92 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.698 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.418 ' HB2' HD13 ' A' ' 140' ' ' ILE . 31.2 t0 -63.84 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.069 0.948 . . . . 0.0 112.776 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -153.38 -119.96 0.78 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.944 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 123.41 24.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.721 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -125.02 161.26 27.13 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.404 172.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.57 119.68 24.04 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.298 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -105.0 117.61 34.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.229 173.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.874 HG13 ' HB3' ' A' ' 63' ' ' ARG . 5.1 p -124.11 141.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.226 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.76 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -136.13 121.2 18.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.583 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -135.22 110.2 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 60' ' ' MET . 11.1 p-10 -116.8 95.91 5.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.127 0.965 . . . . 0.0 110.983 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.72 -82.92 1.38 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.693 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -118.87 -23.62 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.55 ' HB3' ' CB ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -97.28 141.34 30.5 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -148.26 145.46 28.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -150.26 132.3 15.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.871 ' HB3' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -128.22 121.56 29.69 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 139.83 49.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.192 0.52 . . . . 0.0 111.16 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -74.85 138.79 20.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.58 175.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.79 160.2 37.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -121.13 135.37 55.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.22 -175.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 43.1 t -104.92 142.46 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.64 118.46 24.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.251 0.548 . . . . 0.0 111.137 -177.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.942 HD11 HG23 ' A' ' 113' ' ' VAL . 1.5 mp -82.77 119.29 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.605 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.73 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 CA-C-O 120.912 0.297 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 52' ' ' SER . 1.7 p90 -71.8 137.32 47.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -119.28 178.86 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.247 0.546 . . . . 0.0 112.36 -171.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' A' ' 51' ' ' LEU . 1.7 p -90.77 147.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.623 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 15.3 t30 -120.44 130.48 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.96 74.34 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.834 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -78.25 111.24 14.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.5 -24.72 67.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.47 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 136' ' ' THR . . . 69.22 -120.55 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.02 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.21 90.18 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.781 2.321 . . . . 0.0 111.66 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.01 117.66 18.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mt -91.2 134.21 34.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.025 0.44 . . . . 0.0 110.811 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.609 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -136.02 172.56 12.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.107 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.55 133.88 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -64.38 124.69 22.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 -177.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.78 -12.17 36.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.304 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.97 -147.33 22.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.223 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -108.25 153.05 23.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.99 0.424 . . . . 0.0 111.228 -176.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 39' ' ' ALA . 1.4 tp -140.95 113.55 8.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.376 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.827 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -92.95 111.86 23.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -95.91 127.53 42.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.817 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.79 43.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 139.72 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -125.66 137.17 53.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.4 mm? -126.22 164.96 19.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.951 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -111.79 80.98 3.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 99.0 Cg_endo -81.74 142.84 12.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.629 2.219 . . . . 0.0 112.882 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 12.6 Cg_exo -71.6 -26.17 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.958 2.439 . . . . 0.0 111.711 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -129.51 -172.14 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.488 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -68.08 -28.66 67.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB1' ' SD ' ' A' ' 60' ' ' MET . . . 63.36 25.51 14.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.619 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -60.66 -33.7 73.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.922 0.392 . . . . 0.0 111.253 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -113.22 28.48 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.694 ' HE2' ' HB2' ' A' ' 127' ' ' ASP . 7.8 ptm -80.21 169.34 17.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 111.49 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.679 ' HG2' HD13 ' A' ' 75' ' ' LEU . 3.5 mt-10 -89.68 121.18 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.16 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -114.98 139.47 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.45 . . . . 0.0 110.231 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -133.67 118.04 17.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.603 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -132.08 61.1 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.2 147.67 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.266 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.795 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.99 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 6.6 m170 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.837 HD12 ' HB2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.99 151.7 33.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.307 0.575 . . . . 0.0 112.367 -173.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -129.2 109.5 11.2 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.837 ' HB2' HD12 ' A' ' 75' ' ' LEU . 3.0 ttt-85 -116.31 89.09 3.03 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.165 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.0 t0 52.85 59.7 4.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.018 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.11 7.84 84.71 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.1 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.81 124.32 50.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.543 -0.387 . . . . 0.0 111.316 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -126.56 152.64 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.22 -158.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.85 0.357 . . . . 0.0 111.563 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -41.63 99.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.14 -30.41 31.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.12 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.99 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.4 pm0 -112.42 13.77 20.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 HG23 ' HD3' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -46.38 112.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.651 0.739 . . . . 0.0 110.257 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 94' ' ' THR . 3.1 tp -69.05 -12.61 16.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.732 -167.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -13.51 58.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.186 0.517 . . . . 0.0 110.282 173.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.468 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -78.92 -16.8 56.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.267 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.44 -33.34 32.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.24 167.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 124.04 0.838 . . . . 0.0 112.213 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 65.01 -105.92 0.13 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.477 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.461 ' HB3' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -127.51 120.79 29.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -171.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.411 HG23 HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -137.15 92.97 2.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.199 175.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.54 116.11 31.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.461 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.98 109.35 20.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.469 HD13 ' HB ' ' A' ' 107' ' ' THR . 12.7 mt -87.37 106.15 17.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HE2' HG23 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -110.73 -3.73 15.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.456 -172.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.29 -12.79 61.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.517 0.675 . . . . 0.0 111.071 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.65 -17.34 70.93 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.43 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.557 HG23 ' HE2' ' A' ' 98' ' ' LYS . 1.7 tt -57.33 -23.27 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.12 -18.99 58.74 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -120.32 7.9 10.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.225 0.536 . . . . 0.0 109.954 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 80.41 43.67 9.25 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.195 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.2 mppp? -126.67 133.05 51.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.466 0.633 . . . . 0.0 110.854 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.508 HG23 ' HZ ' ' A' ' 125' ' ' PHE . 2.8 m -138.49 134.7 43.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.572 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 97' ' ' LEU . 1.1 m -122.54 111.57 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.599 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 110' ' ' ILE . 13.0 tp -103.44 110.83 23.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.827 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -87.33 106.09 17.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.517 176.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.636 HD12 HD21 ' A' ' 108' ' ' LEU . 4.9 mt -111.68 129.63 66.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 44' ' ' ASN . 5.4 m-85 -107.06 155.96 19.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.789 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.6 t30 69.61 54.21 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.297 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.56 124.0 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.727 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.537 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 68.5 p -101.88 168.05 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.31 -26.39 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.528 0.68 . . . . 0.0 110.196 176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.25 -28.49 31.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER -72.84 -25.68 61.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.871 175.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.52 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.1 t70 -63.13 26.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.358 1.063 . . . . 0.0 113.824 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -100.25 -147.65 21.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.566 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -92.3 107.83 19.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.169 0.509 . . . . 0.0 111.352 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.795 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.5 m-85 -73.92 157.45 36.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -126.84 118.29 24.32 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.343 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 10.3 t -99.51 116.72 32.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 28.9 t -136.34 118.71 20.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.213 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.508 ' HZ ' HG23 ' A' ' 106' ' ' VAL . 2.2 m-85 -112.18 128.21 56.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -120.64 117.64 28.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.593 0.235 . . . . 0.0 110.795 -178.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.694 ' HB2' ' HE2' ' A' ' 60' ' ' MET . 21.1 t0 -117.47 93.76 4.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.036 0.445 . . . . 0.0 110.469 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.49 -80.21 0.9 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.095 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.82 -29.36 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -102.9 150.03 23.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.596 -174.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 16.6 p90 -145.51 144.76 30.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 3.7 tp10 -111.82 131.39 55.37 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.55 121.18 28.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.651 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.22 134.58 44.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.047 0.451 . . . . 0.0 110.391 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.75 130.98 35.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.237 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -132.88 102.0 5.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.232 -178.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 2.7 mm-40 -73.77 125.61 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.676 0.274 . . . . 0.0 110.849 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.85 134.38 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -122.89 104.66 9.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.021 0.439 . . . . 0.0 111.795 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 31.2 mt -76.51 96.25 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.177 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.89 ' HB2' ' HB3' ' A' ' 130' ' ' PHE . 30.5 Cg_exo . . . . . 0 CA--C 1.529 0.226 0 CA-C-O 120.914 0.297 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' HD1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -154.19 143.83 21.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.895 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -115.47 169.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.366 0.603 . . . . 0.0 111.314 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 125' ' ' PHE . 2.2 t -120.16 120.58 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.265 -174.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -78.48 132.85 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.95 -175.63 14.11 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.521 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.25 178.89 4.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -57.9 -38.85 76.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.438 . . . . 0.0 109.974 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' HD3' ' A' ' 36' ' ' PRO . . . 74.73 62.39 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.19 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 20.2 Cg_endo -96.22 75.78 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.422 2.748 . . . . 0.0 111.295 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.415 HG13 ' HG ' ' A' ' 47' ' ' LEU . 21.8 t -78.41 93.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.159 0.504 . . . . 0.0 110.761 -177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.689 ' HA ' ' HG3' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -86.67 103.72 15.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.751 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.31 9.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.809 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.52 140.88 37.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -64.25 110.52 2.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.593 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.75 7.86 88.11 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.403 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.48 -160.24 28.01 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.378 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -82.85 110.87 18.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.145 0.498 . . . . 0.0 110.305 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -98.74 123.85 43.22 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.22 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 8.4 mt-10 -126.23 108.7 11.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.149 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD12 HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -96.3 143.95 26.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.193 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.07 114.63 25.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.065 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.594 ' HB2' ' CH2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -118.59 141.17 48.84 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 146.67 49.89 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.29 145.24 50.86 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.371 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -65.87 108.26 2.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 37.6 Cg_exo -60.7 108.98 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.52 2.814 . . . . 0.0 114.587 -167.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 52' ' ' SER . 71.3 Cg_endo -94.43 -22.27 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.083 2.522 . . . . 0.0 111.602 170.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -156.5 -172.23 3.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.573 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 3.0 pt20 -77.87 -17.36 57.43 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.189 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB2' HG12 ' A' ' 101' ' ' ILE . . . 59.01 13.85 3.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.928 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -65.3 -33.28 75.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.073 0.463 . . . . 0.0 110.053 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.91 17.64 19.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.704 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 127' ' ' ASP . 3.5 ttm -84.69 142.52 29.82 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 77' ' ' ARG . 19.5 mt-10 -88.65 142.45 27.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.681 HD11 HD22 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -135.22 131.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.255 0.55 . . . . 0.0 111.12 -178.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' HD3' ' HB2' ' A' ' 75' ' ' LEU . 1.5 ttp180 -110.81 115.39 29.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.594 ' CH2' ' HB2' ' A' ' 49' ' ' CYS . 4.7 t90 -140.64 79.52 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.834 0.35 . . . . 0.0 111.339 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.64 ' HB3' ' HE2' ' A' ' 90' ' ' TYR . 7.1 m-85 -154.75 169.01 24.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.688 ' HD3' ' HA ' ' A' ' 117' ' ' ASP . 9.4 ttp85 . . . . . 0 N--CA 1.447 -0.612 0 C-N-CA 119.683 -0.807 . . . . 0.0 108.934 168.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.8 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.83 0.348 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.91 143.0 27.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.541 -175.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -95.25 111.15 23.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.609 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -112.16 125.58 54.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.878 -171.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 72.26 -10.99 0.84 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.457 0.646 . . . . 0.0 110.948 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.74 17.79 22.49 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -168.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.98 138.3 53.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.214 -0.493 . . . . 0.0 109.973 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.86 161.83 20.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.263 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.514 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.98 148.67 38.96 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.635 -175.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.42 ' O ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -75.72 -16.99 60.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.265 0.555 . . . . 0.0 110.39 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.95 73.81 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.044 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.8 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 1.7 pp20? -105.36 -41.26 5.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.41 0.148 . . . . 0.0 110.666 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 83' ' ' PHE . 48.5 mt 70.1 95.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.843 0.83 . . . . 0.0 111.41 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.796 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 1.8 tt -75.08 -16.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.274 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -12.96 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.704 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -53.73 -28.13 32.43 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.783 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.64 ' HE2' ' HB3' ' A' ' 65' ' ' PHE . 3.1 m-85 -98.06 -33.24 11.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.276 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 77.63 163.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 124.186 0.929 . . . . 0.0 111.663 175.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.478 ' N ' HG11 ' A' ' 91' ' ' VAL . 0.3 OUTLIER 75.65 -167.12 0.08 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.984 177.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -65.9 112.6 3.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.711 HG22 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -126.33 112.18 15.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.333 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.681 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 1.3 pt-20 -137.54 129.73 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.201 0.524 . . . . 0.0 110.629 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.681 HD22 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.98 107.31 19.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.639 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -74.53 99.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.127 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 6.25 49.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.522 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.24 -34.12 63.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.975 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.02 -17.29 65.52 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.962 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.8 HG12 ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.41 -21.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.72 61.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.625 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 3.65 20.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.81 31.62 8.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.726 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.46 132.68 53.5 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.673 0.737 . . . . 0.0 111.389 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.7 133.79 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 O-C-N 122.161 -0.337 . . . . 0.0 110.515 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.98 111.65 19.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.705 HD21 HD12 ' A' ' 47' ' ' LEU . 27.4 tp -86.43 113.42 22.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.681 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 3.3 mpt_? -98.82 106.77 19.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.711 HG12 HG22 ' A' ' 94' ' ' THR . 14.6 mt -127.45 120.78 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -80.79 127.82 32.95 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 83.26 133.95 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.309 1.006 . . . . 0.0 111.213 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -145.02 139.51 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.304 178.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -111.92 172.71 6.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.203 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 p -65.12 -10.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.162 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.91 -50.33 13.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.012 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.688 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -78.11 -9.75 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.784 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -55.0 -22.47 15.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.276 177.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.13 -86.7 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.173 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.19 155.86 43.52 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.604 -0.35 . . . . 0.0 111.004 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' HD1' HG21 ' A' ' 138' ' ' VAL . 1.7 m-85 -103.81 127.51 51.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.451 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 68.6 t60 -76.49 101.67 5.72 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.73 117.32 34.4 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.413 1.071 . . . . 0.0 109.861 -176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.01 116.49 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 0.8 OUTLIER -96.08 112.78 24.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.287 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 2.8 mtpt -119.7 105.0 10.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.95 0.405 . . . . 0.0 110.834 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.593 ' HB2' ' HE1' ' A' ' 60' ' ' MET . 23.3 t0 -111.37 108.36 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.698 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.18 -102.21 0.7 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.87 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.65 -18.15 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.89 ' HB3' ' HB2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.72 135.96 33.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 110.266 -177.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 1.7 p90 -144.76 151.44 38.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.895 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.5 140.67 43.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 124.82 46.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.322 0.582 . . . . 0.0 110.791 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.38 158.84 42.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.583 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -114.62 112.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.969 0.414 . . . . 0.0 110.427 177.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 120.13 19.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.303 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.06 118.7 13.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.006 0.431 . . . . 0.0 110.731 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.551 HG21 ' HD1' ' A' ' 121' ' ' TYR . 1.8 t -105.38 151.58 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.711 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.37 141.06 37.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.71 139.02 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.537 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.473 0.265 0 CA-C-O 121.078 0.366 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -166.19 147.85 6.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.428 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -138.63 169.73 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.554 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 50' ' ' GLN . 54.7 t -90.73 111.88 24.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -87.82 150.17 23.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.44 -156.14 38.7 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.706 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -147.17 137.02 23.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.726 ' HB2' HG22 ' A' ' 136' ' ' THR . 0.0 OUTLIER -96.49 -49.13 5.28 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 -134.59 47.95 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.85 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.84 97.97 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.417 2.744 . . . . 0.0 112.81 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.24 119.53 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.991 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -106.16 132.83 51.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.927 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.16 170.91 18.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.081 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.28 131.29 47.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.828 ' HB3' HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -71.63 142.22 49.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.022 0.439 . . . . 0.0 110.488 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.1 -29.86 10.5 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.21 -153.51 26.27 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.6 p-10 -110.04 135.72 50.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.502 0.668 . . . . 0.0 111.074 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.587 HD12 HG11 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -97.92 110.9 23.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.304 175.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.73 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -97.15 99.62 11.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.96 127.99 42.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -116.7 119.04 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.612 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.645 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -117.06 139.93 50.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.557 ' O ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -127.3 132.68 50.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.875 -174.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -128.48 156.91 42.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.919 175.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -87.52 101.6 2.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.624 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 87.2 Cg_endo -86.54 126.45 2.62 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 114.142 -166.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.17 -27.23 13.97 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.372 2.048 . . . . 0.0 110.665 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.624 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 2.8 pt20 -136.21 178.46 7.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' HG3' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -71.45 -19.78 62.18 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.59 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.89 19.67 9.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.767 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.55 -30.54 65.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.537 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -113.5 17.2 18.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 5.2 mmt -87.74 -166.61 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.748 0.309 . . . . 0.0 111.26 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 30.9 mt-10 -114.54 136.53 52.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.962 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -132.17 146.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.809 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 10.9 ttt-85 -141.23 115.21 9.18 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.645 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -129.89 90.19 2.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.588 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 77.8 m-85 -143.57 164.18 31.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.068 -172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 120.962 0.411 . . . . 0.0 109.933 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 12.0 p-80 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -164.3 152.16 12.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 -174.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.37 115.61 27.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.416 ' HB2' ' HG2' ' A' ' 61' ' ' GLU . 9.4 ttm180 -111.36 123.92 51.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -3.32 2.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.887 0.851 . . . . 0.0 109.828 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.6 25.76 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -120.9 149.87 41.95 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 115.051 -0.575 . . . . 0.0 110.875 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -99.57 169.99 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -158.43 163.23 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.318 . . . . 0.0 110.759 -176.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -13.7 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.35 -47.51 7.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.31 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -72.4 -32.38 66.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.512 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER 50.11 59.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.656 1.217 . . . . 0.0 112.407 176.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 94' ' ' THR . 16.3 tt -67.11 -1.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.025 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -13.95 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.18 0.514 . . . . 0.0 109.891 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -13.68 62.21 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.053 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 74.6 m-85 -109.75 27.05 9.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 77.2 t 77.78 -75.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.811 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 170.69 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.069 0.462 . . . . 0.0 109.851 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -74.24 70.68 1.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -176.064 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.776 HG22 HD12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -131.79 120.54 22.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.046 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 124.8 46.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.471 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.514 HD13 HD13 ' A' ' 108' ' ' LEU . 69.7 tp -102.88 105.79 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.957 0.408 . . . . 0.0 110.168 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.643 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -82.95 117.69 22.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -110.65 10.73 22.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -37.33 83.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.342 0.592 . . . . 0.0 110.068 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.24 79.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.899 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 56' ' ' GLN . 2.0 tt -57.59 -29.72 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.988 0.394 . . . . 0.0 111.657 -172.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.538 ' HA2' ' HG3' ' A' ' 56' ' ' GLN . . . -66.54 -18.3 67.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.129 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 3.95 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.924 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 41.48 6.77 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.621 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -137.77 133.68 34.36 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.292 0.546 . . . . 0.0 111.097 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' SER . 15.9 m -119.36 139.69 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.405 174.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -117.91 104.39 10.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.803 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 64' ' ' TRP . 8.9 tp -93.65 110.23 21.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.73 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 1.5 ttp85 -93.0 106.32 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 94' ' ' THR . 78.0 mt -113.79 106.41 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.147 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -86.83 146.82 26.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 t30 70.0 54.76 0.34 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 123.987 0.804 . . . . 0.0 110.174 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.582 HG23 HD13 ' A' ' 45' ' ' LEU . 12.2 p -78.29 137.56 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.704 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -120.33 162.01 20.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.926 0.393 . . . . 0.0 111.557 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 9.9 p -68.59 -16.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.439 0.638 . . . . 0.0 110.369 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.24 -33.73 76.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.472 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.93 -12.69 14.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.497 -175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.684 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.59 -9.89 1.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.01 -86.2 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.974 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -140.74 118.69 11.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.086 -0.656 . . . . 0.0 111.608 -175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' CD1' HG21 ' A' ' 138' ' ' VAL . 10.9 m-85 -93.55 127.95 39.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.601 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 1.9 m-70 -101.26 127.54 47.81 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 48.1 t -106.16 116.81 32.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.109 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.725 ' HB ' HH11 ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.12 130.2 74.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.4 m-85 -108.12 126.26 52.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.962 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.584 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -116.82 104.91 11.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.815 0.34 . . . . 0.0 110.305 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.546 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 21.8 t70 -111.45 107.0 16.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.946 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.53 -92.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.156 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.51 -20.26 7.85 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -101.65 155.8 17.88 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 -173.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 33.0 p90 -144.67 150.37 37.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.33 133.42 50.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.815 176.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' HG21 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -114.92 121.49 43.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.293 0.568 . . . . 0.0 110.705 -177.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.26 159.15 21.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.757 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.76 108.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.331 0.586 . . . . 0.0 110.875 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.726 HG22 ' HB2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.34 102.0 11.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.857 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.5 OUTLIER -80.54 129.96 34.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 45' ' ' LEU . 84.4 t -102.8 146.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 0.0 110.48 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.1 94.39 4.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.742 176.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.828 HG22 ' HB3' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -78.09 137.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.963 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 96.1 Cg_endo . . . . . 0 N--CA 1.461 -0.409 0 CA-C-O 121.05 0.354 . . . . 0.0 112.407 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CE2' HD22 ' A' ' 51' ' ' LEU . 3.1 p90 -110.77 159.85 17.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.802 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -135.25 179.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.393 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.6 t -115.57 106.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.89 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -112.33 131.14 55.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.445 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.0 -113.39 0.58 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.908 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.83 161.63 20.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.399 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -83.5 -49.03 9.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.935 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.769 ' HA3' HG21 ' A' ' 136' ' ' THR . . . 139.95 87.02 0.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.579 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -94.6 40.6 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.114 2.542 . . . . 0.0 111.282 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.61 119.78 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.274 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.43 139.33 36.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.627 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.63 169.73 17.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.42 144.77 43.31 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.36 111.81 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.17 84.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.329 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.67 -161.8 30.03 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -99.9 146.9 26.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.389 0.614 . . . . 0.0 111.384 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 113' ' ' VAL . 17.8 tp -134.49 119.26 18.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.803 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.97 110.34 22.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 107' ' ' THR . 0.9 OUTLIER -94.36 127.24 40.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 122.83 47.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.527 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.707 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.64 141.22 48.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.423 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -106.78 141.43 38.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.077 0.465 . . . . 0.0 110.634 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.591 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -125.24 136.9 54.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 -176.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 m -97.95 87.64 0.55 Allowed Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 93.5 Cg_endo -91.2 133.05 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.002 2.468 . . . . 0.0 114.365 -165.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.43 4.14 5.19 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.167 2.578 . . . . 0.0 110.488 168.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.45 -176.35 4.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.194 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -89.62 -6.72 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 71.57 -3.35 2.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.662 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.523 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 3.4 mt-30 -61.99 -28.17 69.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.25 16.63 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.08 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.665 ' HE2' ' HB2' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -93.7 170.72 9.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.392 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.86 130.65 56.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -127.4 147.05 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.351 0.596 . . . . 0.0 111.275 -177.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 116.64 22.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.568 ' HB3' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -126.38 64.33 1.25 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 74' ' ' HIS . 82.3 m-85 -142.24 152.18 42.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.727 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.816 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.674 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.188 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.35 126.37 0.42 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.297 0.373 . . . . 0.0 110.33 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.651 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.08 128.16 41.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 138.26 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.23 -170.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 64.09 21.21 12.5 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.611 0.719 . . . . 0.0 110.061 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.54 17.1 72.41 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 168.64 17.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.141 0.496 . . . . 0.0 111.029 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.32 153.52 18.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.324 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 mtt -135.84 153.35 51.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -5.46 29.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.854 0.359 . . . . 0.0 111.062 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.97 -15.75 69.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.093 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.583 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -118.79 -39.83 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.523 0.201 . . . . 0.0 110.49 178.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.583 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 mt 53.92 85.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 111.954 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.674 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 3.5 tt -65.44 -28.57 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.576 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -14.58 52.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.511 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -14.05 43.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.862 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.2 -52.0 18.53 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 92' ' ' GLU . 4.2 p -178.34 175.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.952 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' H ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -85.77 150.27 24.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.764 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER 63.74 64.78 0.76 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.827 -175.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 m -120.87 106.78 11.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.89 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -117.4 118.39 32.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.515 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.57 98.06 11.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mt -72.07 109.2 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 20.2 mtmt -108.11 14.0 25.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.655 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -20.65 66.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.493 0.663 . . . . 0.0 110.512 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.83 -17.21 66.09 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.473 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.672 HG23 ' N ' ' A' ' 102' ' ' GLY . 1.9 tt -51.9 -38.42 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 101' ' ' ILE . . . -66.59 -19.9 69.46 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.373 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.67 22.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.93 45.02 8.63 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.69 133.08 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.185 -0.597 . . . . 0.0 110.642 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.91 132.25 70.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.151 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -123.53 104.19 8.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 64' ' ' TRP . 7.1 tp -88.7 111.89 22.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.26 0.553 . . . . 0.0 110.286 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -90.51 106.49 18.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.739 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.0 mt -114.15 116.57 52.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.764 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 13.3 m-85 -88.77 146.32 25.08 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.815 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.53 62.98 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.911 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -65.97 141.54 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.949 175.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.96 167.42 15.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.949 0.404 . . . . 0.0 111.803 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -70.56 -13.06 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.396 0.617 . . . . 0.0 110.192 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.494 ' HB3' ' NH2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -73.19 -23.61 60.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.94 171.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.91 -11.27 15.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.763 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -62.04 -5.34 2.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.434 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.09 -133.91 1.46 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.658 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.36 124.98 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.191 0.52 . . . . 0.0 111.281 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.816 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 3.3 m-85 -88.22 135.44 33.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.92 119.83 39.27 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.96 0.409 . . . . 0.0 110.02 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.7 t -104.05 118.34 36.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.341 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.11 128.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.206 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 29.3 m-85 -116.21 137.3 52.26 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -140.61 120.97 13.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.126 0.489 . . . . 0.0 110.918 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.665 ' HB2' ' HE2' ' A' ' 60' ' ' MET . 38.9 t70 -132.48 133.87 44.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.451 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.8 -107.55 1.98 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.312 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -120.21 -6.16 9.91 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.71 141.78 35.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 0.0 111.01 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -134.46 154.33 51.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.802 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -133.41 147.27 51.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.031 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -121.35 149.91 42.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.291 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 138.94 18.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.131 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mm -98.62 128.69 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.769 HG21 ' HA3' ' A' ' 35' ' ' GLY . 63.0 m -124.43 109.12 12.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.685 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.98 134.3 37.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.29 124.23 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.147 0.498 . . . . 0.0 110.106 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -98.7 90.7 4.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.56 119.77 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.345 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.46 -0.498 0 N-CA-C 111.16 -0.361 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -167.49 145.22 4.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.7 pt -132.02 176.83 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.799 0.333 . . . . 0.0 110.663 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 50' ' ' GLN . 37.1 t -102.97 113.85 40.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.782 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -94.66 131.83 40.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.163 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.45 -172.16 15.24 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.8 148.66 22.68 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -47.25 13.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.48 116.88 4.26 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.286 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.91 91.93 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.331 2.02 . . . . 0.0 111.189 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.49 100.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.67 113.32 25.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.926 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -125.98 171.52 10.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.289 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.1 m -122.12 143.88 49.27 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.72 135.93 57.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -174.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.09 89.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.861 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.2 168.02 17.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.73 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.1 p-10 -79.84 122.68 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.19 0.519 . . . . 0.0 110.512 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD12 HD22 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -90.39 111.21 22.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.079 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 1.8 mp0 -94.3 105.73 17.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.574 HD22 HD12 ' A' ' 45' ' ' LEU . 2.0 mm? -96.07 128.46 42.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.45 123.62 49.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.701 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.83 140.26 53.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.884 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -130.53 140.71 50.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.84 158.61 37.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.9 m -90.47 98.87 1.65 Allowed Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 10.2 Cg_endo -88.26 125.25 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.371 2.714 . . . . 0.0 114.006 -167.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 73.0 Cg_endo -81.11 -17.81 9.08 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 110.837 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.32 -171.66 2.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.112 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -89.89 -10.92 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 0.0 110.165 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 60' ' ' MET . . . 66.16 -1.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HG3' ' HB2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -57.25 -42.18 81.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.156 0.503 . . . . 0.0 110.915 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -99.92 26.11 6.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.81 ' HG2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -92.17 175.9 6.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.735 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HG2' HD12 ' A' ' 75' ' ' LEU . 41.8 mt-10 -113.64 129.88 56.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.802 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -125.61 129.17 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.349 0.595 . . . . 0.0 111.216 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 20.4 mtp180 -114.45 117.75 31.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.322 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.688 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.69 60.3 1.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.45 ' CE1' HG13 ' A' ' 87' ' ' ILE . 62.8 m-85 -139.59 152.35 46.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.74 0.781 . . . . 0.0 112.859 -166.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.747 ' HB2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.167 168.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 65.5 m170 . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.594 HD12 ' HG2' ' A' ' 61' ' ' GLU . 1.9 pt? -163.76 143.41 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 0.0 112.009 -170.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.63 ' HE1' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.06 129.27 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.041 175.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -131.41 132.24 44.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.337 -175.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.2 t0 58.22 21.59 8.28 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.609 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.52 14.66 81.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.174 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 147.24 45.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.79 0.328 . . . . 0.0 110.688 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.543 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.0 p30 -118.49 169.68 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.88 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.25 152.99 50.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.09 -17.27 63.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.88 84.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.232 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.843 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 1.7 pp20? -117.63 -38.32 3.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.593 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.7 tp 39.06 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.046 1.339 . . . . 0.0 113.82 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.63 HG21 ' HE1' ' A' ' 76' ' ' TYR . 14.2 tt -56.91 -31.27 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.67 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -12.28 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.194 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.25 -30.94 68.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.701 0.286 . . . . 0.0 110.549 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -71.5 -59.03 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 94' ' ' THR . 1.2 p -159.62 153.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.112 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.478 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -56.26 -47.43 78.59 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -175.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -90.71 77.04 6.38 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.34 0.591 . . . . 0.0 110.887 -177.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.539 HG21 HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.45 94.6 4.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.794 177.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.65 120.96 42.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -175.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.55 106.97 19.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.111 0.482 . . . . 0.0 110.835 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mp -77.24 109.3 11.0 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.503 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HD2' HG21 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.53 -13.02 16.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.657 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -19.81 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 110.964 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.16 66.27 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.653 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.449 HG22 ' N ' ' A' ' 102' ' ' GLY . 1.3 tt -58.96 -27.97 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -66.66 -25.45 72.87 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.499 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.46 -2.53 57.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.109 0.48 . . . . 0.0 109.921 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 85.82 19.84 57.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.353 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.459 ' HG3' ' HB2' ' A' ' 50' ' ' GLN . 6.9 mptt -123.52 132.15 53.83 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.065 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.38 133.62 68.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 3.8 m -119.94 112.95 19.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 64' ' ' TRP . 11.4 tp -100.17 117.28 34.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.806 0.336 . . . . 0.0 110.271 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 18.7 mtt180 -94.77 106.87 18.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.631 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.491 HD13 HD21 ' A' ' 47' ' ' LEU . 21.6 mt -111.79 107.08 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -71.72 123.05 21.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.7 t30 81.1 108.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.042 0.839 . . . . 0.0 111.429 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.871 HG22 HD12 ' A' ' 140' ' ' ILE . 10.3 p -110.89 146.68 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.434 173.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.403 ' HB ' ' OD1' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -113.17 151.66 30.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 111.985 -175.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 41' ' ' LEU . 2.9 p -72.49 -14.13 16.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.582 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.403 ' OD1' ' HB ' ' A' ' 114' ' ' THR . 5.4 p-10 -91.76 -19.1 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.933 0.397 . . . . 0.0 110.335 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.52 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.1 OUTLIER -110.36 2.94 19.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.81 25.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -80.68 -159.05 20.34 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.334 -174.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -87.04 111.83 21.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.883 0.373 . . . . 0.0 110.686 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.747 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-30 -68.52 146.0 53.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.333 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.11 114.31 28.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 0.0 110.427 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -100.18 117.73 35.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.529 177.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 63' ' ' ARG . 47.1 t -118.02 109.04 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.116 0.484 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.507 ' HE1' ' HB2' ' A' ' 134' ' ' HIS . 1.1 m-85 -93.73 115.52 27.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.1 mtpm? -109.11 104.89 14.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.729 0.3 . . . . 0.0 110.325 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.77 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 23.7 t0 -118.39 136.53 53.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.588 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.82 -111.73 2.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -113.15 3.05 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 110.816 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 171.23 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.904 0.383 . . . . 0.0 111.353 -174.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 4.0 p90 -148.45 147.93 29.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -122.75 142.8 50.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.6 121.01 39.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 0.0 110.482 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.55 137.37 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.829 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.38 107.42 22.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.4 m -103.96 105.46 15.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 1.1 mm-40 -67.58 122.43 18.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.491 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 45' ' ' LEU . 4.0 t -91.85 147.77 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.98 115.49 17.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 113' ' ' VAL . 1.2 mp -91.94 126.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.173 -176.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo . . . . . 0 C--O 1.233 0.227 0 N-CA-C 113.376 0.491 . . . . 0.0 113.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -133.71 146.42 50.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.435 -174.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.947 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.2 pt -148.56 167.76 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.036 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 132' ' ' GLU . 39.4 t -91.75 140.82 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.663 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -130.79 179.18 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.0 111.108 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.61 -133.45 11.36 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.78 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.96 176.65 5.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.59 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.318 0.386 . . . . 0.0 110.183 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.862 ' HA3' HG21 ' A' ' 136' ' ' THR . . . 134.06 80.66 0.15 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.017 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.83 57.0 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.01 2.474 . . . . 0.0 111.566 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 HG23 HG21 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -82.14 100.85 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.267 -176.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.31 101.32 13.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.393 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.46 169.5 8.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.722 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -120.59 138.06 54.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.79 0.329 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -66.08 130.52 43.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -176.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.24 -5.04 84.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.485 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.97 -168.27 27.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.903 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.58 113.54 19.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 5.3 tp -85.85 114.89 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.82 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.572 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 3.7 mt-10 -110.38 117.42 33.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 0.7 OUTLIER -108.39 128.53 54.85 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.458 ' C ' ' HH2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -116.21 119.89 37.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -178.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.762 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -117.76 140.36 49.78 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.764 ' HG3' ' HD2' ' A' ' 105' ' ' LYS . 1.9 mp0 -115.86 135.75 53.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.294 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -127.35 153.16 46.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.636 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.74 100.36 5.28 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.7 Cg_endo -88.95 116.09 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.913 2.408 . . . . 0.0 113.584 -170.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.7 -13.84 12.99 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.44 2.094 . . . . 0.0 110.917 171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.422 ' HG3' ' CE ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -134.27 -174.19 3.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.727 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HG3' ' H ' ' A' ' 58' ' ' GLN . 25.8 pt20 -74.96 -22.41 58.58 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.963 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.641 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 64.75 10.29 5.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.963 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -68.26 -11.29 59.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -117.47 15.68 14.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.293 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.641 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -82.88 155.28 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.079 0.466 . . . . 0.0 111.722 -172.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.948 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 2.1 mp0 -84.05 151.57 24.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -134.16 137.86 51.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.911 0.862 . . . . 0.0 111.316 -178.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -132.16 116.68 17.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.482 173.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.762 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -144.09 98.05 3.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.181 0.515 . . . . 0.0 110.286 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.604 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.365 0.126 . . . . 0.0 111.12 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.823 HD12 ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.97 150.35 44.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -173.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.6 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 21.6 t80 -117.64 139.64 50.73 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.627 ' HG2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -117.83 147.48 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.177 -174.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -63.9 104.55 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.114 0.483 . . . . 0.0 110.083 177.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 7.71 55.98 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.115 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.627 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -143.26 122.69 13.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.455 0.645 . . . . 0.0 111.241 176.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -110.89 136.98 49.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.425 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -145.59 147.86 32.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.324 -174.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.445 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -71.16 -3.24 18.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 174.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.36 44.89 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.184 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -64.66 -34.43 78.28 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 89' ' ' LYS . 1.1 tt 44.66 51.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.625 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.919 HD12 HG21 ' A' ' 94' ' ' THR . 3.2 tt -65.83 -17.86 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.647 173.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -15.29 62.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.472 174.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.68 -27.62 40.77 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.302 0.572 . . . . 0.0 109.575 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -75.45 -62.65 1.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 93' ' ' ARG . 9.0 p 172.41 136.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.285 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 55.67 2.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.429 0.633 . . . . 0.0 110.158 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.538 ' HB2' HG23 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -139.65 66.92 1.39 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.919 HG21 HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -122.11 151.39 40.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.079 -172.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -137.23 117.14 13.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.307 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 108' ' ' LEU . 15.7 tp -100.82 101.23 12.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -70.34 99.63 1.59 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.729 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HZ2' ' CG ' ' A' ' 78' ' ' ASP . 3.2 mmmt -103.69 1.47 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.261 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -24.83 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.261 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.78 -17.02 64.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.41 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.577 HD12 ' HZ ' ' A' ' 125' ' ' PHE . 3.5 tt -53.51 -37.66 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 101' ' ' ILE . . . -68.98 -15.19 69.11 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.17 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.8 -4.7 21.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.858 0.361 . . . . 0.0 110.244 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.454 ' HA2' HD22 ' A' ' 51' ' ' LEU . . . 92.41 31.27 9.05 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HD2' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -133.51 133.6 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.152 0.476 . . . . 0.0 111.444 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.61 134.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 O-C-N 122.244 -0.285 . . . . 0.0 110.258 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -122.22 114.06 20.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.256 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 96' ' ' LEU . 24.1 tp -94.45 115.5 27.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 4.9 ttp180 -100.01 107.05 18.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 48.2 mt -110.37 118.7 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.91 128.3 34.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.059 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 26.4 t30 72.18 84.97 0.12 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.801 0.688 . . . . 0.0 111.758 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 p -89.53 142.06 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.581 HG21 HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -124.72 171.34 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.9 0.381 . . . . 0.0 111.676 -178.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -23.12 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -171.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.93 -25.84 60.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.514 0.673 . . . . 0.0 109.894 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . 1.7 m-20 -101.27 -4.07 27.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.422 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.402 ' HB2' HG13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -57.96 -11.85 2.77 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.782 175.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.42 -146.73 0.48 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 121.725 0.625 . . . . 0.0 114.578 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -90.11 136.18 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 111.611 -175.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -105.29 123.4 47.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.277 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -84.62 113.73 21.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.894 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 41.9 t -99.73 117.57 34.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 14.8 t -135.07 118.46 24.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.577 ' HZ ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -100.11 143.41 30.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.948 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.85 118.64 27.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.461 ' OD1' ' HE2' ' A' ' 60' ' ' MET . 66.7 t0 -115.03 85.34 2.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.763 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.73 -90.15 0.16 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.94 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.97 -24.47 13.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.79 25.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 110.786 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.07 143.49 38.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.54 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.947 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 7.0 mm-40 -127.45 132.94 49.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 3.7 pt-20 -123.03 142.66 50.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.423 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -136.84 146.55 45.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.656 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.6 mt -97.02 107.99 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.932 0.396 . . . . 0.0 110.374 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.862 HG21 ' HA3' ' A' ' 35' ' ' GLY . 31.5 m -111.01 100.51 9.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.426 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -84.04 135.14 34.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -88.16 150.73 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.044 0.449 . . . . 0.0 110.637 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.84 101.25 7.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.497 HG23 HD13 ' A' ' 41' ' ' LEU . 35.9 mm -74.34 108.42 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.872 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.233 0.256 0 N-CA-C 112.908 0.311 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -101.49 146.98 26.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -142.61 179.21 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.292 0.568 . . . . 0.0 112.257 -170.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.65 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.935 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -105.96 129.75 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.09 -110.24 1.25 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 123.572 0.545 . . . . 0.0 112.149 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mt -146.76 149.86 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 -46.92 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.37 123.13 1.97 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.793 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.63 73.16 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.852 2.368 . . . . 0.0 110.456 172.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.747 HG23 HG13 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -61.11 114.97 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.02 -174.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.81 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.27 173.08 12.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.965 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -112.32 147.17 36.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.63 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -73.15 152.08 41.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.48 -7.07 82.0 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.68 179.63 22.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.181 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -79.82 109.58 14.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 110.325 178.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.626 HD12 HG11 ' A' ' 138' ' ' VAL . 1.0 OUTLIER -86.99 109.75 19.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.203 178.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.689 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.4 mt-10 -94.25 96.06 9.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.615 HD23 ' CZ2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -104.98 129.51 53.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.775 -175.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -118.07 138.84 51.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 m -117.78 140.2 50.01 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.39 131.85 56.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 110.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -125.4 159.32 32.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.5 -177.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.2 86.5 6.38 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 30.3 Cg_endo -88.39 153.54 6.6 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.806 2.338 . . . . 0.0 112.55 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 7.2 Cg_exo -73.55 -28.04 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.767 2.311 . . . . 0.0 111.742 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.83 -172.49 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -69.4 -8.27 45.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.137 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.74 29.41 18.99 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.107 0.563 . . . . 0.0 112.276 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.49 -42.55 78.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.449 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -101.27 25.0 8.72 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 111.347 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 16.2 ttm -68.88 131.84 45.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.162 0.506 . . . . 0.0 111.457 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.616 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -88.05 143.89 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.558 HG13 ' HB3' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -134.95 148.96 28.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.828 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 3.2 ttp85 -128.74 115.64 18.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.615 ' CZ2' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -126.65 87.7 2.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' HE1' HD12 ' A' ' 87' ' ' ILE . 94.4 m-85 -153.61 148.57 26.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.899 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HD3' ' HB2' ' A' ' 117' ' ' ASP . 41.9 ttt-85 . . . . . 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 165.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -138.77 144.35 39.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.659 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.619 ' HE2' HD13 ' A' ' 87' ' ' ILE . 2.7 t80 -100.57 115.11 29.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.52 121.32 44.85 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.085 -168.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.8 t70 64.94 14.16 9.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.148 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.679 ' HA2' HD22 ' A' ' 96' ' ' LEU . . . 89.82 14.05 60.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.741 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -129.05 148.71 51.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 139.02 50.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.934 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.533 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -105.48 -172.89 2.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -75.53 -9.22 58.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.867 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -55.28 3.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.789 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 82' ' ' MET . 6.9 pm0 -74.77 -37.82 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 122.716 0.406 . . . . 0.0 110.446 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 85' ' ' GLU . 3.0 tp 43.44 97.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.643 1.177 . . . . 0.0 113.421 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 76' ' ' TYR . 2.5 tp -62.89 -18.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.167 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -14.22 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.665 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -66.14 -29.67 70.01 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.045 177.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.68 -71.2 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.512 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.99 141.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.01 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.802 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -161.12 65.77 0.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.55 HG23 HD11 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -127.72 119.16 25.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.223 -174.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.12 99.97 7.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.699 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.679 HD22 ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -86.08 111.39 20.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.186 0.517 . . . . 0.0 110.488 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.71 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.2 mp -81.72 112.94 19.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.912 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.05 1.85 56.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.094 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.31 -33.59 63.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.332 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.19 -16.9 65.98 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.814 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -53.53 -31.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -62.48 -25.4 66.97 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.435 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.2 13.68 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.979 0.419 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.34 43.66 12.53 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.451 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -129.82 133.19 46.79 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.279 -0.542 . . . . 0.0 110.784 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 48' ' ' SER . 14.3 m -121.96 132.96 69.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -116.4 102.86 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.727 178.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 64' ' ' TRP . 4.6 tp -96.05 111.52 23.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.098 0.475 . . . . 0.0 110.195 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.689 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -86.42 106.26 17.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.542 174.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.449 HG13 ' HG ' ' A' ' 108' ' ' LEU . 50.0 mt -112.54 112.76 41.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.624 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 59.6 t80 -80.14 129.76 34.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 35.5 t30 76.23 79.6 0.09 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.914 0.759 . . . . 0.0 111.76 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 41' ' ' LEU . 10.2 p -84.96 149.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 168.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.25 165.52 14.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.964 0.411 . . . . 0.0 111.964 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.3 -28.95 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.13 -43.27 87.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.518 ' HB2' ' HD3' ' A' ' 66' ' ' ARG . 3.6 p-10 -104.17 4.09 33.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.616 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -62.5 -10.38 11.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 176.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.7 -118.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.931 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.2 124.97 35.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.257 0.551 . . . . 0.0 111.765 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 136' ' ' THR . 50.2 p90 -110.92 164.77 12.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.774 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 113.33 24.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.3 t -104.92 122.37 45.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.828 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 97.8 t -131.95 139.24 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.047 -175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.504 ' CZ ' HG22 ' A' ' 106' ' ' VAL . 23.2 m-85 -119.31 140.5 50.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.71 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -130.75 105.04 7.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.653 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 60' ' ' MET . 43.0 t0 -98.5 74.37 2.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.39 -93.36 0.89 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.3 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -97.79 -27.97 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.742 0.306 . . . . 0.0 111.714 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -96.81 143.18 27.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.922 0.391 . . . . 0.0 110.4 -177.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.71 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -138.02 142.77 40.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.395 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -122.44 131.91 54.1 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.486 ' HA ' HG22 ' A' ' 124' ' ' VAL . 8.8 mt-10 -114.36 119.92 38.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 132.19 55.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.158 0.504 . . . . 0.0 111.12 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.5 107.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.576 175.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -120.52 160.66 22.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 139.51 53.83 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.226 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.747 HG13 HG23 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -83.0 150.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -112.58 90.89 3.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mp -80.76 123.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.918 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 N--CA 1.454 -0.824 0 CA-C-O 120.976 0.323 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HE1' ' HA ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -74.83 140.45 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -122.07 168.12 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -170.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HB ' ' CE1' ' A' ' 134' ' ' HIS . 67.0 t -91.35 132.46 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.188 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.46 132.25 55.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.72 -107.31 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.749 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.43 168.39 21.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -175.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -48.63 7.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 111.82 2.53 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.927 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.57 86.87 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.569 2.179 . . . . 0.0 111.355 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -72.28 101.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.323 -176.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.754 HD23 ' HD3' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -87.22 119.72 27.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 171.82 13.8 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.003 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -98.67 133.98 42.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.3 123.42 17.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.85 0.357 . . . . 0.0 111.034 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.434 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 94.44 1.22 64.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.04 -174.42 33.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.214 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.573 ' HB2' ' HD1' ' A' ' 111' ' ' PHE . 10.3 t30 -93.88 119.8 33.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.36 . . . . 0.0 110.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.61 HD12 HG23 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -98.23 122.23 41.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.867 -177.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.766 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -97.17 101.68 13.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.683 174.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 1.1 mp -96.58 127.25 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.49 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -117.63 130.18 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.74 140.19 50.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -110.99 131.34 55.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.138 0.494 . . . . 0.0 110.604 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.54 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.24 154.88 44.31 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.376 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.425 ' N ' HD11 ' A' ' 51' ' ' LEU . 1.4 m -87.27 101.24 2.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.9 Cg_endo -76.41 114.31 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.751 2.3 . . . . 0.0 113.74 -170.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.9 -21.05 9.88 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.44 2.094 . . . . 0.0 110.602 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -171.66 2.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.466 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -68.83 -18.06 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -177.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 56.99 32.32 21.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.261 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.59 -33.81 74.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.722 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -93.39 9.61 35.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 146.68 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.314 0.578 . . . . 0.0 111.39 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -92.68 102.63 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 HG23 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -105.78 130.01 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.689 0.757 . . . . 0.0 111.255 -174.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.586 HH11 HG21 ' A' ' 124' ' ' VAL . 8.1 ttm180 -113.94 117.1 30.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.681 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.885 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.86 55.43 1.45 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.81 167.42 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.324 0.583 . . . . 0.0 112.192 -164.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' CD ' ' HB3' ' A' ' 117' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.24 174.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.86 143.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.556 0.535 . . . . 0.0 110.7 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' HH ' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.21 114.8 28.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.168 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -97.76 120.51 38.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -176.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t70 67.44 14.03 9.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.85 0.833 . . . . 0.0 109.969 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.44 70.72 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.595 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -122.99 151.68 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -101.01 169.32 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.264 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.675 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 2.8 ptt? -140.06 161.33 37.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.79 -27.71 69.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.28 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.17 -5.61 89.04 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.648 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.675 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -111.24 -40.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.6 OUTLIER 37.58 80.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.249 1.02 . . . . 0.0 112.929 177.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.586 HD13 ' HB ' ' A' ' 94' ' ' THR . 14.8 tt -64.04 -19.79 25.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.125 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -13.73 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.552 175.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -66.27 -29.84 70.15 Favored 'General case' 0 CA--C 1.524 -0.037 0 CA-C-O 121.019 0.438 . . . . 0.0 110.234 178.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -52.87 7.99 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.692 HG12 HG21 ' A' ' 94' ' ' THR . 7.3 p 176.4 159.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.317 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -79.34 -25.01 42.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -80.53 66.44 6.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.559 173.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.767 HG22 HG12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.18 89.27 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.66 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -104.87 112.33 25.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.111 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.91 101.77 14.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -75.08 107.21 7.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 1.66 49.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.791 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.23 -29.19 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.16 -16.9 70.76 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.0 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 56' ' ' GLN . 4.8 tp -55.54 -25.53 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.5 -21.12 70.42 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.903 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.26 13.33 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.316 0.579 . . . . 0.0 109.581 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.36 27.13 66.4 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.758 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.87 132.04 56.65 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.968 -0.724 . . . . 0.0 110.84 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.05 131.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -124.08 103.81 8.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.284 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' A' ' 64' ' ' TRP . 9.0 tp -94.86 117.63 30.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.93 0.395 . . . . 0.0 110.336 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.766 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -96.22 107.48 19.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.566 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.767 HG12 HG22 ' A' ' 94' ' ' THR . 53.3 mt -116.28 121.4 67.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.573 ' HD1' ' HB2' ' A' ' 44' ' ' ASN . 22.0 t80 -83.17 130.99 35.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.434 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 56.7 t30 71.78 84.38 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.162 174.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.61 HG23 HD12 ' A' ' 45' ' ' LEU . 90.4 t -102.08 131.92 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.018 171.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.19 177.24 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.94 -29.95 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -171.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -40.62 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.338 0.59 . . . . 0.0 110.276 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -88.47 -7.9 55.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.277 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.66 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -63.88 -21.75 66.6 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.81 177.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.07 -110.05 0.08 OUTLIER Glycine 0 C--O 1.243 0.674 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.928 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.72 120.4 25.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.127 -0.536 . . . . 0.0 111.671 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.21 137.36 44.3 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -105.33 115.7 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -105.98 116.27 31.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.121 175.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.586 HG21 HH11 ' A' ' 63' ' ' ARG . 85.6 t -134.64 121.54 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.505 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.2 m-85 -111.22 113.39 25.85 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 104.37 9.73 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.546 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -105.28 89.34 3.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.21 -82.55 0.13 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.012 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.31 8.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.07 140.22 34.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 40.2 p90 -147.61 142.9 27.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.408 . . . . 0.0 111.06 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.673 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.99 137.8 41.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.745 176.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -122.12 121.26 36.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.954 0.407 . . . . 0.0 110.436 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.54 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -119.36 144.88 46.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.43 108.27 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.07 160.29 14.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.45 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -127.47 135.64 50.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.291 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.58 HG11 ' N ' ' A' ' 139' ' ' LYS . 23.9 t -98.37 147.1 7.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.754 ' HD3' HD23 ' A' ' 38' ' ' LEU . 1.3 mtpt -120.88 90.22 3.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -75.0 133.66 31.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.223 0.535 . . . . 0.0 109.886 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.84 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 N--CA 1.446 -1.266 0 CA-C-O 120.72 0.217 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -156.63 165.18 37.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.86 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pt -134.75 165.66 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.887 0.375 . . . . 0.0 110.547 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 132' ' ' GLU . 95.4 t -91.05 127.27 43.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.411 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.18 179.56 4.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -175.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.45 -133.9 11.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.07 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.42 172.84 6.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 35' ' ' GLY . 1.8 pm0 -69.0 -29.49 67.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 109.39 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.684 ' HA3' HG22 ' A' ' 136' ' ' THR . . . 117.38 72.68 0.46 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.363 173.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.95 52.74 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.497 2.131 . . . . 0.0 111.101 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.57 104.51 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.499 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.55 137.77 32.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . . . -133.76 170.69 15.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.609 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -119.57 138.32 53.28 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.735 -178.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.33 111.08 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.15 8.53 87.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.013 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' A' ' 40' ' ' SER . . . -103.92 -147.55 17.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.98 143.78 41.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 10.3 tp -127.76 118.94 24.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.175 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.39 107.01 18.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.154 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.75 127.71 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 123.75 39.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.01 0.433 . . . . 0.0 111.103 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.25 50.06 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.82 160.01 18.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.249 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -127.64 148.71 50.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.035 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 89.67 0.31 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 162.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 14.3 Cg_exo -67.81 115.21 3.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 2.729 . . . . 0.0 114.248 -162.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.27 -32.98 2.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.874 2.383 . . . . 0.0 110.129 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -146.34 -172.78 4.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.344 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.32 -21.89 59.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 55.57 24.54 7.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -42.42 90.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.189 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.11 5.32 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.607 ' CG ' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -80.22 174.94 11.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -169.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.094 ' HB3' HD12 ' A' ' 75' ' ' LEU . 48.7 mt-10 -106.24 143.63 34.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.448 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -118.89 134.04 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 168.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.623 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -149.54 59.69 1.01 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -137.89 152.37 48.96 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.715 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.4 tpt85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.732 0.777 . . . . 0.0 109.375 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 1.01 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 1.094 HD12 ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -149.22 143.6 26.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.475 -169.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.623 ' HB3' HG21 ' A' ' 62' ' ' ILE . 4.6 t80 -94.44 114.63 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.217 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.75 163.71 35.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.322 -0.151 . . . . 0.0 110.845 -173.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t0 68.69 6.93 5.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.669 0.747 . . . . 0.0 109.93 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.76 -6.15 62.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.439 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 pttp -144.69 179.79 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.081 0.467 . . . . 0.0 111.266 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.9 168.09 19.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.717 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.642 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -134.0 143.27 48.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.797 0.332 . . . . 0.0 111.242 -175.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.36 -23.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 0.0 110.941 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.95 -32.57 77.49 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.399 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 1.01 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 2.0 pp20? -95.2 -30.06 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 HG21 ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER 47.6 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.676 1.19 . . . . 0.0 113.667 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.534 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 8.5 tp -77.8 -7.93 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.123 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -13.45 7.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.713 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -69.56 -26.83 64.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.523 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -72.36 0.32 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.51 -174.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.829 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -92.04 -23.45 19.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.848 0.356 . . . . 0.0 110.302 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.855 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -106.97 88.94 2.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.301 0.572 . . . . 0.0 111.268 -178.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 95.61 5.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.292 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 23.3 tt0 -103.1 98.93 8.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.621 -171.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 117.73 35.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.118 0.485 . . . . 0.0 110.932 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -89.96 109.54 20.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.194 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.14 -10.47 14.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.633 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -17.97 65.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.145 -177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.93 80.33 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.178 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.627 HD13 ' CZ ' ' A' ' 125' ' ' PHE . 5.9 tt -57.56 -29.04 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 122.707 0.403 . . . . 0.0 111.709 -174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -63.49 -20.88 64.04 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.658 178.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.13 4.7 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.166 0.507 . . . . 0.0 110.211 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.08 42.17 8.96 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.711 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 132.64 40.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.818 0.309 . . . . 0.0 110.538 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.79 132.33 59.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.253 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -123.02 124.46 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.461 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 64' ' ' TRP . 40.8 tp -112.11 111.9 23.13 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -96.03 105.95 18.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.81 132.09 51.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.855 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 1.5 m-85 -95.99 143.44 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.0 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.4 t30 67.15 84.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.12 128.67 46.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.007 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.9 p -96.84 175.52 6.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.04 -16.8 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.602 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.43 -44.81 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 41.0 m-20 -65.8 -25.19 67.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.602 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.652 ' HB2' HD13 ' A' ' 140' ' ' ILE . 17.8 t70 -55.36 -17.42 4.83 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.479 ' HA3' ' HE ' ' A' ' 66' ' ' ARG . . . -71.82 -156.96 2.84 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.11 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -78.29 105.94 9.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.923 0.392 . . . . 0.0 111.729 -176.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.623 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -73.97 144.45 45.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 114.02 27.19 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.474 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 51.2 t -97.38 117.06 30.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.518 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 10.6 t -131.6 105.11 9.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.627 ' CZ ' HD13 ' A' ' 101' ' ' ILE . 21.8 t80 -97.82 139.2 34.03 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.186 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.714 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.0 mtpt -122.12 104.58 9.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.219 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.607 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 17.6 t0 -106.71 138.4 42.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.447 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.86 -110.61 1.76 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.96 11.52 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 159.7 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 4.9 p90 -140.67 153.43 45.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.88 0.372 . . . . 0.0 111.17 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.86 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -142.45 157.35 44.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.592 178.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -133.38 154.44 50.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.242 0.544 . . . . 0.0 112.22 -172.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.86 124.55 14.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.167 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.94 108.95 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.433 . . . . 0.0 110.247 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.684 HG22 ' HA3' ' A' ' 35' ' ' GLY . 99.0 m -122.29 102.34 8.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.745 -176.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 5.3 pt-20 -82.84 141.96 31.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.463 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.591 HG11 ' N ' ' A' ' 139' ' ' LYS . 89.6 t -86.82 151.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.591 ' N ' HG11 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -113.63 92.29 3.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 174.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -71.75 120.33 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.251 1.164 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.572 -174.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 CA-C-O 120.656 0.19 . . . . 0.0 111.909 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.842 ' HE2' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.43 158.0 16.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 177.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.614 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.5 pt -129.25 167.93 23.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.727 HG22 ' HB3' ' A' ' 132' ' ' GLU . 44.3 t -91.1 144.7 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.83 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.09 161.31 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.604 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -171.15 28.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.536 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.21 176.85 4.86 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -49.8 73.73 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.158 0.286 . . . . 0.0 110.829 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.56 81.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.518 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.82 89.93 0.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.575 2.183 . . . . 0.0 111.061 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.55 124.78 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.409 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -88.77 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.014 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.41 170.58 9.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -120.98 145.07 48.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -62.57 119.04 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.074 0.464 . . . . 0.0 110.586 -177.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 90.76 -7.33 81.41 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.322 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.11 -176.35 49.04 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.528 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -87.61 115.65 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -108.12 118.65 37.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.407 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.91 112.24 24.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.372 177.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.6 128.1 42.19 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.28 128.5 52.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 140.49 52.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.461 ' O ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -118.82 145.26 45.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.48 -178.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.842 HD23 ' HE2' ' A' ' 28' ' ' PHE . 4.6 mt -117.75 164.37 15.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.71 85.36 0.55 Allowed Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 165.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.562 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 11.7 Cg_exo -68.39 119.2 6.21 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.233 2.622 . . . . 0.0 113.929 -162.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 -31.95 4.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.757 2.304 . . . . 0.0 110.098 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.99 -172.64 3.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.667 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -71.23 -15.93 62.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HA ' ' HE2' ' A' ' 60' ' ' MET . . . 59.46 17.05 5.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -64.3 -22.56 66.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.126 0.489 . . . . 0.0 111.22 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -115.14 24.18 11.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.318 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.654 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -86.55 169.9 12.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -178.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 12.0 tt0 -101.79 123.68 46.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.089 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.37 137.7 45.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.399 0.619 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.666 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 8.0 mtt180 -134.41 116.95 15.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.806 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.737 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -136.85 73.48 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -177.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -149.28 169.69 20.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.184 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-O 121.309 0.576 . . . . 0.0 110.993 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.666 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 82' ' ' MET . 0.1 OUTLIER -161.68 113.72 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -143.42 109.58 5.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 159.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.3 122.68 26.85 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.037 -0.414 . . . . 0.0 111.447 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 56.57 41.01 29.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.151 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.08 24.89 65.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.857 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.1 tptt -145.6 129.63 17.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.836 0.351 . . . . 0.0 111.049 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.26 163.36 17.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.681 ' HB2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -123.34 161.92 23.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.677 ' HA ' HG13 ' A' ' 86' ' ' ILE . 23.9 m-85 -62.24 -20.79 64.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.081 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.49 99.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.246 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.645 ' OE1' ' HA ' ' A' ' 74' ' ' HIS . 3.9 tp10 -104.15 -43.19 5.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.677 HG13 ' HA ' ' A' ' 83' ' ' PHE . 6.2 mt 61.09 109.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 122.037 0.922 . . . . 0.0 112.294 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.2 tp -72.38 -19.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.165 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -14.29 49.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.377 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -72.29 -26.09 61.84 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.403 0.621 . . . . 0.0 109.666 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.546 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 29.4 m-85 -92.23 -65.33 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.215 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p 166.73 153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.2 60.25 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.288 177.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 1.1 mmp_? -145.98 60.69 1.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.7 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -125.46 164.5 20.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.105 -174.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.51 135.76 13.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.588 173.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 108' ' ' LEU . 4.2 tp -108.26 94.29 4.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.809 0.338 . . . . 0.0 110.108 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -70.45 108.76 4.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 109.707 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HG2' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -107.07 6.59 29.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 -176.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.11 -25.91 68.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.012 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.0 -16.8 66.63 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.266 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -53.79 -28.23 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -61.88 -26.71 67.47 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.072 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.53 15.31 19.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 109.857 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.562 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 76.83 43.2 18.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.462 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.275 0.537 . . . . 0.0 110.603 176.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.853 HG21 ' HE2' ' A' ' 125' ' ' PHE . 15.4 m -131.05 139.51 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -126.96 106.43 9.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 96' ' ' LEU . 13.9 tp -90.27 107.59 19.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.146 0.498 . . . . 0.0 110.121 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.573 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -84.79 107.43 16.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.552 178.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.5 mt -116.88 111.35 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.838 0.351 . . . . 0.0 110.498 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 23.9 t80 -81.44 137.04 35.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.548 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 53.9 t30 77.9 75.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.917 0.761 . . . . 0.0 111.71 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 140' ' ' ILE . 9.9 p -78.88 148.73 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 173.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -113.1 164.58 13.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.207 0.527 . . . . 0.0 112.118 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 7.7 p -66.69 -25.35 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.078 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 5.0 t70 -73.57 -34.22 65.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 175.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -78.79 -19.28 52.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.497 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.597 ' HB2' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -54.69 -15.96 2.19 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.633 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.52 -130.98 0.98 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.726 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -94.95 121.4 36.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.073 0.463 . . . . 0.0 111.61 -177.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.737 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.3 m-85 -87.68 142.97 27.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.565 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.75 118.76 35.21 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.186 0.517 . . . . 0.0 111.026 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 37.1 t -100.45 120.67 40.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.195 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.19 121.09 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.853 ' HE2' HG21 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -115.68 137.23 52.28 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.33 -178.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.929 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 20.4 mtpt -121.29 111.71 17.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.654 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 14.8 t70 -101.91 111.84 24.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.99 -105.93 1.69 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.035 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.03 -7.92 9.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.661 ' HD1' ' HD1' ' A' ' 28' ' ' PHE . 3.2 p90 -100.23 148.82 24.21 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.417 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.929 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 4.0 p90 -133.74 151.99 51.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.273 0.559 . . . . 0.0 112.017 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 30' ' ' VAL . 1.6 mm-40 -128.89 156.83 43.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.8 174.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -133.53 142.57 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.392 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -129.09 133.65 47.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.056 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.98 107.91 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.81 0.338 . . . . 0.0 110.498 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.565 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 51.7 m -117.68 118.3 31.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.624 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -77.7 134.85 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.422 HG12 HD11 ' A' ' 140' ' ' ILE . 9.8 p -93.61 149.86 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 38' ' ' LEU . 1.6 tttm -114.02 96.08 5.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.761 0.315 . . . . 0.0 110.745 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 118' ' ' ASP . 1.1 mp -76.3 118.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.492 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 130' ' ' PHE . 13.0 Cg_exo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.96 0.316 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.646 ' HZ ' ' HB3' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -143.65 141.69 30.68 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pp -139.09 178.38 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 110.956 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 134' ' ' HIS . 71.9 t -106.49 145.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.422 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -75.44 144.2 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.802 0.334 . . . . 0.0 110.452 -179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.62 60.95 4.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.736 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.79 109.74 8.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.672 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 4.3 mp0 -77.25 -49.13 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.8 91.4 0.17 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.52 95.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.553 2.835 . . . . 0.0 112.987 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -81.73 97.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.998 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.8 101.76 13.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.417 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.613 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . . . -111.21 170.81 7.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.633 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.0 m -130.56 141.36 50.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 128.08 35.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.31 -23.89 22.22 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.65 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.3 174.67 52.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.7 138.9 39.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -118.1 122.11 42.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.942 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.597 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 6.4 mt-10 -102.52 108.02 19.18 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.542 HD12 HD21 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -95.3 128.38 42.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.328 -176.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.22 129.59 55.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.746 -174.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -138.26 140.11 39.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 131.52 52.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.922 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -111.35 165.0 12.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.367 -173.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -124.92 72.26 63.05 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.398 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.3 155.88 3.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.215 2.61 . . . . 0.0 113.207 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 35.4 Cg_endo -92.55 14.51 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.413 2.742 . . . . 0.0 112.108 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -137.09 -173.03 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.725 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.24 -16.77 34.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.217 175.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 60.72 13.14 4.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.99 174.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.668 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 4.1 tm0? -56.34 -40.78 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 3.0 p80 -115.51 21.96 13.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.031 0.443 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -74.07 -173.52 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -177.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.642 ' HG3' ' HB2' ' A' ' 77' ' ' ARG . 1.3 tt0 -103.81 118.21 36.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.965 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.89 62.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.0 111.92 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' CYS . 7.8 ttt85 -102.25 132.72 48.02 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.458 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -144.89 59.56 1.31 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -142.95 157.98 44.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.352 0.596 . . . . 0.0 111.864 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.819 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 165.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 2.0 m80 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -164.84 149.81 9.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.574 -173.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.95 118.32 32.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.725 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.642 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -132.12 137.71 47.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.113 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' A' ' 59' ' ' HIS . 4.2 m-20 63.07 17.03 9.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.288 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 15.24 70.43 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.481 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -136.59 143.16 43.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 0.0 110.527 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 8.8 p-10 -85.88 137.78 32.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.51 ' HE1' ' HG2' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -82.74 155.91 24.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.042 -176.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -40.21 80.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.215 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.6 0.91 79.93 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.79 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -105.54 -43.18 5.01 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.595 -0.356 . . . . 0.0 110.22 178.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 27.67 84.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.461 1.101 . . . . 0.0 113.019 -178.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 94' ' ' THR . 16.1 tt -62.65 -11.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.557 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -12.34 58.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -13.9 14.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -78.37 7.37 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.13 -0.356 . . . . 0.0 110.751 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.0 33.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.332 0.653 . . . . 0.0 111.657 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -170.71 -164.16 0.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 178.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -79.46 143.02 35.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -139.62 104.04 4.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.953 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -114.88 108.21 16.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.532 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 108' ' ' LEU . 39.5 tp -84.72 109.8 18.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.945 0.403 . . . . 0.0 110.846 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -79.6 105.65 11.06 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -102.13 9.94 39.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.88 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -27.09 67.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.522 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.72 -16.75 65.11 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.172 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.561 HG21 ' N ' ' A' ' 102' ' ' GLY . 0.7 OUTLIER -54.21 -33.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -170.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' HG21 ' A' ' 101' ' ' ILE . . . -70.55 -11.02 67.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.073 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 6.05 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.16 26.55 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.55 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.18 133.08 38.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.384 -0.48 . . . . 0.0 110.796 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.11 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.855 0.359 . . . . 0.0 110.557 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -126.19 105.92 9.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.151 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 96' ' ' LEU . 13.8 tp -90.78 118.13 29.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.597 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -86.88 106.61 17.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.691 175.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 108' ' ' LEU . 56.4 mt -111.37 121.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -82.25 136.03 35.14 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.5 t30 68.59 91.66 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.431 0.634 . . . . 0.0 111.621 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.5 120.71 31.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.4 150.3 24.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.736 -176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.95 -22.57 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.23 -35.96 58.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.214 0.53 . . . . 0.0 109.818 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.09 5.52 46.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.73 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.34 -4.27 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.916 176.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -134.42 0.52 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.0 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -102.17 127.86 48.91 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.343 -0.504 . . . . 0.0 111.032 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.819 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 40.7 m-85 -82.93 151.94 25.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.07 110.41 18.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.783 0.325 . . . . 0.0 111.034 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.5 OUTLIER -98.6 117.15 32.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 t -118.6 107.36 21.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.646 ' HB3' ' HZ ' ' A' ' 28' ' ' PHE . 2.7 t80 -99.26 133.67 43.22 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.777 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -121.53 110.82 16.49 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.12 72.05 5.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.97 -96.82 1.6 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.178 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.33 -27.32 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 111.311 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' HB2' ' HD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -94.48 143.31 26.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 52.4 p90 -146.88 151.08 36.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.49 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -147.53 143.68 27.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.96 41.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.145 0.498 . . . . 0.0 110.753 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.672 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 52.0 t-80 -129.82 138.83 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.61 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.444 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -104.06 107.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.5 m -99.7 107.76 19.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.438 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -75.71 122.73 24.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 -178.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -96.18 150.71 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 110.82 12.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.302 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 118' ' ' ASP . 8.9 mt -76.77 102.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 110.436 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.461 -0.411 0 CA-C-O 120.909 0.295 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -153.71 136.66 15.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.559 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.1 pt -144.53 165.8 12.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.617 0.723 . . . . 0.0 112.062 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 31' ' ' ASN . 56.0 t -97.6 149.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.182 171.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 30' ' ' VAL . 11.3 t-20 -67.07 150.59 48.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.85 63.41 3.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.264 -0.493 . . . . 0.0 113.344 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 tp -139.51 132.4 29.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -85.9 -31.7 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.262 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.59 90.51 0.8 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.807 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.16 80.55 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.808 2.339 . . . . 0.0 110.97 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.53 92.42 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -89.39 110.09 20.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.773 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HB1' HD13 ' A' ' 45' ' ' LEU . . . -120.19 171.97 8.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.137 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.05 133.55 36.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.789 ' HB2' HG21 ' A' ' 140' ' ' ILE . 3.1 tp -66.62 111.69 3.77 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.944 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.464 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.6 11.49 74.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.819 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.38 -152.01 9.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.919 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -87.45 134.25 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.413 . . . . 0.0 111.112 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -119.93 115.44 23.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.519 176.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.5 mt-10 -108.19 110.08 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 110.748 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -96.69 129.22 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.346 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.26 122.16 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.888 0.375 . . . . 0.0 110.632 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.66 140.02 50.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -120.1 130.1 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.109 0.481 . . . . 0.0 110.131 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 30' ' ' VAL . 3.7 mm? -117.72 165.22 13.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.047 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.49 71.6 26.77 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 94.6 Cg_endo -89.48 154.61 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.013 2.475 . . . . 0.0 113.322 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.6 Cg_exo -70.44 -25.54 25.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.003 2.469 . . . . 0.0 111.964 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.21 -173.26 3.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.939 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -22.51 42.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 60' ' ' MET . . . 54.22 32.97 17.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -32.0 66.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.791 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -115.46 28.96 8.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.866 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.918 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -91.73 -165.6 1.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.289 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.474 ' HG2' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.8 126.66 53.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 110.745 -178.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -126.49 146.57 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.243 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.608 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 10.0 ttm180 -132.52 117.37 17.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.36 58.34 1.73 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CE1' HG13 ' A' ' 87' ' ' ILE . 59.4 m-85 -139.38 150.66 45.57 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.676 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -178.69 151.55 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.228 0.537 . . . . 0.0 111.472 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.35 117.52 30.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -127.46 143.1 51.24 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.784 -172.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.62 17.51 10.62 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.827 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.5 83.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.057 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -139.66 177.15 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 111.285 -178.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -95.41 170.07 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.112 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.52 138.96 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.945 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.84 -4.7 36.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.649 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.62 -16.42 70.84 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.781 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.635 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -111.94 -40.96 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.244 -177.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.635 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 76.6 mt 49.15 87.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 112.235 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -74.22 -6.46 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -14.84 27.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 173.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -21.85 64.1 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.899 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.437 ' HD2' HG23 ' A' ' 91' ' ' VAL . 3.0 t80 -85.58 -69.05 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.437 HG23 ' HD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -162.63 145.69 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.228 173.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -72.53 -7.86 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.348 0.594 . . . . 0.0 110.206 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.693 ' HA ' HH11 ' A' ' 93' ' ' ARG . 2.3 mmm180 -97.19 69.32 2.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.158 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.735 HG22 HD11 ' A' ' 108' ' ' LEU . 21.3 m -131.41 103.97 6.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.634 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.75 106.93 17.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.611 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 96' ' ' LEU . 1.1 tp -91.17 100.62 13.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.878 0.37 . . . . 0.0 110.708 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 mt -77.07 117.39 18.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.21 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 6.8 mtmm -108.12 15.4 24.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.645 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.81 -33.67 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.648 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.33 -16.68 70.87 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.037 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -29.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -21.35 59.62 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.155 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -117.21 4.1 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.759 0.314 . . . . 0.0 110.469 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.15 35.06 11.4 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.022 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.3 55.65 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.177 -0.602 . . . . 0.0 110.712 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 132.89 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.853 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.29 110.48 16.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.805 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.735 HD11 HG22 ' A' ' 94' ' ' THR . 5.4 tp -98.41 119.56 37.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.794 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 2.6 mpp_? -96.12 106.71 18.93 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.483 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.563 HG13 ' HG ' ' A' ' 108' ' ' LEU . 69.1 mt -117.61 124.19 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.818 0.342 . . . . 0.0 110.132 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -94.19 132.12 39.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.858 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.464 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 36.9 t-20 75.54 80.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.024 0.827 . . . . 0.0 112.287 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.85 139.5 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.864 172.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.1 p -116.02 -173.71 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -24.6 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -168.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.29 -48.09 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.05 0.452 . . . . 0.0 110.534 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -85.01 -6.61 59.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.626 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.637 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -68.92 -3.59 13.33 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 175.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.31 -99.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.0 -0.619 . . . . 0.0 114.066 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.09 128.01 41.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 111.21 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -90.48 151.5 21.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.307 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.86 108.72 20.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.036 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -101.11 117.91 35.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.329 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 23.1 t -134.03 131.92 55.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -122.43 122.67 39.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.19 104.45 11.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 110.312 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.918 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 58.0 t0 -92.74 83.39 4.83 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.9 -97.55 0.82 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.617 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.44 -5.19 13.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.588 0.232 . . . . 0.0 111.568 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.87 110.06 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.12 141.1 43.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.522 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.559 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -121.02 154.41 36.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 176.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -135.19 128.62 32.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.04 135.47 32.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.451 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.489 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.15 127.2 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.237 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.46 134.71 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.145 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -92.41 115.85 28.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.61 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 16.3 t -96.29 141.64 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -131.13 95.42 3.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -73.47 127.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.175 0.512 . . . . 0.0 109.702 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.033 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 N--CA 1.46 -0.474 0 CA-C-O 120.969 0.32 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HD1' ' C ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -86.71 170.4 11.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.44 168.21 24.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.291 0.567 . . . . 0.0 111.789 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.67 148.59 11.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.375 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -93.31 160.75 14.68 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.08 43.71 2.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.581 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 tp -133.95 94.2 3.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.202 0.525 . . . . 0.0 110.051 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.24 -24.34 13.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.573 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 93.64 1.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.013 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 68.37 3.85 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.761 2.308 . . . . 0.0 110.118 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 130.04 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.719 -169.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.52 91.61 5.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.927 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.68 151.89 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.375 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.74 121.49 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.694 ' HB2' HG23 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -63.39 118.76 8.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 96.8 -2.74 62.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.181 -177.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.73 -165.27 24.28 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.324 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.45 115.97 22.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 113' ' ' VAL . 9.5 tp -100.97 112.47 24.93 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.096 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.98 108.42 19.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.069 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.1 mt -95.94 128.76 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.23 122.27 38.74 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.044 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.17 140.13 50.24 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.4 131.32 56.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -126.44 157.05 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.06 -178.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.26 83.2 51.95 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.22 156.64 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.086 2.524 . . . . 0.0 112.843 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 97.5 Cg_endo -87.5 20.36 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.98 2.453 . . . . 0.0 112.091 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.49 -172.96 3.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.734 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -72.09 -19.11 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.127 0.267 . . . . 0.0 111.681 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 59.62 24.78 13.61 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.197 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -59.09 -40.85 86.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -89.09 18.7 4.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.379 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -49.65 132.54 21.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.229 0.538 . . . . 0.0 112.413 -175.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 75' ' ' LEU . 37.6 tt0 -96.0 101.02 12.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -117.3 137.0 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.163 0.506 . . . . 0.0 111.521 -171.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -114.25 117.02 29.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.745 ' HB2' HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -127.42 59.57 1.43 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.91 171.7 14.82 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.881 -165.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.688 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.129 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.49 133.95 52.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.925 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 110.71 19.92 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 172.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.627 ' HB2' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -116.64 113.64 22.95 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.578 -174.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 t0 64.71 12.1 7.34 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.776 0.672 . . . . 0.0 111.166 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 2.76 58.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.919 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 133.27 47.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.962 0.41 . . . . 0.0 110.853 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -125.11 157.74 35.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.414 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 -172.8 2.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.709 0.29 . . . . 0.0 110.508 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -6.44 56.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.887 0.375 . . . . 0.0 111.575 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.88 -53.35 3.55 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.208 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.689 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.8 pm0 -90.65 12.94 17.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.904 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.575 HG22 ' HB2' ' A' ' 89' ' ' LYS . 3.1 tt -36.89 114.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.235 0 O-C-N 124.619 1.2 . . . . 0.0 110.903 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 94' ' ' THR . 11.4 tt -71.77 -18.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.21 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -15.14 63.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 0.0 110.106 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -81.58 -18.0 46.34 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.423 0.63 . . . . 0.0 109.556 177.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -82.19 -55.72 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.092 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -161.13 155.2 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.148 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.65 -58.08 10.13 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.2 0.312 . . . . 0.0 111.735 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.716 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 6.7 tpp85 -91.95 84.37 5.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.206 0.526 . . . . 0.0 110.969 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -115.76 136.39 53.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.654 178.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -145.56 134.6 22.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.454 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -101.7 108.34 19.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.808 0.337 . . . . 0.0 110.247 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -75.85 106.88 7.67 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.44 2.65 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.374 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -51.61 -38.86 56.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.023 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.63 67.84 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.74 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -55.64 -35.8 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -168.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -69.06 -6.0 50.66 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.511 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.83 1.69 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.057 0.456 . . . . 0.0 109.913 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.58 42.9 9.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.004 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 132.79 38.45 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.162 -0.611 . . . . 0.0 110.573 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.531 HG23 ' CZ ' ' A' ' 125' ' ' PHE . 5.9 m -123.74 133.25 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.405 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.61 103.37 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 96' ' ' LEU . 20.2 tp -86.12 118.07 25.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.46 107.24 19.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.053 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.418 HG13 ' HG ' ' A' ' 108' ' ' LEU . 86.9 mt -115.53 109.39 28.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.716 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 30.0 t80 -80.87 122.89 27.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.903 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 42.7 t30 79.57 75.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.182 0.926 . . . . 0.0 110.791 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 45' ' ' LEU . 3.8 p -74.87 140.11 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.878 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.5 p -103.68 163.4 12.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.516 0.674 . . . . 0.0 112.159 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -69.59 -14.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.219 177.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -75.29 -24.16 57.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.566 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.682 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 42.7 m-20 -103.45 -10.64 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.723 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.79 ' HB2' HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.05 6.63 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -103.85 -128.68 6.37 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.081 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.52 117.75 30.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.763 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.682 ' HE1' ' HB3' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -87.52 157.91 19.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.38 118.83 32.23 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.619 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.6 t -105.46 116.52 32.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.842 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.586 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 6.2 t -123.89 111.26 28.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.531 ' CZ ' HG23 ' A' ' 106' ' ' VAL . 1.4 m-85 -97.38 123.62 41.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.758 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -132.88 136.47 46.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.544 0.688 . . . . 0.0 111.759 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.3 76.51 1.7 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.684 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.99 -98.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.771 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 -27.4 20.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.485 0.184 . . . . 0.0 111.472 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -75.3 132.55 41.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.23 141.08 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 151.46 47.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.639 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.56 51.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.77 137.7 21.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.897 0.379 . . . . 0.0 111.15 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.26 46.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.325 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.453 HG22 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -112.56 157.12 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.149 -178.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 122.66 45.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.38 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 74.2 t -102.62 113.25 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 139' ' ' LYS . 3.1 mmmm -97.76 108.24 20.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.841 0.353 . . . . 0.0 110.066 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.79 HG12 ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -76.81 129.46 37.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.397 0.617 . . . . 0.0 111.225 -176.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.452 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--O 1.233 0.257 0 CA-C-O 121.236 0.431 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -164.7 147.44 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.964 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -143.62 175.38 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.303 -173.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.13 144.36 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.954 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.09 139.31 56.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.731 0.3 . . . . 0.0 110.394 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.37 0.35 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.933 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.26 155.22 42.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.27 -49.4 19.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 66.61 1.77 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.476 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.06 88.11 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.37 2.046 . . . . 0.0 111.791 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 t -75.35 92.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.26 98.83 10.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.153 0.501 . . . . 0.0 110.176 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.793 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -109.37 158.09 18.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.604 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -112.66 129.42 56.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.605 HD13 HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -57.27 125.93 24.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.1 -22.57 22.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.538 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -172.62 41.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.127 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 2.9 p-10 -79.26 125.86 30.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.275 0.559 . . . . 0.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.592 HD12 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -97.58 123.13 41.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.418 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 112.4 24.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.999 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.592 HD22 HD12 ' A' ' 45' ' ' LEU . 1.2 mt -96.42 128.71 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 124.71 52.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -130.35 143.4 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.473 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -132.24 131.03 41.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' C ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.56 166.14 19.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.536 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -97.51 97.87 4.46 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 85.2 Cg_endo -85.16 130.13 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.779 2.319 . . . . 0.0 113.754 -171.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 16.4 Cg_exo -68.65 -37.55 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.753 2.302 . . . . 0.0 110.744 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 5.3 pt20 -133.91 -172.33 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.876 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -69.02 -29.95 68.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.678 0.275 . . . . 0.0 111.339 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HA ' ' HE2' ' A' ' 60' ' ' MET . . . 55.49 26.28 8.79 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.426 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.61 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -62.15 -25.44 67.75 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -113.48 18.94 17.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.846 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -88.42 -166.3 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -176.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.505 ' HG2' HD13 ' A' ' 75' ' ' LEU . 1.3 mt-10 -116.66 131.99 56.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.697 0.284 . . . . 0.0 110.678 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 147.46 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.139 0.495 . . . . 0.0 110.384 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.734 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -128.59 117.45 21.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.047 178.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.515 ' NE1' ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -126.17 59.35 1.33 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 63' ' ' ARG . 83.2 m-85 -136.6 159.44 41.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.338 0.59 . . . . 0.0 112.422 -164.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 117' ' ' ASP . 9.7 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.138 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.639 ' HD2' ' HA ' ' A' ' 85' ' ' GLU . 1.8 m170 . . . . . 0 N--CA 1.456 -0.175 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.505 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -176.22 147.48 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.05 0.452 . . . . 0.0 111.067 -177.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.473 ' HE1' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -111.63 112.11 23.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -105.19 122.38 45.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.68 20.01 8.69 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.571 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.43 9.1 76.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.285 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.68 156.14 24.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.46 148.74 21.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.943 0.402 . . . . 0.0 110.352 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.26 156.59 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.653 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -25.38 67.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.71 -25.97 47.92 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.179 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -82.67 -43.28 17.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 86' ' ' ILE . 1.5 tp 39.77 82.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.605 1.19 . . . . 0.0 112.51 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.473 HG22 ' HE1' ' A' ' 76' ' ' TYR . 29.0 pt -68.52 -1.8 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.212 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -14.91 60.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 173.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -41.31 78.87 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.836 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -81.42 -49.55 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.22 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.34 1.025 . . . . 0.0 112.482 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.706 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER 73.35 -125.49 0.04 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.668 175.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.597 ' HA ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -95.63 96.51 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 -176.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.491 HG21 HG13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -110.54 114.19 27.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 177.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -145.69 123.56 11.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.59 112.85 24.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.0 110.359 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -74.18 105.48 5.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.6 4.8 50.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.919 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.99 -34.62 57.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.501 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.606 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.55 -16.69 65.63 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.945 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -51.32 -38.5 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -167.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.02 -11.14 60.48 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.751 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -116.22 1.15 13.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.52 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 86.11 34.5 12.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.931 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.606 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -124.55 140.14 53.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.875 0.338 . . . . 0.0 110.613 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.43 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 175.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -125.24 104.55 8.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.242 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.468 ' HB3' HD11 ' A' ' 47' ' ' LEU . 5.7 tp -87.84 115.11 25.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 0.0 110.456 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -93.99 107.42 19.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.86 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.491 HG13 HG21 ' A' ' 94' ' ' THR . 1.9 mt -122.35 114.38 42.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -72.74 146.12 46.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.159 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 7.0 t30 75.1 89.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.131 0 O-C-N 123.922 0.764 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG13 ' HB2' ' A' ' 39' ' ' ALA . 4.1 p -107.21 145.11 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 175.48 8.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 41' ' ' LEU . 43.6 t -60.29 -26.34 36.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.282 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -30.2 71.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.474 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 119' ' ' GLY . 15.4 m-20 -93.02 -14.01 27.93 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.05 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.051 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -118.23 -128.62 3.94 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.98 130.4 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.323 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.453 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.5 m-85 -104.28 141.88 35.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.23 120.22 39.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.148 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -98.82 125.11 44.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.403 174.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 3.6 t -134.32 134.04 55.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.614 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 43.0 m-85 -124.61 120.35 31.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.701 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.1 mtpm? -111.16 106.21 15.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.168 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.846 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 49.3 t0 -114.88 114.24 25.24 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.713 0.633 . . . . 0.0 109.754 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.87 -104.06 1.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.962 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -117.4 -10.26 10.74 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.64 154.32 21.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 -176.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -143.63 146.95 33.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 0.0 111.413 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.964 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -126.2 160.81 29.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.321 177.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.49 150.85 45.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.522 . . . . 0.0 111.515 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -147.2 132.87 18.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.036 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -89.21 116.33 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.495 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -116.2 134.55 54.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.247 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.87 139.66 30.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.201 0.525 . . . . 0.0 111.895 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.8 t -106.1 132.13 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.568 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -117.54 106.8 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.388 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.6 119.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.187 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 CA-C-O 121.539 0.558 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HB3' ' HB2' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -146.93 139.35 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.354 -177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.86 159.3 9.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.999 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.27 134.33 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.945 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 140.88 48.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.542 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.18 -126.36 7.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.518 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.8 177.69 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 mp0 -70.46 -33.9 71.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.127 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.79 75.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.979 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.28 70.37 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.001 2.468 . . . . 0.0 111.36 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.484 ' H ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.53 106.92 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.182 -177.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -98.75 147.94 24.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -137.3 171.71 14.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.23 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.2 121.0 36.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.091 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.85 128.38 36.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 83.62 -14.54 41.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.764 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.74 -156.84 27.54 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.976 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.99 130.97 35.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.004 0.43 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.672 ' HG ' HD22 ' A' ' 47' ' ' LEU . 1.2 tp -110.01 110.36 21.25 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -114.01 114.66 26.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 -178.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.672 HD22 ' HG ' ' A' ' 45' ' ' LEU . 1.2 mm? -100.69 128.74 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.362 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.2 121.28 44.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.76 141.07 51.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -134.13 140.82 46.83 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.122 0.487 . . . . 0.0 110.988 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 125' ' ' PHE . 1.2 pp -127.58 161.68 28.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.179 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.504 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 1.6 m -82.18 109.05 13.55 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 8.2 Cg_exo -70.53 112.45 3.22 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.255 2.637 . . . . 0.0 114.271 -167.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 52' ' ' SER . 88.9 Cg_endo -90.94 -8.59 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.95 2.434 . . . . 0.0 110.405 168.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -158.41 -172.17 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.426 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -9.11 58.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.75 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 70.63 -1.85 2.44 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.466 0.706 . . . . 0.0 112.877 173.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -65.66 -18.06 65.05 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.047 0.451 . . . . 0.0 111.255 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.64 6.93 22.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.404 ' HE2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.07 155.21 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.311 0.577 . . . . 0.0 112.101 -172.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.887 ' HG2' HD12 ' A' ' 75' ' ' LEU . 11.1 mt-10 -80.02 107.8 13.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.206 172.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.39 140.79 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.361 0.601 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 1.025 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 1.6 ttp180 -131.81 131.63 43.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.302 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.512 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -147.77 57.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.307 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 22.9 m-70 . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.887 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -155.64 151.08 27.03 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -164.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.0 111.81 24.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.633 ' HG2' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -147.49 153.51 39.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.523 -172.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.633 ' N ' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 64.32 26.06 13.58 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.574 0.546 . . . . 0.0 109.867 175.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.57 73.5 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.963 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -142.51 151.28 41.49 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.115 0.484 . . . . 0.0 111.727 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.71 154.49 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.616 171.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.458 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 23.1 mtp -114.5 -160.04 0.72 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.802 0.334 . . . . 0.0 111.677 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -72.66 -36.41 67.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.651 ' HA3' ' CE1' ' A' ' 74' ' ' HIS . . . -85.04 -44.05 6.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.504 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 1.6 pm0 -87.45 17.91 4.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.441 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.95 108.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.787 0.804 . . . . 0.0 110.421 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 tt -70.0 -16.73 20.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.744 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -12.84 61.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -60.03 -20.57 58.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.335 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -76.11 0.39 19.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 t 57.16 39.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.419 0.688 . . . . 0.0 112.028 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -168.67 177.56 5.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.864 176.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.34 141.95 48.79 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.209 0.528 . . . . 0.0 110.813 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.709 HG22 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -137.51 141.68 41.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.783 -177.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -136.49 104.25 5.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.776 177.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.23 90.28 4.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 107' ' ' THR . 20.6 mt -68.81 120.51 14.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.183 0.516 . . . . 0.0 110.894 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 8.99 27.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.858 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.52 -33.69 70.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.47 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.23 -16.66 64.21 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.178 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 57' ' ' ALA . 2.3 tt -54.05 -36.26 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -167.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 101' ' ' ILE . . . -66.35 -21.92 70.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.104 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.99 2.24 37.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.205 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.01 19.85 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.322 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.66 133.2 53.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.419 0.61 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.99 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 122.237 -0.29 . . . . 0.0 110.27 176.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.442 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.11 107.86 13.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 111.282 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.728 HD23 HD13 ' A' ' 110' ' ' ILE . 45.1 tp -88.33 112.76 23.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.815 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -92.71 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.289 176.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.728 HD13 HD23 ' A' ' 108' ' ' LEU . 57.3 mt -116.49 124.63 72.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.507 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 1.5 t80 -76.57 124.96 28.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.185 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.425 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 54.8 t30 77.04 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.158 0.911 . . . . 0.0 112.053 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 140' ' ' ILE . 11.5 p -133.95 141.52 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.24 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -123.16 174.69 7.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.12 -11.86 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.021 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.64 -24.34 41.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -101.74 -9.97 20.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.592 ' HB2' HD11 ' A' ' 140' ' ' ILE . 36.4 t70 -68.46 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.797 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -127.68 -126.54 2.91 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.822 -177.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 114.8 16.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' HH ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -110.31 128.03 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.51 175.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 118.82 37.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.209 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.7 t -105.46 140.3 38.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.635 175.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 1.9 t -144.43 132.55 17.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.213 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.572 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -120.3 115.45 23.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.336 176.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.606 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.7 mtpm? -130.66 102.26 6.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.845 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -91.74 71.35 5.76 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.56 -107.33 2.29 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.11 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.33 -19.97 27.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.946 0.403 . . . . 0.0 110.429 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 126' ' ' LYS . 21.7 m-85 -68.82 94.37 0.61 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -120.44 137.81 54.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.2 0.524 . . . . 0.0 111.96 -172.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.89 135.2 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.415 171.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -122.7 137.73 54.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.349 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.35 146.95 37.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.219 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 135' ' ' ILE . 1.1 tp -123.14 113.21 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.646 0.736 . . . . 0.0 110.452 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 159.71 18.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.273 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.48 129.11 53.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.22 129.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.66 97.82 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.074 0.464 . . . . 0.0 110.863 -177.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 118' ' ' ASP . 33.8 mt -67.85 114.59 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.437 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.029 0.442 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.09 101.1 5.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.555 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.6 OUTLIER -126.5 21.62 7.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.466 0.65 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.62 105.67 38.68 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.721 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 25' ' ' SER . 9.1 Cg_exo -72.2 -71.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.807 2.338 . . . . 0.0 111.426 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.791 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 1.1 p90 -157.85 146.88 19.52 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.68 178.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.924 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.5 HG23 ' HE1' ' A' ' 125' ' ' PHE . 2.7 t -100.44 148.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.816 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 151.84 41.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.764 0.316 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.03 -127.74 9.33 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.56 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.35 178.76 6.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.07 74.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 136' ' ' THR . . . 119.27 84.23 0.89 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.712 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.05 81.62 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.75 2.3 . . . . 0.0 111.002 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.25 127.69 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.44 142.3 35.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.46 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 113' ' ' VAL . . . -152.19 172.09 16.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.476 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.69 140.02 51.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.767 ' HG ' HG22 ' A' ' 140' ' ' ILE . 2.2 mt -61.55 133.76 56.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.933 0.397 . . . . 0.0 111.107 -174.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.75 -16.42 8.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.918 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.74 -148.8 15.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.182 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -101.31 130.76 47.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.688 HD13 HG22 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -104.3 110.98 23.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.305 175.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.71 106.11 18.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 0.0 109.89 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 1.5 mm? -94.09 128.09 40.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.65 122.12 37.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.547 ' HB3' ' HE2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -126.83 141.12 51.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.461 176.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.601 ' HG3' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -115.15 130.71 56.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -127.79 154.7 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.07 0.462 . . . . 0.0 110.843 -178.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -125.15 83.66 60.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.951 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.791 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -93.99 164.39 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.511 2.807 . . . . 0.0 112.987 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.83 -14.85 10.99 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.765 2.31 . . . . 0.0 111.875 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -116.5 -172.84 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.115 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.3 -11.63 48.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 110.432 178.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.681 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 68.06 7.72 6.03 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.072 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.489 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 1.5 tm0? -58.22 -46.74 85.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.182 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.44 5.08 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.06 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.681 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -80.31 166.22 21.55 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -176.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 77' ' ' ARG . 3.1 mt-10 -105.29 142.8 34.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.59 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HD13 HD22 ' A' ' 96' ' ' LEU . 2.7 tt -137.37 144.49 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.162 0.506 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -127.86 116.76 20.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.615 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -130.74 58.1 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -170.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.739 ' HB2' HG11 ' A' ' 73' ' ' VAL . 1.3 m-85 -149.5 170.51 18.43 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.638 -170.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' CZ ' ' HA ' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -132.94 126.79 32.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.47 176.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.46 164.6 37.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -98.94 127.12 44.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -174.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 51.1 m-85 77.97 146.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.993 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.29 86.78 4.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.046 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.731 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -148.89 -57.39 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.548 172.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.731 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 55.5 Cg_endo -95.64 161.34 1.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.527 2.151 . . . . 0.0 110.998 170.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.739 HG11 ' HB2' ' A' ' 65' ' ' PHE . 70.0 t 63.83 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.787 0.803 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 85' ' ' GLU . 2.4 m170 -122.61 -58.59 1.67 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.787 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 85' ' ' GLU . 6.1 tp 176.1 127.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.973 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.12 138.24 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -137.49 139.62 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -163.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.0 t0 66.82 0.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.437 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.38 4.19 57.37 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 140.92 41.21 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.437 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 169.71 17.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.769 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.912 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 2.6 ttt -132.47 120.89 22.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.966 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.28 -40.57 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.535 ' HA3' ' HE1' ' A' ' 82' ' ' MET . . . -73.84 -10.87 80.84 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.93 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -93.96 -25.98 17.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 42.37 68.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.852 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 94' ' ' THR . 6.5 tp -66.06 -12.29 14.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.267 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -13.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -62.77 -35.21 79.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.834 0.349 . . . . 0.0 110.609 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 21.79 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.479 HG23 ' NH1' ' A' ' 93' ' ' ARG . 0.4 OUTLIER 54.8 -149.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.441 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.46 28.28 4.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.354 0.597 . . . . 0.0 110.645 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.51 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -100.49 35.57 2.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.475 -178.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -120.41 126.12 49.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.922 -175.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -136.33 99.89 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -88.24 100.1 12.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.238 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.11 99.93 0.72 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.885 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.05 -7.65 26.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.159 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -30.83 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.497 0.665 . . . . 0.0 109.99 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.26 -17.87 79.68 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.98 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 57' ' ' ALA . 3.6 tt -61.03 -29.81 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -171.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.494 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -69.53 -15.6 70.86 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.395 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 -4.58 28.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.944 0.402 . . . . 0.0 109.982 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . 89.83 20.72 42.33 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.945 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.601 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -130.28 132.54 45.96 Favored 'General case' 0 C--O 1.22 -0.477 0 O-C-N 122.507 -0.408 . . . . 0.0 111.11 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.66 132.28 69.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 121.763 -0.586 . . . . 0.0 109.75 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -125.25 103.17 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 0.0 111.5 -176.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB2' HD11 ' A' ' 96' ' ' LEU . 2.0 tp -91.69 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.802 0.334 . . . . 0.0 110.621 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 106.31 18.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.14 131.33 62.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.51 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -96.3 137.56 35.19 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.904 -176.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 t30 76.05 74.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.513 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.688 HG22 HD13 ' A' ' 45' ' ' LEU . 12.1 p -81.98 146.97 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.79 168.45 13.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.525 0.202 . . . . 0.0 111.325 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -77.39 -8.15 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.146 0.498 . . . . 0.0 111.643 -173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -35.3 12.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -72.76 -25.4 61.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.53 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.569 ' HA ' ' HB ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -78.11 24.3 0.25 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.87 -108.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.428 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.87 116.2 23.25 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.393 -0.475 . . . . 0.0 109.898 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.616 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -74.37 141.1 45.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.925 178.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.11 105.65 17.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.403 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.7 t -98.68 117.22 32.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.05 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 53.0 t -132.33 124.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.676 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -110.34 135.91 50.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.97 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -123.75 104.8 9.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.444 . . . . 0.0 110.622 178.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.676 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 19.7 t70 -93.07 81.86 4.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.147 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.75 -100.83 0.58 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.694 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -95.75 -10.99 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -93.07 154.92 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.607 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 50.8 p90 -151.26 146.73 26.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.89 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 1.9 mm-40 -139.71 160.37 40.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.885 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' HG2' HG21 ' A' ' 124' ' ' VAL . 2.1 mt-10 -126.46 154.24 43.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -173.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 140.71 14.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.496 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -108.48 107.14 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.541 HG21 ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -95.04 102.03 13.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.055 -176.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.3 116.71 13.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 118' ' ' ASP . 1.3 t -86.53 150.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.164 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.02 112.57 8.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.182 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.767 HG22 ' HG ' ' A' ' 41' ' ' LEU . 47.9 mm -76.33 110.66 11.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.889 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 121.025 0.441 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -0.77 51.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.058 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -35.59 71.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -108.16 98.95 29.06 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.381 169.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.5 -76.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.89 2.394 . . . . 0.0 112.7 -173.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -152.71 149.18 28.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.896 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -143.15 170.63 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 132' ' ' GLU . 84.9 t -96.88 147.89 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.182 175.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.13 136.6 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.55 78.52 1.16 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.582 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -135.41 115.89 13.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' O ' HG21 ' A' ' 136' ' ' THR . 45.7 mp0 -77.19 -44.77 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.07 111.59 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.716 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.63 62.55 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.53 2.154 . . . . 0.0 110.332 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.36 104.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.953 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.99 123.1 37.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.426 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.69 167.15 15.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.634 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.35 139.95 46.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.06 126.39 27.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.933 0.397 . . . . 0.0 110.621 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 85.98 -9.78 67.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.993 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.76 -164.78 39.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.2 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.74 133.01 48.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.49 115.53 24.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.385 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.3 mt-10 -99.42 112.95 25.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.01 0.433 . . . . 0.0 110.004 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 47' ' ' LEU . 10.3 mt -95.6 128.07 42.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.269 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.8 OUTLIER -123.99 123.05 39.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.36 -179.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.682 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -117.55 140.42 49.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -128.7 134.15 48.39 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.164 0.29 . . . . 0.0 111.062 -173.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -127.32 164.85 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -80.56 104.94 3.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 7.4 Cg_exo -72.15 114.81 4.09 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.143 2.562 . . . . 0.0 113.551 -170.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 52' ' ' SER . 98.8 Cg_endo -87.89 -13.24 3.96 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 111.067 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -171.5 3.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.478 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.461 ' HG3' ' OE1' ' A' ' 58' ' ' GLN . 4.8 pm0 -68.02 -7.75 31.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.484 0.183 . . . . 0.0 111.479 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' HG12 ' A' ' 101' ' ' ILE . . . 75.51 -33.77 0.24 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.461 ' OE1' ' HG3' ' A' ' 56' ' ' GLN . 10.1 pt20 -51.74 -39.79 59.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.93 15.02 3.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.562 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ptm -92.9 160.87 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.733 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.987 ' HB3' HD12 ' A' ' 75' ' ' LEU . 71.9 mt-10 -87.2 131.22 34.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -132.26 135.57 57.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.049 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -119.15 117.58 29.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.872 172.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.515 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -126.3 63.8 1.25 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' HE1' HG13 ' A' ' 87' ' ' ILE . 89.5 m-85 -148.93 154.71 39.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.611 -170.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.68 170.65 11.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.213 174.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -132.81 122.23 24.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.257 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.25 131.32 23.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.399 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.45 ' HB3' ' H ' ' A' ' 70' ' ' THR . 0.2 OUTLIER 60.51 -103.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.915 175.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -117.84 34.48 5.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.746 0.308 . . . . 0.0 111.262 -176.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -60.12 113.19 6.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.799 177.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 8.5 Cg_exo -72.35 -178.28 3.21 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.007 2.471 . . . . 0.0 112.663 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.2 89.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -80.26 81.89 6.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.987 HD12 ' HB3' ' A' ' 61' ' ' GLU . 1.5 tp -113.08 130.81 56.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.52 ' HE2' ' HD2' ' A' ' 98' ' ' LYS . 52.5 t80 -126.24 152.85 45.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -141.96 143.33 33.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.04 113.2 4.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.328 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 122.45 16.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.401 0.62 . . . . 0.0 111.141 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.99 161.32 30.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.949 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -167.59 163.03 14.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.759 0.314 . . . . 0.0 110.622 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -12.04 61.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.981 0.419 . . . . 0.0 110.63 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.05 -35.87 79.51 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.029 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -76.68 -41.24 46.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.18 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 tp 21.54 72.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 124.754 1.283 . . . . 0.0 112.373 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.923 HG12 ' HB ' ' A' ' 94' ' ' THR . 14.9 tt -58.8 -23.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.235 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -13.72 59.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.956 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.93 -17.98 60.47 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.815 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.71 -71.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.086 -0.245 . . . . 0.0 110.706 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.0 t -134.84 -67.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.675 0.274 . . . . 0.0 110.817 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -168.98 -63.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.197 0.522 . . . . 0.0 110.25 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -101.0 98.61 9.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.921 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.923 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -130.58 115.05 16.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.536 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -126.7 133.65 50.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.81 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.81 104.53 14.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.97 0.414 . . . . 0.0 110.603 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.52 121.74 25.59 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.756 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -107.87 -4.71 17.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.413 -172.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -62.73 -35.81 80.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 110.959 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.41 -17.79 74.72 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.732 HG12 ' HB2' ' A' ' 57' ' ' ALA . 1.2 tt -62.09 -26.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 122.718 -0.283 . . . . 0.0 111.457 -173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.26 -17.37 63.78 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.801 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.63 5.65 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.229 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 89.23 23.66 33.94 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.123 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.5 OUTLIER -128.72 133.62 48.21 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 117.54 0.67 . . . . 0.0 111.475 -178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -115.04 132.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 O-C-N 121.761 -0.587 . . . . 0.0 109.629 175.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -114.12 103.26 10.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.187 0.518 . . . . 0.0 111.512 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 87' ' ' ILE . 22.9 tp -93.56 111.22 22.85 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.182 0.515 . . . . 0.0 110.264 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -88.08 107.41 18.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.807 178.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.525 HG13 ' HG ' ' A' ' 108' ' ' LEU . 63.5 mt -110.92 127.3 68.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.922 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -106.23 143.14 34.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.596 0.236 . . . . 0.0 110.832 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.426 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m120 68.35 55.72 0.51 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.636 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.831 HG21 HD11 ' A' ' 140' ' ' ILE . 4.5 p -65.88 152.2 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.39 152.39 39.08 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 112.39 -173.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.97 -17.45 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.212 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.47 -38.75 71.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.885 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -96.92 7.74 45.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.226 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.493 ' HA ' HD13 ' A' ' 140' ' ' ILE . 17.2 t70 -55.55 24.88 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 0.0 113.351 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -97.65 -132.66 7.58 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 120.788 -1.195 . . . . 0.0 112.194 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 127.57 43.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.443 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.701 ' CE2' ' HB ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -90.19 161.84 15.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.598 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -103.02 119.06 38.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.623 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -102.34 116.11 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 16.2 t -129.56 117.47 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.265 -176.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.682 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 17.4 m-30 -107.61 128.68 54.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.8 mtpt -122.55 104.9 9.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.44 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 6.2 t70 -91.63 73.94 5.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.525 0.678 . . . . 0.0 109.714 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.29 -83.05 1.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.96 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -116.82 -27.7 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.524 0.202 . . . . 0.0 111.457 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -89.67 125.78 35.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -126.32 150.56 48.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.896 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -132.12 145.38 51.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.877 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 124' ' ' VAL . 33.9 tt0 -132.35 126.39 33.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.388 . . . . 0.0 110.708 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -129.6 143.72 50.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.333 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -102.39 113.89 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.182 0.515 . . . . 0.0 110.191 176.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.619 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -105.65 147.23 28.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.726 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 150.35 28.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.828 0.347 . . . . 0.0 111.655 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.701 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 14.1 p -122.74 131.28 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.97 103.75 11.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.795 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.831 HD11 HG21 ' A' ' 113' ' ' VAL . 1.4 mp -73.41 124.51 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.444 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.611 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.781 0.324 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 74.54 10.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.187 0.517 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 m -128.13 -45.31 1.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.185 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -69.86 112.01 10.93 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.508 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.03 -16.63 11.11 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.459 2.106 . . . . 0.0 112.177 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.472 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -136.45 134.8 38.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.104 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.5 OUTLIER -150.47 161.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.373 0.42 . . . . 0.0 110.175 174.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 31' ' ' ASN . 75.5 t -92.31 145.07 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.491 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' N ' HG12 ' A' ' 30' ' ' VAL . 8.5 t-20 -67.94 162.5 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.85 62.95 2.41 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.294 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 122.78 19.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -83.75 -48.73 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.541 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 106.55 72.35 0.81 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.397 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.98 72.48 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.753 2.302 . . . . 0.0 110.919 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG13 HD11 ' A' ' 45' ' ' LEU . 3.3 t -85.89 103.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 -176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.74 139.39 33.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.45 171.39 14.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.774 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.62 154.25 28.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 130.48 42.54 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.451 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.64 8.62 86.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.205 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.97 -158.73 32.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.016 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -102.65 130.21 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.178 0.513 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.617 ' HB2' HG22 ' A' ' 113' ' ' VAL . 8.6 tp -116.24 110.6 18.99 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.918 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tt0 -105.96 110.54 22.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 4.7 mt -95.8 128.43 42.67 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.67 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -121.55 125.4 46.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.583 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.3 140.23 50.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.85 130.83 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.103 0.477 . . . . 0.0 111.426 -172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.23 165.56 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.627 -176.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.582 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -117.54 82.41 15.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.714 169.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HA ' ' HE1' ' A' ' 28' ' ' PHE . 97.8 Cg_endo -89.86 141.83 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.027 2.485 . . . . 0.0 113.082 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.27 1.24 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.632 2.221 . . . . 0.0 112.646 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -151.97 -174.44 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.257 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -76.88 -18.55 58.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.272 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 61.45 34.97 17.89 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 170.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -64.6 -36.84 85.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.378 0.608 . . . . 0.0 109.56 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' A' ' 78' ' ' ASP . 49.9 t-80 -79.92 -2.67 44.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.094 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 127' ' ' ASP . 3.9 ttm -69.47 141.48 53.97 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.03 0.443 . . . . 0.0 111.396 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.81 116.95 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.927 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -116.44 147.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.338 0.589 . . . . 0.0 111.21 -174.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.739 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -128.56 137.22 51.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.241 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.447 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -151.81 42.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 30.6 m-85 -134.18 158.39 43.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.176 -168.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.57 124.91 51.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.032 0.444 . . . . 0.0 110.308 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.4 154.05 26.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.345 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -64.85 109.77 2.19 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.293 0.37 . . . . 0.0 110.792 -178.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 60.37 67.52 0.84 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.972 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.34 57.87 4.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.351 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' HB2' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -79.64 -60.43 0.52 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -178.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 71' ' ' GLU . 26.2 Cg_endo -92.6 -49.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.076 1.851 . . . . 0.0 113.198 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' H ' ' HD2' ' A' ' 72' ' ' PRO . 1.4 p -84.78 163.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.89 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 1.2 m-70 73.15 97.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.994 0.918 . . . . 0.0 110.739 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -161.9 136.22 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.345 -171.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -103.37 109.28 20.85 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -116.52 130.18 56.6 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.486 -168.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 59' ' ' HIS . 16.4 t0 58.41 20.22 7.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.353 0.597 . . . . 0.0 111.684 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 22.93 58.25 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.885 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.51 139.18 50.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 110.815 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.81 169.98 17.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.176 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.513 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.27 135.11 49.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.924 0.393 . . . . 0.0 110.697 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.522 ' HA ' HD11 ' A' ' 86' ' ' ILE . 78.4 m-85 -87.5 -2.43 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.073 0.464 . . . . 0.0 110.981 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.46 -18.89 63.22 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -108.83 -40.73 4.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.542 0.21 . . . . 0.0 110.6 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 83' ' ' PHE . 31.5 mm 65.86 85.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.698 0.761 . . . . 0.0 111.435 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.544 HD13 HG21 ' A' ' 94' ' ' THR . 2.1 tp -67.8 -20.54 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 0.0 109.692 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -14.02 7.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.696 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -69.44 -22.52 63.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 178.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -74.88 -36.93 62.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.504 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.813 HG12 ' HG2' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 65.65 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.796 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.813 ' HG2' HG12 ' A' ' 91' ' ' VAL . 5.9 mm-40 66.25 -151.11 0.22 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.911 0.484 . . . . 0.0 110.416 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.47 109.28 22.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.156 0.503 . . . . 0.0 110.991 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.65 HG22 HG12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.77 95.36 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.524 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 4.7 tp10 -104.63 108.15 19.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.959 0.409 . . . . 0.0 110.675 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD13 HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -91.96 96.48 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.13 105.33 3.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.85 -8.71 20.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.952 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.56 -39.75 61.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.514 ' HA2' ' OE2' ' A' ' 103' ' ' GLU . . . -62.77 -18.66 59.72 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.543 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -58.61 -25.8 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 117.16 0.48 . . . . 0.0 111.833 -174.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 56' ' ' GLN . . . -63.9 -23.39 67.46 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.561 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.514 ' OE2' ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -105.84 -5.17 19.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.21 42.79 6.12 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.872 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.77 132.6 34.98 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.293 -0.533 . . . . 0.0 110.585 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.488 HG23 ' CZ ' ' A' ' 125' ' ' PHE . 14.0 m -121.67 133.18 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.03 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 103.46 9.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 96' ' ' LEU . 35.2 tp -92.86 110.25 21.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.476 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.735 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -88.95 105.79 17.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.35 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.65 HG12 HG22 ' A' ' 94' ' ' THR . 12.5 mt -112.46 119.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -94.55 140.08 30.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 74.26 67.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.056 0.848 . . . . 0.0 111.134 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.617 HG22 ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -62.02 133.36 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.994 174.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.77 149.44 24.48 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.59 -22.45 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.717 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -75.03 -37.07 61.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -89.74 2.26 55.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.631 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.5 t0 -58.47 27.09 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.94 0.896 . . . . 0.0 112.913 168.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -104.86 -147.43 16.4 Favored Glycine 0 N--CA 1.448 -0.539 0 O-C-N 121.399 -0.813 . . . . 0.0 112.29 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -100.96 120.3 39.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.7 0.286 . . . . 0.0 110.834 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.81 146.24 35.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 110.894 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.489 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 86.4 t60 -99.6 103.45 15.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.336 -177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 46.7 t -106.0 130.88 53.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 23.2 t -144.56 137.29 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 49' ' ' CYS . 17.0 m-85 -115.62 110.97 19.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.571 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -118.01 105.25 11.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 0.0 111.223 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.514 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 19.3 t0 -112.77 99.86 8.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 0.0 109.988 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.35 -103.6 2.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.233 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -112.57 -24.6 9.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.463 0.173 . . . . 0.0 111.274 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.74 129.66 36.63 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.788 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.571 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 23.5 p90 -137.4 127.77 26.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.283 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -112.34 136.36 51.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.942 177.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -110.1 146.87 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.857 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.513 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 7.1 t-80 -149.16 127.1 11.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.15 110.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.912 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.541 HG23 ' HA3' ' A' ' 35' ' ' GLY . 53.4 m -122.11 111.96 17.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.247 -177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.791 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.6 pt-20 -88.25 150.22 23.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.306 0.574 . . . . 0.0 111.867 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 118' ' ' ASP . 8.2 p -97.52 151.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.42 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -122.49 90.83 3.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.923 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' A' ' 118' ' ' ASP . 19.5 mt -76.66 107.32 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.516 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.88 48.54 0.84 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.109 0.481 . . . . 0.0 111.689 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -157.79 63.14 0.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 4.1 tt0 -129.73 122.71 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.393 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 12.2 Cg_exo -70.99 160.63 48.76 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.891 2.394 . . . . 0.0 112.154 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.566 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 4.9 p90 -78.58 164.94 24.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.787 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -128.63 173.85 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 111.673 -176.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG23 ' HE2' ' A' ' 125' ' ' PHE . 82.6 t -89.87 142.26 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.241 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.46 175.62 5.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.709 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.05 -113.47 3.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.772 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.48 176.87 9.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.73 -49.16 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.1 73.03 1.07 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.99 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.16 89.52 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.402 2.068 . . . . 0.0 110.494 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -67.89 129.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -174.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.8 mm? -88.98 128.34 35.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.02 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' A' ' 113' ' ' VAL . . . -133.99 169.71 16.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 128.96 54.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.665 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -62.59 123.91 19.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.73 -9.48 77.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.242 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.85 -171.45 35.73 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.847 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.33 137.35 33.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 tp -111.94 112.92 24.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.926 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -104.78 108.44 19.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.948 177.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.0 OUTLIER -96.61 127.95 43.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.514 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.47 123.87 50.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -121.58 140.73 51.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 1.0 OUTLIER -123.04 131.22 53.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 164.71 14.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.367 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.53 99.13 2.55 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 5.2 Cg_endo -83.76 121.1 2.82 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.162 2.575 . . . . 0.0 113.515 -167.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.02 -6.83 13.18 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.465 2.11 . . . . 0.0 110.356 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -165.62 -179.06 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.972 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' O ' HG23 ' A' ' 101' ' ' ILE . 2.2 pm0 -72.41 -17.24 61.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.535 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.49 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 58.34 30.16 19.18 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.408 0.623 . . . . 0.0 111.098 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -52.31 -58.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.612 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -96.03 26.61 4.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.84 167.68 11.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -97.14 149.97 21.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.685 0.278 . . . . 0.0 110.983 -172.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.425 HG23 HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -137.23 146.67 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.408 0.623 . . . . 0.0 112.195 -178.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.64 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mmm-85 -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -143.33 53.49 1.35 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HZ ' ' CD1' ' A' ' 76' ' ' TYR . 39.6 m-85 -136.46 154.72 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -166.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.593 ' HB2' ' CE1' ' A' ' 121' ' ' TYR . 4.2 ttp180 -80.38 110.72 16.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.981 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -149.45 108.5 3.9 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.478 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.8 pt? -70.32 145.58 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.156 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 62.96 -152.34 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.603 0.564 . . . . 0.0 110.211 -174.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.1 m -129.41 89.63 2.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 111.187 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.5 mm-40 -113.62 142.21 27.29 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 9.8 Cg_exo -71.72 43.61 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.393 2.728 . . . . 0.0 113.905 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -117.2 158.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.467 ' HA ' ' CD ' ' A' ' 85' ' ' GLU . 31.1 m-70 69.57 107.48 0.06 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.636 0.585 . . . . 0.0 110.468 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.04 124.83 1.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.587 -172.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.522 ' CD1' ' HZ ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -108.02 112.4 24.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -119.08 143.96 46.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 68.48 -2.72 1.53 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.319 0.58 . . . . 0.0 110.729 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 9.47 52.11 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.728 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -134.17 167.59 20.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.04 151.9 23.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 164.13 12.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.65 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -22.7 63.81 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.55 -28.64 69.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.478 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' CD ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -86.85 -42.33 13.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.629 ' O ' HG21 ' A' ' 86' ' ' ILE . 7.5 tp 43.7 90.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.663 1.227 . . . . 0.0 112.61 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 HG12 ' HB ' ' A' ' 94' ' ' THR . 3.8 tp -65.39 -12.45 13.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.308 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -14.45 60.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.234 0.54 . . . . 0.0 109.78 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.1 -21.51 54.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.173 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -61.86 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 ' CG1' ' H ' ' A' ' 92' ' ' GLU . 2.1 p -169.72 -71.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.285 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.43 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER 177.85 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 109.887 -177.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -76.88 105.7 8.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.883 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.497 HG22 HG12 ' A' ' 110' ' ' ILE . 25.8 m -152.55 107.49 3.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 131.33 55.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.879 0.371 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -99.51 112.81 24.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.868 0.366 . . . . 0.0 110.177 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.41 105.76 10.95 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.954 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' HD13 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -100.32 1.78 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.456 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.6 -28.5 69.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 110.2 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.04 -17.46 78.31 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.548 HD13 ' HG2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -59.05 -28.29 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.88 0.34 . . . . 0.0 111.454 -173.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.12 -16.98 67.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.751 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -103.47 -4.26 24.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.516 0.326 . . . . 0.0 110.246 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 92.31 20.13 36.44 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.851 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -129.08 133.0 47.49 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 117.142 0.471 . . . . 0.0 111.511 -178.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.73 132.73 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -120.71 108.71 14.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.613 -177.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 64' ' ' TRP . 11.1 tp -91.96 121.67 33.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.289 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.788 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.545 HD11 HD21 ' A' ' 108' ' ' LEU . 38.3 mt -112.59 127.77 69.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.699 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 112' ' ' ASN . 31.4 t80 -83.48 122.61 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 32.6 t30 80.13 119.36 0.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.071 0.857 . . . . 0.0 111.68 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.575 HG13 ' HB1' ' A' ' 39' ' ' ALA . 7.1 p -117.9 134.59 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.412 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.5 p -103.78 171.27 7.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 112.007 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -67.06 -14.14 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.499 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.404 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 13.7 t0 -81.38 -34.02 31.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.455 ' HA ' ' CD ' ' A' ' 66' ' ' ARG . 32.6 m-20 -72.3 -24.84 61.39 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.014 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.56 -3.66 0.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.697 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.69 -132.12 1.71 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.813 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.486 ' HB2' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -106.62 127.12 53.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.105 0.479 . . . . 0.0 111.542 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-85 -90.37 148.48 22.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -106.19 113.66 27.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.781 0.324 . . . . 0.0 110.141 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 4.5 t -103.4 116.21 31.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.128 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.64 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 8.8 t -132.31 113.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.698 ' HE2' HG23 ' A' ' 30' ' ' VAL . 34.7 m-85 -93.27 136.09 33.87 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 126' ' ' LYS . 11.8 mtpp -121.01 102.97 8.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 33.9 t70 -99.05 74.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.548 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.15 -96.94 0.34 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.905 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.89 -27.83 17.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.67 0.271 . . . . 0.0 111.601 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.68 148.46 22.6 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.34 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -146.18 150.34 35.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.46 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.676 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -143.38 132.84 23.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.008 177.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -114.48 121.93 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 109.949 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.05 148.15 50.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -93.29 133.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.153 0.501 . . . . 0.0 110.772 -176.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -128.79 102.38 6.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.63 138.51 38.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 46.0 t -95.48 142.72 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.83 100.78 5.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.7 mt -81.83 97.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.682 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.92 61.81 6.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.243 0.544 . . . . 0.0 111.089 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -89.2 40.22 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -140.54 114.56 7.37 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.314 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' CB ' ' HB3' ' A' ' 130' ' ' PHE . 4.0 Cg_exo -77.2 -88.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.761 2.308 . . . . 0.0 110.991 173.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.76 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 13.4 p90 -140.67 160.55 39.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.75 172.35 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.582 . . . . 0.0 112.123 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.61 147.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.78 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 26.3 t30 -99.2 167.74 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.735 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.16 128.14 45.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.0 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -112.47 176.62 4.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.752 0.311 . . . . 0.0 110.518 -175.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HG2' HD21 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -73.53 -12.3 60.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.009 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 -132.35 11.02 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.567 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 55.5 Cg_endo -71.5 97.68 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.328 2.018 . . . . 0.0 111.513 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.78 113.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.1 mt -95.59 96.2 8.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.606 -175.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -127.4 170.84 12.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.885 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -97.38 145.35 26.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.777 0.322 . . . . 0.0 110.239 -170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.661 ' HB2' HG21 ' A' ' 140' ' ' ILE . 0.9 OUTLIER -70.71 142.65 51.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.13 -173.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.16 -8.07 72.44 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.698 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.12 -167.98 35.98 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.237 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.26 134.59 33.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.285 0.564 . . . . 0.0 110.412 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.936 ' HG ' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -106.05 111.0 23.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.289 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 96.89 6.8 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.63 129.22 42.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.879 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -107.49 128.94 54.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.11 140.26 50.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.672 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -125.96 129.72 49.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.597 0.237 . . . . 0.0 110.758 -175.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 HD23 ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -129.69 165.49 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.564 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.71 83.45 48.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.071 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HD3' HD23 ' A' ' 51' ' ' LEU . 86.6 Cg_endo -95.02 162.73 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.305 2.67 . . . . 0.0 113.107 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -88.44 37.45 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.947 2.431 . . . . 0.0 111.612 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -160.32 177.34 10.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.048 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.88 2.12 55.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.038 0.447 . . . . 0.0 109.817 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 62.28 24.77 14.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.907 172.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -67.81 -24.21 65.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 109.858 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -104.0 17.11 24.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.472 ' HA ' ' HB3' ' A' ' 127' ' ' ASP . 18.6 ttm -76.2 118.95 19.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 110.985 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.529 ' CG ' ' HB3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -78.67 98.88 6.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -111.22 140.48 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 111.336 -172.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.874 ' HB3' HG13 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.33 118.93 13.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -114.19 63.24 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 81.0 m-85 -136.01 151.28 49.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.604 -168.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.584 HH21 ' HB3' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -87.83 141.87 28.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.63 175.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.401 ' HB2' HH12 ' A' ' 63' ' ' ARG . 0.4 OUTLIER -164.64 107.43 0.88 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.77 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -73.44 134.05 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 168.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 5.8 t80 64.51 91.14 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -162.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.17 102.09 0.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.699 -170.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 73' ' ' VAL . 20.3 mm-40 -104.67 121.5 46.75 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.627 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.92 1.37 8.7 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.831 2.354 . . . . 0.0 112.494 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 71' ' ' GLU . 13.4 p -79.78 50.29 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 122.334 1.064 . . . . 0.0 110.847 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -171.16 65.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.778 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -146.71 152.24 38.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.693 -175.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.19 128.85 42.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.634 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.52 128.96 34.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -175.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.6 t70 62.25 15.08 7.25 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.463 0.649 . . . . 0.0 111.269 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' HA2' ' HE2' ' A' ' 98' ' ' LYS . . . 82.47 20.19 62.61 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.975 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.3 154.27 49.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.025 0.441 . . . . 0.0 111.065 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -132.22 139.03 48.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.916 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -177.8 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -67.09 -23.81 65.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.58 -53.36 5.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.047 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 75' ' ' LEU . 16.4 pm0 -93.15 15.31 15.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.543 0.337 . . . . 0.0 111.777 -175.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 83' ' ' PHE . 2.4 tt -42.58 121.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.712 0.768 . . . . 0.0 112.303 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.574 HD12 HD11 ' A' ' 108' ' ' LEU . 14.3 tt -72.75 -36.42 52.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.792 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.557 ' N ' HG21 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -61.69 -13.97 27.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -71.48 -12.42 61.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.534 -177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE1' ' HD1' ' A' ' 65' ' ' PHE . 1.3 t80 -58.76 -60.74 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -64.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -161.44 -91.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.921 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.459 ' H ' ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -72.1 111.78 7.63 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.617 HG22 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -140.91 90.8 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.054 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.01 127.08 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.095 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.477 HD23 ' HD3' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -97.65 100.5 11.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 110.951 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 9.3 mp -73.08 110.98 7.77 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.758 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HD3' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -101.14 -4.71 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.703 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.63 -29.33 67.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.272 0.558 . . . . 0.0 111.07 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.31 -17.94 77.07 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.829 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.528 HG12 ' HB3' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -59.54 -26.37 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -170.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -21.93 67.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.793 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.62 5.03 26.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 0.0 110.206 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 83.3 31.47 27.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.109 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.672 ' HG3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -123.78 132.25 53.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.16 0.48 . . . . 0.0 110.89 179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -121.32 132.79 69.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -120.02 105.04 10.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.309 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.574 HD11 HD12 ' A' ' 87' ' ' ILE . 7.0 tp -94.43 118.18 31.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.353 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -95.14 106.21 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.927 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.617 HG12 HG22 ' A' ' 94' ' ' THR . 65.4 mt -117.35 130.28 72.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.402 ' CG ' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER -91.0 134.53 34.42 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.465 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.8 t30 73.58 81.55 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.098 0.874 . . . . 0.0 112.237 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 140' ' ' ILE . 8.4 p -82.09 140.81 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.992 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -117.65 176.51 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.974 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.42 -14.25 18.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.243 0.544 . . . . 0.0 110.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.584 ' HB3' HH21 ' A' ' 66' ' ' ARG . 30.3 t70 -80.58 -24.56 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.692 ' HB2' HG21 ' A' ' 113' ' ' VAL . 4.3 m-20 -86.13 -20.27 28.92 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.698 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.418 ' HB2' HD13 ' A' ' 140' ' ' ILE . 31.2 t0 -63.84 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.069 0.948 . . . . 0.0 112.776 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -153.38 -119.96 0.78 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.944 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 123.41 24.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.721 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -125.02 161.26 27.13 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.404 172.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.57 119.68 24.04 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.298 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -105.0 117.61 34.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.229 173.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.874 HG13 ' HB3' ' A' ' 63' ' ' ARG . 5.1 p -124.11 141.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.226 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.76 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -136.13 121.2 18.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.583 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -135.22 110.2 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 60' ' ' MET . 11.1 p-10 -116.8 95.91 5.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.127 0.965 . . . . 0.0 110.983 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.72 -82.92 1.38 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.693 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -118.87 -23.62 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.55 ' HB3' ' CB ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -97.28 141.34 30.5 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -148.26 145.46 28.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -150.26 132.3 15.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.871 ' HB3' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -128.22 121.56 29.69 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 139.83 49.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.192 0.52 . . . . 0.0 111.16 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -74.85 138.79 20.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.58 175.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.79 160.2 37.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -121.13 135.37 55.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.22 -175.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 43.1 t -104.92 142.46 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.64 118.46 24.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.251 0.548 . . . . 0.0 111.137 -177.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.942 HD11 HG23 ' A' ' 113' ' ' VAL . 1.5 mp -82.77 119.29 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.605 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.73 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.91 75.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.562 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.5 m -151.85 33.61 0.54 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -61.81 132.41 93.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.934 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.6 Cg_exo -71.03 -175.76 1.58 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 52' ' ' SER . 1.7 p90 -71.8 137.32 47.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -119.28 178.86 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.247 0.546 . . . . 0.0 112.36 -171.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' A' ' 51' ' ' LEU . 1.7 p -90.77 147.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.623 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 15.3 t30 -120.44 130.48 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.96 74.34 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.834 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -78.25 111.24 14.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.5 -24.72 67.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.47 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 136' ' ' THR . . . 69.22 -120.55 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.02 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.21 90.18 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.781 2.321 . . . . 0.0 111.66 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.01 117.66 18.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mt -91.2 134.21 34.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.025 0.44 . . . . 0.0 110.811 -171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.609 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -136.02 172.56 12.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.107 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.55 133.88 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -64.38 124.69 22.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 -177.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.78 -12.17 36.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.304 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.97 -147.33 22.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.223 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -108.25 153.05 23.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.99 0.424 . . . . 0.0 111.228 -176.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 39' ' ' ALA . 1.4 tp -140.95 113.55 8.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.376 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.827 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -92.95 111.86 23.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -95.91 127.53 42.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.817 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.79 43.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 139.72 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -125.66 137.17 53.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.4 mm? -126.22 164.96 19.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.951 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -111.79 80.98 3.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 99.0 Cg_endo -81.74 142.84 12.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.629 2.219 . . . . 0.0 112.882 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 12.6 Cg_exo -71.6 -26.17 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.958 2.439 . . . . 0.0 111.711 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -129.51 -172.14 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.488 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -68.08 -28.66 67.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB1' ' SD ' ' A' ' 60' ' ' MET . . . 63.36 25.51 14.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.619 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -60.66 -33.7 73.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.922 0.392 . . . . 0.0 111.253 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -113.22 28.48 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.694 ' HE2' ' HB2' ' A' ' 127' ' ' ASP . 7.8 ptm -80.21 169.34 17.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 111.49 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.679 ' HG2' HD13 ' A' ' 75' ' ' LEU . 3.5 mt-10 -89.68 121.18 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.16 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -114.98 139.47 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.45 . . . . 0.0 110.231 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -133.67 118.04 17.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.603 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -132.08 61.1 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.2 147.67 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.266 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.795 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -72.05 139.48 48.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 177.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -133.99 114.58 13.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.47 93.48 3.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 63.03 18.74 11.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.31 151.12 19.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.936 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.737 ' HG2' ' HD2' ' A' ' 72' ' ' PRO . 2.5 tt0 -63.16 147.87 93.91 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 171.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.737 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 45.7 Cg_endo -70.98 44.14 0.51 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.753 2.302 . . . . 0.0 112.887 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 71' ' ' GLU . 4.2 t -105.91 72.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.99 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 6.6 m170 -151.16 70.94 0.99 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.248 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.837 HD12 ' HB2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.99 151.7 33.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.307 0.575 . . . . 0.0 112.367 -173.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -129.2 109.5 11.2 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.837 ' HB2' HD12 ' A' ' 75' ' ' LEU . 3.0 ttt-85 -116.31 89.09 3.03 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.165 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.0 t0 52.85 59.7 4.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.018 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.11 7.84 84.71 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.1 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.81 124.32 50.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.543 -0.387 . . . . 0.0 111.316 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -126.56 152.64 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.22 -158.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.85 0.357 . . . . 0.0 111.563 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -41.63 99.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.14 -30.41 31.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.12 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.99 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.4 pm0 -112.42 13.77 20.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 HG23 ' HD3' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -46.38 112.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.651 0.739 . . . . 0.0 110.257 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 94' ' ' THR . 3.1 tp -69.05 -12.61 16.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.732 -167.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -13.51 58.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.186 0.517 . . . . 0.0 110.282 173.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.468 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -78.92 -16.8 56.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.267 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.44 -33.34 32.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.24 167.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 124.04 0.838 . . . . 0.0 112.213 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 65.01 -105.92 0.13 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.477 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.461 ' HB3' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -127.51 120.79 29.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -171.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.411 HG23 HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -137.15 92.97 2.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.199 175.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.54 116.11 31.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.461 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.98 109.35 20.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.469 HD13 ' HB ' ' A' ' 107' ' ' THR . 12.7 mt -87.37 106.15 17.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HE2' HG23 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -110.73 -3.73 15.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.456 -172.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.29 -12.79 61.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.517 0.675 . . . . 0.0 111.071 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.65 -17.34 70.93 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.43 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.557 HG23 ' HE2' ' A' ' 98' ' ' LYS . 1.7 tt -57.33 -23.27 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.12 -18.99 58.74 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -120.32 7.9 10.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.225 0.536 . . . . 0.0 109.954 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 80.41 43.67 9.25 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.195 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.2 mppp? -126.67 133.05 51.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.466 0.633 . . . . 0.0 110.854 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.508 HG23 ' HZ ' ' A' ' 125' ' ' PHE . 2.8 m -138.49 134.7 43.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.572 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 97' ' ' LEU . 1.1 m -122.54 111.57 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.599 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 110' ' ' ILE . 13.0 tp -103.44 110.83 23.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.827 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -87.33 106.09 17.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.517 176.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.636 HD12 HD21 ' A' ' 108' ' ' LEU . 4.9 mt -111.68 129.63 66.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 44' ' ' ASN . 5.4 m-85 -107.06 155.96 19.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.789 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.6 t30 69.61 54.21 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.297 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.56 124.0 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.727 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.537 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 68.5 p -101.88 168.05 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.31 -26.39 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.528 0.68 . . . . 0.0 110.196 176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.25 -28.49 31.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER -72.84 -25.68 61.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.871 175.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.52 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.1 t70 -63.13 26.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.358 1.063 . . . . 0.0 113.824 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -100.25 -147.65 21.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.566 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -92.3 107.83 19.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.169 0.509 . . . . 0.0 111.352 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.795 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.5 m-85 -73.92 157.45 36.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -126.84 118.29 24.32 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.343 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 10.3 t -99.51 116.72 32.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 28.9 t -136.34 118.71 20.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.213 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.508 ' HZ ' HG23 ' A' ' 106' ' ' VAL . 2.2 m-85 -112.18 128.21 56.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -120.64 117.64 28.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.593 0.235 . . . . 0.0 110.795 -178.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.694 ' HB2' ' HE2' ' A' ' 60' ' ' MET . 21.1 t0 -117.47 93.76 4.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.036 0.445 . . . . 0.0 110.469 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.49 -80.21 0.9 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.095 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.82 -29.36 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -102.9 150.03 23.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.596 -174.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 16.6 p90 -145.51 144.76 30.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 3.7 tp10 -111.82 131.39 55.37 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.55 121.18 28.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.651 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.22 134.58 44.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.047 0.451 . . . . 0.0 110.391 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.75 130.98 35.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.237 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -132.88 102.0 5.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.232 -178.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 2.7 mm-40 -73.77 125.61 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.676 0.274 . . . . 0.0 110.849 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.85 134.38 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -122.89 104.66 9.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.021 0.439 . . . . 0.0 111.795 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 31.2 mt -76.51 96.25 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.177 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.747 0.308 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.85 147.91 48.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.331 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -125.7 14.68 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.062 0.934 . . . . 0.0 108.719 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 32.5 mp0 -100.06 125.4 40.1 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.147 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.89 ' HB2' ' HB3' ' A' ' 130' ' ' PHE . 30.5 Cg_exo -61.88 -31.94 85.1 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.708 2.272 . . . . 0.0 112.677 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' HD1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -154.19 143.83 21.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.895 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -115.47 169.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.366 0.603 . . . . 0.0 111.314 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 125' ' ' PHE . 2.2 t -120.16 120.58 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.265 -174.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -78.48 132.85 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.95 -175.63 14.11 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.521 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.25 178.89 4.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -57.9 -38.85 76.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.438 . . . . 0.0 109.974 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' HD3' ' A' ' 36' ' ' PRO . . . 74.73 62.39 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.19 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 20.2 Cg_endo -96.22 75.78 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.422 2.748 . . . . 0.0 111.295 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.415 HG13 ' HG ' ' A' ' 47' ' ' LEU . 21.8 t -78.41 93.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.159 0.504 . . . . 0.0 110.761 -177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.689 ' HA ' ' HG3' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -86.67 103.72 15.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.751 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.31 9.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.809 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.52 140.88 37.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -64.25 110.52 2.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.593 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.75 7.86 88.11 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.403 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.48 -160.24 28.01 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.378 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -82.85 110.87 18.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.145 0.498 . . . . 0.0 110.305 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -98.74 123.85 43.22 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.22 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 8.4 mt-10 -126.23 108.7 11.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.149 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD12 HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -96.3 143.95 26.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.193 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.07 114.63 25.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.065 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.594 ' HB2' ' CH2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -118.59 141.17 48.84 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 146.67 49.89 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.29 145.24 50.86 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.371 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -65.87 108.26 2.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 37.6 Cg_exo -60.7 108.98 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.52 2.814 . . . . 0.0 114.587 -167.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 52' ' ' SER . 71.3 Cg_endo -94.43 -22.27 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.083 2.522 . . . . 0.0 111.602 170.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -156.5 -172.23 3.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.573 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 3.0 pt20 -77.87 -17.36 57.43 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.189 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB2' HG12 ' A' ' 101' ' ' ILE . . . 59.01 13.85 3.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.928 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -65.3 -33.28 75.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.073 0.463 . . . . 0.0 110.053 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.91 17.64 19.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.704 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 127' ' ' ASP . 3.5 ttm -84.69 142.52 29.82 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 77' ' ' ARG . 19.5 mt-10 -88.65 142.45 27.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD11 HD22 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -135.22 131.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.255 0.55 . . . . 0.0 111.12 -178.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' HD3' ' HB2' ' A' ' 75' ' ' LEU . 1.5 ttp180 -110.81 115.39 29.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.594 ' CH2' ' HB2' ' A' ' 49' ' ' CYS . 4.7 t90 -140.64 79.52 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.834 0.35 . . . . 0.0 111.339 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.64 ' HB3' ' HE2' ' A' ' 90' ' ' TYR . 7.1 m-85 -154.75 169.01 24.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.688 ' HD3' ' HA ' ' A' ' 117' ' ' ASP . 9.4 ttp85 -96.67 93.76 6.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.683 -0.807 . . . . 0.0 108.934 168.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -163.83 107.18 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.73 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 mp -104.23 84.93 2.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 110.206 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -107.58 153.42 22.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.24 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -30.03 67.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.16 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HB2' HG22 ' A' ' 73' ' ' VAL . 2.1 mp0 -97.85 163.1 20.17 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.26 40.64 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.057 2.505 . . . . 0.0 112.479 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 71' ' ' GLU . 23.4 t -75.74 144.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.16 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.8 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.6 OUTLIER 65.64 81.5 0.2 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 123.873 0.733 . . . . 0.0 110.794 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.91 143.0 27.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.541 -175.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -95.25 111.15 23.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.609 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -112.16 125.58 54.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.878 -171.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 72.26 -10.99 0.84 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.457 0.646 . . . . 0.0 110.948 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.74 17.79 22.49 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -168.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.98 138.3 53.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.214 -0.493 . . . . 0.0 109.973 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.86 161.83 20.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.263 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.514 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.98 148.67 38.96 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.635 -175.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.42 ' O ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -75.72 -16.99 60.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.265 0.555 . . . . 0.0 110.39 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.95 73.81 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.044 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.8 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 1.7 pp20? -105.36 -41.26 5.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.41 0.148 . . . . 0.0 110.666 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 83' ' ' PHE . 48.5 mt 70.1 95.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.843 0.83 . . . . 0.0 111.41 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.796 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 1.8 tt -75.08 -16.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.274 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -12.96 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.704 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -53.73 -28.13 32.43 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.783 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.64 ' HE2' ' HB3' ' A' ' 65' ' ' PHE . 3.1 m-85 -98.06 -33.24 11.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.276 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 77.63 163.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 124.186 0.929 . . . . 0.0 111.663 175.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.478 ' N ' HG11 ' A' ' 91' ' ' VAL . 0.3 OUTLIER 75.65 -167.12 0.08 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.984 177.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -65.9 112.6 3.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.342 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.711 HG22 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -126.33 112.18 15.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.333 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.681 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 1.3 pt-20 -137.54 129.73 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.201 0.524 . . . . 0.0 110.629 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.681 HD22 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.98 107.31 19.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.639 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -74.53 99.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.127 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 6.25 49.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.522 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.24 -34.12 63.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.975 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.02 -17.29 65.52 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.962 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.8 HG12 ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.41 -21.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.72 61.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.625 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 3.65 20.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.81 31.62 8.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.726 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.46 132.68 53.5 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.673 0.737 . . . . 0.0 111.389 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.7 133.79 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 O-C-N 122.161 -0.337 . . . . 0.0 110.515 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.98 111.65 19.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.705 HD21 HD12 ' A' ' 47' ' ' LEU . 27.4 tp -86.43 113.42 22.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.681 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 3.3 mpt_? -98.82 106.77 19.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.711 HG12 HG22 ' A' ' 94' ' ' THR . 14.6 mt -127.45 120.78 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -80.79 127.82 32.95 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 83.26 133.95 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.309 1.006 . . . . 0.0 111.213 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -145.02 139.51 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.304 178.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -111.92 172.71 6.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.203 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 p -65.12 -10.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.162 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.91 -50.33 13.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.012 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.688 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -78.11 -9.75 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.784 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -55.0 -22.47 15.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.276 177.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.13 -86.7 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.173 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.19 155.86 43.52 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.604 -0.35 . . . . 0.0 111.004 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' HD1' HG21 ' A' ' 138' ' ' VAL . 1.7 m-85 -103.81 127.51 51.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.451 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 68.6 t60 -76.49 101.67 5.72 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.73 117.32 34.4 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.413 1.071 . . . . 0.0 109.861 -176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.01 116.49 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 0.8 OUTLIER -96.08 112.78 24.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.287 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 2.8 mtpt -119.7 105.0 10.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.95 0.405 . . . . 0.0 110.834 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.593 ' HB2' ' HE1' ' A' ' 60' ' ' MET . 23.3 t0 -111.37 108.36 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.698 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.18 -102.21 0.7 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.87 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.65 -18.15 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.89 ' HB3' ' HB2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.72 135.96 33.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 110.266 -177.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 1.7 p90 -144.76 151.44 38.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.895 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.5 140.67 43.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 124.82 46.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.322 0.582 . . . . 0.0 110.791 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.38 158.84 42.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.583 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -114.62 112.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.969 0.414 . . . . 0.0 110.427 177.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 120.13 19.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.303 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.06 118.7 13.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.006 0.431 . . . . 0.0 110.731 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.551 HG21 ' HD1' ' A' ' 121' ' ' TYR . 1.8 t -105.38 151.58 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.711 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.37 141.06 37.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.71 139.02 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.537 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.5 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -68.63 121.62 16.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.6 m -146.09 20.71 1.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 0.0 109.787 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -76.55 118.19 69.85 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.088 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.43 -9.19 24.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.069 2.513 . . . . 0.0 112.482 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -166.19 147.85 6.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.428 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -138.63 169.73 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.554 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 50' ' ' GLN . 54.7 t -90.73 111.88 24.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -87.82 150.17 23.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.44 -156.14 38.7 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.706 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -147.17 137.02 23.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.726 ' HB2' HG22 ' A' ' 136' ' ' THR . 0.0 OUTLIER -96.49 -49.13 5.28 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 -134.59 47.95 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.85 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.84 97.97 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.417 2.744 . . . . 0.0 112.81 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.24 119.53 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.991 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -106.16 132.83 51.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.927 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.16 170.91 18.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.081 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.28 131.29 47.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.828 ' HB3' HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -71.63 142.22 49.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.022 0.439 . . . . 0.0 110.488 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.1 -29.86 10.5 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.21 -153.51 26.27 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.6 p-10 -110.04 135.72 50.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.502 0.668 . . . . 0.0 111.074 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.587 HD12 HG11 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -97.92 110.9 23.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.304 175.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.73 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -97.15 99.62 11.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.96 127.99 42.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -116.7 119.04 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.612 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.645 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -117.06 139.93 50.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.557 ' O ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -127.3 132.68 50.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.875 -174.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -128.48 156.91 42.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.919 175.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -87.52 101.6 2.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.624 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 87.2 Cg_endo -86.54 126.45 2.62 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 114.142 -166.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.17 -27.23 13.97 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.372 2.048 . . . . 0.0 110.665 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.624 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 2.8 pt20 -136.21 178.46 7.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' HG3' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -71.45 -19.78 62.18 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.59 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.89 19.67 9.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.767 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.55 -30.54 65.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.537 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -113.5 17.2 18.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 5.2 mmt -87.74 -166.61 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.748 0.309 . . . . 0.0 111.26 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 30.9 mt-10 -114.54 136.53 52.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.962 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -132.17 146.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.809 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 10.9 ttt-85 -141.23 115.21 9.18 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.645 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -129.89 90.19 2.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.588 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 77.8 m-85 -143.57 164.18 31.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.068 -172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 136.88 56.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.962 0.411 . . . . 0.0 109.933 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.73 106.35 8.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.46 129.73 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.163 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 67.44 -83.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.696 0.622 . . . . 0.0 111.492 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.11 44.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.24 82.53 47.14 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.22 -173.05 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.048 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 48.6 t -64.17 102.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 12.0 p-80 -141.97 102.61 4.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.809 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -164.3 152.16 12.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 -174.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.37 115.61 27.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.416 ' HB2' ' HG2' ' A' ' 61' ' ' GLU . 9.4 ttm180 -111.36 123.92 51.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -3.32 2.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.887 0.851 . . . . 0.0 109.828 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.6 25.76 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -120.9 149.87 41.95 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 115.051 -0.575 . . . . 0.0 110.875 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -99.57 169.99 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -158.43 163.23 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.318 . . . . 0.0 110.759 -176.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -13.7 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.35 -47.51 7.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.31 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -72.4 -32.38 66.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.512 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER 50.11 59.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.656 1.217 . . . . 0.0 112.407 176.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 94' ' ' THR . 16.3 tt -67.11 -1.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.025 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -13.95 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.18 0.514 . . . . 0.0 109.891 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -13.68 62.21 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.053 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 74.6 m-85 -109.75 27.05 9.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 77.2 t 77.78 -75.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.811 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 170.69 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.069 0.462 . . . . 0.0 109.851 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -74.24 70.68 1.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -176.064 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.776 HG22 HD12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -131.79 120.54 22.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.046 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 124.8 46.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.471 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.514 HD13 HD13 ' A' ' 108' ' ' LEU . 69.7 tp -102.88 105.79 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.957 0.408 . . . . 0.0 110.168 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.643 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -82.95 117.69 22.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -110.65 10.73 22.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -37.33 83.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.342 0.592 . . . . 0.0 110.068 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.24 79.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.899 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 56' ' ' GLN . 2.0 tt -57.59 -29.72 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.988 0.394 . . . . 0.0 111.657 -172.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.538 ' HA2' ' HG3' ' A' ' 56' ' ' GLN . . . -66.54 -18.3 67.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.129 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 3.95 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.924 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 41.48 6.77 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.621 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -137.77 133.68 34.36 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.292 0.546 . . . . 0.0 111.097 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' SER . 15.9 m -119.36 139.69 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.405 174.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -117.91 104.39 10.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.803 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 64' ' ' TRP . 8.9 tp -93.65 110.23 21.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.73 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 1.5 ttp85 -93.0 106.32 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 94' ' ' THR . 78.0 mt -113.79 106.41 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.147 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -86.83 146.82 26.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 t30 70.0 54.76 0.34 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 123.987 0.804 . . . . 0.0 110.174 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.582 HG23 HD13 ' A' ' 45' ' ' LEU . 12.2 p -78.29 137.56 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.704 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -120.33 162.01 20.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.926 0.393 . . . . 0.0 111.557 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 9.9 p -68.59 -16.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.439 0.638 . . . . 0.0 110.369 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.24 -33.73 76.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.472 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.93 -12.69 14.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.497 -175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.684 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.59 -9.89 1.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.01 -86.2 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.974 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -140.74 118.69 11.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.086 -0.656 . . . . 0.0 111.608 -175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' CD1' HG21 ' A' ' 138' ' ' VAL . 10.9 m-85 -93.55 127.95 39.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.601 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 1.9 m-70 -101.26 127.54 47.81 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 48.1 t -106.16 116.81 32.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.109 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.725 ' HB ' HH11 ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.12 130.2 74.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.4 m-85 -108.12 126.26 52.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.962 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.584 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -116.82 104.91 11.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.815 0.34 . . . . 0.0 110.305 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.546 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 21.8 t70 -111.45 107.0 16.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.946 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.53 -92.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.156 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.51 -20.26 7.85 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -101.65 155.8 17.88 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 -173.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 33.0 p90 -144.67 150.37 37.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.33 133.42 50.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.815 176.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' HG21 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -114.92 121.49 43.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.293 0.568 . . . . 0.0 110.705 -177.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.26 159.15 21.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.757 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.76 108.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.331 0.586 . . . . 0.0 110.875 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.726 HG22 ' HB2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.34 102.0 11.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.857 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 0.5 OUTLIER -80.54 129.96 34.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 45' ' ' LEU . 84.4 t -102.8 146.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 0.0 110.48 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.1 94.39 4.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.742 176.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.828 HG22 ' HB3' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -78.09 137.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.963 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 tmm? . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.472 -0.195 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 m 59.85 -92.5 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.634 0.584 . . . . 0.0 112.011 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.03 41.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.418 0.627 . . . . 0.0 109.365 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.73 134.83 92.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 96.1 Cg_endo -84.06 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.136 2.557 . . . . 0.0 112.407 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CE2' HD22 ' A' ' 51' ' ' LEU . 3.1 p90 -110.77 159.85 17.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.802 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -135.25 179.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.393 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.6 t -115.57 106.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.89 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -112.33 131.14 55.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.445 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.0 -113.39 0.58 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.908 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.83 161.63 20.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.399 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -83.5 -49.03 9.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.935 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.769 ' HA3' HG21 ' A' ' 136' ' ' THR . . . 139.95 87.02 0.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.579 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -94.6 40.6 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.114 2.542 . . . . 0.0 111.282 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.61 119.78 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.274 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.43 139.33 36.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.627 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.63 169.73 17.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.42 144.77 43.31 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.36 111.81 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.17 84.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.329 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.67 -161.8 30.03 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -99.9 146.9 26.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.389 0.614 . . . . 0.0 111.384 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 113' ' ' VAL . 17.8 tp -134.49 119.26 18.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.803 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.97 110.34 22.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 107' ' ' THR . 0.9 OUTLIER -94.36 127.24 40.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 122.83 47.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.527 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.707 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.64 141.22 48.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.423 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -106.78 141.43 38.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.077 0.465 . . . . 0.0 110.634 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.591 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -125.24 136.9 54.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 -176.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 m -97.95 87.64 0.55 Allowed Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 93.5 Cg_endo -91.2 133.05 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.002 2.468 . . . . 0.0 114.365 -165.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.43 4.14 5.19 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.167 2.578 . . . . 0.0 110.488 168.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.45 -176.35 4.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.194 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -89.62 -6.72 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 71.57 -3.35 2.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.662 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.523 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 3.4 mt-30 -61.99 -28.17 69.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.25 16.63 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.08 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.665 ' HE2' ' HB2' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -93.7 170.72 9.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.392 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.86 130.65 56.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -127.4 147.05 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.351 0.596 . . . . 0.0 111.275 -177.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 116.64 22.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.568 ' HB3' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -126.38 64.33 1.25 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 74' ' ' HIS . 82.3 m-85 -142.24 152.18 42.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.727 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.816 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.42 143.78 57.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 -177.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.612 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 9.7 t30 -120.47 108.15 13.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.024 0.44 . . . . 0.0 111.358 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 mp -108.63 -177.01 3.2 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -78.6 60.23 2.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.216 0.531 . . . . 0.0 110.256 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 -176.01 4.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.303 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 mm-40 -69.19 120.89 79.66 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.253 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 6.2 Cg_exo -79.19 66.14 8.8 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.886 2.391 . . . . 0.0 111.576 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -93.02 78.6 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.922 0.868 . . . . 0.0 110.678 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.674 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -170.41 136.61 1.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.503 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.35 126.37 0.42 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.297 0.373 . . . . 0.0 110.33 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.651 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.08 128.16 41.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 138.26 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.23 -170.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 64.09 21.21 12.5 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.611 0.719 . . . . 0.0 110.061 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.54 17.1 72.41 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 168.64 17.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.141 0.496 . . . . 0.0 111.029 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.32 153.52 18.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.324 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 mtt -135.84 153.35 51.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -5.46 29.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.854 0.359 . . . . 0.0 111.062 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.97 -15.75 69.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.093 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.583 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -118.79 -39.83 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.523 0.201 . . . . 0.0 110.49 178.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.583 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 mt 53.92 85.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 111.954 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.674 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 3.5 tt -65.44 -28.57 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.576 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -14.58 52.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.511 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -14.05 43.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.862 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.2 -52.0 18.53 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 92' ' ' GLU . 4.2 p -178.34 175.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.952 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' H ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -85.77 150.27 24.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.764 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER 63.74 64.78 0.76 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.827 -175.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 m -120.87 106.78 11.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.89 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -117.4 118.39 32.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.515 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.57 98.06 11.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mt -72.07 109.2 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 20.2 mtmt -108.11 14.0 25.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.655 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -20.65 66.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.493 0.663 . . . . 0.0 110.512 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.83 -17.21 66.09 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.473 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.672 HG23 ' N ' ' A' ' 102' ' ' GLY . 1.9 tt -51.9 -38.42 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 101' ' ' ILE . . . -66.59 -19.9 69.46 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.373 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.67 22.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.93 45.02 8.63 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.69 133.08 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.185 -0.597 . . . . 0.0 110.642 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.91 132.25 70.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.151 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -123.53 104.19 8.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 64' ' ' TRP . 7.1 tp -88.7 111.89 22.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.26 0.553 . . . . 0.0 110.286 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -90.51 106.49 18.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.739 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 43.0 mt -114.15 116.57 52.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.764 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 13.3 m-85 -88.77 146.32 25.08 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.815 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.53 62.98 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.911 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -65.97 141.54 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.949 175.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.96 167.42 15.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.949 0.404 . . . . 0.0 111.803 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -70.56 -13.06 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.396 0.617 . . . . 0.0 110.192 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.494 ' HB3' ' NH2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -73.19 -23.61 60.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.94 171.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.91 -11.27 15.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.763 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -62.04 -5.34 2.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.434 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.09 -133.91 1.46 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.658 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.36 124.98 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.191 0.52 . . . . 0.0 111.281 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.816 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 3.3 m-85 -88.22 135.44 33.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.612 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -100.92 119.83 39.27 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.96 0.409 . . . . 0.0 110.02 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.7 t -104.05 118.34 36.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.341 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.11 128.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.206 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 29.3 m-85 -116.21 137.3 52.26 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -140.61 120.97 13.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.126 0.489 . . . . 0.0 110.918 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.665 ' HB2' ' HE2' ' A' ' 60' ' ' MET . 38.9 t70 -132.48 133.87 44.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.451 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.8 -107.55 1.98 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.312 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -120.21 -6.16 9.91 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.71 141.78 35.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 0.0 111.01 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -134.46 154.33 51.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.802 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -133.41 147.27 51.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.031 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -121.35 149.91 42.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.291 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 138.94 18.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.131 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mm -98.62 128.69 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.769 HG21 ' HA3' ' A' ' 35' ' ' GLY . 63.0 m -124.43 109.12 12.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.685 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.98 134.3 37.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.29 124.23 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.147 0.498 . . . . 0.0 110.106 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -98.7 90.7 4.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.56 119.77 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.345 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 tpp . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.64 109.38 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 110.287 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -147.16 36.14 0.91 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.687 0.755 . . . . 0.0 109.406 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -94.14 117.12 67.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.145 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.2 -80.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.079 1.853 . . . . 0.0 111.16 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -167.49 145.22 4.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.7 pt -132.02 176.83 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.799 0.333 . . . . 0.0 110.663 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 50' ' ' GLN . 37.1 t -102.97 113.85 40.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.782 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -94.66 131.83 40.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.163 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.45 -172.16 15.24 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.8 148.66 22.68 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -47.25 13.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.48 116.88 4.26 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.286 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.91 91.93 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.331 2.02 . . . . 0.0 111.189 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.49 100.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.67 113.32 25.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.926 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -125.98 171.52 10.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.289 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.1 m -122.12 143.88 49.27 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.72 135.93 57.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -174.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.09 89.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.861 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.2 168.02 17.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.73 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.1 p-10 -79.84 122.68 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.19 0.519 . . . . 0.0 110.512 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.574 HD12 HD22 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -90.39 111.21 22.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.079 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' CG ' ' A' ' 109' ' ' ARG . 1.8 mp0 -94.3 105.73 17.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.574 HD22 HD12 ' A' ' 45' ' ' LEU . 2.0 mm? -96.07 128.46 42.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.45 123.62 49.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.701 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.83 140.26 53.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.884 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -130.53 140.71 50.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.84 158.61 37.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.9 m -90.47 98.87 1.65 Allowed Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 10.2 Cg_endo -88.26 125.25 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.371 2.714 . . . . 0.0 114.006 -167.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 73.0 Cg_endo -81.11 -17.81 9.08 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 110.837 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.32 -171.66 2.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.112 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -89.89 -10.92 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 0.0 110.165 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 60' ' ' MET . . . 66.16 -1.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HG3' ' HB2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -57.25 -42.18 81.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.156 0.503 . . . . 0.0 110.915 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -99.92 26.11 6.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.81 ' HG2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -92.17 175.9 6.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.735 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HG2' HD12 ' A' ' 75' ' ' LEU . 41.8 mt-10 -113.64 129.88 56.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.802 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -125.61 129.17 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.349 0.595 . . . . 0.0 111.216 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 20.4 mtp180 -114.45 117.75 31.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.322 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.688 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.69 60.3 1.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.45 ' CE1' HG13 ' A' ' 87' ' ' ILE . 62.8 m-85 -139.59 152.35 46.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.74 0.781 . . . . 0.0 112.859 -166.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.747 ' HB2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -148.51 126.22 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.167 168.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -152.2 156.44 39.77 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.85 138.16 43.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.74 66.72 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.33 0.586 . . . . 0.0 111.46 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.17 -58.93 1.96 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -154.6 83.74 3.97 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.465 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.28 170.34 18.72 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.726 2.284 . . . . 0.0 113.201 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.579 ' CG1' ' HA ' ' A' ' 87' ' ' ILE . 2.0 t -68.72 154.72 8.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.464 175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 65.5 m170 -104.0 -86.63 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.859 -171.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.594 HD12 ' HG2' ' A' ' 61' ' ' GLU . 1.9 pt? -163.76 143.41 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 0.0 112.009 -170.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.63 ' HE1' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.06 129.27 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.041 175.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -131.41 132.24 44.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.337 -175.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.2 t0 58.22 21.59 8.28 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.609 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.52 14.66 81.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.174 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 147.24 45.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.79 0.328 . . . . 0.0 110.688 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.543 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.0 p30 -118.49 169.68 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.88 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.25 152.99 50.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.09 -17.27 63.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.88 84.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.232 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.843 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 1.7 pp20? -117.63 -38.32 3.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.593 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.7 tp 39.06 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.046 1.339 . . . . 0.0 113.82 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.63 HG21 ' HE1' ' A' ' 76' ' ' TYR . 14.2 tt -56.91 -31.27 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.67 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -12.28 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.194 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.25 -30.94 68.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.701 0.286 . . . . 0.0 110.549 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -71.5 -59.03 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 94' ' ' THR . 1.2 p -159.62 153.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.112 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.478 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -56.26 -47.43 78.59 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -175.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -90.71 77.04 6.38 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.34 0.591 . . . . 0.0 110.887 -177.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.539 HG21 HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.45 94.6 4.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.794 177.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.65 120.96 42.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -175.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.55 106.97 19.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.111 0.482 . . . . 0.0 110.835 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mp -77.24 109.3 11.0 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.503 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HD2' HG21 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.53 -13.02 16.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.657 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -19.81 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 110.964 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.16 66.27 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.653 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.449 HG22 ' N ' ' A' ' 102' ' ' GLY . 1.3 tt -58.96 -27.97 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -171.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -66.66 -25.45 72.87 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.499 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.46 -2.53 57.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.109 0.48 . . . . 0.0 109.921 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 85.82 19.84 57.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.353 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.459 ' HG3' ' HB2' ' A' ' 50' ' ' GLN . 6.9 mptt -123.52 132.15 53.83 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.065 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.38 133.62 68.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 3.8 m -119.94 112.95 19.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 64' ' ' TRP . 11.4 tp -100.17 117.28 34.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.806 0.336 . . . . 0.0 110.271 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 18.7 mtt180 -94.77 106.87 18.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.631 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.491 HD13 HD21 ' A' ' 47' ' ' LEU . 21.6 mt -111.79 107.08 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -71.72 123.05 21.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.7 t30 81.1 108.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.042 0.839 . . . . 0.0 111.429 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.871 HG22 HD12 ' A' ' 140' ' ' ILE . 10.3 p -110.89 146.68 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.434 173.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.403 ' HB ' ' OD1' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -113.17 151.66 30.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 111.985 -175.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 41' ' ' LEU . 2.9 p -72.49 -14.13 16.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.582 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.403 ' OD1' ' HB ' ' A' ' 114' ' ' THR . 5.4 p-10 -91.76 -19.1 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.933 0.397 . . . . 0.0 110.335 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.52 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.1 OUTLIER -110.36 2.94 19.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.81 25.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -80.68 -159.05 20.34 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.334 -174.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -87.04 111.83 21.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.883 0.373 . . . . 0.0 110.686 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.747 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-30 -68.52 146.0 53.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.333 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.11 114.31 28.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 0.0 110.427 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -100.18 117.73 35.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.529 177.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 63' ' ' ARG . 47.1 t -118.02 109.04 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.116 0.484 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.507 ' HE1' ' HB2' ' A' ' 134' ' ' HIS . 1.1 m-85 -93.73 115.52 27.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.1 mtpm? -109.11 104.89 14.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.729 0.3 . . . . 0.0 110.325 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.77 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 23.7 t0 -118.39 136.53 53.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.588 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.82 -111.73 2.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -113.15 3.05 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 110.816 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 171.23 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.904 0.383 . . . . 0.0 111.353 -174.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 4.0 p90 -148.45 147.93 29.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -122.75 142.8 50.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.6 121.01 39.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 0.0 110.482 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.55 137.37 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.829 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.38 107.42 22.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.4 m -103.96 105.46 15.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 1.1 mm-40 -67.58 122.43 18.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.491 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 45' ' ' LEU . 4.0 t -91.85 147.77 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.98 115.49 17.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 113' ' ' VAL . 1.2 mp -91.94 126.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.173 -176.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.715 0.293 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 m 57.6 27.57 14.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.19 9.87 4.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -74.69 134.6 75.51 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.038 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 19.1 Cg_exo -66.05 -62.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.976 2.451 . . . . 0.0 113.376 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -133.71 146.42 50.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.435 -174.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.947 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.2 pt -148.56 167.76 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.036 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 132' ' ' GLU . 39.4 t -91.75 140.82 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.663 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -130.79 179.18 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.0 111.108 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.61 -133.45 11.36 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.78 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.96 176.65 5.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.59 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.318 0.386 . . . . 0.0 110.183 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.862 ' HA3' HG21 ' A' ' 136' ' ' THR . . . 134.06 80.66 0.15 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.017 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.83 57.0 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.01 2.474 . . . . 0.0 111.566 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG23 HG21 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -82.14 100.85 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.267 -176.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.31 101.32 13.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.393 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.46 169.5 8.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.722 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -120.59 138.06 54.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.79 0.329 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -66.08 130.52 43.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -176.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.24 -5.04 84.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.485 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.97 -168.27 27.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.903 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.58 113.54 19.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 113' ' ' VAL . 5.3 tp -85.85 114.89 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.82 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 3.7 mt-10 -110.38 117.42 33.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 0.7 OUTLIER -108.39 128.53 54.85 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.458 ' C ' ' HH2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -116.21 119.89 37.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -178.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.762 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -117.76 140.36 49.78 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.764 ' HG3' ' HD2' ' A' ' 105' ' ' LYS . 1.9 mp0 -115.86 135.75 53.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.294 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -127.35 153.16 46.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.636 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.74 100.36 5.28 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.7 Cg_endo -88.95 116.09 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.913 2.408 . . . . 0.0 113.584 -170.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.7 -13.84 12.99 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.44 2.094 . . . . 0.0 110.917 171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.422 ' HG3' ' CE ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -134.27 -174.19 3.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.727 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HG3' ' H ' ' A' ' 58' ' ' GLN . 25.8 pt20 -74.96 -22.41 58.58 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.963 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.641 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 64.75 10.29 5.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.963 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -68.26 -11.29 59.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -117.47 15.68 14.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.293 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.641 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -82.88 155.28 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.079 0.466 . . . . 0.0 111.722 -172.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.948 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 2.1 mp0 -84.05 151.57 24.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -134.16 137.86 51.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.911 0.862 . . . . 0.0 111.316 -178.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -132.16 116.68 17.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.482 173.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.762 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -144.09 98.05 3.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.181 0.515 . . . . 0.0 110.286 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.604 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 170.76 6.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.03 117.01 31.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.562 ' HG ' ' OE2' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -119.24 -164.5 1.06 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.762 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.448 ' C ' ' HG1' ' A' ' 70' ' ' THR . 6.5 m-85 -100.31 37.07 1.74 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.284 0.564 . . . . 0.0 110.876 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.448 ' HG1' ' C ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -153.03 64.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.008 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.693 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 35.5 mm-40 -91.5 -37.65 0.37 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -170.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 71' ' ' GLU . 91.9 Cg_exo -17.99 -78.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 125.209 3.939 . . . . 0.0 115.523 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.426 ' H ' ' HB2' ' A' ' 72' ' ' PRO . 3.2 p -100.57 119.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -159.12 37.85 0.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.12 -175.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.823 HD12 ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.97 150.35 44.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -173.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 21.6 t80 -117.64 139.64 50.73 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.627 ' HG2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -117.83 147.48 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.177 -174.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -63.9 104.55 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.114 0.483 . . . . 0.0 110.083 177.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 7.71 55.98 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.115 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.627 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -143.26 122.69 13.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.455 0.645 . . . . 0.0 111.241 176.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -110.89 136.98 49.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.425 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -145.59 147.86 32.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.324 -174.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.445 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -71.16 -3.24 18.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 174.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.36 44.89 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.184 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -64.66 -34.43 78.28 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 89' ' ' LYS . 1.1 tt 44.66 51.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.625 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.919 HD12 HG21 ' A' ' 94' ' ' THR . 3.2 tt -65.83 -17.86 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.647 173.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -15.29 62.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.472 174.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.68 -27.62 40.77 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.302 0.572 . . . . 0.0 109.575 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -75.45 -62.65 1.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 93' ' ' ARG . 9.0 p 172.41 136.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.285 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 55.67 2.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.429 0.633 . . . . 0.0 110.158 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.538 ' HB2' HG23 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -139.65 66.92 1.39 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.919 HG21 HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -122.11 151.39 40.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.079 -172.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -137.23 117.14 13.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.307 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 108' ' ' LEU . 15.7 tp -100.82 101.23 12.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -70.34 99.63 1.59 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.729 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HZ2' ' CG ' ' A' ' 78' ' ' ASP . 3.2 mmmt -103.69 1.47 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.261 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -24.83 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.261 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.78 -17.02 64.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.41 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.577 HD12 ' HZ ' ' A' ' 125' ' ' PHE . 3.5 tt -53.51 -37.66 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 101' ' ' ILE . . . -68.98 -15.19 69.11 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.17 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.8 -4.7 21.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.858 0.361 . . . . 0.0 110.244 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.454 ' HA2' HD22 ' A' ' 51' ' ' LEU . . . 92.41 31.27 9.05 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HD2' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -133.51 133.6 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.152 0.476 . . . . 0.0 111.444 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.61 134.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 O-C-N 122.244 -0.285 . . . . 0.0 110.258 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -122.22 114.06 20.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.256 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 96' ' ' LEU . 24.1 tp -94.45 115.5 27.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 4.9 ttp180 -100.01 107.05 18.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 48.2 mt -110.37 118.7 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.91 128.3 34.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.059 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 26.4 t30 72.18 84.97 0.12 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.801 0.688 . . . . 0.0 111.758 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 p -89.53 142.06 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.581 HG21 HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -124.72 171.34 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.9 0.381 . . . . 0.0 111.676 -178.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -23.12 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -171.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.93 -25.84 60.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.514 0.673 . . . . 0.0 109.894 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . 1.7 m-20 -101.27 -4.07 27.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.422 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.402 ' HB2' HG13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -57.96 -11.85 2.77 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.782 175.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.42 -146.73 0.48 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 121.725 0.625 . . . . 0.0 114.578 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -90.11 136.18 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 111.611 -175.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -105.29 123.4 47.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.277 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -84.62 113.73 21.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.894 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 41.9 t -99.73 117.57 34.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 14.8 t -135.07 118.46 24.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.577 ' HZ ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -100.11 143.41 30.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.948 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.85 118.64 27.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.461 ' OD1' ' HE2' ' A' ' 60' ' ' MET . 66.7 t0 -115.03 85.34 2.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.763 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.73 -90.15 0.16 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.94 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.97 -24.47 13.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.79 25.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 110.786 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.07 143.49 38.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.54 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.947 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 7.0 mm-40 -127.45 132.94 49.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 3.7 pt-20 -123.03 142.66 50.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.423 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -136.84 146.55 45.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.656 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.6 mt -97.02 107.99 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.932 0.396 . . . . 0.0 110.374 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.862 HG21 ' HA3' ' A' ' 35' ' ' GLY . 31.5 m -111.01 100.51 9.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.426 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -84.04 135.14 34.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -88.16 150.73 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.044 0.449 . . . . 0.0 110.637 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.84 101.25 7.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.497 HG23 HD13 ' A' ' 41' ' ' LEU . 35.9 mm -74.34 108.42 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.872 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.61 106.86 14.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 0.0 110.277 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.98 4.28 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.747 0.784 . . . . 0.0 109.102 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -105.55 101.89 34.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.953 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.38 -37.47 4.34 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.75 2.3 . . . . 0.0 112.908 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -101.49 146.98 26.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -142.61 179.21 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.292 0.568 . . . . 0.0 112.257 -170.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.65 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.935 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -105.96 129.75 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.09 -110.24 1.25 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 123.572 0.545 . . . . 0.0 112.149 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mt -146.76 149.86 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 -46.92 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.37 123.13 1.97 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.793 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.63 73.16 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.852 2.368 . . . . 0.0 110.456 172.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.747 HG23 HG13 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -61.11 114.97 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.02 -174.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.81 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.27 173.08 12.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.965 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -112.32 147.17 36.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.63 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -73.15 152.08 41.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.48 -7.07 82.0 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.68 179.63 22.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.181 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -79.82 109.58 14.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 110.325 178.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.626 HD12 HG11 ' A' ' 138' ' ' VAL . 1.0 OUTLIER -86.99 109.75 19.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.203 178.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.689 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.4 mt-10 -94.25 96.06 9.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.615 HD23 ' CZ2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -104.98 129.51 53.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.775 -175.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -118.07 138.84 51.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 m -117.78 140.2 50.01 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.39 131.85 56.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 110.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -125.4 159.32 32.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.5 -177.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.2 86.5 6.38 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 30.3 Cg_endo -88.39 153.54 6.6 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.806 2.338 . . . . 0.0 112.55 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 7.2 Cg_exo -73.55 -28.04 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.767 2.311 . . . . 0.0 111.742 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.83 -172.49 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -69.4 -8.27 45.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.137 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.74 29.41 18.99 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.107 0.563 . . . . 0.0 112.276 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.49 -42.55 78.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.449 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -101.27 25.0 8.72 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 111.347 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 16.2 ttm -68.88 131.84 45.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.162 0.506 . . . . 0.0 111.457 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.616 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -88.05 143.89 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.558 HG13 ' HB3' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -134.95 148.96 28.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.828 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 3.2 ttp85 -128.74 115.64 18.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.615 ' CZ2' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -126.65 87.7 2.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' HE1' HD12 ' A' ' 87' ' ' ILE . 94.4 m-85 -153.61 148.57 26.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.899 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HD3' ' HB2' ' A' ' 117' ' ' ASP . 41.9 ttt-85 -88.72 94.92 10.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 165.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.47 129.32 51.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.066 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 68' ' ' LEU . 97.3 mt -94.52 132.86 38.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.948 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 74.86 148.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.242 0.964 . . . . 0.0 110.999 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.43 109.62 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.707 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.55 103.22 51.22 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.951 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.98 -9.5 25.2 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.216 2.611 . . . . 0.0 112.651 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.57 0.49 8.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.683 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -109.14 80.71 1.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.077 -178.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -138.77 144.35 39.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.659 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.619 ' HE2' HD13 ' A' ' 87' ' ' ILE . 2.7 t80 -100.57 115.11 29.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.52 121.32 44.85 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.085 -168.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.8 t70 64.94 14.16 9.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.148 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.679 ' HA2' HD22 ' A' ' 96' ' ' LEU . . . 89.82 14.05 60.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.741 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -129.05 148.71 51.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 139.02 50.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.934 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.533 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -105.48 -172.89 2.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -75.53 -9.22 58.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.867 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -55.28 3.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.789 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 82' ' ' MET . 6.9 pm0 -74.77 -37.82 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 122.716 0.406 . . . . 0.0 110.446 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 85' ' ' GLU . 3.0 tp 43.44 97.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.643 1.177 . . . . 0.0 113.421 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 76' ' ' TYR . 2.5 tp -62.89 -18.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.167 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -14.22 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.665 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -66.14 -29.67 70.01 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.045 177.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.68 -71.2 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.512 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.99 141.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.01 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.802 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -161.12 65.77 0.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.55 HG23 HD11 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -127.72 119.16 25.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.223 -174.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.12 99.97 7.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.699 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.679 HD22 ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -86.08 111.39 20.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.186 0.517 . . . . 0.0 110.488 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.71 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.2 mp -81.72 112.94 19.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.912 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.05 1.85 56.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.094 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.31 -33.59 63.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.332 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.19 -16.9 65.98 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.814 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -53.53 -31.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -62.48 -25.4 66.97 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.435 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.2 13.68 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.979 0.419 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.34 43.66 12.53 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.451 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -129.82 133.19 46.79 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.279 -0.542 . . . . 0.0 110.784 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 48' ' ' SER . 14.3 m -121.96 132.96 69.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -116.4 102.86 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.727 178.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 64' ' ' TRP . 4.6 tp -96.05 111.52 23.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.098 0.475 . . . . 0.0 110.195 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.689 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -86.42 106.26 17.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.542 174.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.449 HG13 ' HG ' ' A' ' 108' ' ' LEU . 50.0 mt -112.54 112.76 41.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.624 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 59.6 t80 -80.14 129.76 34.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 35.5 t30 76.23 79.6 0.09 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.914 0.759 . . . . 0.0 111.76 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 41' ' ' LEU . 10.2 p -84.96 149.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 168.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.25 165.52 14.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.964 0.411 . . . . 0.0 111.964 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.3 -28.95 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.13 -43.27 87.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.518 ' HB2' ' HD3' ' A' ' 66' ' ' ARG . 3.6 p-10 -104.17 4.09 33.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.616 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -62.5 -10.38 11.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 176.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.7 -118.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.931 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.2 124.97 35.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.257 0.551 . . . . 0.0 111.765 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 136' ' ' THR . 50.2 p90 -110.92 164.77 12.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.774 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 113.33 24.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.3 t -104.92 122.37 45.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.828 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 97.8 t -131.95 139.24 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.047 -175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.504 ' CZ ' HG22 ' A' ' 106' ' ' VAL . 23.2 m-85 -119.31 140.5 50.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.71 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -130.75 105.04 7.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.653 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 60' ' ' MET . 43.0 t0 -98.5 74.37 2.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.39 -93.36 0.89 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.3 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -97.79 -27.97 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.742 0.306 . . . . 0.0 111.714 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -96.81 143.18 27.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.922 0.391 . . . . 0.0 110.4 -177.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.71 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -138.02 142.77 40.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.395 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -122.44 131.91 54.1 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.486 ' HA ' HG22 ' A' ' 124' ' ' VAL . 8.8 mt-10 -114.36 119.92 38.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 132.19 55.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.158 0.504 . . . . 0.0 111.12 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.5 107.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.576 175.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -120.52 160.66 22.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 139.51 53.83 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.226 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.747 HG13 HG23 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -83.0 150.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -112.58 90.89 3.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mp -80.76 123.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.918 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.452 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.341 0.115 . . . . 0.0 110.887 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -103.01 91.4 4.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.51 -179.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -151.49 33.55 0.56 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.445 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -72.15 117.19 56.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.382 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.08 -178.54 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.949 2.433 . . . . 0.0 112.301 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HE1' ' HA ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -74.83 140.45 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -122.07 168.12 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -170.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HB ' ' CE1' ' A' ' 134' ' ' HIS . 67.0 t -91.35 132.46 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.188 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.46 132.25 55.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.72 -107.31 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.749 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.43 168.39 21.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -175.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -48.63 7.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 111.82 2.53 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.927 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.57 86.87 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.569 2.179 . . . . 0.0 111.355 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -72.28 101.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.323 -176.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.754 HD23 ' HD3' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -87.22 119.72 27.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 171.82 13.8 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.003 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -98.67 133.98 42.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.3 123.42 17.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.85 0.357 . . . . 0.0 111.034 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 94.44 1.22 64.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.04 -174.42 33.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.214 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.573 ' HB2' ' HD1' ' A' ' 111' ' ' PHE . 10.3 t30 -93.88 119.8 33.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.36 . . . . 0.0 110.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.61 HD12 HG23 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -98.23 122.23 41.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.867 -177.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.766 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -97.17 101.68 13.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.683 174.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 1.1 mp -96.58 127.25 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.49 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -117.63 130.18 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.74 140.19 50.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -110.99 131.34 55.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.138 0.494 . . . . 0.0 110.604 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.54 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.24 154.88 44.31 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.376 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.425 ' N ' HD11 ' A' ' 51' ' ' LEU . 1.4 m -87.27 101.24 2.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.9 Cg_endo -76.41 114.31 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.751 2.3 . . . . 0.0 113.74 -170.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.9 -21.05 9.88 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.44 2.094 . . . . 0.0 110.602 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -171.66 2.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.466 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -68.83 -18.06 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -177.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 56.99 32.32 21.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.261 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.59 -33.81 74.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.722 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -93.39 9.61 35.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 146.68 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.314 0.578 . . . . 0.0 111.39 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -92.68 102.63 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 HG23 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -105.78 130.01 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.689 0.757 . . . . 0.0 111.255 -174.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.586 HH11 HG21 ' A' ' 124' ' ' VAL . 8.1 ttm180 -113.94 117.1 30.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.681 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.885 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.86 55.43 1.45 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.81 167.42 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.324 0.583 . . . . 0.0 112.192 -164.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HE ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -112.3 144.16 42.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.24 174.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.16 152.6 35.33 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.545 HD23 ' HE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -142.95 -141.47 0.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.859 -175.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.518 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -64.96 71.81 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.486 ' HB ' ' H ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -172.02 -101.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.373 173.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' H ' ' HB ' ' A' ' 70' ' ' THR . 8.2 mm-40 -153.25 158.27 32.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.87 56.21 3.52 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.748 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.4 t -98.78 89.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -172.94 124.78 0.44 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.677 178.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.86 143.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.556 0.535 . . . . 0.0 110.7 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' HH ' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.21 114.8 28.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.168 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -97.76 120.51 38.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -176.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t70 67.44 14.03 9.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.85 0.833 . . . . 0.0 109.969 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.44 70.72 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.595 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -122.99 151.68 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -101.01 169.32 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.264 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.675 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 2.8 ptt? -140.06 161.33 37.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.79 -27.71 69.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.28 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.17 -5.61 89.04 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.648 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.675 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -111.24 -40.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.6 OUTLIER 37.58 80.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.249 1.02 . . . . 0.0 112.929 177.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.586 HD13 ' HB ' ' A' ' 94' ' ' THR . 14.8 tt -64.04 -19.79 25.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.125 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -13.73 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.552 175.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -66.27 -29.84 70.15 Favored 'General case' 0 CA--C 1.524 -0.037 0 CA-C-O 121.019 0.438 . . . . 0.0 110.234 178.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -52.87 7.99 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.692 HG12 HG21 ' A' ' 94' ' ' THR . 7.3 p 176.4 159.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.317 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -79.34 -25.01 42.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -80.53 66.44 6.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.559 173.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.767 HG22 HG12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.18 89.27 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.66 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -104.87 112.33 25.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.111 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.91 101.77 14.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -75.08 107.21 7.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 1.66 49.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.791 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.23 -29.19 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.16 -16.9 70.76 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.0 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 56' ' ' GLN . 4.8 tp -55.54 -25.53 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.5 -21.12 70.42 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.903 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.26 13.33 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.316 0.579 . . . . 0.0 109.581 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.36 27.13 66.4 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.758 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.87 132.04 56.65 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.968 -0.724 . . . . 0.0 110.84 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.05 131.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -124.08 103.81 8.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.284 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' A' ' 64' ' ' TRP . 9.0 tp -94.86 117.63 30.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.93 0.395 . . . . 0.0 110.336 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.766 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -96.22 107.48 19.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.566 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.767 HG12 HG22 ' A' ' 94' ' ' THR . 53.3 mt -116.28 121.4 67.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.573 ' HD1' ' HB2' ' A' ' 44' ' ' ASN . 22.0 t80 -83.17 130.99 35.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.434 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 56.7 t30 71.78 84.38 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.162 174.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.61 HG23 HD12 ' A' ' 45' ' ' LEU . 90.4 t -102.08 131.92 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.018 171.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.19 177.24 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.94 -29.95 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -171.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -40.62 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.338 0.59 . . . . 0.0 110.276 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -88.47 -7.9 55.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.277 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.66 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -63.88 -21.75 66.6 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.81 177.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.07 -110.05 0.08 OUTLIER Glycine 0 C--O 1.243 0.674 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.928 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.72 120.4 25.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.127 -0.536 . . . . 0.0 111.671 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.21 137.36 44.3 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -105.33 115.7 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -105.98 116.27 31.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.121 175.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.586 HG21 HH11 ' A' ' 63' ' ' ARG . 85.6 t -134.64 121.54 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.505 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.2 m-85 -111.22 113.39 25.85 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 104.37 9.73 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.546 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -105.28 89.34 3.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.21 -82.55 0.13 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.012 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.31 8.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.07 140.22 34.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 40.2 p90 -147.61 142.9 27.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.408 . . . . 0.0 111.06 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.673 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.99 137.8 41.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.745 176.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -122.12 121.26 36.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.954 0.407 . . . . 0.0 110.436 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.54 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -119.36 144.88 46.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.43 108.27 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.07 160.29 14.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.45 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -127.47 135.64 50.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.291 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.58 HG11 ' N ' ' A' ' 139' ' ' LYS . 23.9 t -98.37 147.1 7.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.754 ' HD3' HD23 ' A' ' 38' ' ' LEU . 1.3 mtpt -120.88 90.22 3.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -75.0 133.66 31.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.223 0.535 . . . . 0.0 109.886 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.84 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.648 0.261 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.22 61.63 3.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.414 0.626 . . . . 0.0 110.099 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.43 17.92 20.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.377 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -70.78 114.08 23.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.195 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.5 -94.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.977 2.451 . . . . 0.0 112.157 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -156.63 165.18 37.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.86 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pt -134.75 165.66 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.887 0.375 . . . . 0.0 110.547 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 132' ' ' GLU . 95.4 t -91.05 127.27 43.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.411 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.18 179.56 4.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -175.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.45 -133.9 11.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.07 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.42 172.84 6.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 35' ' ' GLY . 1.8 pm0 -69.0 -29.49 67.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 109.39 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.684 ' HA3' HG22 ' A' ' 136' ' ' THR . . . 117.38 72.68 0.46 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.363 173.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.95 52.74 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.497 2.131 . . . . 0.0 111.101 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.57 104.51 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.499 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.55 137.77 32.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . . . -133.76 170.69 15.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.609 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -119.57 138.32 53.28 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.735 -178.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.33 111.08 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.15 8.53 87.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.013 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' A' ' 40' ' ' SER . . . -103.92 -147.55 17.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.98 143.78 41.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 10.3 tp -127.76 118.94 24.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.175 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.39 107.01 18.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.154 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.75 127.71 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 123.75 39.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.01 0.433 . . . . 0.0 111.103 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.25 50.06 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.82 160.01 18.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.249 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -127.64 148.71 50.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.035 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 89.67 0.31 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 162.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 14.3 Cg_exo -67.81 115.21 3.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 2.729 . . . . 0.0 114.248 -162.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.27 -32.98 2.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.874 2.383 . . . . 0.0 110.129 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -146.34 -172.78 4.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.344 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.32 -21.89 59.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 55.57 24.54 7.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -42.42 90.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.189 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.11 5.32 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.607 ' CG ' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -80.22 174.94 11.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -169.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.094 ' HB3' HD12 ' A' ' 75' ' ' LEU . 48.7 mt-10 -106.24 143.63 34.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.448 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -118.89 134.04 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 168.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.623 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -149.54 59.69 1.01 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -137.89 152.37 48.96 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.715 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.4 tpt85 -89.89 95.09 10.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.732 0.777 . . . . 0.0 109.375 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.62 125.93 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.483 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.92 144.87 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.775 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 75.16 4.08 4.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.103 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.98 149.37 27.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.423 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 73' ' ' VAL . 2.1 mt-10 -64.33 155.93 78.15 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.023 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.46 29.31 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.272 2.648 . . . . 0.0 113.754 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -95.8 50.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.399 0.619 . . . . 0.0 109.665 177.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 1.01 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -161.56 82.09 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.117 179.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 1.094 HD12 ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -149.22 143.6 26.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.475 -169.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.623 ' HB3' HG21 ' A' ' 62' ' ' ILE . 4.6 t80 -94.44 114.63 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.217 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.75 163.71 35.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.322 -0.151 . . . . 0.0 110.845 -173.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t0 68.69 6.93 5.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.669 0.747 . . . . 0.0 109.93 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.76 -6.15 62.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.439 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 pttp -144.69 179.79 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.081 0.467 . . . . 0.0 111.266 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.9 168.09 19.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.717 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.642 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -134.0 143.27 48.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.797 0.332 . . . . 0.0 111.242 -175.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.36 -23.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 0.0 110.941 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.95 -32.57 77.49 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.399 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.01 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 2.0 pp20? -95.2 -30.06 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 HG21 ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER 47.6 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.676 1.19 . . . . 0.0 113.667 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.534 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 8.5 tp -77.8 -7.93 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.123 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -13.45 7.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.713 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -69.56 -26.83 64.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.523 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -72.36 0.32 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.51 -174.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.829 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -92.04 -23.45 19.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.848 0.356 . . . . 0.0 110.302 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.855 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -106.97 88.94 2.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.301 0.572 . . . . 0.0 111.268 -178.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 95.61 5.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.292 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 23.3 tt0 -103.1 98.93 8.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.621 -171.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.4 117.73 35.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.118 0.485 . . . . 0.0 110.932 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -89.96 109.54 20.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.194 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.14 -10.47 14.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.633 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -17.97 65.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.145 -177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.93 80.33 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.178 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.627 HD13 ' CZ ' ' A' ' 125' ' ' PHE . 5.9 tt -57.56 -29.04 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 122.707 0.403 . . . . 0.0 111.709 -174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -63.49 -20.88 64.04 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.658 178.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.13 4.7 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.166 0.507 . . . . 0.0 110.211 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.08 42.17 8.96 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.711 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 132.64 40.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.818 0.309 . . . . 0.0 110.538 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.79 132.33 59.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.253 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -123.02 124.46 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.461 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 64' ' ' TRP . 40.8 tp -112.11 111.9 23.13 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -96.03 105.95 18.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.81 132.09 51.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.855 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 1.5 m-85 -95.99 143.44 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.0 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.4 t30 67.15 84.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.12 128.67 46.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.007 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.9 p -96.84 175.52 6.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.04 -16.8 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.602 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.43 -44.81 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 41.0 m-20 -65.8 -25.19 67.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.602 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.652 ' HB2' HD13 ' A' ' 140' ' ' ILE . 17.8 t70 -55.36 -17.42 4.83 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.479 ' HA3' ' HE ' ' A' ' 66' ' ' ARG . . . -71.82 -156.96 2.84 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.11 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -78.29 105.94 9.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.923 0.392 . . . . 0.0 111.729 -176.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.623 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -73.97 144.45 45.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 114.02 27.19 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.474 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 51.2 t -97.38 117.06 30.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.518 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 10.6 t -131.6 105.11 9.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.627 ' CZ ' HD13 ' A' ' 101' ' ' ILE . 21.8 t80 -97.82 139.2 34.03 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.186 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.714 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.0 mtpt -122.12 104.58 9.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.219 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.607 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 17.6 t0 -106.71 138.4 42.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.447 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.86 -110.61 1.76 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.96 11.52 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 159.7 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 4.9 p90 -140.67 153.43 45.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.88 0.372 . . . . 0.0 111.17 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.86 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -142.45 157.35 44.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.592 178.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -133.38 154.44 50.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.242 0.544 . . . . 0.0 112.22 -172.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.86 124.55 14.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.167 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.94 108.95 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.433 . . . . 0.0 110.247 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.684 HG22 ' HA3' ' A' ' 35' ' ' GLY . 99.0 m -122.29 102.34 8.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.745 -176.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 5.3 pt-20 -82.84 141.96 31.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.463 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.591 HG11 ' N ' ' A' ' 139' ' ' LYS . 89.6 t -86.82 151.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.591 ' N ' HG11 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -113.63 92.29 3.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 174.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -71.75 120.33 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.251 1.164 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.572 -174.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.512 0.196 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.3 112.25 5.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.999 0.428 . . . . 0.0 110.42 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.27 27.57 9.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.905 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.86 120.77 63.6 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -86.85 -131.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.768 2.312 . . . . 0.0 111.909 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.842 ' HE2' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.43 158.0 16.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 177.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.5 pt -129.25 167.93 23.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.727 HG22 ' HB3' ' A' ' 132' ' ' GLU . 44.3 t -91.1 144.7 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.83 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.09 161.31 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.604 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -171.15 28.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.536 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.21 176.85 4.86 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -49.8 73.73 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.158 0.286 . . . . 0.0 110.829 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.56 81.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.518 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.82 89.93 0.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.575 2.183 . . . . 0.0 111.061 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.55 124.78 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.409 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -88.77 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.014 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.41 170.58 9.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -120.98 145.07 48.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -62.57 119.04 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.074 0.464 . . . . 0.0 110.586 -177.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 90.76 -7.33 81.41 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.322 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.11 -176.35 49.04 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.528 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -87.61 115.65 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -108.12 118.65 37.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.407 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.91 112.24 24.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.372 177.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.6 128.1 42.19 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.28 128.5 52.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 140.49 52.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.461 ' O ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -118.82 145.26 45.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.48 -178.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.842 HD23 ' HE2' ' A' ' 28' ' ' PHE . 4.6 mt -117.75 164.37 15.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.71 85.36 0.55 Allowed Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 165.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.562 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 11.7 Cg_exo -68.39 119.2 6.21 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.233 2.622 . . . . 0.0 113.929 -162.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 -31.95 4.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.757 2.304 . . . . 0.0 110.098 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.99 -172.64 3.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.667 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -71.23 -15.93 62.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HA ' ' HE2' ' A' ' 60' ' ' MET . . . 59.46 17.05 5.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -64.3 -22.56 66.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.126 0.489 . . . . 0.0 111.22 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -115.14 24.18 11.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.318 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.654 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -86.55 169.9 12.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -178.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 12.0 tt0 -101.79 123.68 46.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.089 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.37 137.7 45.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.399 0.619 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.666 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 8.0 mtt180 -134.41 116.95 15.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.806 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.737 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -136.85 73.48 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -177.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -149.28 169.69 20.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.184 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -94.3 95.94 9.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.309 0.576 . . . . 0.0 110.993 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.28 111.12 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mp -138.09 152.86 49.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.726 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.11 -71.6 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.42 168.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -62.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -171.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 73' ' ' VAL . 5.9 mt-10 -130.21 145.23 56.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.809 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.44 21.95 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.067 2.511 . . . . 0.0 112.48 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.686 HG22 ' HB3' ' A' ' 71' ' ' GLU . 2.9 t -69.03 128.83 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.515 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.666 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -175.32 131.22 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 82' ' ' MET . 0.1 OUTLIER -161.68 113.72 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -143.42 109.58 5.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 159.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.3 122.68 26.85 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.037 -0.414 . . . . 0.0 111.447 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 56.57 41.01 29.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.151 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.08 24.89 65.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.857 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.1 tptt -145.6 129.63 17.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.836 0.351 . . . . 0.0 111.049 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.26 163.36 17.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.681 ' HB2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -123.34 161.92 23.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.677 ' HA ' HG13 ' A' ' 86' ' ' ILE . 23.9 m-85 -62.24 -20.79 64.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.081 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.49 99.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.246 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.645 ' OE1' ' HA ' ' A' ' 74' ' ' HIS . 3.9 tp10 -104.15 -43.19 5.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.677 HG13 ' HA ' ' A' ' 83' ' ' PHE . 6.2 mt 61.09 109.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 122.037 0.922 . . . . 0.0 112.294 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.2 tp -72.38 -19.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.165 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -14.29 49.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.377 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -72.29 -26.09 61.84 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.403 0.621 . . . . 0.0 109.666 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.546 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 29.4 m-85 -92.23 -65.33 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.215 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p 166.73 153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.2 60.25 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.288 177.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 1.1 mmp_? -145.98 60.69 1.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.7 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -125.46 164.5 20.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.105 -174.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.51 135.76 13.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.588 173.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 108' ' ' LEU . 4.2 tp -108.26 94.29 4.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.809 0.338 . . . . 0.0 110.108 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -70.45 108.76 4.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 109.707 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HG2' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -107.07 6.59 29.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 -176.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.11 -25.91 68.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.012 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.0 -16.8 66.63 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.266 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -53.79 -28.23 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -61.88 -26.71 67.47 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.072 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.53 15.31 19.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 109.857 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.562 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 76.83 43.2 18.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.462 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.275 0.537 . . . . 0.0 110.603 176.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.853 HG21 ' HE2' ' A' ' 125' ' ' PHE . 15.4 m -131.05 139.51 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -126.96 106.43 9.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 96' ' ' LEU . 13.9 tp -90.27 107.59 19.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.146 0.498 . . . . 0.0 110.121 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.573 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -84.79 107.43 16.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.552 178.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.5 mt -116.88 111.35 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.838 0.351 . . . . 0.0 110.498 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 23.9 t80 -81.44 137.04 35.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.548 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 53.9 t30 77.9 75.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.917 0.761 . . . . 0.0 111.71 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 140' ' ' ILE . 9.9 p -78.88 148.73 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 173.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -113.1 164.58 13.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.207 0.527 . . . . 0.0 112.118 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 7.7 p -66.69 -25.35 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.078 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 5.0 t70 -73.57 -34.22 65.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 175.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -78.79 -19.28 52.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.497 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.597 ' HB2' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -54.69 -15.96 2.19 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.633 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.52 -130.98 0.98 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.726 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -94.95 121.4 36.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.073 0.463 . . . . 0.0 111.61 -177.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.737 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.3 m-85 -87.68 142.97 27.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.565 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.75 118.76 35.21 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.186 0.517 . . . . 0.0 111.026 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 37.1 t -100.45 120.67 40.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.195 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.19 121.09 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.853 ' HE2' HG21 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -115.68 137.23 52.28 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.33 -178.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.929 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 20.4 mtpt -121.29 111.71 17.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.654 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 14.8 t70 -101.91 111.84 24.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.99 -105.93 1.69 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.035 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.03 -7.92 9.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.661 ' HD1' ' HD1' ' A' ' 28' ' ' PHE . 3.2 p90 -100.23 148.82 24.21 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.417 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.929 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 4.0 p90 -133.74 151.99 51.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.273 0.559 . . . . 0.0 112.017 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 30' ' ' VAL . 1.6 mm-40 -128.89 156.83 43.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.8 174.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -133.53 142.57 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.392 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -129.09 133.65 47.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.056 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.98 107.91 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.81 0.338 . . . . 0.0 110.498 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.565 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 51.7 m -117.68 118.3 31.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.624 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -77.7 134.85 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.422 HG12 HD11 ' A' ' 140' ' ' ILE . 9.8 p -93.61 149.86 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 38' ' ' LEU . 1.6 tttm -114.02 96.08 5.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.761 0.315 . . . . 0.0 110.745 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 118' ' ' ASP . 1.1 mp -76.3 118.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.492 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.13 55.69 1.87 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.672 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.67 11.27 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.407 0.622 . . . . 0.0 110.124 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.4 OUTLIER -87.17 148.5 45.11 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.622 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 13.0 Cg_exo -71.17 -15.0 31.96 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.074 2.516 . . . . 0.0 112.034 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.646 ' HZ ' ' HB3' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -143.65 141.69 30.68 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pp -139.09 178.38 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 110.956 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 134' ' ' HIS . 71.9 t -106.49 145.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.422 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -75.44 144.2 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.802 0.334 . . . . 0.0 110.452 -179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.62 60.95 4.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.736 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.79 109.74 8.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.672 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 4.3 mp0 -77.25 -49.13 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.8 91.4 0.17 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.52 95.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.553 2.835 . . . . 0.0 112.987 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -81.73 97.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.998 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.8 101.76 13.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.417 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . . . -111.21 170.81 7.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.633 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.0 m -130.56 141.36 50.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 128.08 35.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.31 -23.89 22.22 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.65 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.3 174.67 52.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.7 138.9 39.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -118.1 122.11 42.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.942 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.597 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 6.4 mt-10 -102.52 108.02 19.18 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.542 HD12 HD21 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -95.3 128.38 42.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.328 -176.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.22 129.59 55.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.746 -174.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -138.26 140.11 39.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 131.52 52.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.922 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -111.35 165.0 12.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.367 -173.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -124.92 72.26 63.05 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.398 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.3 155.88 3.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.215 2.61 . . . . 0.0 113.207 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 35.4 Cg_endo -92.55 14.51 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.413 2.742 . . . . 0.0 112.108 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -137.09 -173.03 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.725 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.24 -16.77 34.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.217 175.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 60.72 13.14 4.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.99 174.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.668 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 4.1 tm0? -56.34 -40.78 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 3.0 p80 -115.51 21.96 13.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.031 0.443 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -74.07 -173.52 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -177.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.642 ' HG3' ' HB2' ' A' ' 77' ' ' ARG . 1.3 tt0 -103.81 118.21 36.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.965 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.89 62.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.0 111.92 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' CYS . 7.8 ttt85 -102.25 132.72 48.02 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.458 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -144.89 59.56 1.31 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -142.95 157.98 44.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.352 0.596 . . . . 0.0 111.864 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.819 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -141.29 109.79 5.97 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 165.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -165.28 107.43 0.8 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.669 -1.151 . . . . 0.0 107.922 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 113.69 25.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.185 0.517 . . . . 0.0 112.246 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.93 -155.57 0.15 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.922 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.4 63.86 2.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 111.903 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 53.72 70.14 1.9 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.24 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 73' ' ' VAL . 6.0 Cg_exo -77.73 -98.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.921 2.414 . . . . 0.0 111.357 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.466 ' H ' ' HB2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -64.15 143.95 15.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 173.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 2.0 m80 -120.64 -86.26 0.65 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -164.84 149.81 9.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.574 -173.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.95 118.32 32.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.725 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.642 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -132.12 137.71 47.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.113 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' A' ' 59' ' ' HIS . 4.2 m-20 63.07 17.03 9.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.288 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 15.24 70.43 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.481 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -136.59 143.16 43.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 0.0 110.527 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 8.8 p-10 -85.88 137.78 32.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.51 ' HE1' ' HG2' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -82.74 155.91 24.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.042 -176.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -40.21 80.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.215 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.6 0.91 79.93 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.79 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -105.54 -43.18 5.01 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.595 -0.356 . . . . 0.0 110.22 178.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 27.67 84.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.461 1.101 . . . . 0.0 113.019 -178.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 94' ' ' THR . 16.1 tt -62.65 -11.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.557 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -12.34 58.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -13.9 14.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -78.37 7.37 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.13 -0.356 . . . . 0.0 110.751 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.0 33.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.332 0.653 . . . . 0.0 111.657 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -170.71 -164.16 0.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 178.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -79.46 143.02 35.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -139.62 104.04 4.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.953 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -114.88 108.21 16.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.532 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 108' ' ' LEU . 39.5 tp -84.72 109.8 18.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.945 0.403 . . . . 0.0 110.846 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -79.6 105.65 11.06 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -102.13 9.94 39.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.88 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -27.09 67.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.522 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.72 -16.75 65.11 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.172 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.561 HG21 ' N ' ' A' ' 102' ' ' GLY . 0.7 OUTLIER -54.21 -33.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -170.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' HG21 ' A' ' 101' ' ' ILE . . . -70.55 -11.02 67.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.073 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 6.05 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.16 26.55 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.55 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.18 133.08 38.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.384 -0.48 . . . . 0.0 110.796 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.11 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.855 0.359 . . . . 0.0 110.557 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -126.19 105.92 9.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.151 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 96' ' ' LEU . 13.8 tp -90.78 118.13 29.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.597 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -86.88 106.61 17.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.691 175.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 108' ' ' LEU . 56.4 mt -111.37 121.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -82.25 136.03 35.14 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.5 t30 68.59 91.66 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.431 0.634 . . . . 0.0 111.621 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.5 120.71 31.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.4 150.3 24.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.736 -176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.95 -22.57 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.23 -35.96 58.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.214 0.53 . . . . 0.0 109.818 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.09 5.52 46.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.73 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.34 -4.27 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.916 176.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -134.42 0.52 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.0 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -102.17 127.86 48.91 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.343 -0.504 . . . . 0.0 111.032 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.819 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 40.7 m-85 -82.93 151.94 25.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.07 110.41 18.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.783 0.325 . . . . 0.0 111.034 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.5 OUTLIER -98.6 117.15 32.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 t -118.6 107.36 21.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.646 ' HB3' ' HZ ' ' A' ' 28' ' ' PHE . 2.7 t80 -99.26 133.67 43.22 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.777 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -121.53 110.82 16.49 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.12 72.05 5.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.97 -96.82 1.6 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.178 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.33 -27.32 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 111.311 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' HB2' ' HD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -94.48 143.31 26.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 52.4 p90 -146.88 151.08 36.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.49 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -147.53 143.68 27.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.96 41.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.145 0.498 . . . . 0.0 110.753 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.672 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 52.0 t-80 -129.82 138.83 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.61 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.444 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -104.06 107.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.5 m -99.7 107.76 19.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.438 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -75.71 122.73 24.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 -178.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -96.18 150.71 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 110.82 12.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.302 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 118' ' ' ASP . 8.9 mt -76.77 102.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 110.436 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.427 ' H3 ' ' HG2' ' A' ' 23' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m 51.83 72.87 0.35 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.712 0.633 . . . . 0.0 111.073 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -26.82 7.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.021 0.439 . . . . 0.0 110.545 -172.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -106.38 116.45 59.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.752 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.14 -3.24 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.935 2.423 . . . . 0.0 112.552 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -153.71 136.66 15.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.559 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.1 pt -144.53 165.8 12.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.617 0.723 . . . . 0.0 112.062 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 31' ' ' ASN . 56.0 t -97.6 149.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.182 171.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 30' ' ' VAL . 11.3 t-20 -67.07 150.59 48.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.85 63.41 3.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.264 -0.493 . . . . 0.0 113.344 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 tp -139.51 132.4 29.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -85.9 -31.7 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.262 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.59 90.51 0.8 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.807 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.16 80.55 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.808 2.339 . . . . 0.0 110.97 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.53 92.42 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -89.39 110.09 20.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.773 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HB1' HD13 ' A' ' 45' ' ' LEU . . . -120.19 171.97 8.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.137 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.05 133.55 36.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.789 ' HB2' HG21 ' A' ' 140' ' ' ILE . 3.1 tp -66.62 111.69 3.77 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.944 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.6 11.49 74.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.819 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.38 -152.01 9.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.919 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -87.45 134.25 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.413 . . . . 0.0 111.112 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -119.93 115.44 23.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.519 176.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.5 mt-10 -108.19 110.08 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 110.748 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -96.69 129.22 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.346 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.26 122.16 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.888 0.375 . . . . 0.0 110.632 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.66 140.02 50.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -120.1 130.1 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.109 0.481 . . . . 0.0 110.131 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 30' ' ' VAL . 3.7 mm? -117.72 165.22 13.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.047 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.49 71.6 26.77 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 94.6 Cg_endo -89.48 154.61 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.013 2.475 . . . . 0.0 113.322 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.6 Cg_exo -70.44 -25.54 25.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.003 2.469 . . . . 0.0 111.964 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.21 -173.26 3.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.939 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -22.51 42.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 60' ' ' MET . . . 54.22 32.97 17.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -32.0 66.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.791 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -115.46 28.96 8.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.866 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.918 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -91.73 -165.6 1.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.289 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' HG2' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.8 126.66 53.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 110.745 -178.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 0.3 OUTLIER -126.49 146.57 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.243 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.608 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 10.0 ttm180 -132.52 117.37 17.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.36 58.34 1.73 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CE1' HG13 ' A' ' 87' ' ' ILE . 59.4 m-85 -139.38 150.66 45.57 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.676 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.06 96.6 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.658 HD22 ' HB2' ' A' ' 71' ' ' GLU . 11.5 t-20 -129.95 125.34 35.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.31 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -84.53 129.92 34.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.753 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 65.42 -108.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.655 0.597 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -153.47 114.21 4.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.805 0.336 . . . . 0.0 110.577 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.658 ' HB2' HD22 ' A' ' 67' ' ' ASN . 1.1 mt-10 -114.12 123.89 31.85 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 25.6 Cg_exo -62.56 -44.32 18.24 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.968 2.445 . . . . 0.0 113.382 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.48 72.33 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.631 -172.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.5 105.71 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -178.69 151.55 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.228 0.537 . . . . 0.0 111.472 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.35 117.52 30.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -127.46 143.1 51.24 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.784 -172.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.62 17.51 10.62 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.827 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.5 83.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.057 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -139.66 177.15 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 111.285 -178.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -95.41 170.07 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.112 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.52 138.96 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.945 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.84 -4.7 36.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.649 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.62 -16.42 70.84 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.781 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.635 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -111.94 -40.96 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.244 -177.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.635 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 76.6 mt 49.15 87.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 112.235 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -74.22 -6.46 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -14.84 27.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 173.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -21.85 64.1 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.899 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' HD2' HG23 ' A' ' 91' ' ' VAL . 3.0 t80 -85.58 -69.05 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.437 HG23 ' HD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -162.63 145.69 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.228 173.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -72.53 -7.86 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.348 0.594 . . . . 0.0 110.206 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.693 ' HA ' HH11 ' A' ' 93' ' ' ARG . 2.3 mmm180 -97.19 69.32 2.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.158 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.735 HG22 HD11 ' A' ' 108' ' ' LEU . 21.3 m -131.41 103.97 6.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.634 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.75 106.93 17.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.611 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 96' ' ' LEU . 1.1 tp -91.17 100.62 13.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.878 0.37 . . . . 0.0 110.708 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 mt -77.07 117.39 18.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.21 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 6.8 mtmm -108.12 15.4 24.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.645 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.81 -33.67 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.648 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.33 -16.68 70.87 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.037 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -29.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -21.35 59.62 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.155 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -117.21 4.1 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.759 0.314 . . . . 0.0 110.469 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.15 35.06 11.4 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.022 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.3 55.65 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.177 -0.602 . . . . 0.0 110.712 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 132.89 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.853 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.29 110.48 16.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.805 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.735 HD11 HG22 ' A' ' 94' ' ' THR . 5.4 tp -98.41 119.56 37.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.794 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 2.6 mpp_? -96.12 106.71 18.93 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.483 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.563 HG13 ' HG ' ' A' ' 108' ' ' LEU . 69.1 mt -117.61 124.19 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.818 0.342 . . . . 0.0 110.132 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -94.19 132.12 39.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.858 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.464 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 36.9 t-20 75.54 80.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.024 0.827 . . . . 0.0 112.287 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.85 139.5 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.864 172.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.1 p -116.02 -173.71 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -24.6 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -168.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.29 -48.09 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.05 0.452 . . . . 0.0 110.534 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -85.01 -6.61 59.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.626 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.637 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -68.92 -3.59 13.33 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 175.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.31 -99.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.0 -0.619 . . . . 0.0 114.066 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.09 128.01 41.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 111.21 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -90.48 151.5 21.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.307 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.86 108.72 20.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.036 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -101.11 117.91 35.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.329 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 23.1 t -134.03 131.92 55.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -122.43 122.67 39.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.19 104.45 11.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 110.312 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.918 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 58.0 t0 -92.74 83.39 4.83 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.9 -97.55 0.82 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.617 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.44 -5.19 13.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.588 0.232 . . . . 0.0 111.568 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.87 110.06 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.12 141.1 43.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.522 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.559 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -121.02 154.41 36.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 176.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -135.19 128.62 32.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.04 135.47 32.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.451 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.489 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.15 127.2 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.237 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.46 134.71 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.145 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -92.41 115.85 28.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.61 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 16.3 t -96.29 141.64 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -131.13 95.42 3.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -73.47 127.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.175 0.512 . . . . 0.0 109.702 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.033 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.487 ' HG3' ' OG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.58 65.46 6.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.28 0.562 . . . . 0.0 111.208 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.487 ' OG ' ' HG3' ' A' ' 23' ' ' MET . 1.0 OUTLIER -130.29 19.44 5.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -103.6 130.02 24.29 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.304 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 4.0 Cg_exo -75.31 -166.83 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.1 2.534 . . . . 0.0 111.843 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HD1' ' C ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -86.71 170.4 11.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.44 168.21 24.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.291 0.567 . . . . 0.0 111.789 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.67 148.59 11.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.375 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -93.31 160.75 14.68 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.08 43.71 2.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.581 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 tp -133.95 94.2 3.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.202 0.525 . . . . 0.0 110.051 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.24 -24.34 13.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.573 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 93.64 1.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.013 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 68.37 3.85 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.761 2.308 . . . . 0.0 110.118 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 130.04 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.719 -169.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.52 91.61 5.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.927 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.68 151.89 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.375 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.74 121.49 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.694 ' HB2' HG23 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -63.39 118.76 8.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 96.8 -2.74 62.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.181 -177.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.73 -165.27 24.28 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.324 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.45 115.97 22.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 113' ' ' VAL . 9.5 tp -100.97 112.47 24.93 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.096 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.98 108.42 19.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.069 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.1 mt -95.94 128.76 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.23 122.27 38.74 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.044 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.17 140.13 50.24 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.4 131.32 56.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -126.44 157.05 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.06 -178.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.26 83.2 51.95 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.22 156.64 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.086 2.524 . . . . 0.0 112.843 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 97.5 Cg_endo -87.5 20.36 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.98 2.453 . . . . 0.0 112.091 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.49 -172.96 3.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.734 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -72.09 -19.11 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.127 0.267 . . . . 0.0 111.681 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 59.62 24.78 13.61 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.197 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -59.09 -40.85 86.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -89.09 18.7 4.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.379 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -49.65 132.54 21.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.229 0.538 . . . . 0.0 112.413 -175.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 75' ' ' LEU . 37.6 tt0 -96.0 101.02 12.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -117.3 137.0 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.163 0.506 . . . . 0.0 111.521 -171.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -114.25 117.02 29.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.745 ' HB2' HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -127.42 59.57 1.43 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.91 171.7 14.82 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.881 -165.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.59 164.15 12.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.688 164.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -159.81 155.36 25.67 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.695 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.1 mt -95.63 109.02 21.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.884 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.2 m-85 74.52 172.34 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 124.002 0.814 . . . . 0.0 111.099 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.04 92.63 5.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.087 0.47 . . . . 0.0 112.106 -176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.447 ' OE2' ' HD2' ' A' ' 72' ' ' PRO . 1.1 tm-20 -138.01 115.52 9.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.253 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 61.4 Cg_endo -73.82 45.08 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.82 2.346 . . . . 0.0 112.456 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.22 49.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 122.151 0.977 . . . . 0.0 110.35 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -155.95 60.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.912 177.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.49 133.95 52.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.925 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 110.71 19.92 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 172.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.627 ' HB2' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -116.64 113.64 22.95 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.578 -174.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 t0 64.71 12.1 7.34 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.776 0.672 . . . . 0.0 111.166 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 2.76 58.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.919 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 133.27 47.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.962 0.41 . . . . 0.0 110.853 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -125.11 157.74 35.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.414 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 -172.8 2.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.709 0.29 . . . . 0.0 110.508 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -6.44 56.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.887 0.375 . . . . 0.0 111.575 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.88 -53.35 3.55 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.208 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.689 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.8 pm0 -90.65 12.94 17.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.904 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.575 HG22 ' HB2' ' A' ' 89' ' ' LYS . 3.1 tt -36.89 114.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.235 0 O-C-N 124.619 1.2 . . . . 0.0 110.903 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.498 HG12 HG21 ' A' ' 94' ' ' THR . 11.4 tt -71.77 -18.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.21 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -15.14 63.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 0.0 110.106 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -81.58 -18.0 46.34 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.423 0.63 . . . . 0.0 109.556 177.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -82.19 -55.72 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.092 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -161.13 155.2 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.148 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.65 -58.08 10.13 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.2 0.312 . . . . 0.0 111.735 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.716 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 6.7 tpp85 -91.95 84.37 5.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.206 0.526 . . . . 0.0 110.969 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -115.76 136.39 53.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.654 178.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -145.56 134.6 22.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.454 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -101.7 108.34 19.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.808 0.337 . . . . 0.0 110.247 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -75.85 106.88 7.67 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.44 2.65 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.374 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -51.61 -38.86 56.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.023 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.63 67.84 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.74 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -55.64 -35.8 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -168.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 101' ' ' ILE . . . -69.06 -6.0 50.66 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.511 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.83 1.69 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.057 0.456 . . . . 0.0 109.913 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.58 42.9 9.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.004 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 132.79 38.45 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.162 -0.611 . . . . 0.0 110.573 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.531 HG23 ' CZ ' ' A' ' 125' ' ' PHE . 5.9 m -123.74 133.25 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.405 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.61 103.37 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 96' ' ' LEU . 20.2 tp -86.12 118.07 25.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.46 107.24 19.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.053 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.418 HG13 ' HG ' ' A' ' 108' ' ' LEU . 86.9 mt -115.53 109.39 28.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.716 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 30.0 t80 -80.87 122.89 27.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.903 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 42.7 t30 79.57 75.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.182 0.926 . . . . 0.0 110.791 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 45' ' ' LEU . 3.8 p -74.87 140.11 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.878 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.5 p -103.68 163.4 12.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.516 0.674 . . . . 0.0 112.159 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -69.59 -14.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.219 177.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -75.29 -24.16 57.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.566 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.682 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 42.7 m-20 -103.45 -10.64 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.723 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.79 ' HB2' HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.05 6.63 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -103.85 -128.68 6.37 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.081 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.52 117.75 30.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.763 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.682 ' HE1' ' HB3' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -87.52 157.91 19.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.38 118.83 32.23 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.619 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.6 t -105.46 116.52 32.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.842 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.586 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 6.2 t -123.89 111.26 28.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.531 ' CZ ' HG23 ' A' ' 106' ' ' VAL . 1.4 m-85 -97.38 123.62 41.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.758 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -132.88 136.47 46.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.544 0.688 . . . . 0.0 111.759 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.3 76.51 1.7 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.684 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.99 -98.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.771 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 -27.4 20.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.485 0.184 . . . . 0.0 111.472 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -75.3 132.55 41.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.23 141.08 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 151.46 47.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.639 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.56 51.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.77 137.7 21.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.897 0.379 . . . . 0.0 111.15 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.26 46.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.325 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.453 HG22 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -112.56 157.12 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.149 -178.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 122.66 45.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.38 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 74.2 t -102.62 113.25 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 139' ' ' LYS . 3.1 mmmm -97.76 108.24 20.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.841 0.353 . . . . 0.0 110.066 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.79 HG12 ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -76.81 129.46 37.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.397 0.617 . . . . 0.0 111.225 -176.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.452 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ttp . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.607 0.242 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.1 m -60.62 134.53 57.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.578 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.2 24.73 2.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.923 0.868 . . . . 0.0 109.325 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.51 127.56 52.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.649 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.7 -11.52 11.47 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.732 2.288 . . . . 0.0 111.925 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -164.7 147.44 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.964 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -143.62 175.38 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.303 -173.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.13 144.36 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.954 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.09 139.31 56.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.731 0.3 . . . . 0.0 110.394 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.37 0.35 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.933 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.26 155.22 42.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.27 -49.4 19.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 66.61 1.77 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.476 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.06 88.11 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.37 2.046 . . . . 0.0 111.791 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 t -75.35 92.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.26 98.83 10.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.153 0.501 . . . . 0.0 110.176 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.793 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -109.37 158.09 18.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.604 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -112.66 129.42 56.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.605 HD13 HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -57.27 125.93 24.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.1 -22.57 22.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.538 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -172.62 41.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.127 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 2.9 p-10 -79.26 125.86 30.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.275 0.559 . . . . 0.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.592 HD12 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -97.58 123.13 41.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.418 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 112.4 24.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.999 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.592 HD22 HD12 ' A' ' 45' ' ' LEU . 1.2 mt -96.42 128.71 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 124.71 52.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -130.35 143.4 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.473 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -132.24 131.03 41.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' C ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.56 166.14 19.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.536 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -97.51 97.87 4.46 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 85.2 Cg_endo -85.16 130.13 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.779 2.319 . . . . 0.0 113.754 -171.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 16.4 Cg_exo -68.65 -37.55 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.753 2.302 . . . . 0.0 110.744 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 5.3 pt20 -133.91 -172.33 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.876 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -69.02 -29.95 68.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.678 0.275 . . . . 0.0 111.339 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HA ' ' HE2' ' A' ' 60' ' ' MET . . . 55.49 26.28 8.79 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.426 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.61 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -62.15 -25.44 67.75 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -113.48 18.94 17.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.846 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -88.42 -166.3 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -176.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.505 ' HG2' HD13 ' A' ' 75' ' ' LEU . 1.3 mt-10 -116.66 131.99 56.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.697 0.284 . . . . 0.0 110.678 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 147.46 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.139 0.495 . . . . 0.0 110.384 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.734 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -128.59 117.45 21.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.047 178.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.515 ' NE1' ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -126.17 59.35 1.33 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 63' ' ' ARG . 83.2 m-85 -136.6 159.44 41.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.338 0.59 . . . . 0.0 112.422 -164.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 117' ' ' ASP . 9.7 ttp180 -80.84 149.02 29.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.138 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -133.51 132.17 40.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.449 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.87 134.16 55.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 58.89 -102.07 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.571 0.544 . . . . 0.0 109.641 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -156.45 94.92 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.188 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -129.43 87.37 53.47 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.11 54.73 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.231 2.62 . . . . 0.0 112.112 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.1 -2.86 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.639 ' HD2' ' HA ' ' A' ' 85' ' ' GLU . 1.8 m170 -95.6 128.41 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.505 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -176.22 147.48 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.05 0.452 . . . . 0.0 111.067 -177.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.473 ' HE1' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -111.63 112.11 23.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -105.19 122.38 45.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.68 20.01 8.69 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.571 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.43 9.1 76.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.285 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.68 156.14 24.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.46 148.74 21.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.943 0.402 . . . . 0.0 110.352 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.26 156.59 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.653 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -25.38 67.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.71 -25.97 47.92 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.179 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -82.67 -43.28 17.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 86' ' ' ILE . 1.5 tp 39.77 82.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.605 1.19 . . . . 0.0 112.51 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.473 HG22 ' HE1' ' A' ' 76' ' ' TYR . 29.0 pt -68.52 -1.8 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.212 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -14.91 60.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 173.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -41.31 78.87 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.836 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -81.42 -49.55 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.22 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.34 1.025 . . . . 0.0 112.482 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.706 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER 73.35 -125.49 0.04 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.668 175.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.597 ' HA ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -95.63 96.51 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 -176.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.491 HG21 HG13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -110.54 114.19 27.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 177.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -145.69 123.56 11.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.59 112.85 24.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.0 110.359 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -74.18 105.48 5.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.6 4.8 50.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.919 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.99 -34.62 57.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.501 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.606 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.55 -16.69 65.63 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.945 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -51.32 -38.5 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -167.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.02 -11.14 60.48 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.751 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -116.22 1.15 13.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.52 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 86.11 34.5 12.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.931 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.606 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -124.55 140.14 53.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.875 0.338 . . . . 0.0 110.613 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.43 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 175.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -125.24 104.55 8.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.242 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.468 ' HB3' HD11 ' A' ' 47' ' ' LEU . 5.7 tp -87.84 115.11 25.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 0.0 110.456 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -93.99 107.42 19.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.86 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.491 HG13 HG21 ' A' ' 94' ' ' THR . 1.9 mt -122.35 114.38 42.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -72.74 146.12 46.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.159 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 7.0 t30 75.1 89.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.131 0 O-C-N 123.922 0.764 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG13 ' HB2' ' A' ' 39' ' ' ALA . 4.1 p -107.21 145.11 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 175.48 8.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 41' ' ' LEU . 43.6 t -60.29 -26.34 36.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.282 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -30.2 71.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.474 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 119' ' ' GLY . 15.4 m-20 -93.02 -14.01 27.93 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.05 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.051 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -118.23 -128.62 3.94 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.98 130.4 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.323 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.453 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.5 m-85 -104.28 141.88 35.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.23 120.22 39.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.148 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -98.82 125.11 44.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.403 174.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 3.6 t -134.32 134.04 55.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.614 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 43.0 m-85 -124.61 120.35 31.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.701 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.1 mtpm? -111.16 106.21 15.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.168 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.846 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 49.3 t0 -114.88 114.24 25.24 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.713 0.633 . . . . 0.0 109.754 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.87 -104.06 1.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.962 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -117.4 -10.26 10.74 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.64 154.32 21.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 -176.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -143.63 146.95 33.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 0.0 111.413 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.964 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -126.2 160.81 29.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.321 177.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.49 150.85 45.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.522 . . . . 0.0 111.515 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -147.2 132.87 18.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.036 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -89.21 116.33 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.495 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -116.2 134.55 54.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.247 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.87 139.66 30.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.201 0.525 . . . . 0.0 111.895 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.8 t -106.1 132.13 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.568 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -117.54 106.8 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.388 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.6 119.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.187 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.055 0.455 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.48 123.41 19.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -0.65 13.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.878 0.847 . . . . 0.0 109.247 -174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -88.45 113.52 55.77 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.255 -1.338 . . . . 0.0 110.769 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.57 7.22 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.988 2.459 . . . . 0.0 111.481 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HB3' ' HB2' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -146.93 139.35 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.354 -177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.86 159.3 9.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.999 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.27 134.33 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.945 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 140.88 48.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.542 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.18 -126.36 7.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.518 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.8 177.69 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 mp0 -70.46 -33.9 71.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.127 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.79 75.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.979 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.28 70.37 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.001 2.468 . . . . 0.0 111.36 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.484 ' H ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.53 106.92 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.182 -177.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -98.75 147.94 24.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -137.3 171.71 14.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.23 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.2 121.0 36.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.091 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.85 128.38 36.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 83.62 -14.54 41.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.764 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.74 -156.84 27.54 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.976 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.99 130.97 35.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.004 0.43 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.672 ' HG ' HD22 ' A' ' 47' ' ' LEU . 1.2 tp -110.01 110.36 21.25 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -114.01 114.66 26.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 -178.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.672 HD22 ' HG ' ' A' ' 45' ' ' LEU . 1.2 mm? -100.69 128.74 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.362 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.2 121.28 44.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.76 141.07 51.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -134.13 140.82 46.83 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.122 0.487 . . . . 0.0 110.988 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 125' ' ' PHE . 1.2 pp -127.58 161.68 28.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.179 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.504 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 1.6 m -82.18 109.05 13.55 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 8.2 Cg_exo -70.53 112.45 3.22 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.255 2.637 . . . . 0.0 114.271 -167.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 52' ' ' SER . 88.9 Cg_endo -90.94 -8.59 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.95 2.434 . . . . 0.0 110.405 168.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -158.41 -172.17 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.426 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -9.11 58.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.75 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 70.63 -1.85 2.44 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.466 0.706 . . . . 0.0 112.877 173.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -65.66 -18.06 65.05 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.047 0.451 . . . . 0.0 111.255 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.64 6.93 22.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.404 ' HE2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.07 155.21 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.311 0.577 . . . . 0.0 112.101 -172.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.887 ' HG2' HD12 ' A' ' 75' ' ' LEU . 11.1 mt-10 -80.02 107.8 13.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.206 172.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.39 140.79 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.361 0.601 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 1.025 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 1.6 ttp180 -131.81 131.63 43.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.302 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.512 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -147.77 57.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' HB2' HD22 ' A' ' 67' ' ' ASN . 62.6 m-85 -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.307 -170.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 98.55 7.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.55 HD22 ' HB2' ' A' ' 65' ' ' PHE . 1.7 p30 -158.33 144.94 17.46 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.42 161.29 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.413 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.18 56.2 1.78 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 123.487 0.492 . . . . 0.0 110.595 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.93 74.43 5.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.757 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.473 ' CB ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 mt-10 -72.57 -54.29 5.22 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.038 172.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD3' ' CB ' ' A' ' 71' ' ' GLU . 1.5 Cg_endo -85.27 115.2 1.62 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.516 2.144 . . . . 0.0 111.06 172.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 22.9 m-70 -141.39 136.64 31.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.444 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.887 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -155.64 151.08 27.03 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -164.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.0 111.81 24.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.633 ' HG2' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -147.49 153.51 39.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.523 -172.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.633 ' N ' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 64.32 26.06 13.58 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.574 0.546 . . . . 0.0 109.867 175.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.57 73.5 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.963 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -142.51 151.28 41.49 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.115 0.484 . . . . 0.0 111.727 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.71 154.49 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.616 171.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.458 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 23.1 mtp -114.5 -160.04 0.72 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.802 0.334 . . . . 0.0 111.677 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -72.66 -36.41 67.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.651 ' HA3' ' CE1' ' A' ' 74' ' ' HIS . . . -85.04 -44.05 6.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.504 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 1.6 pm0 -87.45 17.91 4.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.441 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.95 108.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.787 0.804 . . . . 0.0 110.421 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 tt -70.0 -16.73 20.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.744 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -12.84 61.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -60.03 -20.57 58.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.335 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -76.11 0.39 19.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 t 57.16 39.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.419 0.688 . . . . 0.0 112.028 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -168.67 177.56 5.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.864 176.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.34 141.95 48.79 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.209 0.528 . . . . 0.0 110.813 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.709 HG22 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -137.51 141.68 41.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.783 -177.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -136.49 104.25 5.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.776 177.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.23 90.28 4.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 107' ' ' THR . 20.6 mt -68.81 120.51 14.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.183 0.516 . . . . 0.0 110.894 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 8.99 27.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.858 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.52 -33.69 70.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.47 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.23 -16.66 64.21 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.178 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 57' ' ' ALA . 2.3 tt -54.05 -36.26 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -167.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 101' ' ' ILE . . . -66.35 -21.92 70.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.104 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.99 2.24 37.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.205 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.01 19.85 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.322 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.66 133.2 53.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.419 0.61 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.99 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 122.237 -0.29 . . . . 0.0 110.27 176.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.442 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.11 107.86 13.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 111.282 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.728 HD23 HD13 ' A' ' 110' ' ' ILE . 45.1 tp -88.33 112.76 23.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.815 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -92.71 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.289 176.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.728 HD13 HD23 ' A' ' 108' ' ' LEU . 57.3 mt -116.49 124.63 72.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.507 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 1.5 t80 -76.57 124.96 28.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.185 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.425 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 54.8 t30 77.04 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.158 0.911 . . . . 0.0 112.053 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 140' ' ' ILE . 11.5 p -133.95 141.52 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.24 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -123.16 174.69 7.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.12 -11.86 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.021 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.64 -24.34 41.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -101.74 -9.97 20.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.592 ' HB2' HD11 ' A' ' 140' ' ' ILE . 36.4 t70 -68.46 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.797 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -127.68 -126.54 2.91 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.822 -177.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.4 114.8 16.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' HH ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -110.31 128.03 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.51 175.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 118.82 37.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.209 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.7 t -105.46 140.3 38.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.635 175.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 1.9 t -144.43 132.55 17.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.213 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.572 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -120.3 115.45 23.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.336 176.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.606 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.7 mtpm? -130.66 102.26 6.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.845 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -91.74 71.35 5.76 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.56 -107.33 2.29 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.11 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.33 -19.97 27.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.946 0.403 . . . . 0.0 110.429 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 126' ' ' LYS . 21.7 m-85 -68.82 94.37 0.61 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -120.44 137.81 54.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.2 0.524 . . . . 0.0 111.96 -172.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.89 135.2 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.415 171.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -122.7 137.73 54.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.349 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.35 146.95 37.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.219 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 135' ' ' ILE . 1.1 tp -123.14 113.21 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.646 0.736 . . . . 0.0 110.452 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 159.71 18.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.273 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.48 129.11 53.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.22 129.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.66 97.82 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.074 0.464 . . . . 0.0 110.863 -177.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 118' ' ' ASP . 33.8 mt -67.85 114.59 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.437 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 121.216 0.423 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 1.1 p90 -157.85 146.88 19.52 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.68 178.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.924 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.44 148.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.816 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 151.84 41.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.764 0.316 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.03 -127.74 9.33 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.56 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.35 178.76 6.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.07 74.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 119.27 84.23 0.89 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.712 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.05 81.62 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.75 2.3 . . . . 0.0 111.002 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -85.25 127.69 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.44 142.3 35.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.46 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.19 172.09 16.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.476 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.69 140.02 51.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.55 133.76 56.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.933 0.397 . . . . 0.0 111.107 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.75 -16.42 8.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.918 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.74 -148.8 15.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.182 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -101.31 130.76 47.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.728 HD13 HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -104.3 110.98 23.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.305 175.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.71 106.11 18.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 0.0 109.89 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 108' ' ' LEU . 1.5 mm? -94.09 128.09 40.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.65 122.12 37.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.541 ' HB3' ' HE2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -126.83 141.12 51.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.461 176.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.627 ' HG3' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -115.15 130.71 56.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -127.79 154.7 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.07 0.462 . . . . 0.0 110.843 -178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -125.15 83.66 60.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.951 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -93.99 164.39 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.511 2.807 . . . . 0.0 112.987 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.83 -14.85 10.99 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.765 2.31 . . . . 0.0 111.875 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -116.5 -172.84 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.115 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.5 ' NE2' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.3 -11.63 48.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 110.432 178.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 68.06 7.72 6.03 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.072 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 1.5 tm0? -58.22 -46.74 85.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.182 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.44 5.08 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.06 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -80.31 166.22 21.55 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -176.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 77' ' ' ARG . 3.1 mt-10 -105.29 142.8 34.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.59 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 64' ' ' TRP . 2.7 tt -137.37 144.49 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.162 0.506 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -127.86 116.76 20.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -130.74 58.1 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -170.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.5 170.51 18.43 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.638 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 117' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.47 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 85' ' ' GLU . 2.4 m170 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.365 0.126 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 61' ' ' GLU . 6.1 tp 176.1 127.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.973 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.12 138.24 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.553 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -137.49 139.62 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -163.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.0 t0 66.82 0.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.437 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.38 4.19 57.37 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 140.92 41.21 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.437 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 169.71 17.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.769 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.923 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 2.6 ttt -132.47 120.89 22.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.966 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.28 -40.57 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.87 80.84 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.93 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -93.96 -25.98 17.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 42.37 68.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.852 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 94' ' ' THR . 6.5 tp -66.06 -12.29 14.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.267 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -13.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -62.77 -35.21 79.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.834 0.349 . . . . 0.0 110.609 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 21.79 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 54.8 -149.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.441 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.46 28.28 4.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.354 0.597 . . . . 0.0 110.645 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -100.49 35.57 2.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.475 -178.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.652 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -120.41 126.12 49.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.922 -175.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -136.33 99.89 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -88.24 100.1 12.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.238 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.11 99.93 0.72 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.885 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.05 -7.65 26.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.159 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -30.83 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.497 0.665 . . . . 0.0 109.99 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.26 -17.87 79.68 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.98 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.517 HG12 ' HB3' ' A' ' 57' ' ' ALA . 3.6 tt -61.03 -29.81 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -171.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.53 -15.6 70.86 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.395 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 -4.58 28.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.944 0.402 . . . . 0.0 109.982 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . 89.83 20.72 42.33 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.945 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.627 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -130.28 132.54 45.96 Favored 'General case' 0 C--O 1.22 -0.477 0 O-C-N 122.507 -0.408 . . . . 0.0 111.11 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.436 HG11 HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -119.66 132.28 69.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 121.763 -0.586 . . . . 0.0 109.75 174.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -125.25 103.17 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 0.0 111.5 -176.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 47' ' ' LEU . 2.0 tp -91.69 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.802 0.334 . . . . 0.0 110.621 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 106.31 18.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -111.14 131.33 62.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -96.3 137.56 35.19 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.904 -176.574 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 40.4 t30 76.05 74.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.513 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.98 146.97 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.79 168.45 13.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.525 0.202 . . . . 0.0 111.325 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -77.39 -8.15 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.146 0.498 . . . . 0.0 111.643 -173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -35.3 12.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -72.76 -25.4 61.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.53 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HA ' ' HB ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -78.11 24.3 0.25 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.87 -108.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.428 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.87 116.2 23.25 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.393 -0.475 . . . . 0.0 109.898 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -74.37 141.1 45.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.925 178.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.11 105.65 17.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.403 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.7 t -98.68 117.22 32.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.05 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 53.0 t -132.33 124.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.676 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -110.34 135.91 50.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.97 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -123.75 104.8 9.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.444 . . . . 0.0 110.622 178.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.699 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 19.7 t70 -93.07 81.86 4.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.147 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.75 -100.83 0.58 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.694 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -95.75 -10.99 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -93.07 154.92 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.607 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 50.8 p90 -151.26 146.73 26.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.89 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 1.9 mm-40 -139.71 160.37 40.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.885 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG22 ' A' ' 124' ' ' VAL . 2.1 mt-10 -126.46 154.24 43.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -173.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 140.71 14.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.515 HG13 ' H ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -108.48 107.14 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.615 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.3 OUTLIER -95.04 102.03 13.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.055 -176.225 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.3 116.71 13.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 118' ' ' ASP . 1.3 t -86.53 150.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.164 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.02 112.57 8.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.182 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.33 110.66 11.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.889 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.946 0.311 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.71 149.18 28.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.905 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -143.15 170.63 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.71 HG23 ' HB3' ' A' ' 132' ' ' GLU . 84.9 t -96.88 147.89 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.182 175.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.13 136.6 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.55 78.52 1.16 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.582 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -135.41 115.89 13.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -77.19 -44.77 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.07 111.59 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.716 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.63 62.55 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.53 2.154 . . . . 0.0 110.332 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.36 104.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.953 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 139' ' ' LYS . 1.2 mt -93.99 123.1 37.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.426 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.69 167.15 15.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.634 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.35 139.95 46.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD12 HG21 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -63.06 126.39 27.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.933 0.397 . . . . 0.0 110.621 -177.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 85.98 -9.78 67.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.993 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.76 -164.78 39.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.2 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.74 133.01 48.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.49 115.53 24.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.385 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.3 mt-10 -99.42 112.95 25.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.01 0.433 . . . . 0.0 110.004 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 121' ' ' TYR . 10.3 mt -95.6 128.07 42.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.269 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.8 OUTLIER -123.99 123.05 39.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.36 -179.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.707 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -117.55 140.42 49.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -128.7 134.15 48.39 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.164 0.29 . . . . 0.0 111.062 -173.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.32 164.85 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -80.56 104.94 3.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 7.4 Cg_exo -72.15 114.81 4.09 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.143 2.562 . . . . 0.0 113.551 -170.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 52' ' ' SER . 98.8 Cg_endo -87.89 -13.24 3.96 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 111.067 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -171.5 3.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.478 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.475 ' HG3' ' OE1' ' A' ' 58' ' ' GLN . 4.8 pm0 -68.02 -7.75 31.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.484 0.183 . . . . 0.0 111.479 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 75.51 -33.77 0.24 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HA ' HD13 ' A' ' 101' ' ' ILE . 10.1 pt20 -51.74 -39.79 59.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.413 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -83.93 15.02 3.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.562 -173.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ptm -92.9 160.87 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.733 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 75' ' ' LEU . 71.9 mt-10 -87.2 131.22 34.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -132.26 135.57 57.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.049 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.521 HH11 ' HB2' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -119.15 117.58 29.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.872 172.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.441 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -126.3 63.8 1.25 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' HE1' HG13 ' A' ' 87' ' ' ILE . 89.5 m-85 -148.93 154.71 39.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.611 -170.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.641 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.213 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 61' ' ' GLU . 1.5 tp -113.08 130.81 56.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HE2' ' HD2' ' A' ' 98' ' ' LYS . 52.5 t80 -126.24 152.85 45.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 59' ' ' HIS . 20.8 ttp85 -141.96 143.33 33.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.04 113.2 4.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.328 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 122.45 16.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.401 0.62 . . . . 0.0 111.141 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.99 161.32 30.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.949 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -167.59 163.03 14.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.759 0.314 . . . . 0.0 110.622 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -12.04 61.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.981 0.419 . . . . 0.0 110.63 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.05 -35.87 79.51 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.029 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -76.68 -41.24 46.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.18 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 tp 21.54 72.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 124.754 1.283 . . . . 0.0 112.373 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.923 HG12 ' HB ' ' A' ' 94' ' ' THR . 14.9 tt -58.8 -23.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.235 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -13.72 59.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.956 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.93 -17.98 60.47 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.815 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.59 ' HD2' HG23 ' A' ' 91' ' ' VAL . 13.1 t80 -64.71 -71.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.086 -0.245 . . . . 0.0 110.706 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 ' HD2' ' A' ' 90' ' ' TYR . 97.0 t -134.84 -67.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.675 0.274 . . . . 0.0 110.817 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -168.98 -63.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.197 0.522 . . . . 0.0 110.25 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.745 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -101.0 98.61 9.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.921 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.923 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -130.58 115.05 16.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.536 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -126.7 133.65 50.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.81 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.542 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -102.81 104.53 14.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.97 0.414 . . . . 0.0 110.603 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.52 121.74 25.59 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.756 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HB2' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -107.87 -4.71 17.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.413 -172.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -62.73 -35.81 80.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 110.959 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.41 -17.79 74.72 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 58' ' ' GLN . 1.2 tt -62.09 -26.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 122.718 -0.283 . . . . 0.0 111.457 -173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.26 -17.37 63.78 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.801 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.63 5.65 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.229 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 89.23 23.66 33.94 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.123 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.5 OUTLIER -128.72 133.62 48.21 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 117.54 0.67 . . . . 0.0 111.475 -178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -115.04 132.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 O-C-N 121.761 -0.587 . . . . 0.0 109.629 175.013 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -114.12 103.26 10.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.187 0.518 . . . . 0.0 111.512 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.542 HD13 HD12 ' A' ' 96' ' ' LEU . 22.9 tp -93.56 111.22 22.85 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.182 0.515 . . . . 0.0 110.264 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -88.08 107.41 18.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.807 178.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.528 HG13 ' HG ' ' A' ' 108' ' ' LEU . 63.5 mt -110.92 127.3 68.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.922 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.745 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -106.23 143.14 34.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.596 0.236 . . . . 0.0 110.832 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 7.1 m-80 68.35 55.72 0.51 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.636 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.88 152.2 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.39 152.39 39.08 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 112.39 -173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.97 -17.45 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.212 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.47 -38.75 71.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.885 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -96.92 7.74 45.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.226 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.477 ' HA ' HG13 ' A' ' 138' ' ' VAL . 17.2 t70 -55.55 24.88 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 0.0 113.351 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -97.65 -132.66 7.58 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 120.788 -1.195 . . . . 0.0 112.194 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 127.57 43.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.443 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.714 ' CE2' ' HB ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -90.19 161.84 15.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.598 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -103.02 119.06 38.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.623 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -102.34 116.11 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.692 HG22 ' HG3' ' A' ' 133' ' ' GLU . 16.2 t -129.56 117.47 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.265 -176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 17.4 m-30 -107.61 128.68 54.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.8 mtpt -122.55 104.9 9.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 6.2 t70 -91.63 73.94 5.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.525 0.678 . . . . 0.0 109.714 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.29 -83.05 1.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.96 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -116.82 -27.7 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.524 0.202 . . . . 0.0 111.457 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -89.67 125.78 35.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -126.32 150.56 48.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.905 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -132.12 145.38 51.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.877 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.692 ' HG3' HG22 ' A' ' 124' ' ' VAL . 33.9 tt0 -132.35 126.39 33.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.388 . . . . 0.0 110.708 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -129.6 143.72 50.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.333 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -102.39 113.89 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.182 0.515 . . . . 0.0 110.191 176.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.635 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -105.65 147.23 28.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.726 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 150.35 28.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.828 0.347 . . . . 0.0 111.655 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.714 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 14.1 p -122.74 131.28 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.53 ' HB3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.97 103.75 11.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.795 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.607 HG21 HD12 ' A' ' 41' ' ' LEU . 1.4 mp -73.41 124.51 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.444 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.611 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 CA-C-O 121.104 0.377 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -136.45 134.8 38.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.104 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.5 OUTLIER -150.47 161.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.373 0.42 . . . . 0.0 110.175 174.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 51' ' ' LEU . 75.5 t -92.31 145.07 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.491 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.5 t-20 -67.94 162.5 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.85 62.95 2.41 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.294 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 122.78 19.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -83.75 -48.73 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' H ' ' HD3' ' A' ' 36' ' ' PRO . . . 106.55 72.35 0.81 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.397 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HD3' ' H ' ' A' ' 35' ' ' GLY . 5.3 Cg_exo -78.98 72.48 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.753 2.302 . . . . 0.0 110.919 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.89 103.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.74 139.39 33.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.45 171.39 14.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.774 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.62 154.25 28.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -69.6 130.48 42.54 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.451 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.64 8.62 86.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.205 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.97 -158.73 32.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.016 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -102.65 130.21 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.178 0.513 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 113' ' ' VAL . 8.6 tp -116.24 110.6 18.99 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.918 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tt0 -105.96 110.54 22.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 4.7 mt -95.8 128.43 42.67 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.67 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -121.55 125.4 46.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.583 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.3 140.23 50.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.85 130.83 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.103 0.477 . . . . 0.0 111.426 -172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.23 165.56 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.627 -176.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.558 ' H ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -117.54 82.41 15.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.714 169.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 28' ' ' PHE . 97.8 Cg_endo -89.86 141.83 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.027 2.485 . . . . 0.0 113.082 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.27 1.24 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.632 2.221 . . . . 0.0 112.646 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -151.97 -174.44 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.257 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -76.88 -18.55 58.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.272 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 61.45 34.97 17.89 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 170.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -64.6 -36.84 85.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.378 0.608 . . . . 0.0 109.56 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.625 ' HA ' ' OD1' ' A' ' 78' ' ' ASP . 49.9 t-80 -79.92 -2.67 44.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.094 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 3.9 ttm -69.47 141.48 53.97 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.03 0.443 . . . . 0.0 111.396 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CD ' ' HD3' ' A' ' 126' ' ' LYS . 2.7 tt0 -97.81 116.95 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.927 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -116.44 147.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.338 0.589 . . . . 0.0 111.21 -174.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.738 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -128.56 137.22 51.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.241 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.446 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -151.81 42.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 30.6 m-85 -134.18 158.39 43.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.176 -168.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.032 0.444 . . . . 0.0 110.308 177.858 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 1.2 m-70 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.228 0.537 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -161.9 136.22 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.345 -171.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -103.37 109.28 20.85 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -116.52 130.18 56.6 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.486 -168.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' ' HA ' ' A' ' 59' ' ' HIS . 16.4 t0 58.41 20.22 7.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.353 0.597 . . . . 0.0 111.684 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 22.93 58.25 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.885 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.51 139.18 50.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 110.815 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.81 169.98 17.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.176 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.27 135.11 49.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.924 0.393 . . . . 0.0 110.697 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.5 -2.43 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.073 0.464 . . . . 0.0 110.981 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.46 -18.89 63.22 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -108.83 -40.73 4.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.542 0.21 . . . . 0.0 110.6 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 31.5 mm 65.86 85.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.698 0.761 . . . . 0.0 111.435 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 94' ' ' THR . 2.1 tp -67.8 -20.54 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 0.0 109.692 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -14.02 7.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.696 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -69.44 -22.52 63.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 178.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 91' ' ' VAL . 2.4 m-85 -74.88 -36.93 62.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.504 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.722 HG13 ' HG2' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 65.65 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.796 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.722 ' HG2' HG13 ' A' ' 91' ' ' VAL . 5.9 mm-40 66.25 -151.11 0.22 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.911 0.484 . . . . 0.0 110.416 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.47 109.28 22.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.156 0.503 . . . . 0.0 110.991 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 HD11 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -115.77 95.36 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.524 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 4.7 tp10 -104.63 108.15 19.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.959 0.409 . . . . 0.0 110.675 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -91.96 96.48 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.13 105.33 3.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -102.85 -8.71 20.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.952 -175.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.56 -39.75 61.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.524 ' HA2' ' OE2' ' A' ' 103' ' ' GLU . . . -62.77 -18.66 59.72 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.543 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER -58.61 -25.8 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 117.16 0.48 . . . . 0.0 111.833 -174.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 56' ' ' GLN . . . -63.9 -23.39 67.46 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.561 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.524 ' OE2' ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -105.84 -5.17 19.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.21 42.79 6.12 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.872 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.77 132.6 34.98 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.293 -0.533 . . . . 0.0 110.585 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.573 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 14.0 m -121.67 133.18 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.03 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -120.87 103.46 9.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 64' ' ' TRP . 35.2 tp -92.86 110.25 21.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.476 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -88.95 105.79 17.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.35 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.667 HG12 HG23 ' A' ' 94' ' ' THR . 12.5 mt -112.46 119.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -94.55 140.08 30.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 74.26 67.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.056 0.848 . . . . 0.0 111.134 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -62.02 133.36 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.994 174.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.77 149.44 24.48 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 41' ' ' LEU . 7.9 p -67.59 -22.45 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.717 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -75.03 -37.07 61.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -89.74 2.26 55.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.5 t0 -58.47 27.09 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.94 0.896 . . . . 0.0 112.913 168.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -104.86 -147.43 16.4 Favored Glycine 0 N--CA 1.448 -0.539 0 O-C-N 121.399 -0.813 . . . . 0.0 112.29 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.808 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -100.96 120.3 39.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.7 0.286 . . . . 0.0 110.834 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.81 146.24 35.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 110.894 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 86.4 t60 -99.6 103.45 15.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.336 -177.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 46.7 t -106.0 130.88 53.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.738 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 23.2 t -144.56 137.29 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 17.0 m-85 -115.62 110.97 19.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.611 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -118.01 105.25 11.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 0.0 111.223 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 19.3 t0 -112.77 99.86 8.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 0.0 109.988 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.35 -103.6 2.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.233 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -112.57 -24.6 9.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.463 0.173 . . . . 0.0 111.274 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.74 129.66 36.63 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.788 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 23.5 p90 -137.4 127.77 26.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.283 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -112.34 136.36 51.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.942 177.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -110.1 146.87 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.857 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.508 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 7.1 t-80 -149.16 127.1 11.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.15 110.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.912 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 53.4 m -122.11 111.96 17.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.247 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.6 pt-20 -88.25 150.22 23.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.306 0.574 . . . . 0.0 111.867 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.52 151.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.42 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -122.49 90.83 3.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.923 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.529 HG21 HD12 ' A' ' 41' ' ' LEU . 19.5 mt -76.66 107.32 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.516 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.463 -0.294 0 CA-C-O 121.028 0.345 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.591 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 4.9 p90 -78.58 164.94 24.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.787 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -128.63 173.85 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 111.673 -176.461 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.615 HG22 ' HE2' ' A' ' 125' ' ' PHE . 82.6 t -89.87 142.26 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.241 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.46 175.62 5.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.709 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.05 -113.47 3.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.772 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.48 176.87 9.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.73 -49.16 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.1 73.03 1.07 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.99 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.16 89.52 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.402 2.068 . . . . 0.0 110.494 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -67.89 129.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -174.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.8 mm? -88.98 128.34 35.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.02 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.71 16.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 128.96 54.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.665 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -62.59 123.91 19.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.73 -9.48 77.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.242 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.85 -171.45 35.73 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.847 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.33 137.35 33.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 tp -111.94 112.92 24.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.926 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -104.78 108.44 19.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.948 177.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.0 OUTLIER -96.61 127.95 43.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.514 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.47 123.87 50.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -121.58 140.73 51.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 1.0 OUTLIER -123.04 131.22 53.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -117.57 164.71 14.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.367 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.53 99.13 2.55 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -83.76 121.1 2.82 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.162 2.575 . . . . 0.0 113.515 -167.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.02 -6.83 13.18 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.465 2.11 . . . . 0.0 110.356 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -165.62 -179.06 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.972 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -72.41 -17.24 61.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.535 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 58.34 30.16 19.18 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.408 0.623 . . . . 0.0 111.098 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -52.31 -58.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.612 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -96.03 26.61 4.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.84 167.68 11.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -97.14 149.97 21.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.685 0.278 . . . . 0.0 110.983 -172.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 146.67 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.408 0.623 . . . . 0.0 112.195 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.661 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mmm-85 -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -143.33 53.49 1.35 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.524 ' HZ ' ' CD1' ' A' ' 76' ' ' TYR . 39.6 m-85 -136.46 154.72 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -166.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HB2' ' CE1' ' A' ' 121' ' ' TYR . 4.2 ttp180 . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.981 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HA ' ' CD ' ' A' ' 85' ' ' GLU . 31.1 m-70 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.96 0.41 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.04 124.83 1.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.587 -172.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CD1' ' HZ ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -108.02 112.4 24.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -119.08 143.96 46.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 68.48 -2.72 1.53 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.319 0.58 . . . . 0.0 110.729 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 9.47 52.11 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.728 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -134.17 167.59 20.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.04 151.9 23.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 164.13 12.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.65 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -22.7 63.81 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.55 -28.64 69.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.478 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.476 ' CD ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -86.85 -42.33 13.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 86' ' ' ILE . 7.5 tp 43.7 90.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.663 1.227 . . . . 0.0 112.61 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 94' ' ' THR . 3.8 tp -65.39 -12.45 13.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.308 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -14.45 60.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.234 0.54 . . . . 0.0 109.78 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.1 -21.51 54.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.173 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -61.86 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 92' ' ' GLU . 2.1 p -169.72 -71.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.285 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 177.85 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 109.887 -177.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' PHE . 5.7 mtm-85 -76.88 105.7 8.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.883 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 87' ' ' ILE . 25.8 m -152.55 107.49 3.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 131.33 55.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.879 0.371 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -99.51 112.81 24.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.868 0.366 . . . . 0.0 110.177 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.41 105.76 10.95 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.954 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 1.78 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.456 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.6 -28.5 69.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 110.2 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.04 -17.46 78.31 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -28.29 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.88 0.34 . . . . 0.0 111.454 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.12 -16.98 67.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.751 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -103.47 -4.26 24.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.516 0.326 . . . . 0.0 110.246 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 92.31 20.13 36.44 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.851 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -129.08 133.0 47.49 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 117.142 0.471 . . . . 0.0 111.511 -178.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.73 132.73 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -120.71 108.71 14.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.613 -177.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 64' ' ' TRP . 11.1 tp -91.96 121.67 33.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.289 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.788 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.405 HG13 ' HG ' ' A' ' 108' ' ' LEU . 38.3 mt -112.59 127.77 69.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.699 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 112' ' ' ASN . 31.4 t80 -83.48 122.61 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 32.6 t30 80.13 119.36 0.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.071 0.857 . . . . 0.0 111.68 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 140' ' ' ILE . 7.1 p -117.9 134.59 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.412 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.5 p -103.78 171.27 7.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 112.007 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -67.06 -14.14 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.499 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 13.7 t0 -81.38 -34.02 31.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' HA ' ' CD ' ' A' ' 66' ' ' ARG . 32.6 m-20 -72.3 -24.84 61.39 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.014 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.56 -3.66 0.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.697 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.69 -132.12 1.71 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.813 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -106.62 127.12 53.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.105 0.479 . . . . 0.0 111.542 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-85 -90.37 148.48 22.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -106.19 113.66 27.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.781 0.324 . . . . 0.0 110.141 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 4.5 t -103.4 116.21 31.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.128 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.661 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 8.8 t -132.31 113.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.615 ' HE2' HG22 ' A' ' 30' ' ' VAL . 34.7 m-85 -93.27 136.09 33.87 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HB3' ' HE3' ' A' ' 126' ' ' LYS . 11.8 mtpp -121.01 102.97 8.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 33.9 t70 -99.05 74.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.548 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.15 -96.94 0.34 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.905 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.89 -27.83 17.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.67 0.271 . . . . 0.0 111.601 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB2' ' HD1' ' A' ' 28' ' ' PHE . 2.9 m-85 -90.68 148.46 22.6 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.34 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -146.18 150.34 35.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.46 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.683 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -143.38 132.84 23.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.008 177.314 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -114.48 121.93 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 109.949 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.05 148.15 50.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -93.29 133.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.153 0.501 . . . . 0.0 110.772 -176.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -128.79 102.38 6.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.63 138.51 38.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 46.0 t -95.48 142.72 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.83 100.78 5.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 113' ' ' VAL . 70.7 mt -81.83 97.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.682 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.56 ' CB ' ' HB3' ' A' ' 130' ' ' PHE . 4.0 Cg_exo . . . . . 0 N--CA 1.459 -0.551 0 N-CA-C 110.991 -0.426 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.765 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 13.4 p90 -140.67 160.55 39.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.75 172.35 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.582 . . . . 0.0 112.123 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.61 147.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.78 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 26.3 t30 -99.2 167.74 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.735 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.16 128.14 45.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.0 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.691 HD11 ' HA ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -112.47 176.62 4.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.752 0.311 . . . . 0.0 110.518 -175.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -73.53 -12.3 60.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.009 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 -132.35 11.02 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.567 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 55.5 Cg_endo -71.5 97.68 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.328 2.018 . . . . 0.0 111.513 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.78 113.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.1 mt -95.59 96.2 8.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.606 -175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -127.4 170.84 12.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.885 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -97.38 145.35 26.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.777 0.322 . . . . 0.0 110.239 -170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 140' ' ' ILE . 0.9 OUTLIER -70.71 142.65 51.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.13 -173.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.16 -8.07 72.44 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.698 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.12 -167.98 35.98 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.237 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.26 134.59 33.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.285 0.564 . . . . 0.0 110.412 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.941 ' HG ' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -106.05 111.0 23.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.289 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 96.89 6.8 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.63 129.22 42.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.879 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -107.49 128.94 54.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.691 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.11 140.26 50.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.699 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -125.96 129.72 49.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.597 0.237 . . . . 0.0 110.758 -175.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.69 165.49 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.564 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.71 83.45 48.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.071 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -95.02 162.73 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.305 2.67 . . . . 0.0 113.107 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -88.44 37.45 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.947 2.431 . . . . 0.0 111.612 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -160.32 177.34 10.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.048 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.88 2.12 55.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.038 0.447 . . . . 0.0 109.817 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 62.28 24.77 14.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -67.81 -24.21 65.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 109.858 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -104.0 17.11 24.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.493 ' HA ' ' HB3' ' A' ' 127' ' ' ASP . 18.6 ttm -76.2 118.95 19.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 110.985 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -78.67 98.88 6.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.464 HD12 HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -111.22 140.48 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 111.336 -172.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.868 ' HB3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.33 118.93 13.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -114.19 63.24 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 81.0 m-85 -136.01 151.28 49.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.604 -168.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.593 HH11 ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.63 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -146.71 152.24 38.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.693 -175.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.19 128.85 42.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.634 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.564 ' HB3' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.52 128.96 34.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -175.27 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.6 t70 62.25 15.08 7.25 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.463 0.649 . . . . 0.0 111.269 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 98' ' ' LYS . . . 82.47 20.19 62.61 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.975 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.3 154.27 49.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.025 0.441 . . . . 0.0 111.065 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -132.22 139.03 48.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.916 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -177.8 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -23.81 65.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.58 -53.36 5.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.047 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 75' ' ' LEU . 16.4 pm0 -93.15 15.31 15.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.543 0.337 . . . . 0.0 111.777 -175.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.708 HG23 ' HB2' ' A' ' 89' ' ' LYS . 2.4 tt -42.58 121.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.712 0.768 . . . . 0.0 112.303 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 108' ' ' LEU . 14.3 tt -72.75 -36.42 52.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.792 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -13.97 27.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.708 ' HB2' HG23 ' A' ' 86' ' ' ILE . 4.3 ttpt -71.48 -12.42 61.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.534 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE1' ' HD1' ' A' ' 65' ' ' PHE . 1.3 t80 -58.76 -60.74 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -64.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -161.44 -91.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.921 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -72.1 111.78 7.63 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.52 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -140.91 90.8 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.054 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.01 127.08 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.095 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -97.65 100.5 11.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 110.951 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 9.3 mp -73.08 110.98 7.77 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.758 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HD3' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -101.14 -4.71 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.703 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.63 -29.33 67.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.272 0.558 . . . . 0.0 111.07 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.31 -17.94 77.07 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.829 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.564 HD12 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -59.54 -26.37 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -170.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -21.93 67.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.793 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.62 5.03 26.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 0.0 110.206 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 83.3 31.47 27.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.109 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HG3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -123.78 132.25 53.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.16 0.48 . . . . 0.0 110.89 179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -121.32 132.79 69.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -120.02 105.04 10.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.309 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 96' ' ' LEU . 7.0 tp -94.43 118.18 31.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.353 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 109' ' ' ARG . 5.7 ttt180 -95.14 106.21 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.927 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 94' ' ' THR . 65.4 mt -117.35 130.28 72.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER -91.0 134.53 34.42 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.465 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.8 t30 73.58 81.55 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.098 0.874 . . . . 0.0 112.237 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.941 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 8.4 p -82.09 140.81 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.992 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -117.65 176.51 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.974 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.42 -14.25 18.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.243 0.544 . . . . 0.0 110.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.583 ' HB3' HH21 ' A' ' 66' ' ' ARG . 30.3 t70 -80.58 -24.56 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 4.3 m-20 -86.13 -20.27 28.92 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.698 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.415 ' HB2' HD13 ' A' ' 140' ' ' ILE . 31.2 t0 -63.84 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.069 0.948 . . . . 0.0 112.776 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -153.38 -119.96 0.78 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.944 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 123.41 24.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -125.02 161.26 27.13 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.404 172.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.57 119.68 24.04 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.298 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -105.0 117.61 34.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.229 173.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.868 HG12 ' HB3' ' A' ' 63' ' ' ARG . 5.1 p -124.11 141.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.226 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.765 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -136.13 121.2 18.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.583 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -135.22 110.2 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 60' ' ' MET . 11.1 p-10 -116.8 95.91 5.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.127 0.965 . . . . 0.0 110.983 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.72 -82.92 1.38 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.693 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -118.87 -23.62 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.56 ' HB3' ' CB ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -97.28 141.34 30.5 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -148.26 145.46 28.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -150.26 132.3 15.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.804 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -128.22 121.56 29.69 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 139.83 49.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.192 0.52 . . . . 0.0 111.16 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.85 138.79 20.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.58 175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.79 160.2 37.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -121.13 135.37 55.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.22 -175.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 43.1 t -104.92 142.46 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.64 118.46 24.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.251 0.548 . . . . 0.0 111.137 -177.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.618 HD11 HG22 ' A' ' 113' ' ' VAL . 1.5 mp -82.77 119.29 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.605 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.73 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 CA-C-O 120.912 0.297 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 52' ' ' SER . 1.7 p90 -71.8 137.32 47.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -119.28 178.86 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.247 0.546 . . . . 0.0 112.36 -171.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.761 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 p -90.77 147.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.623 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 15.3 t30 -120.44 130.48 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.96 74.34 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.834 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -78.25 111.24 14.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.5 -24.72 67.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.47 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 136' ' ' THR . . . 69.22 -120.55 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.02 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.21 90.18 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.781 2.321 . . . . 0.0 111.66 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -74.01 117.66 18.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 139' ' ' LYS . 3.9 mt -91.2 134.21 34.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.025 0.44 . . . . 0.0 110.811 -171.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.667 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -136.02 172.56 12.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.107 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.55 133.88 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -64.38 124.69 22.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 -177.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.78 -12.17 36.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.304 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.97 -147.33 22.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.223 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -108.25 153.05 23.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.99 0.424 . . . . 0.0 111.228 -176.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 39' ' ' ALA . 1.4 tp -140.95 113.55 8.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.376 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.852 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -92.95 111.86 23.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 64' ' ' TRP . 3.0 mt -95.91 127.53 42.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.817 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.79 43.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 139.72 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 16.7 mp0 -125.66 137.17 53.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.4 mm? -126.22 164.96 19.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.951 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -111.79 80.98 3.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 99.0 Cg_endo -81.74 142.84 12.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.629 2.219 . . . . 0.0 112.882 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 12.6 Cg_exo -71.6 -26.17 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.958 2.439 . . . . 0.0 111.711 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -129.51 -172.14 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -68.08 -28.66 67.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB1' ' SD ' ' A' ' 60' ' ' MET . . . 63.36 25.51 14.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.619 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -60.66 -33.7 73.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.922 0.392 . . . . 0.0 111.253 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -113.22 28.48 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.636 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 7.8 ptm -80.21 169.34 17.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 111.49 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.843 ' HG2' HD12 ' A' ' 75' ' ' LEU . 3.5 mt-10 -89.68 121.18 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.16 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -114.98 139.47 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.45 . . . . 0.0 110.231 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -133.67 118.04 17.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -132.08 61.1 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.2 147.67 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.266 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 2.9 m-70 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.843 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -114.99 151.7 33.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.307 0.575 . . . . 0.0 112.367 -173.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -129.2 109.5 11.2 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' HG3' ' HG3' ' A' ' 61' ' ' GLU . 3.0 ttt-85 -116.31 89.09 3.03 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.165 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.0 t0 52.85 59.7 4.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.018 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.11 7.84 84.71 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.1 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.81 124.32 50.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.543 -0.387 . . . . 0.0 111.316 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -126.56 152.64 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.407 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -118.22 -158.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.85 0.357 . . . . 0.0 111.563 -172.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -41.63 99.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.14 -30.41 31.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.12 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.4 pm0 -112.42 13.77 20.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.509 HG23 ' HD3' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -46.38 112.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.651 0.739 . . . . 0.0 110.257 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -69.05 -12.61 16.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.732 -167.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -13.51 58.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.186 0.517 . . . . 0.0 110.282 173.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -78.92 -16.8 56.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.267 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.44 -33.34 32.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.24 167.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 124.04 0.838 . . . . 0.0 112.213 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 65.01 -105.92 0.13 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.477 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -127.51 120.79 29.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -171.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.15 92.97 2.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.199 175.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.54 116.11 31.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.461 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -102.98 109.35 20.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 107' ' ' THR . 12.7 mt -87.37 106.15 17.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.701 ' HE2' HG21 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -110.73 -3.73 15.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.456 -172.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.29 -12.79 61.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.517 0.675 . . . . 0.0 111.071 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.65 -17.34 70.93 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.43 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.701 HG21 ' HE2' ' A' ' 98' ' ' LYS . 1.7 tt -57.33 -23.27 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.12 -18.99 58.74 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -120.32 7.9 10.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.225 0.536 . . . . 0.0 109.954 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 80.41 43.67 9.25 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.195 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 1.2 mppp? -126.67 133.05 51.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.466 0.633 . . . . 0.0 110.854 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.49 134.7 43.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.572 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.731 ' HB ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -122.54 111.57 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.599 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 96' ' ' LEU . 13.0 tp -103.44 110.83 23.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.852 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -87.33 106.09 17.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.517 176.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.68 129.63 66.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 44' ' ' ASN . 5.4 m-85 -107.06 155.96 19.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.789 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.6 t30 69.61 54.21 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.297 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.56 124.0 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.727 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.617 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 68.5 p -101.88 168.05 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.31 -26.39 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.528 0.68 . . . . 0.0 110.196 176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.25 -28.49 31.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER -72.84 -25.68 61.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.871 175.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.1 t70 -63.13 26.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.358 1.063 . . . . 0.0 113.824 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -100.25 -147.65 21.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.566 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -92.3 107.83 19.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.169 0.509 . . . . 0.0 111.352 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.804 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.5 m-85 -73.92 157.45 36.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -126.84 118.29 24.32 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.343 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 10.3 t -99.51 116.72 32.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 28.9 t -136.34 118.71 20.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.213 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -112.18 128.21 56.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -120.64 117.64 28.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.593 0.235 . . . . 0.0 110.795 -178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.506 ' HB2' ' HE3' ' A' ' 60' ' ' MET . 21.1 t0 -117.47 93.76 4.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.036 0.445 . . . . 0.0 110.469 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.49 -80.21 0.9 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.095 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.82 -29.36 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -102.9 150.03 23.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.596 -174.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 16.6 p90 -145.51 144.76 30.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 3.7 tp10 -111.82 131.39 55.37 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.55 121.18 28.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.651 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.22 134.58 44.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.047 0.451 . . . . 0.0 110.391 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.75 130.98 35.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.237 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -132.88 102.0 5.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.232 -178.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 2.7 mm-40 -73.77 125.61 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.676 0.274 . . . . 0.0 110.849 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 118' ' ' ASP . 9.3 p -88.85 134.38 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -122.89 104.66 9.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.021 0.439 . . . . 0.0 111.795 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 31.2 mt -76.51 96.25 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.177 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.927 ' HB2' ' HB3' ' A' ' 130' ' ' PHE . 30.5 Cg_exo . . . . . 0 CA--C 1.529 0.226 0 CA-C-O 120.914 0.297 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HD1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -154.19 143.83 21.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.888 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -115.47 169.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.366 0.603 . . . . 0.0 111.314 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 125' ' ' PHE . 2.2 t -120.16 120.58 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.265 -174.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -78.48 132.85 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.95 -175.63 14.11 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.521 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 35' ' ' GLY . 0.4 OUTLIER -114.25 178.89 4.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -38.85 76.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.438 . . . . 0.0 109.974 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' H ' HD12 ' A' ' 33' ' ' LEU . . . 74.73 62.39 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.19 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 20.2 Cg_endo -96.22 75.78 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.422 2.748 . . . . 0.0 111.295 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 47' ' ' LEU . 21.8 t -78.41 93.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.159 0.504 . . . . 0.0 110.761 -177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HA ' ' HG3' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -86.67 103.72 15.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.751 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.31 9.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.809 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.52 140.88 37.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD12 HG21 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -64.25 110.52 2.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.593 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.75 7.86 88.11 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.403 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.48 -160.24 28.01 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.378 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -82.85 110.87 18.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.145 0.498 . . . . 0.0 110.305 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HB ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -98.74 123.85 43.22 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.22 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 8.4 mt-10 -126.23 108.7 11.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.149 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -96.3 143.95 26.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.193 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.07 114.63 25.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.065 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -118.59 141.17 48.84 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 146.67 49.89 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.29 145.24 50.86 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.371 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -65.87 108.26 2.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 37.6 Cg_exo -60.7 108.98 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.52 2.814 . . . . 0.0 114.587 -167.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 52' ' ' SER . 71.3 Cg_endo -94.43 -22.27 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.083 2.522 . . . . 0.0 111.602 170.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -156.5 -172.23 3.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.573 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 3.0 pt20 -77.87 -17.36 57.43 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.189 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . 59.01 13.85 3.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.928 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -65.3 -33.28 75.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.073 0.463 . . . . 0.0 110.053 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.91 17.64 19.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.704 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.514 ' HB3' ' O ' ' A' ' 57' ' ' ALA . 3.5 ttm -84.69 142.52 29.82 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.646 ' HG2' ' HA ' ' A' ' 77' ' ' ARG . 19.5 mt-10 -88.65 142.45 27.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.861 HD13 HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -135.22 131.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.255 0.55 . . . . 0.0 111.12 -178.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 75' ' ' LEU . 1.5 ttp180 -110.81 115.39 29.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 49' ' ' CYS . 4.7 t90 -140.64 79.52 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.834 0.35 . . . . 0.0 111.339 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HB3' ' HE2' ' A' ' 90' ' ' TYR . 7.1 m-85 -154.75 169.01 24.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD3' ' HA ' ' A' ' 117' ' ' ASP . 9.4 ttp85 . . . . . 0 N--CA 1.447 -0.612 0 C-N-CA 119.683 -0.807 . . . . 0.0 108.934 168.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.811 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.83 0.348 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.91 143.0 27.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.541 -175.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.1 t80 -95.25 111.15 23.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -112.16 125.58 54.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.878 -171.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 72.26 -10.99 0.84 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.457 0.646 . . . . 0.0 110.948 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 100.74 17.79 22.49 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -168.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.98 138.3 53.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.214 -0.493 . . . . 0.0 109.973 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.86 161.83 20.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.263 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.98 148.67 38.96 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.635 -175.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' O ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -75.72 -16.99 60.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.265 0.555 . . . . 0.0 110.39 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.95 73.81 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.044 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.81 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 1.7 pp20? -105.36 -41.26 5.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.41 0.148 . . . . 0.0 110.666 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 83' ' ' PHE . 48.5 mt 70.1 95.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.843 0.83 . . . . 0.0 111.41 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.811 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 1.8 tt -75.08 -16.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.274 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -12.96 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.704 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -53.73 -28.13 32.43 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.783 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.644 ' HE2' ' HB3' ' A' ' 65' ' ' PHE . 3.1 m-85 -98.06 -33.24 11.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.276 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.63 163.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 124.186 0.929 . . . . 0.0 111.663 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.3 OUTLIER 75.65 -167.12 0.08 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.984 177.087 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 93' ' ' ARG . 7.8 ttp180 -65.9 112.6 3.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.342 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.912 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -126.33 112.18 15.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.333 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 1.3 pt-20 -137.54 129.73 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.201 0.524 . . . . 0.0 110.629 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.98 107.31 19.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.639 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -74.53 99.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.127 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -96.2 6.25 49.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.522 178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.24 -34.12 63.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.975 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.02 -17.29 65.52 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.962 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.527 HD12 HG13 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -60.41 -21.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.72 61.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.625 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 3.65 20.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.81 31.62 8.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.726 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.46 132.68 53.5 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.673 0.737 . . . . 0.0 111.389 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -125.7 133.79 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 O-C-N 122.161 -0.337 . . . . 0.0 110.515 177.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.98 111.65 19.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 27.4 tp -86.43 113.42 22.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 3.3 mpt_? -98.82 106.77 19.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.929 ' HB ' HD23 ' A' ' 45' ' ' LEU . 14.6 mt -127.45 120.78 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -80.79 127.82 32.95 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 83.26 133.95 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.309 1.006 . . . . 0.0 111.213 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -145.02 139.51 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.304 178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -111.92 172.71 6.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.203 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 p -65.12 -10.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.162 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.91 -50.33 13.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.012 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.717 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -78.11 -9.75 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.784 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -55.0 -22.47 15.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.276 177.113 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.13 -86.7 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.173 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -145.19 155.86 43.52 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.604 -0.35 . . . . 0.0 111.004 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.552 ' HD1' HG21 ' A' ' 138' ' ' VAL . 1.7 m-85 -103.81 127.51 51.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.451 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 68.6 t60 -76.49 101.67 5.72 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.73 117.32 34.4 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.413 1.071 . . . . 0.0 109.861 -176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.01 116.49 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 0.8 OUTLIER -96.08 112.78 24.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.287 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 2.8 mtpt -119.7 105.0 10.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.95 0.405 . . . . 0.0 110.834 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.37 108.36 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.698 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.18 -102.21 0.7 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.87 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.65 -18.15 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.927 ' HB3' ' HB2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.72 135.96 33.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 110.266 -177.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 1.7 p90 -144.76 151.44 38.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.888 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.5 140.67 43.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 124.82 46.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.322 0.582 . . . . 0.0 110.791 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.38 158.84 42.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.583 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -114.62 112.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.969 0.414 . . . . 0.0 110.427 177.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 120.13 19.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.303 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.06 118.7 13.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.006 0.431 . . . . 0.0 110.731 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.552 HG21 ' HD1' ' A' ' 121' ' ' TYR . 1.8 t -105.38 151.58 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.711 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.37 141.06 37.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.578 HG21 HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -93.71 139.02 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.537 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.473 0.265 0 CA-C-O 121.078 0.366 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -166.19 147.85 6.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.423 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -138.63 169.73 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.554 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 132' ' ' GLU . 54.7 t -90.73 111.88 24.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -87.82 150.17 23.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.44 -156.14 38.7 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.706 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -147.17 137.02 23.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.853 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -96.49 -49.13 5.28 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 55.04 -134.59 47.95 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.85 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 5.6 Cg_exo -80.84 97.97 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.417 2.744 . . . . 0.0 112.81 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.24 119.53 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.991 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -106.16 132.83 51.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.927 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.16 170.91 18.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.081 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.28 131.29 47.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.415 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -71.63 142.22 49.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.022 0.439 . . . . 0.0 110.488 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.1 -29.86 10.5 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.21 -153.51 26.27 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.6 p-10 -110.04 135.72 50.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.502 0.668 . . . . 0.0 111.074 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -97.92 110.9 23.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.304 175.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.754 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -97.15 99.62 11.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.96 127.99 42.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -116.7 119.04 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.612 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -117.06 139.93 50.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.3 132.68 50.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.875 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.454 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -128.48 156.91 42.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.919 175.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -87.52 101.6 2.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 87.2 Cg_endo -86.54 126.45 2.62 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 114.142 -166.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.17 -27.23 13.97 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.372 2.048 . . . . 0.0 110.665 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.635 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 2.8 pt20 -136.21 178.46 7.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HG3' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -71.45 -19.78 62.18 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.59 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.89 19.67 9.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.767 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.55 -30.54 65.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.537 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -113.5 17.2 18.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 5.2 mmt -87.74 -166.61 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.748 0.309 . . . . 0.0 111.26 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.924 ' HB3' HD11 ' A' ' 75' ' ' LEU . 30.9 mt-10 -114.54 136.53 52.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.962 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -132.17 146.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.821 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 10.9 ttt-85 -141.23 115.21 9.18 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.636 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -129.89 90.19 2.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.604 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 77.8 m-85 -143.57 164.18 31.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.068 -172.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 120.962 0.411 . . . . 0.0 109.933 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.654 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 12.0 p-80 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -164.3 152.16 12.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 -174.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.37 115.61 27.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.417 ' HB2' ' HG2' ' A' ' 61' ' ' GLU . 9.4 ttm180 -111.36 123.92 51.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -3.32 2.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.887 0.851 . . . . 0.0 109.828 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.6 25.76 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -120.9 149.87 41.95 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 115.051 -0.575 . . . . 0.0 110.875 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -99.57 169.99 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -158.43 163.23 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.318 . . . . 0.0 110.759 -176.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -13.7 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.35 -47.51 7.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.31 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -72.4 -32.38 66.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.512 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER 50.11 59.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.656 1.217 . . . . 0.0 112.407 176.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.755 HD11 HG21 ' A' ' 94' ' ' THR . 16.3 tt -67.11 -1.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.025 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -13.95 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.18 0.514 . . . . 0.0 109.891 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -13.68 62.21 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.053 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 74.6 m-85 -109.75 27.05 9.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 77.2 t 77.78 -75.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.811 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 170.69 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.069 0.462 . . . . 0.0 109.851 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -74.24 70.68 1.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -176.064 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.755 HG21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -131.79 120.54 22.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.046 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 124.8 46.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.471 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 tp -102.88 105.79 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.957 0.408 . . . . 0.0 110.168 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -82.95 117.69 22.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -110.65 10.73 22.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -37.33 83.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.342 0.592 . . . . 0.0 110.068 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.24 79.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.899 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 56' ' ' GLN . 2.0 tt -57.59 -29.72 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.988 0.394 . . . . 0.0 111.657 -172.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.562 ' HA2' ' HG3' ' A' ' 56' ' ' GLN . . . -66.54 -18.3 67.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.129 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 3.95 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.924 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 41.48 6.77 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.621 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -137.77 133.68 34.36 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.292 0.546 . . . . 0.0 111.097 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' SER . 15.9 m -119.36 139.69 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.405 174.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -117.91 104.39 10.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.803 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 tp -93.65 110.23 21.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.754 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 1.5 ttp85 -93.0 106.32 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 94' ' ' THR . 78.0 mt -113.79 106.41 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.147 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -86.83 146.82 26.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 t30 70.0 54.76 0.34 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 123.987 0.804 . . . . 0.0 110.174 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 45' ' ' LEU . 12.2 p -78.29 137.56 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.704 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -120.33 162.01 20.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.926 0.393 . . . . 0.0 111.557 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 9.9 p -68.59 -16.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.439 0.638 . . . . 0.0 110.369 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.24 -33.73 76.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.472 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.93 -12.69 14.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.497 -175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.59 -9.89 1.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.01 -86.2 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.974 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -140.74 118.69 11.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.086 -0.656 . . . . 0.0 111.608 -175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.499 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 10.9 m-85 -93.55 127.95 39.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.601 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 1.9 m-70 -101.26 127.54 47.81 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 48.1 t -106.16 116.81 32.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.109 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.743 ' HB ' HH11 ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.12 130.2 74.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.4 m-85 -108.12 126.26 52.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.962 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -116.82 104.91 11.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.815 0.34 . . . . 0.0 110.305 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 21.8 t70 -111.45 107.0 16.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.946 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.53 -92.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.156 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.51 -20.26 7.85 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -101.65 155.8 17.88 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 -173.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 33.0 p90 -144.67 150.37 37.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.33 133.42 50.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.815 176.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -114.92 121.49 43.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.293 0.568 . . . . 0.0 110.705 -177.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.26 159.15 21.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.757 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.76 108.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.331 0.586 . . . . 0.0 110.875 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.34 102.0 11.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.857 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -80.54 129.96 34.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 45' ' ' LEU . 84.4 t -102.8 146.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 0.0 110.48 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.1 94.39 4.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.742 176.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.686 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -78.09 137.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.963 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.461 -0.409 0 CA-C-O 121.05 0.354 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 125' ' ' PHE . 3.1 p90 -110.77 159.85 17.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.806 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -135.25 179.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.393 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 132' ' ' GLU . 77.6 t -115.57 106.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.89 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -112.33 131.14 55.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.445 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.0 -113.39 0.58 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.908 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.83 161.63 20.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.399 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -83.5 -49.03 9.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.935 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.968 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 139.95 87.02 0.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.579 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -94.6 40.6 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.114 2.542 . . . . 0.0 111.282 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.61 119.78 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.274 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.43 139.33 36.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.627 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -140.63 169.73 17.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.42 144.77 43.31 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 111.81 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.17 84.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.329 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.67 -161.8 30.03 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -99.9 146.9 26.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.389 0.614 . . . . 0.0 111.384 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.8 tp -134.49 119.26 18.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.803 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.97 110.34 22.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 107' ' ' THR . 0.9 OUTLIER -94.36 127.24 40.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 122.83 47.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.527 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.698 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.64 141.22 48.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.423 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -106.78 141.43 38.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.077 0.465 . . . . 0.0 110.634 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -125.24 136.9 54.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 -176.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 m -97.95 87.64 0.55 Allowed Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 93.5 Cg_endo -91.2 133.05 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.002 2.468 . . . . 0.0 114.365 -165.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.43 4.14 5.19 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.167 2.578 . . . . 0.0 110.488 168.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' HB3' ' H ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -140.45 -176.35 4.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.194 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -89.62 -6.72 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 71.57 -3.35 2.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.662 174.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 3.4 mt-30 -61.99 -28.17 69.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.25 16.63 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.08 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.7 170.72 9.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.392 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.86 130.65 56.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -127.4 147.05 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.351 0.596 . . . . 0.0 111.275 -177.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 116.64 22.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -126.38 64.33 1.25 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 74' ' ' HIS . 82.3 m-85 -142.24 152.18 42.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.727 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.68 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.188 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.35 126.37 0.42 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.297 0.373 . . . . 0.0 110.33 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.08 128.16 41.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.69 138.26 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.23 -170.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 64.09 21.21 12.5 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.611 0.719 . . . . 0.0 110.061 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.54 17.1 72.41 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 168.64 17.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.141 0.496 . . . . 0.0 111.029 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.32 153.52 18.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.324 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 mtt -135.84 153.35 51.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -5.46 29.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.854 0.359 . . . . 0.0 111.062 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.97 -15.75 69.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.093 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.579 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -118.79 -39.83 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.523 0.201 . . . . 0.0 110.49 178.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 mt 53.92 85.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 111.954 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.68 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 3.5 tt -65.44 -28.57 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.576 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -14.58 52.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.511 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HD2' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -86.76 -14.05 43.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.862 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.2 -52.0 18.53 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 92' ' ' GLU . 4.2 p -178.34 175.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.952 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -85.77 150.27 24.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER 63.74 64.78 0.76 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.827 -175.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.577 HG23 HG12 ' A' ' 110' ' ' ILE . 1.2 m -120.87 106.78 11.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.89 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -117.4 118.39 32.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD22 HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -87.57 98.06 11.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mt -72.07 109.2 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.657 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 20.2 mtmt -108.11 14.0 25.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.655 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -20.65 66.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.493 0.663 . . . . 0.0 110.512 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.83 -17.21 66.09 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.473 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 57' ' ' ALA . 1.9 tt -51.9 -38.42 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 -19.9 69.46 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.373 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.67 22.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.93 45.02 8.63 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.69 133.08 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.185 -0.597 . . . . 0.0 110.642 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.91 132.25 70.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.151 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -123.53 104.19 8.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.588 HD13 HD22 ' A' ' 96' ' ' LEU . 7.1 tp -88.7 111.89 22.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.26 0.553 . . . . 0.0 110.286 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -90.51 106.49 18.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.739 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 94' ' ' THR . 43.0 mt -114.15 116.57 52.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.777 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 13.3 m-85 -88.77 146.32 25.08 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.815 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.53 62.98 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.911 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.578 HG21 ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -65.97 141.54 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.949 175.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.96 167.42 15.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.949 0.404 . . . . 0.0 111.803 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.614 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -70.56 -13.06 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.396 0.617 . . . . 0.0 110.192 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -73.19 -23.61 60.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.94 171.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.91 -11.27 15.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.763 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -62.04 -5.34 2.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.434 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.09 -133.91 1.46 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.658 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.36 124.98 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.191 0.52 . . . . 0.0 111.281 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.84 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 3.3 m-85 -88.22 135.44 33.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.92 119.83 39.27 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.96 0.409 . . . . 0.0 110.02 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.7 t -104.05 118.34 36.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.341 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 133' ' ' GLU . 3.5 t -131.11 128.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.206 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.698 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 29.3 m-85 -116.21 137.3 52.26 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 131' ' ' TYR . 4.3 ptmt -140.61 120.97 13.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.126 0.489 . . . . 0.0 110.918 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -132.48 133.87 44.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.8 -107.55 1.98 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.312 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -120.21 -6.16 9.91 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.71 141.78 35.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 0.0 111.01 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 126' ' ' LYS . 52.8 p90 -134.46 154.33 51.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.806 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -133.41 147.27 51.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.031 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HG2' HG13 ' A' ' 124' ' ' VAL . 28.5 mt-10 -121.35 149.91 42.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.291 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 138.94 18.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.131 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mm -98.62 128.69 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.968 HG23 ' HA3' ' A' ' 35' ' ' GLY . 63.0 m -124.43 109.12 12.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.685 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.98 134.3 37.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.29 124.23 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.147 0.498 . . . . 0.0 110.106 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -98.7 90.7 4.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.56 119.77 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.345 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.46 -0.498 0 N-CA-C 111.16 -0.361 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -167.49 145.22 4.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.69 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.7 pt -132.02 176.83 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.799 0.333 . . . . 0.0 110.663 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 51' ' ' LEU . 37.1 t -102.97 113.85 40.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.782 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -94.66 131.83 40.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.163 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.45 -172.16 15.24 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.8 148.66 22.68 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.679 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.15 -47.25 13.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.48 116.88 4.26 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.286 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.91 91.93 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.331 2.02 . . . . 0.0 111.189 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -69.49 100.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.67 113.32 25.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.926 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -125.98 171.52 10.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.289 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.1 m -122.12 143.88 49.27 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD12 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.72 135.93 57.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -174.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.09 89.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.861 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.2 168.02 17.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.73 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.1 p-10 -79.84 122.68 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.19 0.519 . . . . 0.0 110.512 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.675 HD11 HG11 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -90.39 111.21 22.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.079 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 1.8 mp0 -94.3 105.73 17.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 45' ' ' LEU . 2.0 mm? -96.07 128.46 42.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.45 123.62 49.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.701 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.83 140.26 53.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.884 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -130.53 140.71 50.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -127.84 158.61 37.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.9 m -90.47 98.87 1.65 Allowed Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 10.2 Cg_endo -88.26 125.25 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.371 2.714 . . . . 0.0 114.006 -167.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 73.0 Cg_endo -81.11 -17.81 9.08 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 110.837 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' OE1' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -120.32 -171.66 2.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.112 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -89.89 -10.92 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 0.0 110.165 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HA ' ' HG2' ' A' ' 60' ' ' MET . . . 66.16 -1.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -57.25 -42.18 81.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.156 0.503 . . . . 0.0 110.915 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -99.92 26.11 6.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -92.17 175.9 6.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.735 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 41.8 mt-10 -113.64 129.88 56.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.802 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -125.61 129.17 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.349 0.595 . . . . 0.0 111.216 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 20.4 mtp180 -114.45 117.75 31.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.322 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -125.69 60.3 1.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 87' ' ' ILE . 62.8 m-85 -139.59 152.35 46.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.74 0.781 . . . . 0.0 112.859 -166.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.167 168.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 65.5 m170 . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 61' ' ' GLU . 1.9 pt? -163.76 143.41 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 0.0 112.009 -170.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.06 129.27 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.041 175.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -131.41 132.24 44.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.337 -175.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.2 t0 58.22 21.59 8.28 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.609 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.52 14.66 81.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.174 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 147.24 45.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.79 0.328 . . . . 0.0 110.688 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.556 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.0 p30 -118.49 169.68 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.88 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.25 152.99 50.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.09 -17.27 63.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.88 84.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.232 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 1.7 pp20? -117.63 -38.32 3.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.7 tp 39.06 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.046 1.339 . . . . 0.0 113.82 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG21 ' HE1' ' A' ' 76' ' ' TYR . 14.2 tt -56.91 -31.27 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.67 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -12.28 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.194 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.25 -30.94 68.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.701 0.286 . . . . 0.0 110.549 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -71.5 -59.03 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 94' ' ' THR . 1.2 p -159.62 153.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.112 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -56.26 -47.43 78.59 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -175.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -90.71 77.04 6.38 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.34 0.591 . . . . 0.0 110.887 -177.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.528 HG23 HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.45 94.6 4.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.794 177.008 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.65 120.96 42.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -175.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -99.55 106.97 19.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.111 0.482 . . . . 0.0 110.835 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mp -77.24 109.3 11.0 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.503 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.53 -13.02 16.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.657 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -19.81 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 110.964 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.16 66.27 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.653 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.96 -27.97 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.66 -25.45 72.87 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.499 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.46 -2.53 57.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.109 0.48 . . . . 0.0 109.921 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 85.82 19.84 57.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.353 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 50' ' ' GLN . 6.9 mptt -123.52 132.15 53.83 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.065 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.38 133.62 68.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 3.8 m -119.94 112.95 19.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 96' ' ' LEU . 11.4 tp -100.17 117.28 34.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.806 0.336 . . . . 0.0 110.271 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 18.7 mtt180 -94.77 106.87 18.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.631 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.598 HD12 HD23 ' A' ' 47' ' ' LEU . 21.6 mt -111.79 107.08 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -71.72 123.05 21.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.7 t30 81.1 108.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.042 0.839 . . . . 0.0 111.429 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.89 146.68 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.434 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.412 ' HB ' ' OD1' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -113.17 151.66 30.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 111.985 -175.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -72.49 -14.13 16.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.582 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' OD1' ' HB ' ' A' ' 114' ' ' THR . 5.4 p-10 -91.76 -19.1 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.933 0.397 . . . . 0.0 110.335 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.534 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.1 OUTLIER -110.36 2.94 19.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB2' HD13 ' A' ' 140' ' ' ILE . 4.7 p-10 -62.81 25.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -80.68 -159.05 20.34 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.334 -174.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -87.04 111.83 21.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.883 0.373 . . . . 0.0 110.686 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.773 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-30 -68.52 146.0 53.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.333 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.11 114.31 28.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 0.0 110.427 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -100.18 117.73 35.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.529 177.172 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 63' ' ' ARG . 47.1 t -118.02 109.04 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.116 0.484 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 134' ' ' HIS . 1.1 m-85 -93.73 115.52 27.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.1 mtpm? -109.11 104.89 14.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.729 0.3 . . . . 0.0 110.325 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.791 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 23.7 t0 -118.39 136.53 53.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.588 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.82 -111.73 2.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -113.15 3.05 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 110.816 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 171.23 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.904 0.383 . . . . 0.0 111.353 -174.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 4.0 p90 -148.45 147.93 29.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -122.75 142.8 50.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.6 121.01 39.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 0.0 110.482 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.54 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.55 137.37 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.829 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.38 107.42 22.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 34' ' ' GLU . 1.4 m -103.96 105.46 15.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 1.1 mm-40 -67.58 122.43 18.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.491 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 45' ' ' LEU . 4.0 t -91.85 147.77 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.98 115.49 17.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.2 mp -91.94 126.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.173 -176.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo . . . . . 0 C--O 1.233 0.227 0 N-CA-C 113.376 0.491 . . . . 0.0 113.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -133.71 146.42 50.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.435 -174.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.966 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.2 pt -148.56 167.76 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.036 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 132' ' ' GLU . 39.4 t -91.75 140.82 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.663 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -130.79 179.18 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.0 111.108 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.61 -133.45 11.36 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.78 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.493 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.96 176.65 5.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.59 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.318 0.386 . . . . 0.0 110.183 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.931 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 134.06 80.66 0.15 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.017 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.83 57.0 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.01 2.474 . . . . 0.0 111.566 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -82.14 100.85 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.267 -176.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.31 101.32 13.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.393 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.46 169.5 8.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.722 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -120.59 138.06 54.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.79 0.329 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -66.08 130.52 43.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -176.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.24 -5.04 84.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.485 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.97 -168.27 27.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.903 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.58 113.54 19.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' HB ' ' A' ' 110' ' ' ILE . 5.3 tp -85.85 114.89 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.82 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 3.7 mt-10 -110.38 117.42 33.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 0.7 OUTLIER -108.39 128.53 54.85 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.271 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.458 ' C ' ' HH2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -116.21 119.89 37.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -178.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.774 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -117.76 140.36 49.78 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.089 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.793 ' HG3' ' HD2' ' A' ' 105' ' ' LYS . 21.9 mp0 -115.86 135.75 53.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.294 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.698 HD23 ' HA2' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -127.35 153.16 46.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.636 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.74 100.36 5.28 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.7 Cg_endo -88.95 116.09 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.913 2.408 . . . . 0.0 113.584 -170.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.7 -13.84 12.99 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.44 2.094 . . . . 0.0 110.917 171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' ' CE ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -134.27 -174.19 3.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.727 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 58' ' ' GLN . 25.8 pt20 -74.96 -22.41 58.58 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.963 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 64.75 10.29 5.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.963 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.493 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -68.26 -11.29 59.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -117.47 15.68 14.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.293 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.664 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -82.88 155.28 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.079 0.466 . . . . 0.0 111.722 -172.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.968 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 2.1 mp0 -84.05 151.57 24.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -134.16 137.86 51.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.911 0.862 . . . . 0.0 111.316 -178.38 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -132.16 116.68 17.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.482 173.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.774 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -144.09 98.05 3.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.181 0.515 . . . . 0.0 110.286 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.604 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.365 0.126 . . . . 0.0 111.12 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.889 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.97 150.35 44.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -173.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.611 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 21.6 t80 -117.64 139.64 50.73 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.641 ' HG2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -117.83 147.48 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.177 -174.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -63.9 104.55 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.114 0.483 . . . . 0.0 110.083 177.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 7.71 55.98 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.115 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.641 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -143.26 122.69 13.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.455 0.645 . . . . 0.0 111.241 176.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -110.89 136.98 49.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.425 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -145.59 147.86 32.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.324 -174.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.453 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -71.16 -3.24 18.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 174.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.36 44.89 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.184 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -64.66 -34.43 78.28 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 89' ' ' LYS . 1.1 tt 44.66 51.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.625 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.487 HD11 HG21 ' A' ' 94' ' ' THR . 3.2 tt -65.83 -17.86 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.647 173.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -15.29 62.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.472 174.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.68 -27.62 40.77 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.302 0.572 . . . . 0.0 109.575 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -75.45 -62.65 1.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 111' ' ' PHE . 9.0 p 172.41 136.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.285 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 55.67 2.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.429 0.633 . . . . 0.0 110.158 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.65 66.92 1.39 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.487 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -122.11 151.39 40.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.079 -172.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -137.23 117.14 13.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.307 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 108' ' ' LEU . 15.7 tp -100.82 101.23 12.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -70.34 99.63 1.59 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.729 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -103.69 1.47 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.261 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -24.83 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.261 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.78 -17.02 64.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.41 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 tt -53.51 -37.66 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.98 -15.19 69.11 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.17 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.8 -4.7 21.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.858 0.361 . . . . 0.0 110.244 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.698 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 92.41 31.27 9.05 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -133.51 133.6 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.152 0.476 . . . . 0.0 111.444 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.61 134.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 O-C-N 122.244 -0.285 . . . . 0.0 110.258 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -122.22 114.06 20.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.256 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 96' ' ' LEU . 24.1 tp -94.45 115.5 27.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 4.9 ttp180 -100.01 107.05 18.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.646 ' HB ' HD23 ' A' ' 45' ' ' LEU . 48.2 mt -110.37 118.7 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' HG11 ' A' ' 91' ' ' VAL . 11.0 t80 -75.91 128.3 34.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.059 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 26.4 t30 72.18 84.97 0.12 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.801 0.688 . . . . 0.0 111.758 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 p -89.53 142.06 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.447 HG22 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -124.72 171.34 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.9 0.381 . . . . 0.0 111.676 -178.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -23.12 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -171.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.93 -25.84 60.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.514 0.673 . . . . 0.0 109.894 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.447 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . 1.7 m-20 -101.27 -4.07 27.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.422 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -57.96 -11.85 2.77 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.782 175.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.42 -146.73 0.48 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 121.725 0.625 . . . . 0.0 114.578 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -90.11 136.18 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 111.611 -175.63 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -105.29 123.4 47.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.277 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -84.62 113.73 21.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.894 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 41.9 t -99.73 117.57 34.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 14.8 t -135.07 118.46 24.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.11 143.41 30.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.968 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.85 118.64 27.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -115.03 85.34 2.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.763 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.73 -90.15 0.16 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.94 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.97 -24.47 13.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.79 25.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 110.786 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.07 143.49 38.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.54 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.966 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 7.0 mm-40 -127.45 132.94 49.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 3.7 pt-20 -123.03 142.66 50.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.423 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -136.84 146.55 45.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.656 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.6 mt -97.02 107.99 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.932 0.396 . . . . 0.0 110.374 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.931 HG23 ' HA3' ' A' ' 35' ' ' GLY . 31.5 m -111.01 100.51 9.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.426 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -84.04 135.14 34.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -88.16 150.73 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.044 0.449 . . . . 0.0 110.637 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.84 101.25 7.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 118' ' ' ASP . 35.9 mm -74.34 108.42 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.872 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.233 0.256 0 N-CA-C 112.908 0.311 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -101.49 146.98 26.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.61 179.21 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.292 0.568 . . . . 0.0 112.257 -170.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -90.65 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.935 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -105.96 129.75 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.09 -110.24 1.25 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 123.572 0.545 . . . . 0.0 112.149 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 33' ' ' LEU . 4.3 mt -146.76 149.86 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 -46.92 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.37 123.13 1.97 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.793 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.63 73.16 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.852 2.368 . . . . 0.0 110.456 172.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.66 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.11 114.97 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.02 -174.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.81 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.754 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.27 173.08 12.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.965 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -112.32 147.17 36.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -73.15 152.08 41.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.48 -7.07 82.0 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.68 179.63 22.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.181 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -79.82 109.58 14.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 110.325 178.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.727 HD13 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -86.99 109.75 19.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.203 178.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.694 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.4 mt-10 -94.25 96.06 9.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.727 HD21 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -104.98 129.51 53.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.775 -175.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -118.07 138.84 51.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 m -117.78 140.2 50.01 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.39 131.85 56.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 110.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -125.4 159.32 32.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.5 -177.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.2 86.5 6.38 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.3 Cg_endo -88.39 153.54 6.6 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.806 2.338 . . . . 0.0 112.55 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 7.2 Cg_exo -73.55 -28.04 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.767 2.311 . . . . 0.0 111.742 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.83 -172.49 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -69.4 -8.27 45.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.137 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 60.74 29.41 18.99 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.107 0.563 . . . . 0.0 112.276 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.49 -42.55 78.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.449 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -101.27 25.0 8.72 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 111.347 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 16.2 ttm -68.88 131.84 45.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.162 0.506 . . . . 0.0 111.457 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -88.05 143.89 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.7 HG21 HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -134.95 148.96 28.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.84 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 3.2 ttp85 -128.74 115.64 18.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.623 ' CZ2' HD22 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -126.65 87.7 2.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -153.61 148.57 26.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.899 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HD3' ' HB2' ' A' ' 117' ' ' ASP . 41.9 ttt-85 . . . . . 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 165.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.636 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -138.77 144.35 39.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.659 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' HE2' HD13 ' A' ' 87' ' ' ILE . 2.7 t80 -100.57 115.11 29.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.52 121.32 44.85 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.085 -168.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.8 t70 64.94 14.16 9.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.148 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.777 ' HA2' HD22 ' A' ' 96' ' ' LEU . . . 89.82 14.05 60.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.741 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -129.05 148.71 51.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 139.02 50.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.934 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.585 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -105.48 -172.89 2.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -75.53 -9.22 58.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.867 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -55.28 3.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.789 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 82' ' ' MET . 6.9 pm0 -74.77 -37.82 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 122.716 0.406 . . . . 0.0 110.446 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 86' ' ' ILE . 3.0 tp 43.44 97.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.643 1.177 . . . . 0.0 113.421 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.728 HD13 ' HE2' ' A' ' 76' ' ' TYR . 2.5 tp -62.89 -18.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.167 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -14.22 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.665 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -66.14 -29.67 70.01 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.045 177.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.68 -71.2 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.512 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.99 141.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.01 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.802 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -161.12 65.77 0.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.72 119.16 25.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.223 -174.178 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.12 99.97 7.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.699 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.777 HD22 ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -86.08 111.39 20.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.186 0.517 . . . . 0.0 110.488 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.2 mp -81.72 112.94 19.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.912 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.05 1.85 56.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.094 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.31 -33.59 63.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.332 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.19 -16.9 65.98 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.814 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -31.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.48 -25.4 66.97 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.435 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.2 13.68 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.979 0.419 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.34 43.66 12.53 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.477 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -129.82 133.19 46.79 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.279 -0.542 . . . . 0.0 110.784 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 62' ' ' ILE . 14.3 m -121.96 132.96 69.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.721 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -116.4 102.86 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.727 178.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.644 HD13 HD12 ' A' ' 96' ' ' LEU . 4.6 tp -96.05 111.52 23.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.098 0.475 . . . . 0.0 110.195 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.694 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -86.42 106.26 17.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.542 174.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.455 HG13 ' HG ' ' A' ' 108' ' ' LEU . 50.0 mt -112.54 112.76 41.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 59.6 t80 -80.14 129.76 34.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 35.5 t30 76.23 79.6 0.09 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.914 0.759 . . . . 0.0 111.76 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 41' ' ' LEU . 10.2 p -84.96 149.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 168.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.25 165.52 14.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.964 0.411 . . . . 0.0 111.964 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.3 -28.95 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.13 -43.27 87.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.552 ' HB2' ' HD3' ' A' ' 66' ' ' ARG . 3.6 p-10 -104.17 4.09 33.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.616 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -62.5 -10.38 11.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 176.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.7 -118.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.931 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.2 124.97 35.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.257 0.551 . . . . 0.0 111.765 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 136' ' ' THR . 50.2 p90 -110.92 164.77 12.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.774 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 113.33 24.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.3 t -104.92 122.37 45.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.84 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 97.8 t -131.95 139.24 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.047 -175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 23.2 m-85 -119.31 140.5 50.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -130.75 105.04 7.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.653 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 43.0 t0 -98.5 74.37 2.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.39 -93.36 0.89 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.3 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -97.79 -27.97 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.742 0.306 . . . . 0.0 111.714 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -96.81 143.18 27.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.922 0.391 . . . . 0.0 110.4 -177.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.738 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -138.02 142.77 40.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.395 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.44 131.91 54.1 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HA ' HG22 ' A' ' 124' ' ' VAL . 8.8 mt-10 -114.36 119.92 38.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 132.19 55.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.158 0.504 . . . . 0.0 111.12 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.452 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -103.5 107.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.576 175.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -120.52 160.66 22.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 139.51 53.83 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.226 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -83.0 150.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.028 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -112.58 90.89 3.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mp -80.76 123.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.918 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 N--CA 1.454 -0.824 0 CA-C-O 120.976 0.323 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HE1' ' HA ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -74.83 140.45 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -122.07 168.12 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -170.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 134' ' ' HIS . 67.0 t -91.35 132.46 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.188 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.46 132.25 55.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.72 -107.31 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.749 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.43 168.39 21.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -175.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -48.63 7.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 111.82 2.53 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.927 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.57 86.87 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.569 2.179 . . . . 0.0 111.355 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -72.28 101.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.323 -176.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -87.22 119.72 27.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 171.82 13.8 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.003 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -98.67 133.98 42.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.3 123.42 17.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.85 0.357 . . . . 0.0 111.034 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 94.44 1.22 64.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.04 -174.42 33.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.214 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' HB2' ' HD1' ' A' ' 111' ' ' PHE . 10.3 t30 -93.88 119.8 33.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.36 . . . . 0.0 110.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.499 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -98.23 122.23 41.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.867 -177.81 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -97.17 101.68 13.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.683 174.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.499 ' HG ' HD22 ' A' ' 45' ' ' LEU . 1.1 mp -96.58 127.25 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.49 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -117.63 130.18 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.74 140.19 50.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 30' ' ' VAL . 8.0 tt0 -110.99 131.34 55.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.138 0.494 . . . . 0.0 110.604 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.24 154.88 44.31 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.376 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -87.27 101.24 2.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.9 Cg_endo -76.41 114.31 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.751 2.3 . . . . 0.0 113.74 -170.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.9 -21.05 9.88 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.44 2.094 . . . . 0.0 110.602 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -171.66 2.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -18.06 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 56.99 32.32 21.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.261 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -61.59 -33.81 74.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.722 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -93.39 9.61 35.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 146.68 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.314 0.578 . . . . 0.0 111.39 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -92.68 102.63 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.78 130.01 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.689 0.757 . . . . 0.0 111.255 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.577 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 8.1 ttm180 -113.94 117.1 30.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.681 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.602 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -125.86 55.43 1.45 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.81 167.42 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.324 0.583 . . . . 0.0 112.192 -164.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' CD ' ' HB3' ' A' ' 117' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.24 174.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.86 143.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.556 0.535 . . . . 0.0 110.7 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.21 114.8 28.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.168 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.445 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -97.76 120.51 38.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -176.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t70 67.44 14.03 9.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.85 0.833 . . . . 0.0 109.969 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.44 70.72 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.595 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -122.99 151.68 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -101.01 169.32 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.264 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.705 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 2.8 ptt? -140.06 161.33 37.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.79 -27.71 69.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.28 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.17 -5.61 89.04 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.648 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -111.24 -40.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.6 OUTLIER 37.58 80.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.249 1.02 . . . . 0.0 112.929 177.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 76' ' ' TYR . 14.8 tt -64.04 -19.79 25.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.125 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -13.73 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.552 175.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -66.27 -29.84 70.15 Favored 'General case' 0 CA--C 1.524 -0.037 0 CA-C-O 121.019 0.438 . . . . 0.0 110.234 178.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -52.87 7.99 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.44 HG12 HG23 ' A' ' 94' ' ' THR . 7.3 p 176.4 159.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.317 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -79.34 -25.01 42.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -80.53 66.44 6.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.559 173.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.18 89.27 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.66 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -104.87 112.33 25.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.111 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -89.91 101.77 14.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 178.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -75.08 107.21 7.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 1.66 49.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.791 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.23 -29.19 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.16 -16.9 70.76 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.0 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 tp -55.54 -25.53 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.5 -21.12 70.42 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.903 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.26 13.33 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.316 0.579 . . . . 0.0 109.581 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.36 27.13 66.4 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.758 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.87 132.04 56.65 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.968 -0.724 . . . . 0.0 110.84 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.05 131.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -124.08 103.81 8.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.284 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' HG13 ' A' ' 110' ' ' ILE . 9.0 tp -94.86 117.63 30.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.93 0.395 . . . . 0.0 110.336 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.797 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -96.22 107.48 19.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.566 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 94' ' ' THR . 53.3 mt -116.28 121.4 67.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' HD1' ' HB2' ' A' ' 44' ' ' ASN . 22.0 t80 -83.17 130.99 35.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.448 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 56.7 t30 71.78 84.38 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.162 174.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.08 131.92 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.018 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.19 177.24 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.94 -29.95 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -171.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -40.62 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.338 0.59 . . . . 0.0 110.276 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' ' CD ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.47 -7.9 55.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.277 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -63.88 -21.75 66.6 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.81 177.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.07 -110.05 0.08 OUTLIER Glycine 0 C--O 1.243 0.674 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.928 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.72 120.4 25.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.127 -0.536 . . . . 0.0 111.671 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.21 137.36 44.3 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -105.33 115.7 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -105.98 116.27 31.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.121 175.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 85.6 t -134.64 121.54 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.505 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.2 m-85 -111.22 113.39 25.85 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 104.37 9.73 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.546 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -105.28 89.34 3.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.21 -82.55 0.13 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.012 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.31 8.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.07 140.22 34.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 40.2 p90 -147.61 142.9 27.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.408 . . . . 0.0 111.06 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.675 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.99 137.8 41.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.745 176.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 124' ' ' VAL . 4.6 mt-10 -122.12 121.26 36.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.954 0.407 . . . . 0.0 110.436 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -119.36 144.88 46.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.43 108.27 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.602 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -97.07 160.29 14.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.45 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -127.47 135.64 50.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.291 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 23.9 t -98.37 147.1 7.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HB2' ' HA ' ' A' ' 38' ' ' LEU . 1.3 mtpt -120.88 90.22 3.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -75.0 133.66 31.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.223 0.535 . . . . 0.0 109.886 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.84 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 N--CA 1.446 -1.266 0 CA-C-O 120.72 0.217 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -156.63 165.18 37.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.875 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pt -134.75 165.66 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.887 0.375 . . . . 0.0 110.547 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.898 HG23 ' HB3' ' A' ' 132' ' ' GLU . 95.4 t -91.05 127.27 43.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.411 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.18 179.56 4.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.45 -133.9 11.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.07 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -111.42 172.84 6.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 35' ' ' GLY . 1.8 pm0 -69.0 -29.49 67.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 109.39 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.871 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 117.38 72.68 0.46 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.363 173.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.95 52.74 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.497 2.131 . . . . 0.0 111.101 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 138' ' ' VAL . 2.3 m -78.57 104.51 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.499 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.55 137.77 32.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -133.76 170.69 15.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.616 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -119.57 138.32 53.28 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.735 -178.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.33 111.08 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.15 8.53 87.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.013 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 40' ' ' SER . . . -103.92 -147.55 17.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.98 143.78 41.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 39' ' ' ALA . 10.3 tp -127.76 118.94 24.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.175 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -101.39 107.01 18.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.154 178.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -96.75 127.71 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.037 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 123.75 39.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.01 0.433 . . . . 0.0 111.103 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.25 50.06 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.82 160.01 18.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.249 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.502 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -127.64 148.71 50.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.035 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 89.67 0.31 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 162.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 14.3 Cg_exo -67.81 115.21 3.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 2.729 . . . . 0.0 114.248 -162.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.27 -32.98 2.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.874 2.383 . . . . 0.0 110.129 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -146.34 -172.78 4.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.344 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.32 -21.89 59.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 55.57 24.54 7.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -42.42 90.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.189 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.11 5.32 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -80.22 174.94 11.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -169.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.148 ' HB3' HD11 ' A' ' 75' ' ' LEU . 48.7 mt-10 -106.24 143.63 34.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.448 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.517 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -118.89 134.04 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 168.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -149.54 59.69 1.01 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -137.89 152.37 48.96 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.715 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HE ' ' HA3' ' A' ' 119' ' ' GLY . 11.4 tpt85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.732 0.777 . . . . 0.0 109.375 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 1.038 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.148 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -149.22 143.6 26.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.475 -169.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.76 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.6 t80 -94.44 114.63 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.217 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.671 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.75 163.71 35.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.322 -0.151 . . . . 0.0 110.845 -173.112 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t0 68.69 6.93 5.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.669 0.747 . . . . 0.0 109.93 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.76 -6.15 62.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.439 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 pttp -144.69 179.79 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.081 0.467 . . . . 0.0 111.266 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.9 168.09 19.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.717 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.654 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -134.0 143.27 48.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.797 0.332 . . . . 0.0 111.242 -175.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.36 -23.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 0.0 110.941 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.95 -32.57 77.49 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.399 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 2.0 pp20? -95.2 -30.06 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER 47.6 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.676 1.19 . . . . 0.0 113.667 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 8.5 tp -77.8 -7.93 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.123 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -13.45 7.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.713 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -69.56 -26.83 64.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.523 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -72.36 0.32 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -154.51 -174.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.829 -178.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -92.04 -23.45 19.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.848 0.356 . . . . 0.0 110.302 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.881 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -106.97 88.94 2.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.301 0.572 . . . . 0.0 111.268 -178.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.504 HG22 HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -116.46 95.61 5.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.292 173.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 23.3 tt0 -103.1 98.93 8.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.621 -171.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.821 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -100.4 117.73 35.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.118 0.485 . . . . 0.0 110.932 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -89.96 109.54 20.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.194 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.14 -10.47 14.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.633 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -17.97 65.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.145 -177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.93 80.33 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.178 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.674 HD11 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 tt -57.56 -29.04 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 122.707 0.403 . . . . 0.0 111.709 -174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.88 64.04 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.658 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.13 4.7 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.166 0.507 . . . . 0.0 110.211 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.08 42.17 8.96 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.711 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 132.64 40.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.818 0.309 . . . . 0.0 110.538 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.79 132.33 59.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.253 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 46' ' ' GLU . 1.2 m -123.02 124.46 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.461 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.821 HD13 HD12 ' A' ' 96' ' ' LEU . 40.8 tp -112.11 111.9 23.13 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -96.03 105.95 18.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.81 132.09 51.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.881 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 1.5 m-85 -95.99 143.44 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.0 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HB3' HG11 ' A' ' 91' ' ' VAL . 49.4 t30 67.15 84.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -95.12 128.67 46.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.007 178.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.9 p -96.84 175.52 6.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.04 -16.8 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.602 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.43 -44.81 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.516 ' HB2' HG12 ' A' ' 113' ' ' VAL . 41.0 m-20 -65.8 -25.19 67.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.602 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.733 ' HB2' HD13 ' A' ' 140' ' ' ILE . 17.8 t70 -55.36 -17.42 4.83 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA3' ' HE ' ' A' ' 66' ' ' ARG . . . -71.82 -156.96 2.84 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.11 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -78.29 105.94 9.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.923 0.392 . . . . 0.0 111.729 -176.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -73.97 144.45 45.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.12 114.02 27.19 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.474 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 51.2 t -97.38 117.06 30.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.517 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 10.6 t -131.6 105.11 9.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.674 ' HZ ' HD11 ' A' ' 101' ' ' ILE . 21.8 t80 -97.82 139.2 34.03 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.186 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.0 mtpt -122.12 104.58 9.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.219 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 17.6 t0 -106.71 138.4 42.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.447 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.86 -110.61 1.76 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.96 11.52 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 159.7 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 4.9 p90 -140.67 153.43 45.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.88 0.372 . . . . 0.0 111.17 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.898 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -142.45 157.35 44.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.592 178.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -133.38 154.44 50.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.242 0.544 . . . . 0.0 112.22 -172.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.86 124.55 14.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.167 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.94 108.95 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.433 . . . . 0.0 110.247 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.871 HG23 ' HA3' ' A' ' 35' ' ' GLY . 99.0 m -122.29 102.34 8.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.745 -176.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 5.3 pt-20 -82.84 141.96 31.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.463 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 37' ' ' VAL . 89.6 t -86.82 151.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -113.63 92.29 3.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 174.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -71.75 120.33 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 139' ' ' LYS . 2.3 t . . . . . 0 C--O 1.251 1.164 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.572 -174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 CA-C-O 120.656 0.19 . . . . 0.0 111.909 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -105.43 158.0 16.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 177.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.63 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.5 pt -129.25 167.93 23.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' HB3' ' A' ' 132' ' ' GLU . 44.3 t -91.1 144.7 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.83 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.09 161.31 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.604 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -171.15 28.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.536 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.21 176.85 4.86 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -49.8 73.73 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.158 0.286 . . . . 0.0 110.829 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.56 81.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.518 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.82 89.93 0.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.575 2.183 . . . . 0.0 111.061 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -68.55 124.78 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.409 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -88.77 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.014 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.41 170.58 9.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -120.98 145.07 48.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 119.04 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.074 0.464 . . . . 0.0 110.586 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 90.76 -7.33 81.41 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.322 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.11 -176.35 49.04 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.528 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -87.61 115.65 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -108.12 118.65 37.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.407 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.91 112.24 24.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.372 177.136 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.6 128.1 42.19 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.28 128.5 52.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 140.49 52.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.82 145.26 45.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.48 -178.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 28' ' ' PHE . 4.6 mt -117.75 164.37 15.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.71 85.36 0.55 Allowed Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 165.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 11.7 Cg_exo -68.39 119.2 6.21 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.233 2.622 . . . . 0.0 113.929 -162.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 -31.95 4.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.757 2.304 . . . . 0.0 110.098 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.99 -172.64 3.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.667 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -71.23 -15.93 62.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 59.46 17.05 5.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -64.3 -22.56 66.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.126 0.489 . . . . 0.0 111.22 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -115.14 24.18 11.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.318 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.677 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -86.55 169.9 12.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -178.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 12.0 tt0 -101.79 123.68 46.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.089 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.37 137.7 45.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.399 0.619 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.681 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 8.0 mtt180 -134.41 116.95 15.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.806 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.753 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -136.85 73.48 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -177.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -149.28 169.69 20.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.184 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-O 121.309 0.576 . . . . 0.0 110.993 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 82' ' ' MET . 0.1 OUTLIER -161.68 113.72 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -143.42 109.58 5.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 159.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.3 122.68 26.85 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.037 -0.414 . . . . 0.0 111.447 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 56.57 41.01 29.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.151 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.08 24.89 65.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.857 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 12.1 tptt -145.6 129.63 17.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.836 0.351 . . . . 0.0 111.049 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.26 163.36 17.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.798 ' HB2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -123.34 161.92 23.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.709 ' HA ' HG13 ' A' ' 86' ' ' ILE . 23.9 m-85 -62.24 -20.79 64.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.081 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.49 99.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.246 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OE1' ' HA ' ' A' ' 74' ' ' HIS . 3.9 tp10 -104.15 -43.19 5.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.709 HG13 ' HA ' ' A' ' 83' ' ' PHE . 6.2 mt 61.09 109.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 122.037 0.922 . . . . 0.0 112.294 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 94' ' ' THR . 8.2 tp -72.38 -19.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.165 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -14.29 49.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.377 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -72.29 -26.09 61.84 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.403 0.621 . . . . 0.0 109.666 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 29.4 m-85 -92.23 -65.33 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.215 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.558 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p 166.73 153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.2 60.25 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.288 177.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 1.1 mmp_? -145.98 60.69 1.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.7 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -125.46 164.5 20.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.105 -174.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.51 135.76 13.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.588 173.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 4.2 tp -108.26 94.29 4.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.809 0.338 . . . . 0.0 110.108 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -70.45 108.76 4.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 109.707 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -107.07 6.59 29.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 -176.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.11 -25.91 68.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.012 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.0 -16.8 66.63 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.266 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.496 HD13 ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -53.79 -28.23 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.88 -26.71 67.47 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.072 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.53 15.31 19.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 109.857 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.584 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 76.83 43.2 18.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.462 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.489 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.275 0.537 . . . . 0.0 110.603 176.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' A' ' 125' ' ' PHE . 15.4 m -131.05 139.51 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -126.96 106.43 9.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 96' ' ' LEU . 13.9 tp -90.27 107.59 19.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.146 0.498 . . . . 0.0 110.121 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -84.79 107.43 16.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.552 178.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.5 mt -116.88 111.35 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.838 0.351 . . . . 0.0 110.498 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 23.9 t80 -81.44 137.04 35.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.546 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 53.9 t30 77.9 75.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.917 0.761 . . . . 0.0 111.71 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.88 148.73 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -113.1 164.58 13.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.207 0.527 . . . . 0.0 112.118 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 7.7 p -66.69 -25.35 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.078 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 5.0 t70 -73.57 -34.22 65.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 175.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -78.79 -19.28 52.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.497 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.615 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -54.69 -15.96 2.19 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.633 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.52 -130.98 0.98 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.726 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -94.95 121.4 36.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.073 0.463 . . . . 0.0 111.61 -177.082 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.3 m-85 -87.68 142.97 27.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.565 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.75 118.76 35.21 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.186 0.517 . . . . 0.0 111.026 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 37.1 t -100.45 120.67 40.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.195 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.19 121.09 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CD1' HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.68 137.23 52.28 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.33 -178.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.947 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 20.4 mtpt -121.29 111.71 17.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.677 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 14.8 t70 -101.91 111.84 24.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.99 -105.93 1.69 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.035 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.03 -7.92 9.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 28' ' ' PHE . 3.2 p90 -100.23 148.82 24.21 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.417 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.947 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 4.0 p90 -133.74 151.99 51.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.273 0.559 . . . . 0.0 112.017 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.765 ' HB3' HG23 ' A' ' 30' ' ' VAL . 1.6 mm-40 -128.89 156.83 43.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.8 174.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -133.53 142.57 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.392 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -129.09 133.65 47.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.056 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.98 107.91 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.81 0.338 . . . . 0.0 110.498 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.562 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 51.7 m -117.68 118.3 31.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.624 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -77.7 134.85 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.61 149.86 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -114.02 96.08 5.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.761 0.315 . . . . 0.0 110.745 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.1 mp -76.3 118.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.492 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 130' ' ' PHE . 13.0 Cg_exo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.96 0.316 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.642 ' HZ ' ' HB3' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -143.65 141.69 30.68 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 HG22 ' HG3' ' A' ' 132' ' ' GLU . 1.1 pp -139.09 178.38 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 110.956 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 134' ' ' HIS . 71.9 t -106.49 145.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.422 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.44 144.2 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.802 0.334 . . . . 0.0 110.452 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.62 60.95 4.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.736 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -135.79 109.74 8.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 4.3 mp0 -77.25 -49.13 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.8 91.4 0.17 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.52 95.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.553 2.835 . . . . 0.0 112.987 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.73 97.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.998 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.8 101.76 13.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.417 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 45' ' ' LEU . . . -111.21 170.81 7.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.633 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.0 m -130.56 141.36 50.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 128.08 35.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.31 -23.89 22.22 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.65 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.3 174.67 52.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.7 138.9 39.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -118.1 122.11 42.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.942 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.643 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 6.4 mt-10 -102.52 108.02 19.18 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 HD12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -95.3 128.38 42.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.328 -176.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.22 129.59 55.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.746 -174.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -138.26 140.11 39.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 131.52 52.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.922 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -111.35 165.0 12.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.367 -173.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -124.92 72.26 63.05 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.398 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 92.9 Cg_endo -91.3 155.88 3.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.215 2.61 . . . . 0.0 113.207 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 35.4 Cg_endo -92.55 14.51 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.413 2.742 . . . . 0.0 112.108 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -137.09 -173.03 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.725 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.24 -16.77 34.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.217 175.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 60.72 13.14 4.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.99 174.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.693 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 4.1 tm0? -56.34 -40.78 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 3.0 p80 -115.51 21.96 13.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.031 0.443 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -74.07 -173.52 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -177.14 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 77' ' ' ARG . 1.3 tt0 -103.81 118.21 36.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.965 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -127.3 123.89 62.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.0 111.92 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 123' ' ' CYS . 7.8 ttt85 -102.25 132.72 48.02 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.469 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -144.89 59.56 1.31 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -142.95 157.98 44.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.352 0.596 . . . . 0.0 111.864 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 165.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 2.0 m80 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -164.84 149.81 9.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.574 -173.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' A' ' 62' ' ' ILE . 29.5 t80 -95.95 118.32 32.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.725 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.664 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -132.12 137.71 47.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.113 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 59' ' ' HIS . 4.2 m-20 63.07 17.03 9.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.288 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 15.24 70.43 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.481 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -136.59 143.16 43.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 0.0 110.527 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 8.8 p-10 -85.88 137.78 32.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.74 155.91 24.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.042 -176.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -40.21 80.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.215 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.6 0.91 79.93 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.79 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -105.54 -43.18 5.01 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.595 -0.356 . . . . 0.0 110.22 178.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 27.67 84.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.461 1.101 . . . . 0.0 113.019 -178.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 94' ' ' THR . 16.1 tt -62.65 -11.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.557 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -12.34 58.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -13.9 14.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -78.37 7.37 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.13 -0.356 . . . . 0.0 110.751 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.0 33.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.332 0.653 . . . . 0.0 111.657 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -170.71 -164.16 0.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 178.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -79.46 143.02 35.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -139.62 104.04 4.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.953 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -114.88 108.21 16.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.532 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.72 109.8 18.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.945 0.403 . . . . 0.0 110.846 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.6 105.65 11.06 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -102.13 9.94 39.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.88 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -27.09 67.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.522 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.72 -16.75 65.11 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.172 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -33.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -170.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.55 -11.02 67.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.073 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 6.05 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.16 26.55 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.55 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.18 133.08 38.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.384 -0.48 . . . . 0.0 110.796 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.11 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.855 0.359 . . . . 0.0 110.557 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -126.19 105.92 9.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.151 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' HG ' HG13 ' A' ' 110' ' ' ILE . 13.8 tp -90.78 118.13 29.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.643 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -86.88 106.61 17.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.691 175.643 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.639 HD12 HD23 ' A' ' 47' ' ' LEU . 56.4 mt -111.37 121.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.516 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -82.25 136.03 35.14 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.5 t30 68.59 91.66 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.431 0.634 . . . . 0.0 111.621 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.7 p -79.5 120.71 31.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.4 150.3 24.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.736 -176.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.95 -22.57 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.23 -35.96 58.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.214 0.53 . . . . 0.0 109.818 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.09 5.52 46.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.73 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.34 -4.27 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.916 176.167 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -134.42 0.52 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.0 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -102.17 127.86 48.91 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.343 -0.504 . . . . 0.0 111.032 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.843 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 40.7 m-85 -82.93 151.94 25.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.07 110.41 18.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.783 0.325 . . . . 0.0 111.034 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.5 OUTLIER -98.6 117.15 32.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.418 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 133' ' ' GLU . 8.0 t -118.6 107.36 21.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.642 ' HB3' ' HZ ' ' A' ' 28' ' ' PHE . 2.7 t80 -99.26 133.67 43.22 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.777 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -121.53 110.82 16.49 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.12 72.05 5.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.97 -96.82 1.6 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.178 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.33 -27.32 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 111.311 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.509 ' HB2' ' HD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -94.48 143.31 26.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 52.4 p90 -146.88 151.08 36.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.49 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.648 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -147.53 143.68 27.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.685 ' HB3' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -112.71 144.96 41.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.145 0.498 . . . . 0.0 110.753 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 30' ' ' VAL . 52.0 t-80 -129.82 138.83 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.61 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -104.06 107.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.5 m -99.7 107.76 19.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.438 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -75.71 122.73 24.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 -178.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -96.18 150.71 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 110.82 12.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.302 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 113' ' ' VAL . 8.9 mt -76.77 102.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 110.436 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.461 -0.411 0 CA-C-O 120.909 0.295 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -153.71 136.66 15.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.1 pt -144.53 165.8 12.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.617 0.723 . . . . 0.0 112.062 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.556 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.0 t -97.6 149.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.182 171.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -67.07 150.59 48.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.85 63.41 3.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.264 -0.493 . . . . 0.0 113.344 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 tp -139.51 132.4 29.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -85.9 -31.7 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.262 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.59 90.51 0.8 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.807 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.16 80.55 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.808 2.339 . . . . 0.0 110.97 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.53 92.42 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -89.39 110.09 20.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.773 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.19 171.97 8.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.137 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.05 133.55 36.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 140' ' ' ILE . 3.1 tp -66.62 111.69 3.77 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.944 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.6 11.49 74.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.819 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.38 -152.01 9.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.919 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -87.45 134.25 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.413 . . . . 0.0 111.112 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -119.93 115.44 23.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.519 176.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.5 mt-10 -108.19 110.08 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 110.748 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.69 129.22 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.346 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.26 122.16 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.888 0.375 . . . . 0.0 110.632 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.66 140.02 50.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -120.1 130.1 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.109 0.481 . . . . 0.0 110.131 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.7 mm? -117.72 165.22 13.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.047 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.49 71.6 26.77 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 94.6 Cg_endo -89.48 154.61 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.013 2.475 . . . . 0.0 113.322 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.6 Cg_exo -70.44 -25.54 25.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.003 2.469 . . . . 0.0 111.964 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.21 -173.26 3.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.939 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -22.51 42.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 54.22 32.97 17.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -57.62 -32.0 66.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.791 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -115.46 28.96 8.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.866 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.935 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -91.73 -165.6 1.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.289 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.8 126.66 53.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 110.745 -178.347 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.466 HD13 HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -126.49 146.57 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.243 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.632 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 10.0 ttm180 -132.52 117.37 17.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.527 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -131.36 58.34 1.73 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CE1' HG13 ' A' ' 87' ' ' ILE . 59.4 m-85 -139.38 150.66 45.57 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.676 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -178.69 151.55 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.228 0.537 . . . . 0.0 111.472 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.35 117.52 30.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -127.46 143.1 51.24 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.784 -172.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.62 17.51 10.62 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.827 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.5 83.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.057 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -139.66 177.15 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 111.285 -178.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -95.41 170.07 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.112 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.52 138.96 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.945 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.84 -4.7 36.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.649 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.62 -16.42 70.84 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.781 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.633 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -111.94 -40.96 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.244 -177.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.633 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 76.6 mt 49.15 87.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 112.235 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -74.22 -6.46 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -14.84 27.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 173.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -21.85 64.1 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.899 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.0 t80 -85.58 -69.05 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -162.63 145.69 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.228 173.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -72.53 -7.86 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.348 0.594 . . . . 0.0 110.206 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.721 ' HA ' HH11 ' A' ' 93' ' ' ARG . 2.3 mmm180 -97.19 69.32 2.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.158 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.673 HG21 HD12 ' A' ' 87' ' ' ILE . 21.3 m -131.41 103.97 6.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.634 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.75 106.93 17.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.611 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 108' ' ' LEU . 1.1 tp -91.17 100.62 13.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.878 0.37 . . . . 0.0 110.708 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.478 HD12 ' HB ' ' A' ' 107' ' ' THR . 30.3 mt -77.07 117.39 18.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.21 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.42 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 6.8 mtmm -108.12 15.4 24.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.645 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.81 -33.67 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.648 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.33 -16.68 70.87 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.037 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -29.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -21.35 59.62 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.155 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -117.21 4.1 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.759 0.314 . . . . 0.0 110.469 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.15 35.06 11.4 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.022 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.3 55.65 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.177 -0.602 . . . . 0.0 110.712 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.466 HG11 HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -128.34 132.89 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.853 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.478 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.29 110.48 16.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.805 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 96' ' ' LEU . 5.4 tp -98.41 119.56 37.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.794 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 2.6 mpp_? -96.12 106.71 18.93 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.483 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.605 ' HB ' HD23 ' A' ' 45' ' ' LEU . 69.1 mt -117.61 124.19 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.818 0.342 . . . . 0.0 110.132 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -94.19 132.12 39.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.858 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.478 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 36.9 t-20 75.54 80.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.024 0.827 . . . . 0.0 112.287 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.895 HG21 HD22 ' A' ' 45' ' ' LEU . 41.3 t -107.85 139.5 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.864 172.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.448 ' HA ' HD12 ' A' ' 41' ' ' LEU . 6.1 p -116.02 -173.71 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -24.6 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -168.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.29 -48.09 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.05 0.452 . . . . 0.0 110.534 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.407 ' OD2' HG13 ' A' ' 113' ' ' VAL . 7.2 p-10 -85.01 -6.61 59.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.626 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -68.92 -3.59 13.33 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 175.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.31 -99.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.0 -0.619 . . . . 0.0 114.066 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.09 128.01 41.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 111.21 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -90.48 151.5 21.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.307 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.86 108.72 20.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.036 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -101.11 117.91 35.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.329 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 23.1 t -134.03 131.92 55.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -122.43 122.67 39.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.19 104.45 11.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 110.312 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.935 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 58.0 t0 -92.74 83.39 4.83 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.9 -97.55 0.82 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.617 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.44 -5.19 13.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.588 0.232 . . . . 0.0 111.568 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.87 110.06 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.12 141.1 43.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.522 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.583 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -121.02 154.41 36.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 176.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -135.19 128.62 32.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.04 135.47 32.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.451 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.15 127.2 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.237 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.527 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -105.46 134.71 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.145 -176.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -92.41 115.85 28.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.61 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 16.3 t -96.29 141.64 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -131.13 95.42 3.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -73.47 127.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.175 0.512 . . . . 0.0 109.702 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.033 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 N--CA 1.46 -0.474 0 CA-C-O 120.969 0.32 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.478 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -86.71 170.4 11.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.236 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.44 168.21 24.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.291 0.567 . . . . 0.0 111.789 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.67 148.59 11.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.375 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -93.31 160.75 14.68 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.08 43.71 2.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.581 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 tp -133.95 94.2 3.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.202 0.525 . . . . 0.0 110.051 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -102.24 -24.34 13.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.573 175.187 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 93.64 1.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.013 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 68.37 3.85 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.761 2.308 . . . . 0.0 110.118 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 130.04 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.719 -169.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -97.52 91.61 5.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.927 174.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.68 151.89 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.375 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.74 121.49 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -63.39 118.76 8.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 96.8 -2.74 62.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.181 -177.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.73 -165.27 24.28 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.324 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.45 115.97 22.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 tp -100.97 112.47 24.93 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.096 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.98 108.42 19.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.069 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.1 mt -95.94 128.76 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -122.23 122.27 38.74 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.044 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.17 140.13 50.24 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.4 131.32 56.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -126.44 157.05 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.06 -178.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.26 83.2 51.95 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.22 156.64 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.086 2.524 . . . . 0.0 112.843 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 97.5 Cg_endo -87.5 20.36 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.98 2.453 . . . . 0.0 112.091 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.49 -172.96 3.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.734 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -72.09 -19.11 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.127 0.267 . . . . 0.0 111.681 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 59.62 24.78 13.61 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.197 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -59.09 -40.85 86.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -89.09 18.7 4.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.379 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -49.65 132.54 21.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.229 0.538 . . . . 0.0 112.413 -175.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 75' ' ' LEU . 37.6 tt0 -96.0 101.02 12.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG12 ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -117.3 137.0 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.163 0.506 . . . . 0.0 111.521 -171.429 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.603 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -114.25 117.02 29.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.465 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -127.42 59.57 1.43 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.91 171.7 14.82 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.881 -165.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.688 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.129 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -110.49 133.95 52.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.925 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 110.71 19.92 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 172.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -116.64 113.64 22.95 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.578 -174.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 t0 64.71 12.1 7.34 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.776 0.672 . . . . 0.0 111.166 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 2.76 58.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.919 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 133.27 47.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.962 0.41 . . . . 0.0 110.853 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -125.11 157.74 35.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.414 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 -172.8 2.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.709 0.29 . . . . 0.0 110.508 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -6.44 56.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.887 0.375 . . . . 0.0 111.575 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.88 -53.35 3.55 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.208 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.8 pm0 -90.65 12.94 17.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.904 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' A' ' 89' ' ' LYS . 3.1 tt -36.89 114.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.235 0 O-C-N 124.619 1.2 . . . . 0.0 110.903 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.558 HG12 HG21 ' A' ' 94' ' ' THR . 11.4 tt -71.77 -18.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.21 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -15.14 63.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 0.0 110.106 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.757 ' HB2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -81.58 -18.0 46.34 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.423 0.63 . . . . 0.0 109.556 177.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -82.19 -55.72 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.092 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.892 HG12 HG23 ' A' ' 94' ' ' THR . 0.3 OUTLIER -161.13 155.2 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.148 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.65 -58.08 10.13 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.2 0.312 . . . . 0.0 111.735 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.757 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 6.7 tpp85 -91.95 84.37 5.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.206 0.526 . . . . 0.0 110.969 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.892 HG23 HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -115.76 136.39 53.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.654 178.28 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -145.56 134.6 22.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.454 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -101.7 108.34 19.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.808 0.337 . . . . 0.0 110.247 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -75.85 106.88 7.67 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.44 2.65 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.374 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -51.61 -38.86 56.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.023 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.63 67.84 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.74 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -35.8 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -168.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.06 -6.0 50.66 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.511 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.83 1.69 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.057 0.456 . . . . 0.0 109.913 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.58 42.9 9.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.004 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 132.79 38.45 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.162 -0.611 . . . . 0.0 110.573 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 m -123.74 133.25 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.405 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.61 103.37 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 96' ' ' LEU . 20.2 tp -86.12 118.07 25.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.46 107.24 19.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.053 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HG ' ' A' ' 108' ' ' LEU . 86.9 mt -115.53 109.39 28.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.757 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 30.0 t80 -80.87 122.89 27.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.903 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 42.7 t30 79.57 75.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.182 0.926 . . . . 0.0 110.791 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.87 140.11 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.878 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.5 p -103.68 163.4 12.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.516 0.674 . . . . 0.0 112.159 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.684 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -69.59 -14.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.219 177.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -75.29 -24.16 57.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.566 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.69 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 42.7 m-20 -103.45 -10.64 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.723 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.833 ' HB2' HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.05 6.63 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.85 -128.68 6.37 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.081 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.52 117.75 30.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.763 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.69 ' HE1' ' HB3' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -87.52 157.91 19.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.38 118.83 32.23 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.619 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.6 t -105.46 116.52 32.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.842 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.603 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 6.2 t -123.89 111.26 28.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.533 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 1.4 m-85 -97.38 123.62 41.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.758 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 12.9 mtpt -132.88 136.47 46.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.544 0.688 . . . . 0.0 111.759 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.3 76.51 1.7 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.684 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.99 -98.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.771 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 -27.4 20.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.485 0.184 . . . . 0.0 111.472 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -75.3 132.55 41.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.424 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 12.6 p90 -151.23 141.08 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 151.46 47.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.639 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.56 51.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.77 137.7 21.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.897 0.379 . . . . 0.0 111.15 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.26 46.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.325 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.441 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -112.56 157.12 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.149 -178.272 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 122.66 45.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.38 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 74.2 t -102.62 113.25 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 3.1 mmmm -97.76 108.24 20.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.841 0.353 . . . . 0.0 110.066 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.833 HG12 ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -76.81 129.46 37.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.397 0.617 . . . . 0.0 111.225 -176.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.452 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--O 1.233 0.257 0 CA-C-O 121.236 0.431 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -164.7 147.44 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -143.62 175.38 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.303 -173.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.13 144.36 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.954 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.09 139.31 56.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.731 0.3 . . . . 0.0 110.394 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.37 0.35 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.933 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.26 155.22 42.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.27 -49.4 19.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 66.61 1.77 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.476 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.06 88.11 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.37 2.046 . . . . 0.0 111.791 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 t -75.35 92.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.26 98.83 10.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.153 0.501 . . . . 0.0 110.176 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 113' ' ' VAL . . . -109.37 158.09 18.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.604 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -112.66 129.42 56.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -57.27 125.93 24.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.1 -22.57 22.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.538 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -172.62 41.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.127 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 2.9 p-10 -79.26 125.86 30.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.275 0.559 . . . . 0.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -97.58 123.13 41.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.418 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 112.4 24.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.999 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 45' ' ' LEU . 1.2 mt -96.42 128.71 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 124.71 52.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -130.35 143.4 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.18 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.489 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -132.24 131.03 41.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.56 166.14 19.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.536 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -97.51 97.87 4.46 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 85.2 Cg_endo -85.16 130.13 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.779 2.319 . . . . 0.0 113.754 -171.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 16.4 Cg_exo -68.65 -37.55 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.753 2.302 . . . . 0.0 110.744 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 5.3 pt20 -133.91 -172.33 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.876 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.659 ' HG2' ' H ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -69.02 -29.95 68.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.678 0.275 . . . . 0.0 111.339 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 55.49 26.28 8.79 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.426 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.659 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -62.15 -25.44 67.75 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.337 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -113.48 18.94 17.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.864 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -88.42 -166.3 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -176.538 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 1.3 mt-10 -116.66 131.99 56.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.697 0.284 . . . . 0.0 110.678 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 147.46 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.139 0.495 . . . . 0.0 110.384 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.764 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -128.59 117.45 21.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.047 178.123 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.516 ' NE1' ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -126.17 59.35 1.33 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 63' ' ' ARG . 83.2 m-85 -136.6 159.44 41.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.338 0.59 . . . . 0.0 112.422 -164.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HD2' ' HA ' ' A' ' 117' ' ' ASP . 9.7 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.138 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.4 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.175 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 147.48 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.05 0.452 . . . . 0.0 111.067 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.63 112.11 23.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -105.19 122.38 45.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.68 20.01 8.69 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.571 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.43 9.1 76.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.285 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.68 156.14 24.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.46 148.74 21.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.943 0.402 . . . . 0.0 110.352 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.26 156.59 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.653 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -25.38 67.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.71 -25.97 47.92 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.179 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.67 -43.28 17.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.5 tp 39.77 82.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.605 1.19 . . . . 0.0 112.51 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 94' ' ' THR . 29.0 pt -68.52 -1.8 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.212 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -14.91 60.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 173.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -41.31 78.87 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.836 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG12 ' A' ' 91' ' ' VAL . 38.9 m-85 -81.42 -49.55 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 73.22 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.34 1.025 . . . . 0.0 112.482 174.069 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER 73.35 -125.49 0.04 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.668 175.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HA ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -95.63 96.51 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 -176.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -110.54 114.19 27.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 177.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -145.69 123.56 11.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.568 HD22 ' HD2' ' A' ' 76' ' ' TYR . 12.2 tp -92.59 112.85 24.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.0 110.359 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -74.18 105.48 5.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.6 4.8 50.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.919 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.99 -34.62 57.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.501 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.55 -16.69 65.63 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.945 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -51.32 -38.5 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -167.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.02 -11.14 60.48 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.751 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -116.22 1.15 13.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.52 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.11 34.5 12.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.931 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.639 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -124.55 140.14 53.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.875 0.338 . . . . 0.0 110.613 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.43 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 175.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -125.24 104.55 8.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.242 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 64' ' ' TRP . 5.7 tp -87.84 115.11 25.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 0.0 110.456 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -93.99 107.42 19.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.86 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 108' ' ' LEU . 1.9 mt -122.35 114.38 42.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -72.74 146.12 46.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.159 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 7.0 t30 75.1 89.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.131 0 O-C-N 123.922 0.764 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.432 HG11 ' HB1' ' A' ' 39' ' ' ALA . 4.1 p -107.21 145.11 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 175.48 8.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 41' ' ' LEU . 43.6 t -60.29 -26.34 36.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.282 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -30.2 71.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.474 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 119' ' ' GLY . 15.4 m-20 -93.02 -14.01 27.93 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.05 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.051 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -118.23 -128.62 3.94 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.98 130.4 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.323 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.479 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.5 m-85 -104.28 141.88 35.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.23 120.22 39.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.148 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -98.82 125.11 44.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.403 174.176 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.764 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 3.6 t -134.32 134.04 55.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 43.0 m-85 -124.61 120.35 31.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.701 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.1 mtpm? -111.16 106.21 15.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.168 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.864 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 49.3 t0 -114.88 114.24 25.24 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.713 0.633 . . . . 0.0 109.754 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.87 -104.06 1.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.962 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -117.4 -10.26 10.74 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.64 154.32 21.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 -176.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.525 ' HD2' HG13 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -143.63 146.95 33.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 0.0 111.413 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.984 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -126.2 160.81 29.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.321 177.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.49 150.85 45.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.522 . . . . 0.0 111.515 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -147.2 132.87 18.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.036 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -89.21 116.33 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.483 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -116.2 134.55 54.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.247 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.87 139.66 30.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.201 0.525 . . . . 0.0 111.895 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.8 t -106.1 132.13 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.568 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -117.54 106.8 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.388 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 41' ' ' LEU . 1.5 mp -73.6 119.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.187 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 CA-C-O 121.539 0.558 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -146.93 139.35 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.354 -177.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.86 159.3 9.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.999 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.27 134.33 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.945 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 140.88 48.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.542 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.18 -126.36 7.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.518 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.8 177.69 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 mp0 -70.46 -33.9 71.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.127 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.79 75.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.979 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.28 70.37 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.001 2.468 . . . . 0.0 111.36 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.53 106.92 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.182 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -98.75 147.94 24.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -137.3 171.71 14.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.23 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.2 121.0 36.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.091 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.85 128.38 36.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 83.62 -14.54 41.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.764 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.74 -156.84 27.54 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.976 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.99 130.97 35.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.004 0.43 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 110' ' ' ILE . 1.2 tp -110.01 110.36 21.25 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -114.01 114.66 26.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 -178.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 45' ' ' LEU . 1.2 mm? -100.69 128.74 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.362 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.2 121.28 44.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.76 141.07 51.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -134.13 140.82 46.83 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.122 0.487 . . . . 0.0 110.988 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD23 ' CD1' ' A' ' 125' ' ' PHE . 1.2 pp -127.58 161.68 28.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.179 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 1.6 m -82.18 109.05 13.55 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 8.2 Cg_exo -70.53 112.45 3.22 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.255 2.637 . . . . 0.0 114.271 -167.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 52' ' ' SER . 88.9 Cg_endo -90.94 -8.59 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.95 2.434 . . . . 0.0 110.405 168.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -158.41 -172.17 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.426 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -9.11 58.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.75 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 70.63 -1.85 2.44 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.466 0.706 . . . . 0.0 112.877 173.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -65.66 -18.06 65.05 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.047 0.451 . . . . 0.0 111.255 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.64 6.93 22.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.07 155.21 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.311 0.577 . . . . 0.0 112.101 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.026 ' HG2' HD13 ' A' ' 75' ' ' LEU . 11.1 mt-10 -80.02 107.8 13.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.206 172.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.39 140.79 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.361 0.601 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 1.051 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 1.6 ttp180 -131.81 131.63 43.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.302 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.534 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -147.77 57.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.307 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 22.9 m-70 . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -155.64 151.08 27.03 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -164.688 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.0 111.81 24.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -147.49 153.51 39.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.523 -172.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.64 ' N ' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 64.32 26.06 13.58 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.574 0.546 . . . . 0.0 109.867 175.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.57 73.5 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.963 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -142.51 151.28 41.49 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.115 0.484 . . . . 0.0 111.727 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.71 154.49 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.616 171.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.54 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 23.1 mtp -114.5 -160.04 0.72 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.802 0.334 . . . . 0.0 111.677 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' H ' ' HB3' ' A' ' 82' ' ' MET . 25.7 p90 -72.66 -36.41 67.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.654 ' HA3' ' CE1' ' A' ' 74' ' ' HIS . . . -85.04 -44.05 6.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.504 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 1.6 pm0 -87.45 17.91 4.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.441 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.95 108.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.787 0.804 . . . . 0.0 110.421 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 108' ' ' LEU . 9.3 tt -70.0 -16.73 20.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.744 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -12.84 61.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -60.03 -20.57 58.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.335 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -76.11 0.39 19.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 t 57.16 39.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.419 0.688 . . . . 0.0 112.028 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -168.67 177.56 5.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.864 176.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HG3' ' HB2' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -72.34 141.95 48.79 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.209 0.528 . . . . 0.0 110.813 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.665 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -137.51 141.68 41.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.783 -177.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -136.49 104.25 5.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.776 177.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -78.23 90.28 4.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' A' ' 107' ' ' THR . 20.6 mt -68.81 120.51 14.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.183 0.516 . . . . 0.0 110.894 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 8.99 27.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.858 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.52 -33.69 70.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.47 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.23 -16.66 64.21 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.178 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 57' ' ' ALA . 2.3 tt -54.05 -36.26 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -167.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.92 70.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.104 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.99 2.24 37.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.205 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.01 19.85 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.322 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.66 133.2 53.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.419 0.61 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.99 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 122.237 -0.29 . . . . 0.0 110.27 176.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.539 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.11 107.86 13.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 111.282 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.549 HD13 HD12 ' A' ' 96' ' ' LEU . 45.1 tp -88.33 112.76 23.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.815 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -92.71 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.289 176.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.665 HG12 HG23 ' A' ' 94' ' ' THR . 57.3 mt -116.49 124.63 72.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 1.5 t80 -76.57 124.96 28.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.185 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 54.8 t30 77.04 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.158 0.911 . . . . 0.0 112.053 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 140' ' ' ILE . 11.5 p -133.95 141.52 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.24 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -123.16 174.69 7.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.12 -11.86 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.021 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.64 -24.34 41.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -101.74 -9.97 20.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 140' ' ' ILE . 36.4 t70 -68.46 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.797 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -127.68 -126.54 2.91 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.822 -177.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -77.4 114.8 16.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -174.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -110.31 128.03 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.51 175.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 118.82 37.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.209 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.7 t -105.46 140.3 38.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.635 175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 1.9 t -144.43 132.55 17.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.213 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -120.3 115.45 23.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.336 176.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.619 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.7 mtpm? -130.66 102.26 6.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.845 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -91.74 71.35 5.76 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.56 -107.33 2.29 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.11 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.33 -19.97 27.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.946 0.403 . . . . 0.0 110.429 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' LYS . 21.7 m-85 -68.82 94.37 0.61 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.619 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -120.44 137.81 54.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.2 0.524 . . . . 0.0 111.96 -172.055 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.89 135.2 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.415 171.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -122.7 137.73 54.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.349 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.35 146.95 37.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.219 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 120' ' ' SER . 1.1 tp -123.14 113.21 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.646 0.736 . . . . 0.0 110.452 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 159.71 18.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.273 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.48 129.11 53.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.22 129.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.66 97.82 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.074 0.464 . . . . 0.0 110.863 -177.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 118' ' ' ASP . 33.8 mt -67.85 114.59 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.437 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.029 0.442 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.09 101.1 5.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.555 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.6 OUTLIER -126.5 21.62 7.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.466 0.65 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.62 105.67 38.68 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.721 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 25' ' ' SER . 9.1 Cg_exo -72.2 -71.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.807 2.338 . . . . 0.0 111.426 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 1.1 p90 -157.85 146.88 19.52 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.68 178.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.924 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.44 148.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.816 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 151.84 41.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.764 0.316 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.03 -127.74 9.33 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.56 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.35 178.76 6.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.07 74.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 119.27 84.23 0.89 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.712 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.05 81.62 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.75 2.3 . . . . 0.0 111.002 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -85.25 127.69 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.44 142.3 35.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.46 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.19 172.09 16.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.476 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.69 140.02 51.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.55 133.76 56.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.933 0.397 . . . . 0.0 111.107 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.75 -16.42 8.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.918 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.74 -148.8 15.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.182 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -101.31 130.76 47.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.728 HD13 HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -104.3 110.98 23.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.305 175.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.71 106.11 18.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 0.0 109.89 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 108' ' ' LEU . 1.5 mm? -94.09 128.09 40.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.65 122.12 37.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.541 ' HB3' ' HE2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -126.83 141.12 51.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.461 176.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.627 ' HG3' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -115.15 130.71 56.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -127.79 154.7 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.07 0.462 . . . . 0.0 110.843 -178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -125.15 83.66 60.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.951 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -93.99 164.39 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.511 2.807 . . . . 0.0 112.987 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.83 -14.85 10.99 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.765 2.31 . . . . 0.0 111.875 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -116.5 -172.84 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.115 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.5 ' NE2' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.3 -11.63 48.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 110.432 178.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 68.06 7.72 6.03 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.072 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 1.5 tm0? -58.22 -46.74 85.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.182 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.44 5.08 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.06 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -80.31 166.22 21.55 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -176.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 77' ' ' ARG . 3.1 mt-10 -105.29 142.8 34.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.59 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 64' ' ' TRP . 2.7 tt -137.37 144.49 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.162 0.506 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -127.86 116.76 20.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -130.74 58.1 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -170.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 1.3 m-85 -149.5 170.51 18.43 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.638 -170.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -132.94 126.79 32.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.47 176.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.46 164.6 37.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -98.94 127.12 44.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -174.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 51.1 m-85 77.97 146.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.993 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.29 86.78 4.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.046 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.748 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -148.89 -57.39 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.548 172.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 55.5 Cg_endo -95.64 161.34 1.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.527 2.151 . . . . 0.0 110.998 170.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 65' ' ' PHE . 70.0 t 63.83 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.787 0.803 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 85' ' ' GLU . 2.4 m170 -122.61 -58.59 1.67 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.787 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 61' ' ' GLU . 6.1 tp 176.1 127.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.973 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.12 138.24 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.553 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -137.49 139.62 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -163.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.0 t0 66.82 0.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.437 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.38 4.19 57.37 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 140.92 41.21 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.437 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 169.71 17.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.769 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.923 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 2.6 ttt -132.47 120.89 22.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.966 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.28 -40.57 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.87 80.84 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.93 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -93.96 -25.98 17.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 42.37 68.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.852 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 94' ' ' THR . 6.5 tp -66.06 -12.29 14.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.267 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -13.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -62.77 -35.21 79.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.834 0.349 . . . . 0.0 110.609 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 21.79 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 54.8 -149.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.441 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.46 28.28 4.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.354 0.597 . . . . 0.0 110.645 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -100.49 35.57 2.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.475 -178.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.652 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -120.41 126.12 49.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.922 -175.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -136.33 99.89 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -88.24 100.1 12.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.238 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.11 99.93 0.72 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.885 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.05 -7.65 26.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.159 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -30.83 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.497 0.665 . . . . 0.0 109.99 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.26 -17.87 79.68 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.98 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.517 HG12 ' HB3' ' A' ' 57' ' ' ALA . 3.6 tt -61.03 -29.81 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -171.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.53 -15.6 70.86 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.395 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 -4.58 28.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.944 0.402 . . . . 0.0 109.982 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . 89.83 20.72 42.33 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.945 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.627 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -130.28 132.54 45.96 Favored 'General case' 0 C--O 1.22 -0.477 0 O-C-N 122.507 -0.408 . . . . 0.0 111.11 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.436 HG11 HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -119.66 132.28 69.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 121.763 -0.586 . . . . 0.0 109.75 174.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -125.25 103.17 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 0.0 111.5 -176.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 47' ' ' LEU . 2.0 tp -91.69 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.802 0.334 . . . . 0.0 110.621 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 106.31 18.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -111.14 131.33 62.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -96.3 137.56 35.19 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.904 -176.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 40.4 t30 76.05 74.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.513 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.98 146.97 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.79 168.45 13.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.525 0.202 . . . . 0.0 111.325 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -77.39 -8.15 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.146 0.498 . . . . 0.0 111.643 -173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -35.3 12.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -72.76 -25.4 61.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.53 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HA ' ' HB ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -78.11 24.3 0.25 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.87 -108.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.428 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.87 116.2 23.25 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.393 -0.475 . . . . 0.0 109.898 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -74.37 141.1 45.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.925 178.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.11 105.65 17.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.403 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.7 t -98.68 117.22 32.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.05 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 53.0 t -132.33 124.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.676 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -110.34 135.91 50.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.97 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -123.75 104.8 9.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.444 . . . . 0.0 110.622 178.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.699 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 19.7 t70 -93.07 81.86 4.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.147 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.75 -100.83 0.58 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.694 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -95.75 -10.99 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -93.07 154.92 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.607 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 50.8 p90 -151.26 146.73 26.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.89 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 1.9 mm-40 -139.71 160.37 40.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.885 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG22 ' A' ' 124' ' ' VAL . 2.1 mt-10 -126.46 154.24 43.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -173.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 140.71 14.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.515 HG13 ' H ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -108.48 107.14 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.615 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.3 OUTLIER -95.04 102.03 13.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.055 -176.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.3 116.71 13.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 118' ' ' ASP . 1.3 t -86.53 150.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.164 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.02 112.57 8.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.182 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.33 110.66 11.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.889 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 121.025 0.441 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -0.77 51.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.058 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -35.59 71.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -108.16 98.95 29.06 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.381 169.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.5 -76.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.89 2.394 . . . . 0.0 112.7 -173.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.71 149.18 28.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.905 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -143.15 170.63 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.71 HG23 ' HB3' ' A' ' 132' ' ' GLU . 84.9 t -96.88 147.89 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.182 175.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.13 136.6 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.55 78.52 1.16 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.582 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -135.41 115.89 13.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -77.19 -44.77 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.07 111.59 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.716 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.63 62.55 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.53 2.154 . . . . 0.0 110.332 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.36 104.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.953 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 139' ' ' LYS . 1.2 mt -93.99 123.1 37.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.426 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.69 167.15 15.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.634 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.35 139.95 46.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD12 HG21 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -63.06 126.39 27.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.933 0.397 . . . . 0.0 110.621 -177.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 85.98 -9.78 67.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.993 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.76 -164.78 39.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.2 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.74 133.01 48.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.49 115.53 24.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.385 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.3 mt-10 -99.42 112.95 25.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.01 0.433 . . . . 0.0 110.004 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 121' ' ' TYR . 10.3 mt -95.6 128.07 42.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.269 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.8 OUTLIER -123.99 123.05 39.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.36 -179.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.707 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -117.55 140.42 49.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -128.7 134.15 48.39 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.164 0.29 . . . . 0.0 111.062 -173.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.32 164.85 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -80.56 104.94 3.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 7.4 Cg_exo -72.15 114.81 4.09 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.143 2.562 . . . . 0.0 113.551 -170.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 52' ' ' SER . 98.8 Cg_endo -87.89 -13.24 3.96 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 111.067 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -171.5 3.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.478 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' HG3' ' OE1' ' A' ' 58' ' ' GLN . 4.8 pm0 -68.02 -7.75 31.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.484 0.183 . . . . 0.0 111.479 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 75.51 -33.77 0.24 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HA ' HD13 ' A' ' 101' ' ' ILE . 10.1 pt20 -51.74 -39.79 59.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -83.93 15.02 3.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.562 -173.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ptm -92.9 160.87 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.733 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 75' ' ' LEU . 71.9 mt-10 -87.2 131.22 34.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -132.26 135.57 57.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.049 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.521 HH11 ' HB2' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -119.15 117.58 29.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.872 172.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.441 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -126.3 63.8 1.25 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' HE1' HG13 ' A' ' 87' ' ' ILE . 89.5 m-85 -148.93 154.71 39.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.611 -170.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.641 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.68 170.65 11.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.213 174.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -132.81 122.23 24.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.257 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.406 ' H ' ' HB2' ' A' ' 71' ' ' GLU . 13.2 tp -142.25 131.32 23.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.399 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HB3' ' H ' ' A' ' 70' ' ' THR . 0.2 OUTLIER 60.51 -103.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.915 175.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -117.84 34.48 5.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.746 0.308 . . . . 0.0 111.262 -176.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -60.12 113.19 6.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.799 177.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 8.5 Cg_exo -72.35 -178.28 3.21 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.007 2.471 . . . . 0.0 112.663 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.2 89.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -80.26 81.89 6.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 61' ' ' GLU . 1.5 tp -113.08 130.81 56.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HE2' ' HD2' ' A' ' 98' ' ' LYS . 52.5 t80 -126.24 152.85 45.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 59' ' ' HIS . 20.8 ttp85 -141.96 143.33 33.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.04 113.2 4.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.328 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 122.45 16.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.401 0.62 . . . . 0.0 111.141 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.99 161.32 30.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.949 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -167.59 163.03 14.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.759 0.314 . . . . 0.0 110.622 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -12.04 61.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.981 0.419 . . . . 0.0 110.63 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.05 -35.87 79.51 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.029 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -76.68 -41.24 46.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.18 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 tp 21.54 72.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 124.754 1.283 . . . . 0.0 112.373 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.923 HG12 ' HB ' ' A' ' 94' ' ' THR . 14.9 tt -58.8 -23.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.235 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -13.72 59.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.956 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.93 -17.98 60.47 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.815 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.59 ' HD2' HG23 ' A' ' 91' ' ' VAL . 13.1 t80 -64.71 -71.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.086 -0.245 . . . . 0.0 110.706 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 ' HD2' ' A' ' 90' ' ' TYR . 97.0 t -134.84 -67.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.675 0.274 . . . . 0.0 110.817 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -168.98 -63.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.197 0.522 . . . . 0.0 110.25 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.745 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -101.0 98.61 9.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.921 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.923 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -130.58 115.05 16.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.536 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -126.7 133.65 50.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.81 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.542 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -102.81 104.53 14.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.97 0.414 . . . . 0.0 110.603 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.52 121.74 25.59 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.756 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HB2' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -107.87 -4.71 17.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.413 -172.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -62.73 -35.81 80.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 110.959 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.41 -17.79 74.72 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 58' ' ' GLN . 1.2 tt -62.09 -26.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 122.718 -0.283 . . . . 0.0 111.457 -173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.26 -17.37 63.78 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.801 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.63 5.65 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.229 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 89.23 23.66 33.94 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.123 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.5 OUTLIER -128.72 133.62 48.21 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 117.54 0.67 . . . . 0.0 111.475 -178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -115.04 132.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 O-C-N 121.761 -0.587 . . . . 0.0 109.629 175.013 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -114.12 103.26 10.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.187 0.518 . . . . 0.0 111.512 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.542 HD13 HD12 ' A' ' 96' ' ' LEU . 22.9 tp -93.56 111.22 22.85 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.182 0.515 . . . . 0.0 110.264 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -88.08 107.41 18.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.807 178.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.528 HG13 ' HG ' ' A' ' 108' ' ' LEU . 63.5 mt -110.92 127.3 68.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.922 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.745 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -106.23 143.14 34.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.596 0.236 . . . . 0.0 110.832 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 7.1 m-80 68.35 55.72 0.51 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.636 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.88 152.2 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.39 152.39 39.08 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 112.39 -173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.97 -17.45 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.212 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.47 -38.75 71.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.885 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -96.92 7.74 45.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.226 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.477 ' HA ' HG13 ' A' ' 138' ' ' VAL . 17.2 t70 -55.55 24.88 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 0.0 113.351 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -97.65 -132.66 7.58 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 120.788 -1.195 . . . . 0.0 112.194 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 127.57 43.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.443 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.714 ' CE2' ' HB ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -90.19 161.84 15.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.598 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -103.02 119.06 38.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.623 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -102.34 116.11 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.692 HG22 ' HG3' ' A' ' 133' ' ' GLU . 16.2 t -129.56 117.47 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.265 -176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 17.4 m-30 -107.61 128.68 54.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.8 mtpt -122.55 104.9 9.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 6.2 t70 -91.63 73.94 5.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.525 0.678 . . . . 0.0 109.714 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.29 -83.05 1.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.96 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -116.82 -27.7 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.524 0.202 . . . . 0.0 111.457 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -89.67 125.78 35.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -126.32 150.56 48.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.905 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -132.12 145.38 51.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.877 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.692 ' HG3' HG22 ' A' ' 124' ' ' VAL . 33.9 tt0 -132.35 126.39 33.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.388 . . . . 0.0 110.708 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -129.6 143.72 50.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.333 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -102.39 113.89 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.182 0.515 . . . . 0.0 110.191 176.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.635 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -105.65 147.23 28.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.726 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 150.35 28.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.828 0.347 . . . . 0.0 111.655 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.714 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 14.1 p -122.74 131.28 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.53 ' HB3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.97 103.75 11.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.795 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.607 HG21 HD12 ' A' ' 41' ' ' LEU . 1.4 mp -73.41 124.51 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.444 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.611 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.781 0.324 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 74.54 10.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.187 0.517 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 m -128.13 -45.31 1.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.185 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -69.86 112.01 10.93 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.508 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.03 -16.63 11.11 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.459 2.106 . . . . 0.0 112.177 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -136.45 134.8 38.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.104 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.5 OUTLIER -150.47 161.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.373 0.42 . . . . 0.0 110.175 174.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 51' ' ' LEU . 75.5 t -92.31 145.07 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.491 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.5 t-20 -67.94 162.5 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.85 62.95 2.41 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.294 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 122.78 19.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -83.75 -48.73 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' H ' ' HD3' ' A' ' 36' ' ' PRO . . . 106.55 72.35 0.81 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.397 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HD3' ' H ' ' A' ' 35' ' ' GLY . 5.3 Cg_exo -78.98 72.48 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.753 2.302 . . . . 0.0 110.919 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.89 103.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.74 139.39 33.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.45 171.39 14.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.774 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.62 154.25 28.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -69.6 130.48 42.54 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.451 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.64 8.62 86.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.205 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.97 -158.73 32.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.016 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -102.65 130.21 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.178 0.513 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 113' ' ' VAL . 8.6 tp -116.24 110.6 18.99 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.918 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tt0 -105.96 110.54 22.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 4.7 mt -95.8 128.43 42.67 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.67 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -121.55 125.4 46.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.583 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.3 140.23 50.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.85 130.83 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.103 0.477 . . . . 0.0 111.426 -172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.23 165.56 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.627 -176.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.558 ' H ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -117.54 82.41 15.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.714 169.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 28' ' ' PHE . 97.8 Cg_endo -89.86 141.83 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.027 2.485 . . . . 0.0 113.082 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.27 1.24 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.632 2.221 . . . . 0.0 112.646 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -151.97 -174.44 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.257 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -76.88 -18.55 58.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.272 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 61.45 34.97 17.89 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 170.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -64.6 -36.84 85.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.378 0.608 . . . . 0.0 109.56 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.625 ' HA ' ' OD1' ' A' ' 78' ' ' ASP . 49.9 t-80 -79.92 -2.67 44.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.094 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 3.9 ttm -69.47 141.48 53.97 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.03 0.443 . . . . 0.0 111.396 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CD ' ' HD3' ' A' ' 126' ' ' LYS . 2.7 tt0 -97.81 116.95 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.927 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -116.44 147.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.338 0.589 . . . . 0.0 111.21 -174.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.738 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -128.56 137.22 51.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.241 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.446 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -151.81 42.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 30.6 m-85 -134.18 158.39 43.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.176 -168.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.57 124.91 51.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.032 0.444 . . . . 0.0 110.308 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.4 154.05 26.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.345 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -64.85 109.77 2.19 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.293 0.37 . . . . 0.0 110.792 -178.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 60.37 67.52 0.84 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.972 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.34 57.87 4.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.351 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' CB ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -79.64 -60.43 0.52 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -178.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 71' ' ' GLU . 26.2 Cg_endo -92.6 -49.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.076 1.851 . . . . 0.0 113.198 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.78 163.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.89 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 1.2 m-70 73.15 97.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.994 0.918 . . . . 0.0 110.739 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -161.9 136.22 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.345 -171.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -103.37 109.28 20.85 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -116.52 130.18 56.6 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.486 -168.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' ' HA ' ' A' ' 59' ' ' HIS . 16.4 t0 58.41 20.22 7.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.353 0.597 . . . . 0.0 111.684 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 22.93 58.25 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.885 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.51 139.18 50.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 110.815 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.81 169.98 17.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.176 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.27 135.11 49.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.924 0.393 . . . . 0.0 110.697 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.5 -2.43 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.073 0.464 . . . . 0.0 110.981 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.46 -18.89 63.22 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -108.83 -40.73 4.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.542 0.21 . . . . 0.0 110.6 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 31.5 mm 65.86 85.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.698 0.761 . . . . 0.0 111.435 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 94' ' ' THR . 2.1 tp -67.8 -20.54 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 0.0 109.692 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -14.02 7.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.696 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -69.44 -22.52 63.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 178.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 91' ' ' VAL . 2.4 m-85 -74.88 -36.93 62.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.504 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG13 ' HG2' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 65.65 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.796 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.722 ' HG2' HG13 ' A' ' 91' ' ' VAL . 5.9 mm-40 66.25 -151.11 0.22 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.911 0.484 . . . . 0.0 110.416 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.47 109.28 22.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.156 0.503 . . . . 0.0 110.991 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 HD11 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -115.77 95.36 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.524 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 4.7 tp10 -104.63 108.15 19.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.959 0.409 . . . . 0.0 110.675 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -91.96 96.48 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.13 105.33 3.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -102.85 -8.71 20.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.952 -175.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.56 -39.75 61.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.524 ' HA2' ' OE2' ' A' ' 103' ' ' GLU . . . -62.77 -18.66 59.72 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.543 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER -58.61 -25.8 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 117.16 0.48 . . . . 0.0 111.833 -174.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 56' ' ' GLN . . . -63.9 -23.39 67.46 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.561 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.524 ' OE2' ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -105.84 -5.17 19.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.21 42.79 6.12 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.872 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.77 132.6 34.98 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.293 -0.533 . . . . 0.0 110.585 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.573 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 14.0 m -121.67 133.18 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.03 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -120.87 103.46 9.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 64' ' ' TRP . 35.2 tp -92.86 110.25 21.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.476 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -88.95 105.79 17.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.35 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.667 HG12 HG23 ' A' ' 94' ' ' THR . 12.5 mt -112.46 119.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -94.55 140.08 30.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 74.26 67.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.056 0.848 . . . . 0.0 111.134 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -62.02 133.36 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.994 174.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.77 149.44 24.48 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 41' ' ' LEU . 7.9 p -67.59 -22.45 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.717 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -75.03 -37.07 61.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -89.74 2.26 55.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.5 t0 -58.47 27.09 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.94 0.896 . . . . 0.0 112.913 168.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -104.86 -147.43 16.4 Favored Glycine 0 N--CA 1.448 -0.539 0 O-C-N 121.399 -0.813 . . . . 0.0 112.29 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.808 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -100.96 120.3 39.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.7 0.286 . . . . 0.0 110.834 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.81 146.24 35.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 110.894 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 86.4 t60 -99.6 103.45 15.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.336 -177.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 46.7 t -106.0 130.88 53.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.738 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 23.2 t -144.56 137.29 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 17.0 m-85 -115.62 110.97 19.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.611 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -118.01 105.25 11.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 0.0 111.223 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 19.3 t0 -112.77 99.86 8.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 0.0 109.988 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.35 -103.6 2.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.233 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -112.57 -24.6 9.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.463 0.173 . . . . 0.0 111.274 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.74 129.66 36.63 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.788 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 23.5 p90 -137.4 127.77 26.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.283 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -112.34 136.36 51.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.942 177.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -110.1 146.87 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.857 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.508 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 7.1 t-80 -149.16 127.1 11.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.15 110.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.912 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 53.4 m -122.11 111.96 17.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.247 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.6 pt-20 -88.25 150.22 23.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.306 0.574 . . . . 0.0 111.867 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.52 151.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.42 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -122.49 90.83 3.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.923 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.529 HG21 HD12 ' A' ' 41' ' ' LEU . 19.5 mt -76.66 107.32 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.516 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.88 48.54 0.84 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.109 0.481 . . . . 0.0 111.689 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -157.79 63.14 0.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 4.1 tt0 -129.73 122.71 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.393 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 12.2 Cg_exo -70.99 160.63 48.76 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.891 2.394 . . . . 0.0 112.154 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.591 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 4.9 p90 -78.58 164.94 24.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.787 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -128.63 173.85 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 111.673 -176.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.615 HG22 ' HE2' ' A' ' 125' ' ' PHE . 82.6 t -89.87 142.26 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.241 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.46 175.62 5.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.709 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.05 -113.47 3.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.772 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.48 176.87 9.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.73 -49.16 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.1 73.03 1.07 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.99 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.16 89.52 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.402 2.068 . . . . 0.0 110.494 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -67.89 129.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -174.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.8 mm? -88.98 128.34 35.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.02 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.71 16.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 128.96 54.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.665 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -62.59 123.91 19.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.73 -9.48 77.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.242 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.85 -171.45 35.73 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.847 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.33 137.35 33.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 tp -111.94 112.92 24.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.926 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -104.78 108.44 19.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.948 177.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.0 OUTLIER -96.61 127.95 43.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.514 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.47 123.87 50.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -121.58 140.73 51.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 1.0 OUTLIER -123.04 131.22 53.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -117.57 164.71 14.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.367 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.53 99.13 2.55 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -83.76 121.1 2.82 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.162 2.575 . . . . 0.0 113.515 -167.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.02 -6.83 13.18 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.465 2.11 . . . . 0.0 110.356 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -165.62 -179.06 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.972 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -72.41 -17.24 61.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.535 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 58.34 30.16 19.18 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.408 0.623 . . . . 0.0 111.098 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -52.31 -58.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.612 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -96.03 26.61 4.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.84 167.68 11.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -97.14 149.97 21.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.685 0.278 . . . . 0.0 110.983 -172.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 146.67 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.408 0.623 . . . . 0.0 112.195 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.661 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mmm-85 -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -143.33 53.49 1.35 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.524 ' HZ ' ' CD1' ' A' ' 76' ' ' TYR . 39.6 m-85 -136.46 154.72 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -166.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HB2' ' CE1' ' A' ' 121' ' ' TYR . 4.2 ttp180 -80.38 110.72 16.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.981 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -149.45 108.5 3.9 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.478 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -70.32 145.58 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.156 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER 62.96 -152.34 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.603 0.564 . . . . 0.0 110.211 -174.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.1 m -129.41 89.63 2.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 111.187 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.5 mm-40 -113.62 142.21 27.29 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 9.8 Cg_exo -71.72 43.61 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.393 2.728 . . . . 0.0 113.905 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -117.2 158.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HA ' ' CD ' ' A' ' 85' ' ' GLU . 31.1 m-70 69.57 107.48 0.06 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.636 0.585 . . . . 0.0 110.468 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.04 124.83 1.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.587 -172.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CD1' ' HZ ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -108.02 112.4 24.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -119.08 143.96 46.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 68.48 -2.72 1.53 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.319 0.58 . . . . 0.0 110.729 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 9.47 52.11 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.728 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -134.17 167.59 20.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.04 151.9 23.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 164.13 12.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.65 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -22.7 63.81 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.55 -28.64 69.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.478 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' CD ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -86.85 -42.33 13.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 86' ' ' ILE . 7.5 tp 43.7 90.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.663 1.227 . . . . 0.0 112.61 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 94' ' ' THR . 3.8 tp -65.39 -12.45 13.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.308 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -14.45 60.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.234 0.54 . . . . 0.0 109.78 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.1 -21.51 54.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.173 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -61.86 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 92' ' ' GLU . 2.1 p -169.72 -71.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.285 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 177.85 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 109.887 -177.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' PHE . 5.7 mtm-85 -76.88 105.7 8.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.883 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 87' ' ' ILE . 25.8 m -152.55 107.49 3.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 131.33 55.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.879 0.371 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -99.51 112.81 24.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.868 0.366 . . . . 0.0 110.177 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.41 105.76 10.95 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.954 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 1.78 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.456 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.6 -28.5 69.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 110.2 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.04 -17.46 78.31 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -28.29 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.88 0.34 . . . . 0.0 111.454 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.12 -16.98 67.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.751 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -103.47 -4.26 24.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.516 0.326 . . . . 0.0 110.246 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 92.31 20.13 36.44 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.851 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -129.08 133.0 47.49 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 117.142 0.471 . . . . 0.0 111.511 -178.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.73 132.73 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -120.71 108.71 14.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.613 -177.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 64' ' ' TRP . 11.1 tp -91.96 121.67 33.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.289 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.788 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.405 HG13 ' HG ' ' A' ' 108' ' ' LEU . 38.3 mt -112.59 127.77 69.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.699 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 112' ' ' ASN . 31.4 t80 -83.48 122.61 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 32.6 t30 80.13 119.36 0.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.071 0.857 . . . . 0.0 111.68 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 140' ' ' ILE . 7.1 p -117.9 134.59 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.412 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.5 p -103.78 171.27 7.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 112.007 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -67.06 -14.14 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.499 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 13.7 t0 -81.38 -34.02 31.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' HA ' ' CD ' ' A' ' 66' ' ' ARG . 32.6 m-20 -72.3 -24.84 61.39 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.014 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.56 -3.66 0.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.697 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.69 -132.12 1.71 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.813 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -106.62 127.12 53.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.105 0.479 . . . . 0.0 111.542 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-85 -90.37 148.48 22.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -106.19 113.66 27.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.781 0.324 . . . . 0.0 110.141 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 4.5 t -103.4 116.21 31.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.128 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.661 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 8.8 t -132.31 113.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.615 ' HE2' HG22 ' A' ' 30' ' ' VAL . 34.7 m-85 -93.27 136.09 33.87 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HB3' ' HE3' ' A' ' 126' ' ' LYS . 11.8 mtpp -121.01 102.97 8.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 33.9 t70 -99.05 74.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.548 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.15 -96.94 0.34 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.905 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.89 -27.83 17.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.67 0.271 . . . . 0.0 111.601 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB2' ' HD1' ' A' ' 28' ' ' PHE . 2.9 m-85 -90.68 148.46 22.6 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.34 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -146.18 150.34 35.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.46 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.683 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -143.38 132.84 23.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.008 177.314 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -114.48 121.93 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 109.949 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.05 148.15 50.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -93.29 133.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.153 0.501 . . . . 0.0 110.772 -176.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -128.79 102.38 6.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.63 138.51 38.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 46.0 t -95.48 142.72 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.83 100.78 5.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 113' ' ' VAL . 70.7 mt -81.83 97.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.682 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.92 61.81 6.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.243 0.544 . . . . 0.0 111.089 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -89.2 40.22 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -140.54 114.56 7.37 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.314 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.56 ' CB ' ' HB3' ' A' ' 130' ' ' PHE . 4.0 Cg_exo -77.2 -88.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.761 2.308 . . . . 0.0 110.991 173.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.765 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 13.4 p90 -140.67 160.55 39.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.75 172.35 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.582 . . . . 0.0 112.123 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.61 147.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.78 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 26.3 t30 -99.2 167.74 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.735 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.16 128.14 45.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.0 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.691 HD11 ' HA ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -112.47 176.62 4.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.752 0.311 . . . . 0.0 110.518 -175.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -73.53 -12.3 60.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.009 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 -132.35 11.02 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.567 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 55.5 Cg_endo -71.5 97.68 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.328 2.018 . . . . 0.0 111.513 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.78 113.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.1 mt -95.59 96.2 8.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.606 -175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -127.4 170.84 12.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.885 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -97.38 145.35 26.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.777 0.322 . . . . 0.0 110.239 -170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 140' ' ' ILE . 0.9 OUTLIER -70.71 142.65 51.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.13 -173.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.16 -8.07 72.44 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.698 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.12 -167.98 35.98 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.237 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.26 134.59 33.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.285 0.564 . . . . 0.0 110.412 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.941 ' HG ' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -106.05 111.0 23.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.289 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 96.89 6.8 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.63 129.22 42.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.879 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -107.49 128.94 54.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.691 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.11 140.26 50.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.699 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -125.96 129.72 49.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.597 0.237 . . . . 0.0 110.758 -175.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.69 165.49 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.564 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.71 83.45 48.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.071 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -95.02 162.73 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.305 2.67 . . . . 0.0 113.107 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -88.44 37.45 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.947 2.431 . . . . 0.0 111.612 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -160.32 177.34 10.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.048 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.88 2.12 55.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.038 0.447 . . . . 0.0 109.817 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 62.28 24.77 14.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -67.81 -24.21 65.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 109.858 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -104.0 17.11 24.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.493 ' HA ' ' HB3' ' A' ' 127' ' ' ASP . 18.6 ttm -76.2 118.95 19.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 110.985 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -78.67 98.88 6.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.464 HD12 HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -111.22 140.48 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 111.336 -172.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.868 ' HB3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.33 118.93 13.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -114.19 63.24 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 81.0 m-85 -136.01 151.28 49.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.604 -168.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.593 HH11 ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -87.83 141.87 28.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.63 175.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.425 ' HB2' HH12 ' A' ' 63' ' ' ARG . 0.4 OUTLIER -164.64 107.43 0.88 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.77 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -73.44 134.05 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 168.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 5.8 t80 64.51 91.14 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -162.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.17 102.09 0.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.699 -170.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.567 ' HB3' HG12 ' A' ' 73' ' ' VAL . 20.3 mm-40 -104.67 121.5 46.75 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.627 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.92 1.37 8.7 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.831 2.354 . . . . 0.0 112.494 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.567 HG12 ' HB3' ' A' ' 71' ' ' GLU . 13.4 p -79.78 50.29 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 122.334 1.064 . . . . 0.0 110.847 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -171.16 65.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.778 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -146.71 152.24 38.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.693 -175.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.19 128.85 42.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.634 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.564 ' HB3' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.52 128.96 34.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -175.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.6 t70 62.25 15.08 7.25 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.463 0.649 . . . . 0.0 111.269 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 98' ' ' LYS . . . 82.47 20.19 62.61 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.975 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.3 154.27 49.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.025 0.441 . . . . 0.0 111.065 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -132.22 139.03 48.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.916 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -177.8 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -23.81 65.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.58 -53.36 5.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.047 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 75' ' ' LEU . 16.4 pm0 -93.15 15.31 15.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.543 0.337 . . . . 0.0 111.777 -175.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.708 HG23 ' HB2' ' A' ' 89' ' ' LYS . 2.4 tt -42.58 121.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.712 0.768 . . . . 0.0 112.303 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 108' ' ' LEU . 14.3 tt -72.75 -36.42 52.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.792 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -13.97 27.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.708 ' HB2' HG23 ' A' ' 86' ' ' ILE . 4.3 ttpt -71.48 -12.42 61.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.534 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE1' ' HD1' ' A' ' 65' ' ' PHE . 1.3 t80 -58.76 -60.74 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -64.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -161.44 -91.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.921 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -72.1 111.78 7.63 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.52 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -140.91 90.8 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.054 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.01 127.08 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.095 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -97.65 100.5 11.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 110.951 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 9.3 mp -73.08 110.98 7.77 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.758 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HD3' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -101.14 -4.71 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.703 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.63 -29.33 67.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.272 0.558 . . . . 0.0 111.07 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.31 -17.94 77.07 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.829 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.564 HD12 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -59.54 -26.37 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -170.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -21.93 67.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.793 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.62 5.03 26.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 0.0 110.206 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 83.3 31.47 27.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.109 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HG3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -123.78 132.25 53.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.16 0.48 . . . . 0.0 110.89 179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -121.32 132.79 69.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -120.02 105.04 10.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.309 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 96' ' ' LEU . 7.0 tp -94.43 118.18 31.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.353 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 109' ' ' ARG . 5.7 ttt180 -95.14 106.21 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.927 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 94' ' ' THR . 65.4 mt -117.35 130.28 72.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER -91.0 134.53 34.42 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.465 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.8 t30 73.58 81.55 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.098 0.874 . . . . 0.0 112.237 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.941 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 8.4 p -82.09 140.81 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.992 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -117.65 176.51 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.974 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.42 -14.25 18.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.243 0.544 . . . . 0.0 110.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.583 ' HB3' HH21 ' A' ' 66' ' ' ARG . 30.3 t70 -80.58 -24.56 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 4.3 m-20 -86.13 -20.27 28.92 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.698 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.415 ' HB2' HD13 ' A' ' 140' ' ' ILE . 31.2 t0 -63.84 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.069 0.948 . . . . 0.0 112.776 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -153.38 -119.96 0.78 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.944 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 123.41 24.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -125.02 161.26 27.13 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.404 172.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.57 119.68 24.04 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.298 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -105.0 117.61 34.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.229 173.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.868 HG12 ' HB3' ' A' ' 63' ' ' ARG . 5.1 p -124.11 141.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.226 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.765 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -136.13 121.2 18.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.583 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -135.22 110.2 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 60' ' ' MET . 11.1 p-10 -116.8 95.91 5.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.127 0.965 . . . . 0.0 110.983 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.72 -82.92 1.38 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.693 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -118.87 -23.62 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.56 ' HB3' ' CB ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -97.28 141.34 30.5 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -148.26 145.46 28.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -150.26 132.3 15.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.804 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -128.22 121.56 29.69 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 139.83 49.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.192 0.52 . . . . 0.0 111.16 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.85 138.79 20.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.58 175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.79 160.2 37.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -121.13 135.37 55.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.22 -175.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 43.1 t -104.92 142.46 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.64 118.46 24.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.251 0.548 . . . . 0.0 111.137 -177.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.618 HD11 HG22 ' A' ' 113' ' ' VAL . 1.5 mp -82.77 119.29 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.605 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.73 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.91 75.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.562 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.5 m -151.85 33.61 0.54 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -61.81 132.41 93.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.934 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.6 Cg_exo -71.03 -175.76 1.58 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 52' ' ' SER . 1.7 p90 -71.8 137.32 47.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -119.28 178.86 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.247 0.546 . . . . 0.0 112.36 -171.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.761 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 p -90.77 147.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.623 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 15.3 t30 -120.44 130.48 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.96 74.34 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.834 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -78.25 111.24 14.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.5 -24.72 67.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.47 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 136' ' ' THR . . . 69.22 -120.55 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.02 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.21 90.18 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.781 2.321 . . . . 0.0 111.66 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -74.01 117.66 18.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 139' ' ' LYS . 3.9 mt -91.2 134.21 34.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.025 0.44 . . . . 0.0 110.811 -171.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.667 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -136.02 172.56 12.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.107 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.55 133.88 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -64.38 124.69 22.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 -177.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.78 -12.17 36.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.304 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.97 -147.33 22.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.223 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -108.25 153.05 23.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.99 0.424 . . . . 0.0 111.228 -176.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 39' ' ' ALA . 1.4 tp -140.95 113.55 8.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.376 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.852 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -92.95 111.86 23.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 64' ' ' TRP . 3.0 mt -95.91 127.53 42.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.817 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.79 43.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 139.72 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 16.7 mp0 -125.66 137.17 53.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.4 mm? -126.22 164.96 19.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.951 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -111.79 80.98 3.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 99.0 Cg_endo -81.74 142.84 12.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.629 2.219 . . . . 0.0 112.882 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 12.6 Cg_exo -71.6 -26.17 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.958 2.439 . . . . 0.0 111.711 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -129.51 -172.14 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -68.08 -28.66 67.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB1' ' SD ' ' A' ' 60' ' ' MET . . . 63.36 25.51 14.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.619 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -60.66 -33.7 73.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.922 0.392 . . . . 0.0 111.253 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -113.22 28.48 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.636 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 7.8 ptm -80.21 169.34 17.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 111.49 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.843 ' HG2' HD12 ' A' ' 75' ' ' LEU . 3.5 mt-10 -89.68 121.18 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.16 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -114.98 139.47 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.45 . . . . 0.0 110.231 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -133.67 118.04 17.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -132.08 61.1 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.2 147.67 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.266 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -72.05 139.48 48.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 177.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -133.99 114.58 13.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -132.47 93.48 3.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 63.03 18.74 11.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.31 151.12 19.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.936 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.756 ' HG2' ' HD2' ' A' ' 72' ' ' PRO . 2.5 tt0 -63.16 147.87 93.91 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 171.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.756 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 45.7 Cg_endo -70.98 44.14 0.51 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.753 2.302 . . . . 0.0 112.887 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 71' ' ' GLU . 4.2 t -105.91 72.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 6.6 m170 -151.16 70.94 0.99 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.248 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.843 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -114.99 151.7 33.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.307 0.575 . . . . 0.0 112.367 -173.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -129.2 109.5 11.2 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' HG3' ' HG3' ' A' ' 61' ' ' GLU . 3.0 ttt-85 -116.31 89.09 3.03 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.165 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.0 t0 52.85 59.7 4.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.018 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.11 7.84 84.71 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.1 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.81 124.32 50.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.543 -0.387 . . . . 0.0 111.316 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -126.56 152.64 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.407 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -118.22 -158.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.85 0.357 . . . . 0.0 111.563 -172.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -41.63 99.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.14 -30.41 31.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.12 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.4 pm0 -112.42 13.77 20.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.509 HG23 ' HD3' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -46.38 112.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.651 0.739 . . . . 0.0 110.257 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -69.05 -12.61 16.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.732 -167.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -13.51 58.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.186 0.517 . . . . 0.0 110.282 173.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -78.92 -16.8 56.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.267 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.44 -33.34 32.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.24 167.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 124.04 0.838 . . . . 0.0 112.213 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 65.01 -105.92 0.13 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.477 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -127.51 120.79 29.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -171.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.15 92.97 2.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.199 175.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.54 116.11 31.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.461 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -102.98 109.35 20.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 107' ' ' THR . 12.7 mt -87.37 106.15 17.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.701 ' HE2' HG21 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -110.73 -3.73 15.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.456 -172.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.29 -12.79 61.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.517 0.675 . . . . 0.0 111.071 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.65 -17.34 70.93 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.43 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.701 HG21 ' HE2' ' A' ' 98' ' ' LYS . 1.7 tt -57.33 -23.27 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.12 -18.99 58.74 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -120.32 7.9 10.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.225 0.536 . . . . 0.0 109.954 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 80.41 43.67 9.25 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.195 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 1.2 mppp? -126.67 133.05 51.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.466 0.633 . . . . 0.0 110.854 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.49 134.7 43.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.572 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.731 ' HB ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -122.54 111.57 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.599 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 96' ' ' LEU . 13.0 tp -103.44 110.83 23.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.852 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -87.33 106.09 17.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.517 176.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.68 129.63 66.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 44' ' ' ASN . 5.4 m-85 -107.06 155.96 19.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.789 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.6 t30 69.61 54.21 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.297 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.56 124.0 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.727 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.617 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 68.5 p -101.88 168.05 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.31 -26.39 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.528 0.68 . . . . 0.0 110.196 176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.25 -28.49 31.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER -72.84 -25.68 61.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.871 175.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.1 t70 -63.13 26.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.358 1.063 . . . . 0.0 113.824 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -100.25 -147.65 21.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.566 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -92.3 107.83 19.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.169 0.509 . . . . 0.0 111.352 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.804 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.5 m-85 -73.92 157.45 36.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -126.84 118.29 24.32 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.343 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 10.3 t -99.51 116.72 32.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 28.9 t -136.34 118.71 20.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.213 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -112.18 128.21 56.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -120.64 117.64 28.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.593 0.235 . . . . 0.0 110.795 -178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.506 ' HB2' ' HE3' ' A' ' 60' ' ' MET . 21.1 t0 -117.47 93.76 4.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.036 0.445 . . . . 0.0 110.469 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.49 -80.21 0.9 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.095 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.82 -29.36 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -102.9 150.03 23.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.596 -174.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 16.6 p90 -145.51 144.76 30.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 3.7 tp10 -111.82 131.39 55.37 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.55 121.18 28.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.651 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.22 134.58 44.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.047 0.451 . . . . 0.0 110.391 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.75 130.98 35.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.237 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -132.88 102.0 5.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.232 -178.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 2.7 mm-40 -73.77 125.61 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.676 0.274 . . . . 0.0 110.849 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 118' ' ' ASP . 9.3 p -88.85 134.38 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -122.89 104.66 9.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.021 0.439 . . . . 0.0 111.795 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 31.2 mt -76.51 96.25 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.177 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.747 0.308 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.85 147.91 48.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.331 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -125.7 14.68 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.062 0.934 . . . . 0.0 108.719 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 32.5 mp0 -100.06 125.4 40.1 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.147 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.927 ' HB2' ' HB3' ' A' ' 130' ' ' PHE . 30.5 Cg_exo -61.88 -31.94 85.1 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.708 2.272 . . . . 0.0 112.677 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HD1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -154.19 143.83 21.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.888 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -115.47 169.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.366 0.603 . . . . 0.0 111.314 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 125' ' ' PHE . 2.2 t -120.16 120.58 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.265 -174.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -78.48 132.85 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.95 -175.63 14.11 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.521 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 35' ' ' GLY . 0.4 OUTLIER -114.25 178.89 4.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -38.85 76.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.438 . . . . 0.0 109.974 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' H ' HD12 ' A' ' 33' ' ' LEU . . . 74.73 62.39 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.19 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 20.2 Cg_endo -96.22 75.78 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.422 2.748 . . . . 0.0 111.295 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 47' ' ' LEU . 21.8 t -78.41 93.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.159 0.504 . . . . 0.0 110.761 -177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HA ' ' HG3' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -86.67 103.72 15.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.751 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.31 9.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.809 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.52 140.88 37.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD12 HG21 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -64.25 110.52 2.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.593 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.75 7.86 88.11 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.403 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.48 -160.24 28.01 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.378 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -82.85 110.87 18.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.145 0.498 . . . . 0.0 110.305 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HB ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -98.74 123.85 43.22 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.22 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 8.4 mt-10 -126.23 108.7 11.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.149 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -96.3 143.95 26.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.193 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.07 114.63 25.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.065 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -118.59 141.17 48.84 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 146.67 49.89 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.29 145.24 50.86 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.371 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -65.87 108.26 2.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 37.6 Cg_exo -60.7 108.98 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.52 2.814 . . . . 0.0 114.587 -167.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 52' ' ' SER . 71.3 Cg_endo -94.43 -22.27 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.083 2.522 . . . . 0.0 111.602 170.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -156.5 -172.23 3.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.573 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 3.0 pt20 -77.87 -17.36 57.43 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.189 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . 59.01 13.85 3.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.928 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -65.3 -33.28 75.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.073 0.463 . . . . 0.0 110.053 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.91 17.64 19.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.704 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.514 ' HB3' ' O ' ' A' ' 57' ' ' ALA . 3.5 ttm -84.69 142.52 29.82 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.646 ' HG2' ' HA ' ' A' ' 77' ' ' ARG . 19.5 mt-10 -88.65 142.45 27.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.861 HD13 HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -135.22 131.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.255 0.55 . . . . 0.0 111.12 -178.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 75' ' ' LEU . 1.5 ttp180 -110.81 115.39 29.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 49' ' ' CYS . 4.7 t90 -140.64 79.52 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.834 0.35 . . . . 0.0 111.339 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HB3' ' HE2' ' A' ' 90' ' ' TYR . 7.1 m-85 -154.75 169.01 24.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD3' ' HA ' ' A' ' 117' ' ' ASP . 9.4 ttp85 -96.67 93.76 6.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.683 -0.807 . . . . 0.0 108.934 168.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -163.83 107.18 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.73 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 mp -104.23 84.93 2.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 110.206 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -107.58 153.42 22.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.24 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -30.03 67.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.16 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.732 ' HB2' HG23 ' A' ' 73' ' ' VAL . 2.1 mp0 -97.85 163.1 20.17 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.26 40.64 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.057 2.505 . . . . 0.0 112.479 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.732 HG23 ' HB2' ' A' ' 71' ' ' GLU . 23.4 t -75.74 144.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.16 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.811 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER 65.64 81.5 0.2 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 123.873 0.733 . . . . 0.0 110.794 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.91 143.0 27.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.541 -175.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.1 t80 -95.25 111.15 23.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -112.16 125.58 54.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.878 -171.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 72.26 -10.99 0.84 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.457 0.646 . . . . 0.0 110.948 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 100.74 17.79 22.49 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -168.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.98 138.3 53.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.214 -0.493 . . . . 0.0 109.973 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.86 161.83 20.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.263 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.98 148.67 38.96 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.635 -175.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' O ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -75.72 -16.99 60.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.265 0.555 . . . . 0.0 110.39 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.95 73.81 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.044 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.81 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 1.7 pp20? -105.36 -41.26 5.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.41 0.148 . . . . 0.0 110.666 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 83' ' ' PHE . 48.5 mt 70.1 95.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.843 0.83 . . . . 0.0 111.41 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.811 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 1.8 tt -75.08 -16.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.274 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -12.96 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.704 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -53.73 -28.13 32.43 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.783 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.644 ' HE2' ' HB3' ' A' ' 65' ' ' PHE . 3.1 m-85 -98.06 -33.24 11.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.276 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.63 163.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 124.186 0.929 . . . . 0.0 111.663 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.3 OUTLIER 75.65 -167.12 0.08 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.984 177.087 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 93' ' ' ARG . 7.8 ttp180 -65.9 112.6 3.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.342 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.912 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -126.33 112.18 15.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.333 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 1.3 pt-20 -137.54 129.73 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.201 0.524 . . . . 0.0 110.629 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.98 107.31 19.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.639 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -74.53 99.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.127 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -96.2 6.25 49.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.522 178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.24 -34.12 63.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.975 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.02 -17.29 65.52 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.962 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.527 HD12 HG13 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -60.41 -21.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.72 61.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.625 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 3.65 20.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.81 31.62 8.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.726 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.46 132.68 53.5 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.673 0.737 . . . . 0.0 111.389 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -125.7 133.79 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 O-C-N 122.161 -0.337 . . . . 0.0 110.515 177.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.98 111.65 19.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 27.4 tp -86.43 113.42 22.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 3.3 mpt_? -98.82 106.77 19.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.929 ' HB ' HD23 ' A' ' 45' ' ' LEU . 14.6 mt -127.45 120.78 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -80.79 127.82 32.95 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 83.26 133.95 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.309 1.006 . . . . 0.0 111.213 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -145.02 139.51 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.304 178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -111.92 172.71 6.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.203 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 p -65.12 -10.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.162 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.91 -50.33 13.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.012 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.717 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -78.11 -9.75 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.784 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -55.0 -22.47 15.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.276 177.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.13 -86.7 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.173 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -145.19 155.86 43.52 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.604 -0.35 . . . . 0.0 111.004 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.552 ' HD1' HG21 ' A' ' 138' ' ' VAL . 1.7 m-85 -103.81 127.51 51.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.451 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 68.6 t60 -76.49 101.67 5.72 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.73 117.32 34.4 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.413 1.071 . . . . 0.0 109.861 -176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.01 116.49 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 0.8 OUTLIER -96.08 112.78 24.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.287 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 2.8 mtpt -119.7 105.0 10.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.95 0.405 . . . . 0.0 110.834 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.37 108.36 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.698 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.18 -102.21 0.7 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.87 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.65 -18.15 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.927 ' HB3' ' HB2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.72 135.96 33.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 110.266 -177.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 1.7 p90 -144.76 151.44 38.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.888 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.5 140.67 43.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 124.82 46.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.322 0.582 . . . . 0.0 110.791 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.38 158.84 42.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.583 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -114.62 112.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.969 0.414 . . . . 0.0 110.427 177.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 120.13 19.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.303 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.06 118.7 13.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.006 0.431 . . . . 0.0 110.731 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.552 HG21 ' HD1' ' A' ' 121' ' ' TYR . 1.8 t -105.38 151.58 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.711 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.37 141.06 37.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.578 HG21 HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -93.71 139.02 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.537 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.478 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -68.63 121.62 16.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.6 m -146.09 20.71 1.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 0.0 109.787 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -76.55 118.19 69.85 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.088 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.43 -9.19 24.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.069 2.513 . . . . 0.0 112.482 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -166.19 147.85 6.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.423 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -138.63 169.73 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.554 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 132' ' ' GLU . 54.7 t -90.73 111.88 24.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -87.82 150.17 23.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.44 -156.14 38.7 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.706 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -147.17 137.02 23.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.853 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -96.49 -49.13 5.28 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 55.04 -134.59 47.95 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.85 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 5.6 Cg_exo -80.84 97.97 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.417 2.744 . . . . 0.0 112.81 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.24 119.53 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.991 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -106.16 132.83 51.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.927 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.16 170.91 18.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.081 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.28 131.29 47.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.415 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -71.63 142.22 49.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.022 0.439 . . . . 0.0 110.488 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.1 -29.86 10.5 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.21 -153.51 26.27 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.6 p-10 -110.04 135.72 50.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.502 0.668 . . . . 0.0 111.074 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -97.92 110.9 23.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.304 175.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.754 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -97.15 99.62 11.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.96 127.99 42.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -116.7 119.04 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.612 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -117.06 139.93 50.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.3 132.68 50.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.875 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.454 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -128.48 156.91 42.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.919 175.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -87.52 101.6 2.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 87.2 Cg_endo -86.54 126.45 2.62 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 114.142 -166.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.17 -27.23 13.97 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.372 2.048 . . . . 0.0 110.665 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.635 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 2.8 pt20 -136.21 178.46 7.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HG3' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -71.45 -19.78 62.18 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.59 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.89 19.67 9.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.767 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.55 -30.54 65.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.537 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -113.5 17.2 18.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 5.2 mmt -87.74 -166.61 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.748 0.309 . . . . 0.0 111.26 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.924 ' HB3' HD11 ' A' ' 75' ' ' LEU . 30.9 mt-10 -114.54 136.53 52.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.962 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -132.17 146.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.821 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 10.9 ttt-85 -141.23 115.21 9.18 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.636 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -129.89 90.19 2.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 77.8 m-85 -143.57 164.18 31.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.068 -172.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 136.88 56.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.962 0.411 . . . . 0.0 109.933 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.73 106.35 8.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -160.46 129.73 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.163 -177.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 67.44 -83.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.696 0.622 . . . . 0.0 111.492 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.11 44.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.24 82.53 47.14 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.22 -173.05 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.048 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 48.6 t -64.17 102.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.654 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 12.0 p-80 -141.97 102.61 4.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -164.3 152.16 12.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 -174.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.37 115.61 27.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.417 ' HB2' ' HG2' ' A' ' 61' ' ' GLU . 9.4 ttm180 -111.36 123.92 51.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -3.32 2.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.887 0.851 . . . . 0.0 109.828 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.6 25.76 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -120.9 149.87 41.95 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 115.051 -0.575 . . . . 0.0 110.875 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -99.57 169.99 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -158.43 163.23 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.318 . . . . 0.0 110.759 -176.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -13.7 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.35 -47.51 7.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.31 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -72.4 -32.38 66.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.512 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER 50.11 59.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.656 1.217 . . . . 0.0 112.407 176.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.755 HD11 HG21 ' A' ' 94' ' ' THR . 16.3 tt -67.11 -1.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.025 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -13.95 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.18 0.514 . . . . 0.0 109.891 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -13.68 62.21 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.053 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 74.6 m-85 -109.75 27.05 9.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 77.2 t 77.78 -75.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.811 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 170.69 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.069 0.462 . . . . 0.0 109.851 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -74.24 70.68 1.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -176.064 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.755 HG21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -131.79 120.54 22.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.046 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 124.8 46.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.471 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 tp -102.88 105.79 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.957 0.408 . . . . 0.0 110.168 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -82.95 117.69 22.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -110.65 10.73 22.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -37.33 83.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.342 0.592 . . . . 0.0 110.068 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.24 79.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.899 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 56' ' ' GLN . 2.0 tt -57.59 -29.72 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.988 0.394 . . . . 0.0 111.657 -172.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.562 ' HA2' ' HG3' ' A' ' 56' ' ' GLN . . . -66.54 -18.3 67.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.129 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 3.95 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.924 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 41.48 6.77 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.621 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -137.77 133.68 34.36 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.292 0.546 . . . . 0.0 111.097 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' SER . 15.9 m -119.36 139.69 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.405 174.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -117.91 104.39 10.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.803 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 tp -93.65 110.23 21.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.754 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 1.5 ttp85 -93.0 106.32 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 94' ' ' THR . 78.0 mt -113.79 106.41 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.147 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -86.83 146.82 26.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 t30 70.0 54.76 0.34 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 123.987 0.804 . . . . 0.0 110.174 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 45' ' ' LEU . 12.2 p -78.29 137.56 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.704 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -120.33 162.01 20.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.926 0.393 . . . . 0.0 111.557 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 9.9 p -68.59 -16.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.439 0.638 . . . . 0.0 110.369 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.24 -33.73 76.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.472 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.93 -12.69 14.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.497 -175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.59 -9.89 1.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.01 -86.2 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.974 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -140.74 118.69 11.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.086 -0.656 . . . . 0.0 111.608 -175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.499 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 10.9 m-85 -93.55 127.95 39.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.601 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 1.9 m-70 -101.26 127.54 47.81 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 48.1 t -106.16 116.81 32.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.109 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.743 ' HB ' HH11 ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.12 130.2 74.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.4 m-85 -108.12 126.26 52.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.962 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -116.82 104.91 11.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.815 0.34 . . . . 0.0 110.305 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 21.8 t70 -111.45 107.0 16.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.946 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.53 -92.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.156 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.51 -20.26 7.85 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -101.65 155.8 17.88 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 -173.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 33.0 p90 -144.67 150.37 37.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.33 133.42 50.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.815 176.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -114.92 121.49 43.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.293 0.568 . . . . 0.0 110.705 -177.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.26 159.15 21.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.757 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.76 108.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.331 0.586 . . . . 0.0 110.875 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.34 102.0 11.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.857 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -80.54 129.96 34.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 45' ' ' LEU . 84.4 t -102.8 146.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 0.0 110.48 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.1 94.39 4.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.742 176.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.686 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -78.09 137.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.963 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 tmm? . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.472 -0.195 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 m 59.85 -92.5 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.634 0.584 . . . . 0.0 112.011 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.03 41.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.418 0.627 . . . . 0.0 109.365 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.73 134.83 92.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.06 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.136 2.557 . . . . 0.0 112.407 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 125' ' ' PHE . 3.1 p90 -110.77 159.85 17.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.806 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -135.25 179.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.393 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 132' ' ' GLU . 77.6 t -115.57 106.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.89 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -112.33 131.14 55.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.445 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.0 -113.39 0.58 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.908 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.83 161.63 20.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.399 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -83.5 -49.03 9.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.935 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.968 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 139.95 87.02 0.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.579 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -94.6 40.6 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.114 2.542 . . . . 0.0 111.282 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.61 119.78 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.274 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.43 139.33 36.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.627 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -140.63 169.73 17.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.42 144.77 43.31 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 111.81 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.17 84.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.329 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.67 -161.8 30.03 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -99.9 146.9 26.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.389 0.614 . . . . 0.0 111.384 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.8 tp -134.49 119.26 18.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.803 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.97 110.34 22.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 107' ' ' THR . 0.9 OUTLIER -94.36 127.24 40.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 122.83 47.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.527 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.698 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.64 141.22 48.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.423 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -106.78 141.43 38.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.077 0.465 . . . . 0.0 110.634 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -125.24 136.9 54.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 -176.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 m -97.95 87.64 0.55 Allowed Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 93.5 Cg_endo -91.2 133.05 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.002 2.468 . . . . 0.0 114.365 -165.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.43 4.14 5.19 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.167 2.578 . . . . 0.0 110.488 168.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' HB3' ' H ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -140.45 -176.35 4.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.194 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -89.62 -6.72 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 71.57 -3.35 2.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.662 174.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 3.4 mt-30 -61.99 -28.17 69.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.25 16.63 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.08 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.7 170.72 9.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.392 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.86 130.65 56.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -127.4 147.05 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.351 0.596 . . . . 0.0 111.275 -177.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 116.64 22.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -126.38 64.33 1.25 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 74' ' ' HIS . 82.3 m-85 -142.24 152.18 42.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.727 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.42 143.78 57.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 -177.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 9.7 t30 -120.47 108.15 13.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.024 0.44 . . . . 0.0 111.358 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 mp -108.63 -177.01 3.2 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -78.6 60.23 2.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.216 0.531 . . . . 0.0 110.256 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 -176.01 4.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.303 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 3.7 mm-40 -69.19 120.89 79.66 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.253 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 6.2 Cg_exo -79.19 66.14 8.8 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.886 2.391 . . . . 0.0 111.576 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -93.02 78.6 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.922 0.868 . . . . 0.0 110.678 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.68 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -170.41 136.61 1.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.503 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.35 126.37 0.42 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.297 0.373 . . . . 0.0 110.33 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.08 128.16 41.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.69 138.26 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.23 -170.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 64.09 21.21 12.5 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.611 0.719 . . . . 0.0 110.061 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.54 17.1 72.41 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 168.64 17.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.141 0.496 . . . . 0.0 111.029 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.32 153.52 18.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.324 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 mtt -135.84 153.35 51.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -5.46 29.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.854 0.359 . . . . 0.0 111.062 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.97 -15.75 69.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.093 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.579 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -118.79 -39.83 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.523 0.201 . . . . 0.0 110.49 178.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 mt 53.92 85.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 111.954 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.68 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 3.5 tt -65.44 -28.57 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.576 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -14.58 52.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.511 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HD2' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -86.76 -14.05 43.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.862 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.2 -52.0 18.53 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 92' ' ' GLU . 4.2 p -178.34 175.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.952 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -85.77 150.27 24.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER 63.74 64.78 0.76 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.827 -175.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.577 HG23 HG12 ' A' ' 110' ' ' ILE . 1.2 m -120.87 106.78 11.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.89 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -117.4 118.39 32.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD22 HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -87.57 98.06 11.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mt -72.07 109.2 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.657 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 20.2 mtmt -108.11 14.0 25.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.655 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -20.65 66.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.493 0.663 . . . . 0.0 110.512 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.83 -17.21 66.09 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.473 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 57' ' ' ALA . 1.9 tt -51.9 -38.42 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 -19.9 69.46 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.373 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.67 22.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.93 45.02 8.63 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.69 133.08 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.185 -0.597 . . . . 0.0 110.642 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.91 132.25 70.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.151 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -123.53 104.19 8.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.588 HD13 HD22 ' A' ' 96' ' ' LEU . 7.1 tp -88.7 111.89 22.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.26 0.553 . . . . 0.0 110.286 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -90.51 106.49 18.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.739 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 94' ' ' THR . 43.0 mt -114.15 116.57 52.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.777 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 13.3 m-85 -88.77 146.32 25.08 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.815 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.53 62.98 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.911 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.578 HG21 ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -65.97 141.54 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.949 175.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.96 167.42 15.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.949 0.404 . . . . 0.0 111.803 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.614 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -70.56 -13.06 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.396 0.617 . . . . 0.0 110.192 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -73.19 -23.61 60.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.94 171.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.91 -11.27 15.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.763 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -62.04 -5.34 2.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.434 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.09 -133.91 1.46 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.658 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.36 124.98 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.191 0.52 . . . . 0.0 111.281 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.84 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 3.3 m-85 -88.22 135.44 33.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.644 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -100.92 119.83 39.27 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.96 0.409 . . . . 0.0 110.02 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.7 t -104.05 118.34 36.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.341 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 133' ' ' GLU . 3.5 t -131.11 128.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.206 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.698 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 29.3 m-85 -116.21 137.3 52.26 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 131' ' ' TYR . 4.3 ptmt -140.61 120.97 13.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.126 0.489 . . . . 0.0 110.918 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -132.48 133.87 44.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.8 -107.55 1.98 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.312 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -120.21 -6.16 9.91 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.71 141.78 35.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 0.0 111.01 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 126' ' ' LYS . 52.8 p90 -134.46 154.33 51.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.806 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -133.41 147.27 51.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.031 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HG2' HG13 ' A' ' 124' ' ' VAL . 28.5 mt-10 -121.35 149.91 42.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.291 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 138.94 18.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.131 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mm -98.62 128.69 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.968 HG23 ' HA3' ' A' ' 35' ' ' GLY . 63.0 m -124.43 109.12 12.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.685 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.98 134.3 37.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.29 124.23 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.147 0.498 . . . . 0.0 110.106 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -98.7 90.7 4.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.56 119.77 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.345 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 tpp . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.64 109.38 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 110.287 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -147.16 36.14 0.91 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.687 0.755 . . . . 0.0 109.406 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -94.14 117.12 67.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.145 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.2 -80.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.079 1.853 . . . . 0.0 111.16 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -167.49 145.22 4.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.69 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.7 pt -132.02 176.83 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.799 0.333 . . . . 0.0 110.663 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 51' ' ' LEU . 37.1 t -102.97 113.85 40.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.782 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -94.66 131.83 40.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.163 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.45 -172.16 15.24 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.8 148.66 22.68 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.679 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.15 -47.25 13.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.48 116.88 4.26 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.286 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.91 91.93 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.331 2.02 . . . . 0.0 111.189 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -69.49 100.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.67 113.32 25.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.926 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -125.98 171.52 10.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.289 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.1 m -122.12 143.88 49.27 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD12 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.72 135.93 57.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -174.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.09 89.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.861 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.2 168.02 17.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.73 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.1 p-10 -79.84 122.68 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.19 0.519 . . . . 0.0 110.512 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.675 HD11 HG11 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -90.39 111.21 22.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.079 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 1.8 mp0 -94.3 105.73 17.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 45' ' ' LEU . 2.0 mm? -96.07 128.46 42.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.45 123.62 49.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.701 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.83 140.26 53.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.884 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -130.53 140.71 50.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -127.84 158.61 37.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.9 m -90.47 98.87 1.65 Allowed Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 10.2 Cg_endo -88.26 125.25 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.371 2.714 . . . . 0.0 114.006 -167.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 73.0 Cg_endo -81.11 -17.81 9.08 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 110.837 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' OE1' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -120.32 -171.66 2.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.112 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -89.89 -10.92 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 0.0 110.165 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HA ' ' HG2' ' A' ' 60' ' ' MET . . . 66.16 -1.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -57.25 -42.18 81.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.156 0.503 . . . . 0.0 110.915 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -99.92 26.11 6.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -92.17 175.9 6.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.735 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 41.8 mt-10 -113.64 129.88 56.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.802 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -125.61 129.17 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.349 0.595 . . . . 0.0 111.216 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 20.4 mtp180 -114.45 117.75 31.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.322 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -125.69 60.3 1.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 87' ' ' ILE . 62.8 m-85 -139.59 152.35 46.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.74 0.781 . . . . 0.0 112.859 -166.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -148.51 126.22 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.167 168.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -152.2 156.44 39.77 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.85 138.16 43.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.74 66.72 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.33 0.586 . . . . 0.0 111.46 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.17 -58.93 1.96 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -154.6 83.74 3.97 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.465 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.28 170.34 18.72 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.726 2.284 . . . . 0.0 113.201 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.591 ' CG1' ' HA ' ' A' ' 87' ' ' ILE . 2.0 t -68.72 154.72 8.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.464 175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 65.5 m170 -104.0 -86.63 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.859 -171.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 61' ' ' GLU . 1.9 pt? -163.76 143.41 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 0.0 112.009 -170.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.06 129.27 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.041 175.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -131.41 132.24 44.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.337 -175.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.2 t0 58.22 21.59 8.28 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.609 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.52 14.66 81.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.174 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 147.24 45.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.79 0.328 . . . . 0.0 110.688 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.556 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.0 p30 -118.49 169.68 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.88 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.25 152.99 50.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.09 -17.27 63.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.88 84.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.232 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 1.7 pp20? -117.63 -38.32 3.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.7 tp 39.06 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.046 1.339 . . . . 0.0 113.82 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.591 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 14.2 tt -56.91 -31.27 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.67 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -12.28 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.194 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.25 -30.94 68.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.701 0.286 . . . . 0.0 110.549 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -71.5 -59.03 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 94' ' ' THR . 1.2 p -159.62 153.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.112 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -56.26 -47.43 78.59 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -175.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -90.71 77.04 6.38 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.34 0.591 . . . . 0.0 110.887 -177.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.528 HG23 HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.45 94.6 4.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.794 177.008 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.65 120.96 42.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -175.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -99.55 106.97 19.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.111 0.482 . . . . 0.0 110.835 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mp -77.24 109.3 11.0 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.503 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.53 -13.02 16.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.657 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -19.81 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 110.964 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.16 66.27 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.653 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.96 -27.97 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.66 -25.45 72.87 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.499 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.46 -2.53 57.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.109 0.48 . . . . 0.0 109.921 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 85.82 19.84 57.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.353 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 50' ' ' GLN . 6.9 mptt -123.52 132.15 53.83 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.065 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.38 133.62 68.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 3.8 m -119.94 112.95 19.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 96' ' ' LEU . 11.4 tp -100.17 117.28 34.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.806 0.336 . . . . 0.0 110.271 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 18.7 mtt180 -94.77 106.87 18.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.631 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.598 HD12 HD23 ' A' ' 47' ' ' LEU . 21.6 mt -111.79 107.08 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -71.72 123.05 21.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.7 t30 81.1 108.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.042 0.839 . . . . 0.0 111.429 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.89 146.68 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.434 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.412 ' HB ' ' OD1' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -113.17 151.66 30.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 111.985 -175.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -72.49 -14.13 16.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.582 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' OD1' ' HB ' ' A' ' 114' ' ' THR . 5.4 p-10 -91.76 -19.1 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.933 0.397 . . . . 0.0 110.335 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.534 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.1 OUTLIER -110.36 2.94 19.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB2' HD13 ' A' ' 140' ' ' ILE . 4.7 p-10 -62.81 25.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -80.68 -159.05 20.34 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.334 -174.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -87.04 111.83 21.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.883 0.373 . . . . 0.0 110.686 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.773 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-30 -68.52 146.0 53.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.333 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.11 114.31 28.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 0.0 110.427 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -100.18 117.73 35.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.529 177.172 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 63' ' ' ARG . 47.1 t -118.02 109.04 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.116 0.484 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 134' ' ' HIS . 1.1 m-85 -93.73 115.52 27.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.1 mtpm? -109.11 104.89 14.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.729 0.3 . . . . 0.0 110.325 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.791 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 23.7 t0 -118.39 136.53 53.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.588 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.82 -111.73 2.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -113.15 3.05 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 110.816 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 171.23 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.904 0.383 . . . . 0.0 111.353 -174.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 4.0 p90 -148.45 147.93 29.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -122.75 142.8 50.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.6 121.01 39.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 0.0 110.482 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.54 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.55 137.37 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.829 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.38 107.42 22.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 34' ' ' GLU . 1.4 m -103.96 105.46 15.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 1.1 mm-40 -67.58 122.43 18.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.491 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 45' ' ' LEU . 4.0 t -91.85 147.77 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.98 115.49 17.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.2 mp -91.94 126.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.173 -176.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.715 0.293 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 m 57.6 27.57 14.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.19 9.87 4.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -74.69 134.6 75.51 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.038 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 19.1 Cg_exo -66.05 -62.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.976 2.451 . . . . 0.0 113.376 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -133.71 146.42 50.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.435 -174.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.966 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.2 pt -148.56 167.76 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.036 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 132' ' ' GLU . 39.4 t -91.75 140.82 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.663 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -130.79 179.18 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.0 111.108 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.61 -133.45 11.36 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.78 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.493 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.96 176.65 5.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.59 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.318 0.386 . . . . 0.0 110.183 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.931 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 134.06 80.66 0.15 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.017 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.83 57.0 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.01 2.474 . . . . 0.0 111.566 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -82.14 100.85 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.267 -176.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.31 101.32 13.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.393 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.46 169.5 8.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.722 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -120.59 138.06 54.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.79 0.329 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -66.08 130.52 43.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -176.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.24 -5.04 84.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.485 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.97 -168.27 27.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.903 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.58 113.54 19.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' HB ' ' A' ' 110' ' ' ILE . 5.3 tp -85.85 114.89 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.82 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 3.7 mt-10 -110.38 117.42 33.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 0.7 OUTLIER -108.39 128.53 54.85 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.271 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.458 ' C ' ' HH2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -116.21 119.89 37.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -178.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.774 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -117.76 140.36 49.78 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.089 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.793 ' HG3' ' HD2' ' A' ' 105' ' ' LYS . 21.9 mp0 -115.86 135.75 53.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.294 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.698 HD23 ' HA2' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -127.35 153.16 46.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.636 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.74 100.36 5.28 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.7 Cg_endo -88.95 116.09 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.913 2.408 . . . . 0.0 113.584 -170.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.7 -13.84 12.99 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.44 2.094 . . . . 0.0 110.917 171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' ' CE ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -134.27 -174.19 3.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.727 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 58' ' ' GLN . 25.8 pt20 -74.96 -22.41 58.58 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.963 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 64.75 10.29 5.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.963 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.493 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -68.26 -11.29 59.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -117.47 15.68 14.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.293 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.664 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -82.88 155.28 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.079 0.466 . . . . 0.0 111.722 -172.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.968 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 2.1 mp0 -84.05 151.57 24.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -134.16 137.86 51.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.911 0.862 . . . . 0.0 111.316 -178.38 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -132.16 116.68 17.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.482 173.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.774 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -144.09 98.05 3.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.181 0.515 . . . . 0.0 110.286 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.604 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 170.76 6.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.03 117.01 31.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.568 ' HG ' ' OE2' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -119.24 -164.5 1.06 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.762 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -100.31 37.07 1.74 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.284 0.564 . . . . 0.0 110.876 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.03 64.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.706 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 35.5 mm-40 -91.5 -37.65 0.37 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -170.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.706 ' HD2' ' N ' ' A' ' 71' ' ' GLU . 91.9 Cg_exo -17.99 -78.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 125.209 3.939 . . . . 0.0 115.523 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.452 HG22 ' HA3' ' A' ' 84' ' ' GLY . 3.2 p -100.57 119.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -159.12 37.85 0.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.12 -175.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.889 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.97 150.35 44.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -173.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.611 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 21.6 t80 -117.64 139.64 50.73 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.641 ' HG2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -117.83 147.48 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.177 -174.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -63.9 104.55 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.114 0.483 . . . . 0.0 110.083 177.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 7.71 55.98 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.115 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.641 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -143.26 122.69 13.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.455 0.645 . . . . 0.0 111.241 176.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -110.89 136.98 49.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.425 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -145.59 147.86 32.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.324 -174.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.453 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -71.16 -3.24 18.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 174.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' HA3' HG22 ' A' ' 73' ' ' VAL . . . -68.51 -49.36 44.89 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.184 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -64.66 -34.43 78.28 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 89' ' ' LYS . 1.1 tt 44.66 51.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.625 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.487 HD11 HG21 ' A' ' 94' ' ' THR . 3.2 tt -65.83 -17.86 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.647 173.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -15.29 62.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.472 174.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.68 -27.62 40.77 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.302 0.572 . . . . 0.0 109.575 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -75.45 -62.65 1.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 111' ' ' PHE . 9.0 p 172.41 136.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.285 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 55.67 2.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.429 0.633 . . . . 0.0 110.158 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.65 66.92 1.39 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.487 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -122.11 151.39 40.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.079 -172.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -137.23 117.14 13.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.307 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 108' ' ' LEU . 15.7 tp -100.82 101.23 12.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -70.34 99.63 1.59 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.729 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -103.69 1.47 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.261 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -24.83 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.261 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.78 -17.02 64.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.41 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 tt -53.51 -37.66 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.98 -15.19 69.11 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.17 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.8 -4.7 21.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.858 0.361 . . . . 0.0 110.244 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.698 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 92.41 31.27 9.05 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -133.51 133.6 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.152 0.476 . . . . 0.0 111.444 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.61 134.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 O-C-N 122.244 -0.285 . . . . 0.0 110.258 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -122.22 114.06 20.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.256 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 96' ' ' LEU . 24.1 tp -94.45 115.5 27.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 4.9 ttp180 -100.01 107.05 18.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.646 ' HB ' HD23 ' A' ' 45' ' ' LEU . 48.2 mt -110.37 118.7 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' HG11 ' A' ' 91' ' ' VAL . 11.0 t80 -75.91 128.3 34.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.059 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 26.4 t30 72.18 84.97 0.12 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.801 0.688 . . . . 0.0 111.758 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 p -89.53 142.06 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.447 HG22 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -124.72 171.34 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.9 0.381 . . . . 0.0 111.676 -178.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -23.12 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -171.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.93 -25.84 60.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.514 0.673 . . . . 0.0 109.894 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.447 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . 1.7 m-20 -101.27 -4.07 27.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.422 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -57.96 -11.85 2.77 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.782 175.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.42 -146.73 0.48 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 121.725 0.625 . . . . 0.0 114.578 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -90.11 136.18 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 111.611 -175.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -105.29 123.4 47.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.277 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -84.62 113.73 21.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.894 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 41.9 t -99.73 117.57 34.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 14.8 t -135.07 118.46 24.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.11 143.41 30.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.968 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.85 118.64 27.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -115.03 85.34 2.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.763 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.73 -90.15 0.16 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.94 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.97 -24.47 13.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.79 25.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 110.786 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.07 143.49 38.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.54 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.966 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 7.0 mm-40 -127.45 132.94 49.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 3.7 pt-20 -123.03 142.66 50.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.423 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -136.84 146.55 45.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.656 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.6 mt -97.02 107.99 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.932 0.396 . . . . 0.0 110.374 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.931 HG23 ' HA3' ' A' ' 35' ' ' GLY . 31.5 m -111.01 100.51 9.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.426 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -84.04 135.14 34.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -88.16 150.73 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.044 0.449 . . . . 0.0 110.637 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.84 101.25 7.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 118' ' ' ASP . 35.9 mm -74.34 108.42 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.872 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.61 106.86 14.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 0.0 110.277 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.98 4.28 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.747 0.784 . . . . 0.0 109.102 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -105.55 101.89 34.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.953 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.38 -37.47 4.34 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.75 2.3 . . . . 0.0 112.908 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -101.49 146.98 26.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.61 179.21 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.292 0.568 . . . . 0.0 112.257 -170.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -90.65 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.935 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -105.96 129.75 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.09 -110.24 1.25 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 123.572 0.545 . . . . 0.0 112.149 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 33' ' ' LEU . 4.3 mt -146.76 149.86 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 -46.92 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.37 123.13 1.97 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.793 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.63 73.16 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.852 2.368 . . . . 0.0 110.456 172.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.66 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.11 114.97 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.02 -174.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.81 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.754 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.27 173.08 12.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.965 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -112.32 147.17 36.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -73.15 152.08 41.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.48 -7.07 82.0 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.68 179.63 22.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.181 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -79.82 109.58 14.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 110.325 178.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.727 HD13 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -86.99 109.75 19.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.203 178.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.694 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.4 mt-10 -94.25 96.06 9.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.727 HD21 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -104.98 129.51 53.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.775 -175.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -118.07 138.84 51.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 m -117.78 140.2 50.01 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.39 131.85 56.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 110.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -125.4 159.32 32.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.5 -177.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.2 86.5 6.38 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.3 Cg_endo -88.39 153.54 6.6 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.806 2.338 . . . . 0.0 112.55 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 7.2 Cg_exo -73.55 -28.04 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.767 2.311 . . . . 0.0 111.742 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.83 -172.49 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -69.4 -8.27 45.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.137 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 60.74 29.41 18.99 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.107 0.563 . . . . 0.0 112.276 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.49 -42.55 78.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.449 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -101.27 25.0 8.72 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 111.347 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 16.2 ttm -68.88 131.84 45.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.162 0.506 . . . . 0.0 111.457 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -88.05 143.89 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.7 HG21 HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -134.95 148.96 28.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.84 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 3.2 ttp85 -128.74 115.64 18.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.623 ' CZ2' HD22 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -126.65 87.7 2.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -153.61 148.57 26.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.899 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HD3' ' HB2' ' A' ' 117' ' ' ASP . 41.9 ttt-85 -88.72 94.92 10.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 165.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.47 129.32 51.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.066 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.52 132.86 38.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.948 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 74.86 148.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.242 0.964 . . . . 0.0 110.999 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.43 109.62 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.707 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.55 103.22 51.22 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.951 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.98 -9.5 25.2 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.216 2.611 . . . . 0.0 112.651 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.57 0.49 8.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.683 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -109.14 80.71 1.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.077 -178.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -138.77 144.35 39.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.659 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' HE2' HD13 ' A' ' 87' ' ' ILE . 2.7 t80 -100.57 115.11 29.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.52 121.32 44.85 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.085 -168.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.8 t70 64.94 14.16 9.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.148 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.777 ' HA2' HD22 ' A' ' 96' ' ' LEU . . . 89.82 14.05 60.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.741 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -129.05 148.71 51.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 139.02 50.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.934 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.585 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -105.48 -172.89 2.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -75.53 -9.22 58.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.867 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -55.28 3.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.789 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 82' ' ' MET . 6.9 pm0 -74.77 -37.82 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 122.716 0.406 . . . . 0.0 110.446 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 86' ' ' ILE . 3.0 tp 43.44 97.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.643 1.177 . . . . 0.0 113.421 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.728 HD13 ' HE2' ' A' ' 76' ' ' TYR . 2.5 tp -62.89 -18.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.167 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -14.22 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.665 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -66.14 -29.67 70.01 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.045 177.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.68 -71.2 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.512 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.99 141.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.01 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.802 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -161.12 65.77 0.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.72 119.16 25.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.223 -174.178 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.12 99.97 7.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.699 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.777 HD22 ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -86.08 111.39 20.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.186 0.517 . . . . 0.0 110.488 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.2 mp -81.72 112.94 19.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.912 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.05 1.85 56.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.094 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.31 -33.59 63.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.332 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.19 -16.9 65.98 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.814 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -31.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.48 -25.4 66.97 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.435 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.2 13.68 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.979 0.419 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.34 43.66 12.53 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.477 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -129.82 133.19 46.79 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.279 -0.542 . . . . 0.0 110.784 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 62' ' ' ILE . 14.3 m -121.96 132.96 69.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.721 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -116.4 102.86 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.727 178.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.644 HD13 HD12 ' A' ' 96' ' ' LEU . 4.6 tp -96.05 111.52 23.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.098 0.475 . . . . 0.0 110.195 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.694 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -86.42 106.26 17.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.542 174.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.455 HG13 ' HG ' ' A' ' 108' ' ' LEU . 50.0 mt -112.54 112.76 41.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 59.6 t80 -80.14 129.76 34.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 35.5 t30 76.23 79.6 0.09 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.914 0.759 . . . . 0.0 111.76 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 41' ' ' LEU . 10.2 p -84.96 149.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 168.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.25 165.52 14.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.964 0.411 . . . . 0.0 111.964 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.3 -28.95 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.13 -43.27 87.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.552 ' HB2' ' HD3' ' A' ' 66' ' ' ARG . 3.6 p-10 -104.17 4.09 33.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.616 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -62.5 -10.38 11.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 176.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.7 -118.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.931 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.2 124.97 35.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.257 0.551 . . . . 0.0 111.765 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 136' ' ' THR . 50.2 p90 -110.92 164.77 12.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.774 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 113.33 24.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.3 t -104.92 122.37 45.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.84 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 97.8 t -131.95 139.24 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.047 -175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 23.2 m-85 -119.31 140.5 50.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -130.75 105.04 7.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.653 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 43.0 t0 -98.5 74.37 2.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.39 -93.36 0.89 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.3 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -97.79 -27.97 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.742 0.306 . . . . 0.0 111.714 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -96.81 143.18 27.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.922 0.391 . . . . 0.0 110.4 -177.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.738 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -138.02 142.77 40.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.395 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.44 131.91 54.1 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HA ' HG22 ' A' ' 124' ' ' VAL . 8.8 mt-10 -114.36 119.92 38.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 132.19 55.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.158 0.504 . . . . 0.0 111.12 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.452 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -103.5 107.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.576 175.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -120.52 160.66 22.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 139.51 53.83 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.226 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -83.0 150.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -112.58 90.89 3.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mp -80.76 123.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.918 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.458 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.341 0.115 . . . . 0.0 110.887 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -103.01 91.4 4.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.51 -179.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -151.49 33.55 0.56 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.445 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -72.15 117.19 56.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.382 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.08 -178.54 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.949 2.433 . . . . 0.0 112.301 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HE1' ' HA ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -74.83 140.45 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -122.07 168.12 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -170.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 134' ' ' HIS . 67.0 t -91.35 132.46 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.188 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.46 132.25 55.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.72 -107.31 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.749 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.43 168.39 21.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -175.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -48.63 7.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 111.82 2.53 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.927 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.57 86.87 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.569 2.179 . . . . 0.0 111.355 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -72.28 101.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.323 -176.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -87.22 119.72 27.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 171.82 13.8 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.003 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -98.67 133.98 42.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.3 123.42 17.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.85 0.357 . . . . 0.0 111.034 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 94.44 1.22 64.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.04 -174.42 33.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.214 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' HB2' ' HD1' ' A' ' 111' ' ' PHE . 10.3 t30 -93.88 119.8 33.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.36 . . . . 0.0 110.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.499 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -98.23 122.23 41.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.867 -177.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -97.17 101.68 13.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.683 174.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.499 ' HG ' HD22 ' A' ' 45' ' ' LEU . 1.1 mp -96.58 127.25 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.49 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -117.63 130.18 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.74 140.19 50.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 30' ' ' VAL . 8.0 tt0 -110.99 131.34 55.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.138 0.494 . . . . 0.0 110.604 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.24 154.88 44.31 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.376 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -87.27 101.24 2.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.9 Cg_endo -76.41 114.31 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.751 2.3 . . . . 0.0 113.74 -170.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.9 -21.05 9.88 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.44 2.094 . . . . 0.0 110.602 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -171.66 2.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -18.06 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 56.99 32.32 21.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.261 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -61.59 -33.81 74.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.722 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -93.39 9.61 35.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 146.68 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.314 0.578 . . . . 0.0 111.39 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -92.68 102.63 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.78 130.01 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.689 0.757 . . . . 0.0 111.255 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.577 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 8.1 ttm180 -113.94 117.1 30.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.681 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.602 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -125.86 55.43 1.45 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.81 167.42 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.324 0.583 . . . . 0.0 112.192 -164.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' CD ' ' HB3' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -112.3 144.16 42.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.24 174.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.16 152.6 35.33 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.52 ' HB3' ' H ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -142.95 -141.47 0.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.859 -175.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.52 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -64.96 71.81 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -172.02 -101.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.373 173.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.431 ' H ' ' HB ' ' A' ' 70' ' ' THR . 8.2 mm-40 -153.25 158.27 32.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.87 56.21 3.52 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.748 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.4 t -98.78 89.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.94 124.78 0.44 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.677 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.86 143.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.556 0.535 . . . . 0.0 110.7 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.21 114.8 28.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.168 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.445 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -97.76 120.51 38.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -176.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t70 67.44 14.03 9.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.85 0.833 . . . . 0.0 109.969 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.44 70.72 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.595 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -122.99 151.68 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -101.01 169.32 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.264 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.705 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 2.8 ptt? -140.06 161.33 37.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.79 -27.71 69.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.28 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.17 -5.61 89.04 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.648 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -111.24 -40.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.6 OUTLIER 37.58 80.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.249 1.02 . . . . 0.0 112.929 177.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 76' ' ' TYR . 14.8 tt -64.04 -19.79 25.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.125 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -13.73 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.552 175.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -66.27 -29.84 70.15 Favored 'General case' 0 CA--C 1.524 -0.037 0 CA-C-O 121.019 0.438 . . . . 0.0 110.234 178.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -52.87 7.99 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.44 HG12 HG23 ' A' ' 94' ' ' THR . 7.3 p 176.4 159.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.317 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -79.34 -25.01 42.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -80.53 66.44 6.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.559 173.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.18 89.27 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.66 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -104.87 112.33 25.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.111 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -89.91 101.77 14.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 178.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -75.08 107.21 7.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 1.66 49.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.791 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.23 -29.19 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.16 -16.9 70.76 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.0 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 tp -55.54 -25.53 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.5 -21.12 70.42 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.903 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.26 13.33 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.316 0.579 . . . . 0.0 109.581 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.36 27.13 66.4 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.758 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.87 132.04 56.65 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.968 -0.724 . . . . 0.0 110.84 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.05 131.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -124.08 103.81 8.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.284 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' HG13 ' A' ' 110' ' ' ILE . 9.0 tp -94.86 117.63 30.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.93 0.395 . . . . 0.0 110.336 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.797 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -96.22 107.48 19.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.566 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 94' ' ' THR . 53.3 mt -116.28 121.4 67.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' HD1' ' HB2' ' A' ' 44' ' ' ASN . 22.0 t80 -83.17 130.99 35.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.448 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 56.7 t30 71.78 84.38 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.162 174.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.08 131.92 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.018 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.19 177.24 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.94 -29.95 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -171.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -40.62 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.338 0.59 . . . . 0.0 110.276 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' ' CD ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.47 -7.9 55.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.277 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -63.88 -21.75 66.6 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.81 177.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.07 -110.05 0.08 OUTLIER Glycine 0 C--O 1.243 0.674 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.928 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.72 120.4 25.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.127 -0.536 . . . . 0.0 111.671 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.21 137.36 44.3 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -105.33 115.7 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -105.98 116.27 31.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.121 175.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 85.6 t -134.64 121.54 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.505 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.2 m-85 -111.22 113.39 25.85 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 104.37 9.73 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.546 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -105.28 89.34 3.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.21 -82.55 0.13 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.012 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.31 8.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.07 140.22 34.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 40.2 p90 -147.61 142.9 27.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.408 . . . . 0.0 111.06 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.675 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.99 137.8 41.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.745 176.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 124' ' ' VAL . 4.6 mt-10 -122.12 121.26 36.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.954 0.407 . . . . 0.0 110.436 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -119.36 144.88 46.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.43 108.27 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.602 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -97.07 160.29 14.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.45 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -127.47 135.64 50.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.291 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 23.9 t -98.37 147.1 7.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HB2' ' HA ' ' A' ' 38' ' ' LEU . 1.3 mtpt -120.88 90.22 3.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -75.0 133.66 31.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.223 0.535 . . . . 0.0 109.886 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.84 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.648 0.261 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.22 61.63 3.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.414 0.626 . . . . 0.0 110.099 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.43 17.92 20.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.377 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 25.0 tt0 -70.78 114.08 23.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.195 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 27.0 Cg_endo -90.5 -94.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.977 2.451 . . . . 0.0 112.157 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -156.63 165.18 37.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.875 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pt -134.75 165.66 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.887 0.375 . . . . 0.0 110.547 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.898 HG23 ' HB3' ' A' ' 132' ' ' GLU . 95.4 t -91.05 127.27 43.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.411 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.18 179.56 4.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.45 -133.9 11.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.07 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -111.42 172.84 6.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 35' ' ' GLY . 1.8 pm0 -69.0 -29.49 67.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 109.39 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.871 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 117.38 72.68 0.46 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.363 173.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.95 52.74 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.497 2.131 . . . . 0.0 111.101 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 138' ' ' VAL . 2.3 m -78.57 104.51 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.499 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.55 137.77 32.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -133.76 170.69 15.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.616 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -119.57 138.32 53.28 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.735 -178.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.33 111.08 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.15 8.53 87.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.013 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 40' ' ' SER . . . -103.92 -147.55 17.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.98 143.78 41.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 39' ' ' ALA . 10.3 tp -127.76 118.94 24.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.175 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -101.39 107.01 18.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.154 178.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -96.75 127.71 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.037 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 123.75 39.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.01 0.433 . . . . 0.0 111.103 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.25 50.06 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.82 160.01 18.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.249 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.502 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -127.64 148.71 50.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.035 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 89.67 0.31 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 162.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 14.3 Cg_exo -67.81 115.21 3.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 2.729 . . . . 0.0 114.248 -162.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.27 -32.98 2.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.874 2.383 . . . . 0.0 110.129 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -146.34 -172.78 4.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.344 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.32 -21.89 59.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 55.57 24.54 7.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -42.42 90.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.189 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.11 5.32 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -80.22 174.94 11.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -169.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.148 ' HB3' HD11 ' A' ' 75' ' ' LEU . 48.7 mt-10 -106.24 143.63 34.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.448 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.517 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -118.89 134.04 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 168.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -149.54 59.69 1.01 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -137.89 152.37 48.96 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.715 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HE ' ' HA3' ' A' ' 119' ' ' GLY . 11.4 tpt85 -89.89 95.09 10.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.732 0.777 . . . . 0.0 109.375 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.62 125.93 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.483 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.92 144.87 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.775 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 75.16 4.08 4.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.103 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.98 149.37 27.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.423 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.33 155.93 78.15 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.023 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.46 29.31 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.272 2.648 . . . . 0.0 113.754 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.8 50.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.399 0.619 . . . . 0.0 109.665 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 1.038 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -161.56 82.09 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.117 179.28 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.148 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -149.22 143.6 26.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.475 -169.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.76 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.6 t80 -94.44 114.63 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.217 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.671 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.75 163.71 35.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.322 -0.151 . . . . 0.0 110.845 -173.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t0 68.69 6.93 5.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.669 0.747 . . . . 0.0 109.93 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.76 -6.15 62.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.439 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 pttp -144.69 179.79 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.081 0.467 . . . . 0.0 111.266 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.9 168.09 19.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.717 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.654 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -134.0 143.27 48.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.797 0.332 . . . . 0.0 111.242 -175.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.36 -23.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 0.0 110.941 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.95 -32.57 77.49 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.399 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 2.0 pp20? -95.2 -30.06 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER 47.6 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.676 1.19 . . . . 0.0 113.667 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 8.5 tp -77.8 -7.93 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.123 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -13.45 7.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.713 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -69.56 -26.83 64.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.523 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -72.36 0.32 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -154.51 -174.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.829 -178.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -92.04 -23.45 19.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.848 0.356 . . . . 0.0 110.302 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.881 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -106.97 88.94 2.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.301 0.572 . . . . 0.0 111.268 -178.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.504 HG22 HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -116.46 95.61 5.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.292 173.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 23.3 tt0 -103.1 98.93 8.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.621 -171.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.821 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -100.4 117.73 35.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.118 0.485 . . . . 0.0 110.932 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -89.96 109.54 20.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.194 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.14 -10.47 14.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.633 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -17.97 65.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.145 -177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.93 80.33 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.178 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.674 HD11 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 tt -57.56 -29.04 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 122.707 0.403 . . . . 0.0 111.709 -174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.88 64.04 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.658 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.13 4.7 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.166 0.507 . . . . 0.0 110.211 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.08 42.17 8.96 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.711 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 132.64 40.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.818 0.309 . . . . 0.0 110.538 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.79 132.33 59.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.253 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 46' ' ' GLU . 1.2 m -123.02 124.46 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.461 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.821 HD13 HD12 ' A' ' 96' ' ' LEU . 40.8 tp -112.11 111.9 23.13 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -96.03 105.95 18.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.81 132.09 51.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.881 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 1.5 m-85 -95.99 143.44 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.0 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HB3' HG11 ' A' ' 91' ' ' VAL . 49.4 t30 67.15 84.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -95.12 128.67 46.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.007 178.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.9 p -96.84 175.52 6.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.04 -16.8 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.602 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.43 -44.81 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.516 ' HB2' HG12 ' A' ' 113' ' ' VAL . 41.0 m-20 -65.8 -25.19 67.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.602 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.733 ' HB2' HD13 ' A' ' 140' ' ' ILE . 17.8 t70 -55.36 -17.42 4.83 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA3' ' HE ' ' A' ' 66' ' ' ARG . . . -71.82 -156.96 2.84 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.11 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -78.29 105.94 9.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.923 0.392 . . . . 0.0 111.729 -176.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -73.97 144.45 45.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.12 114.02 27.19 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.474 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 51.2 t -97.38 117.06 30.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.517 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 10.6 t -131.6 105.11 9.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.674 ' HZ ' HD11 ' A' ' 101' ' ' ILE . 21.8 t80 -97.82 139.2 34.03 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.186 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.0 mtpt -122.12 104.58 9.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.219 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 17.6 t0 -106.71 138.4 42.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.447 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.86 -110.61 1.76 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.96 11.52 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 159.7 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 4.9 p90 -140.67 153.43 45.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.88 0.372 . . . . 0.0 111.17 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.898 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -142.45 157.35 44.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.592 178.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -133.38 154.44 50.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.242 0.544 . . . . 0.0 112.22 -172.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.86 124.55 14.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.167 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.94 108.95 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.433 . . . . 0.0 110.247 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.871 HG23 ' HA3' ' A' ' 35' ' ' GLY . 99.0 m -122.29 102.34 8.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.745 -176.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 5.3 pt-20 -82.84 141.96 31.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.463 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 37' ' ' VAL . 89.6 t -86.82 151.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -113.63 92.29 3.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 174.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -71.75 120.33 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 139' ' ' LYS . 2.3 t . . . . . 0 C--O 1.251 1.164 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.572 -174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.512 0.196 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.3 112.25 5.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.999 0.428 . . . . 0.0 110.42 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.27 27.57 9.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.905 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.86 120.77 63.6 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -86.85 -131.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.768 2.312 . . . . 0.0 111.909 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -105.43 158.0 16.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 177.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.63 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.5 pt -129.25 167.93 23.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' HB3' ' A' ' 132' ' ' GLU . 44.3 t -91.1 144.7 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.83 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.09 161.31 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.604 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -171.15 28.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.536 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.21 176.85 4.86 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -49.8 73.73 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.158 0.286 . . . . 0.0 110.829 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.56 81.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.518 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.82 89.93 0.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.575 2.183 . . . . 0.0 111.061 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -68.55 124.78 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.409 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -88.77 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.014 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.41 170.58 9.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -120.98 145.07 48.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 119.04 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.074 0.464 . . . . 0.0 110.586 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 90.76 -7.33 81.41 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.322 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.11 -176.35 49.04 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.528 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -87.61 115.65 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -108.12 118.65 37.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.407 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.91 112.24 24.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.372 177.136 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.6 128.1 42.19 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.28 128.5 52.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 140.49 52.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.82 145.26 45.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.48 -178.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 28' ' ' PHE . 4.6 mt -117.75 164.37 15.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.71 85.36 0.55 Allowed Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 165.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 11.7 Cg_exo -68.39 119.2 6.21 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.233 2.622 . . . . 0.0 113.929 -162.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 -31.95 4.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.757 2.304 . . . . 0.0 110.098 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.99 -172.64 3.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.667 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -71.23 -15.93 62.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 59.46 17.05 5.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -64.3 -22.56 66.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.126 0.489 . . . . 0.0 111.22 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -115.14 24.18 11.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.318 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.677 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -86.55 169.9 12.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -178.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 12.0 tt0 -101.79 123.68 46.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.089 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.37 137.7 45.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.399 0.619 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.681 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 8.0 mtt180 -134.41 116.95 15.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.806 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.753 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -136.85 73.48 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -177.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -149.28 169.69 20.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.184 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -94.3 95.94 9.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.309 0.576 . . . . 0.0 110.993 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.28 111.12 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mp -138.09 152.86 49.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.726 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.11 -71.6 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.42 168.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -62.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -171.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.755 ' HB3' HG23 ' A' ' 73' ' ' VAL . 5.9 mt-10 -130.21 145.23 56.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.809 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.44 21.95 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.067 2.511 . . . . 0.0 112.48 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.755 HG23 ' HB3' ' A' ' 71' ' ' GLU . 2.9 t -69.03 128.83 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.515 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -175.32 131.22 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.046 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 82' ' ' MET . 0.1 OUTLIER -161.68 113.72 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -143.42 109.58 5.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 159.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.3 122.68 26.85 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.037 -0.414 . . . . 0.0 111.447 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 56.57 41.01 29.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.151 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.08 24.89 65.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.857 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 12.1 tptt -145.6 129.63 17.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.836 0.351 . . . . 0.0 111.049 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.26 163.36 17.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.798 ' HB2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -123.34 161.92 23.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.709 ' HA ' HG13 ' A' ' 86' ' ' ILE . 23.9 m-85 -62.24 -20.79 64.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.081 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.49 99.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.246 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OE1' ' HA ' ' A' ' 74' ' ' HIS . 3.9 tp10 -104.15 -43.19 5.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.709 HG13 ' HA ' ' A' ' 83' ' ' PHE . 6.2 mt 61.09 109.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 122.037 0.922 . . . . 0.0 112.294 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 94' ' ' THR . 8.2 tp -72.38 -19.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.165 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -14.29 49.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.377 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -72.29 -26.09 61.84 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.403 0.621 . . . . 0.0 109.666 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 29.4 m-85 -92.23 -65.33 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.215 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.558 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p 166.73 153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.2 60.25 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.288 177.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 1.1 mmp_? -145.98 60.69 1.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.7 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -125.46 164.5 20.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.105 -174.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.51 135.76 13.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.588 173.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 4.2 tp -108.26 94.29 4.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.809 0.338 . . . . 0.0 110.108 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -70.45 108.76 4.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 109.707 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -107.07 6.59 29.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 -176.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.11 -25.91 68.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.012 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.0 -16.8 66.63 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.266 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.496 HD13 ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -53.79 -28.23 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.88 -26.71 67.47 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.072 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.53 15.31 19.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 109.857 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.584 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 76.83 43.2 18.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.462 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.489 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.275 0.537 . . . . 0.0 110.603 176.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' A' ' 125' ' ' PHE . 15.4 m -131.05 139.51 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -126.96 106.43 9.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 96' ' ' LEU . 13.9 tp -90.27 107.59 19.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.146 0.498 . . . . 0.0 110.121 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -84.79 107.43 16.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.552 178.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.5 mt -116.88 111.35 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.838 0.351 . . . . 0.0 110.498 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 23.9 t80 -81.44 137.04 35.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.546 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 53.9 t30 77.9 75.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.917 0.761 . . . . 0.0 111.71 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.88 148.73 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -113.1 164.58 13.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.207 0.527 . . . . 0.0 112.118 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 7.7 p -66.69 -25.35 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.078 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 5.0 t70 -73.57 -34.22 65.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 175.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -78.79 -19.28 52.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.497 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.615 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -54.69 -15.96 2.19 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.633 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.52 -130.98 0.98 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.726 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -94.95 121.4 36.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.073 0.463 . . . . 0.0 111.61 -177.082 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.3 m-85 -87.68 142.97 27.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.565 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.75 118.76 35.21 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.186 0.517 . . . . 0.0 111.026 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 37.1 t -100.45 120.67 40.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.195 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.19 121.09 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CD1' HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.68 137.23 52.28 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.33 -178.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.947 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 20.4 mtpt -121.29 111.71 17.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.677 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 14.8 t70 -101.91 111.84 24.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.99 -105.93 1.69 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.035 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.03 -7.92 9.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 28' ' ' PHE . 3.2 p90 -100.23 148.82 24.21 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.417 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.947 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 4.0 p90 -133.74 151.99 51.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.273 0.559 . . . . 0.0 112.017 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.765 ' HB3' HG23 ' A' ' 30' ' ' VAL . 1.6 mm-40 -128.89 156.83 43.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.8 174.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -133.53 142.57 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.392 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -129.09 133.65 47.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.056 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.98 107.91 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.81 0.338 . . . . 0.0 110.498 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.562 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 51.7 m -117.68 118.3 31.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.624 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -77.7 134.85 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.61 149.86 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -114.02 96.08 5.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.761 0.315 . . . . 0.0 110.745 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.1 mp -76.3 118.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.492 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.13 55.69 1.87 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.672 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.67 11.27 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.407 0.622 . . . . 0.0 110.124 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.4 OUTLIER -87.17 148.5 45.11 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.622 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 13.0 Cg_exo -71.17 -15.0 31.96 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.074 2.516 . . . . 0.0 112.034 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.642 ' HZ ' ' HB3' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -143.65 141.69 30.68 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 HG22 ' HG3' ' A' ' 132' ' ' GLU . 1.1 pp -139.09 178.38 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 110.956 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 134' ' ' HIS . 71.9 t -106.49 145.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.422 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.44 144.2 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.802 0.334 . . . . 0.0 110.452 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.62 60.95 4.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.736 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -135.79 109.74 8.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 4.3 mp0 -77.25 -49.13 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.8 91.4 0.17 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.52 95.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.553 2.835 . . . . 0.0 112.987 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.73 97.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.998 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.8 101.76 13.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.417 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 45' ' ' LEU . . . -111.21 170.81 7.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.633 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.0 m -130.56 141.36 50.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 128.08 35.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.31 -23.89 22.22 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.65 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.3 174.67 52.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.7 138.9 39.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -118.1 122.11 42.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.942 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.643 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 6.4 mt-10 -102.52 108.02 19.18 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 HD12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -95.3 128.38 42.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.328 -176.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.22 129.59 55.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.746 -174.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -138.26 140.11 39.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 131.52 52.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.922 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -111.35 165.0 12.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.367 -173.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -124.92 72.26 63.05 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.398 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 92.9 Cg_endo -91.3 155.88 3.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.215 2.61 . . . . 0.0 113.207 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 35.4 Cg_endo -92.55 14.51 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.413 2.742 . . . . 0.0 112.108 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -137.09 -173.03 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.725 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.24 -16.77 34.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.217 175.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 60.72 13.14 4.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.99 174.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.693 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 4.1 tm0? -56.34 -40.78 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 3.0 p80 -115.51 21.96 13.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.031 0.443 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -74.07 -173.52 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -177.14 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 77' ' ' ARG . 1.3 tt0 -103.81 118.21 36.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.965 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -127.3 123.89 62.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.0 111.92 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 123' ' ' CYS . 7.8 ttt85 -102.25 132.72 48.02 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.469 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -144.89 59.56 1.31 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -142.95 157.98 44.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.352 0.596 . . . . 0.0 111.864 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -141.29 109.79 5.97 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 165.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -165.28 107.43 0.8 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.669 -1.151 . . . . 0.0 107.922 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 113.69 25.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.185 0.517 . . . . 0.0 112.246 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.93 -155.57 0.15 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.922 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.4 63.86 2.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 111.903 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 53.72 70.14 1.9 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.24 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 73' ' ' VAL . 6.0 Cg_exo -77.73 -98.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.921 2.414 . . . . 0.0 111.357 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.438 ' H ' ' HB2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -64.15 143.95 15.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 173.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 2.0 m80 -120.64 -86.26 0.65 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -164.84 149.81 9.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.574 -173.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' A' ' 62' ' ' ILE . 29.5 t80 -95.95 118.32 32.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.725 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.664 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -132.12 137.71 47.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.113 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 59' ' ' HIS . 4.2 m-20 63.07 17.03 9.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.288 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 15.24 70.43 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.481 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -136.59 143.16 43.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 0.0 110.527 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 8.8 p-10 -85.88 137.78 32.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.74 155.91 24.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.042 -176.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -40.21 80.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.215 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.6 0.91 79.93 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.79 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -105.54 -43.18 5.01 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.595 -0.356 . . . . 0.0 110.22 178.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 27.67 84.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.461 1.101 . . . . 0.0 113.019 -178.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 94' ' ' THR . 16.1 tt -62.65 -11.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.557 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -12.34 58.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -13.9 14.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -78.37 7.37 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.13 -0.356 . . . . 0.0 110.751 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.0 33.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.332 0.653 . . . . 0.0 111.657 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -170.71 -164.16 0.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 178.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -79.46 143.02 35.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -139.62 104.04 4.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.953 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -114.88 108.21 16.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.532 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.72 109.8 18.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.945 0.403 . . . . 0.0 110.846 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.6 105.65 11.06 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -102.13 9.94 39.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.88 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -27.09 67.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.522 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.72 -16.75 65.11 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.172 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -33.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -170.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.55 -11.02 67.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.073 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 6.05 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.16 26.55 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.55 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.18 133.08 38.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.384 -0.48 . . . . 0.0 110.796 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.11 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.855 0.359 . . . . 0.0 110.557 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -126.19 105.92 9.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.151 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' HG ' HG13 ' A' ' 110' ' ' ILE . 13.8 tp -90.78 118.13 29.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.643 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -86.88 106.61 17.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.691 175.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.639 HD12 HD23 ' A' ' 47' ' ' LEU . 56.4 mt -111.37 121.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.516 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -82.25 136.03 35.14 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.5 t30 68.59 91.66 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.431 0.634 . . . . 0.0 111.621 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.7 p -79.5 120.71 31.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.4 150.3 24.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.736 -176.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.95 -22.57 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.23 -35.96 58.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.214 0.53 . . . . 0.0 109.818 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.09 5.52 46.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.73 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.34 -4.27 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.916 176.167 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -134.42 0.52 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.0 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -102.17 127.86 48.91 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.343 -0.504 . . . . 0.0 111.032 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.843 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 40.7 m-85 -82.93 151.94 25.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.07 110.41 18.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.783 0.325 . . . . 0.0 111.034 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.5 OUTLIER -98.6 117.15 32.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 133' ' ' GLU . 8.0 t -118.6 107.36 21.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.642 ' HB3' ' HZ ' ' A' ' 28' ' ' PHE . 2.7 t80 -99.26 133.67 43.22 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.777 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -121.53 110.82 16.49 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.12 72.05 5.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.97 -96.82 1.6 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.178 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.33 -27.32 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 111.311 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.509 ' HB2' ' HD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -94.48 143.31 26.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 52.4 p90 -146.88 151.08 36.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.49 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.648 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -147.53 143.68 27.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.685 ' HB3' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -112.71 144.96 41.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.145 0.498 . . . . 0.0 110.753 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 30' ' ' VAL . 52.0 t-80 -129.82 138.83 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.61 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -104.06 107.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.5 m -99.7 107.76 19.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.438 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -75.71 122.73 24.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 -178.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -96.18 150.71 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 110.82 12.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.302 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 113' ' ' VAL . 8.9 mt -76.77 102.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 110.436 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m 51.83 72.87 0.35 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.712 0.633 . . . . 0.0 111.073 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -26.82 7.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.021 0.439 . . . . 0.0 110.545 -172.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -106.38 116.45 59.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.752 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.14 -3.24 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.935 2.423 . . . . 0.0 112.552 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -153.71 136.66 15.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.1 pt -144.53 165.8 12.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.617 0.723 . . . . 0.0 112.062 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.556 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.0 t -97.6 149.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.182 171.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -67.07 150.59 48.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.85 63.41 3.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.264 -0.493 . . . . 0.0 113.344 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 tp -139.51 132.4 29.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -85.9 -31.7 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.262 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.59 90.51 0.8 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.807 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.16 80.55 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.808 2.339 . . . . 0.0 110.97 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.53 92.42 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -89.39 110.09 20.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.773 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.19 171.97 8.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.137 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.05 133.55 36.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 140' ' ' ILE . 3.1 tp -66.62 111.69 3.77 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.944 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.6 11.49 74.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.819 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.38 -152.01 9.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.919 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -87.45 134.25 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.413 . . . . 0.0 111.112 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -119.93 115.44 23.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.519 176.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.5 mt-10 -108.19 110.08 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 110.748 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.69 129.22 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.346 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.26 122.16 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.888 0.375 . . . . 0.0 110.632 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.66 140.02 50.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -120.1 130.1 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.109 0.481 . . . . 0.0 110.131 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.7 mm? -117.72 165.22 13.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.047 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.49 71.6 26.77 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 94.6 Cg_endo -89.48 154.61 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.013 2.475 . . . . 0.0 113.322 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.6 Cg_exo -70.44 -25.54 25.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.003 2.469 . . . . 0.0 111.964 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.21 -173.26 3.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.939 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -22.51 42.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 54.22 32.97 17.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -57.62 -32.0 66.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.791 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -115.46 28.96 8.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.866 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.935 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -91.73 -165.6 1.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.289 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.8 126.66 53.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 110.745 -178.347 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.466 HD13 HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -126.49 146.57 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.243 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.632 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 10.0 ttm180 -132.52 117.37 17.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.527 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -131.36 58.34 1.73 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CE1' HG13 ' A' ' 87' ' ' ILE . 59.4 m-85 -139.38 150.66 45.57 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.676 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -70.06 96.6 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.662 HD21 ' HB2' ' A' ' 71' ' ' GLU . 11.5 t-20 -129.95 125.34 35.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.31 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -84.53 129.92 34.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.753 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 65.42 -108.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.655 0.597 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -153.47 114.21 4.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.805 0.336 . . . . 0.0 110.577 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.662 ' HB2' HD21 ' A' ' 67' ' ' ASN . 1.1 mt-10 -114.12 123.89 31.85 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 25.6 Cg_exo -62.56 -44.32 18.24 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.968 2.445 . . . . 0.0 113.382 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.48 72.33 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.631 -172.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.5 105.71 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -178.69 151.55 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.228 0.537 . . . . 0.0 111.472 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.35 117.52 30.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -127.46 143.1 51.24 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.784 -172.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.62 17.51 10.62 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.827 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.5 83.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.057 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -139.66 177.15 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 111.285 -178.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -95.41 170.07 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.112 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.52 138.96 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.945 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.84 -4.7 36.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.649 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.62 -16.42 70.84 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.781 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.633 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -111.94 -40.96 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.244 -177.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.633 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 76.6 mt 49.15 87.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 112.235 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -74.22 -6.46 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -14.84 27.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 173.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -21.85 64.1 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.899 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.0 t80 -85.58 -69.05 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -162.63 145.69 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.228 173.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -72.53 -7.86 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.348 0.594 . . . . 0.0 110.206 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.721 ' HA ' HH11 ' A' ' 93' ' ' ARG . 2.3 mmm180 -97.19 69.32 2.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.158 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.673 HG21 HD12 ' A' ' 87' ' ' ILE . 21.3 m -131.41 103.97 6.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.634 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.75 106.93 17.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.611 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 108' ' ' LEU . 1.1 tp -91.17 100.62 13.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.878 0.37 . . . . 0.0 110.708 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 HD12 ' HB ' ' A' ' 107' ' ' THR . 30.3 mt -77.07 117.39 18.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.21 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.42 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 6.8 mtmm -108.12 15.4 24.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.645 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.81 -33.67 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.648 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.33 -16.68 70.87 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.037 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -29.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -21.35 59.62 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.155 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -117.21 4.1 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.759 0.314 . . . . 0.0 110.469 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.15 35.06 11.4 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.022 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.3 55.65 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.177 -0.602 . . . . 0.0 110.712 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.466 HG11 HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -128.34 132.89 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.853 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.478 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.29 110.48 16.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.805 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 96' ' ' LEU . 5.4 tp -98.41 119.56 37.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.794 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 2.6 mpp_? -96.12 106.71 18.93 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.483 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.605 ' HB ' HD23 ' A' ' 45' ' ' LEU . 69.1 mt -117.61 124.19 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.818 0.342 . . . . 0.0 110.132 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -94.19 132.12 39.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.858 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.478 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 36.9 t-20 75.54 80.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.024 0.827 . . . . 0.0 112.287 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.895 HG21 HD22 ' A' ' 45' ' ' LEU . 41.3 t -107.85 139.5 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.864 172.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.448 ' HA ' HD12 ' A' ' 41' ' ' LEU . 6.1 p -116.02 -173.71 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -24.6 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -168.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.29 -48.09 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.05 0.452 . . . . 0.0 110.534 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.407 ' OD2' HG13 ' A' ' 113' ' ' VAL . 7.2 p-10 -85.01 -6.61 59.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.626 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -68.92 -3.59 13.33 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 175.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.31 -99.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.0 -0.619 . . . . 0.0 114.066 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.09 128.01 41.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 111.21 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -90.48 151.5 21.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.307 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.86 108.72 20.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.036 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -101.11 117.91 35.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.329 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 23.1 t -134.03 131.92 55.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -122.43 122.67 39.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.19 104.45 11.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 110.312 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.935 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 58.0 t0 -92.74 83.39 4.83 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.9 -97.55 0.82 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.617 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.44 -5.19 13.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.588 0.232 . . . . 0.0 111.568 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.87 110.06 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.12 141.1 43.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.522 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.583 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -121.02 154.41 36.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 176.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -135.19 128.62 32.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.04 135.47 32.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.451 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.15 127.2 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.237 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.527 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -105.46 134.71 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.145 -176.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -92.41 115.85 28.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.61 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 16.3 t -96.29 141.64 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -131.13 95.42 3.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -73.47 127.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.175 0.512 . . . . 0.0 109.702 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.033 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.5 ' HG3' ' OG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.58 65.46 6.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.28 0.562 . . . . 0.0 111.208 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.5 ' OG ' ' HG3' ' A' ' 23' ' ' MET . 1.0 OUTLIER -130.29 19.44 5.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -103.6 130.02 24.29 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.304 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 4.0 Cg_exo -75.31 -166.83 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.1 2.534 . . . . 0.0 111.843 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.478 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -86.71 170.4 11.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.44 168.21 24.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.291 0.567 . . . . 0.0 111.789 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.67 148.59 11.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.375 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -93.31 160.75 14.68 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.08 43.71 2.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.581 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 tp -133.95 94.2 3.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.202 0.525 . . . . 0.0 110.051 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -102.24 -24.34 13.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.573 175.187 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 93.64 1.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.013 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 68.37 3.85 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.761 2.308 . . . . 0.0 110.118 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 130.04 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.719 -169.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -97.52 91.61 5.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.927 174.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.68 151.89 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.375 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.74 121.49 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -63.39 118.76 8.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 96.8 -2.74 62.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.181 -177.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.73 -165.27 24.28 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.324 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.45 115.97 22.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 tp -100.97 112.47 24.93 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.096 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.98 108.42 19.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.069 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.1 mt -95.94 128.76 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -122.23 122.27 38.74 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.044 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.17 140.13 50.24 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.4 131.32 56.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -126.44 157.05 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.06 -178.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.26 83.2 51.95 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.22 156.64 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.086 2.524 . . . . 0.0 112.843 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 97.5 Cg_endo -87.5 20.36 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.98 2.453 . . . . 0.0 112.091 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.49 -172.96 3.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.734 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -72.09 -19.11 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.127 0.267 . . . . 0.0 111.681 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 59.62 24.78 13.61 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.197 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -59.09 -40.85 86.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -89.09 18.7 4.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.379 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -49.65 132.54 21.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.229 0.538 . . . . 0.0 112.413 -175.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 75' ' ' LEU . 37.6 tt0 -96.0 101.02 12.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG12 ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -117.3 137.0 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.163 0.506 . . . . 0.0 111.521 -171.429 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.603 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -114.25 117.02 29.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.465 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -127.42 59.57 1.43 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.91 171.7 14.82 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.881 -165.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.59 164.15 12.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.688 164.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -159.81 155.36 25.67 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.695 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.1 mt -95.63 109.02 21.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.884 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.2 m-85 74.52 172.34 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 124.002 0.814 . . . . 0.0 111.099 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.04 92.63 5.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.087 0.47 . . . . 0.0 112.106 -176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.512 ' HB3' HG12 ' A' ' 73' ' ' VAL . 1.1 tm-20 -138.01 115.52 9.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.253 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 61.4 Cg_endo -73.82 45.08 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.82 2.346 . . . . 0.0 112.456 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 71' ' ' GLU . 12.2 p -108.22 49.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 122.151 0.977 . . . . 0.0 110.35 -177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -155.95 60.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.912 177.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -110.49 133.95 52.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.925 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 110.71 19.92 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 172.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -116.64 113.64 22.95 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.578 -174.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 t0 64.71 12.1 7.34 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.776 0.672 . . . . 0.0 111.166 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 2.76 58.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.919 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 133.27 47.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.962 0.41 . . . . 0.0 110.853 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -125.11 157.74 35.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.414 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 -172.8 2.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.709 0.29 . . . . 0.0 110.508 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -6.44 56.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.887 0.375 . . . . 0.0 111.575 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.88 -53.35 3.55 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.208 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.8 pm0 -90.65 12.94 17.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.904 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' A' ' 89' ' ' LYS . 3.1 tt -36.89 114.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.235 0 O-C-N 124.619 1.2 . . . . 0.0 110.903 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.558 HG12 HG21 ' A' ' 94' ' ' THR . 11.4 tt -71.77 -18.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.21 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -15.14 63.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 0.0 110.106 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.757 ' HB2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -81.58 -18.0 46.34 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.423 0.63 . . . . 0.0 109.556 177.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -82.19 -55.72 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.092 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.892 HG12 HG23 ' A' ' 94' ' ' THR . 0.3 OUTLIER -161.13 155.2 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.148 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.65 -58.08 10.13 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.2 0.312 . . . . 0.0 111.735 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.757 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 6.7 tpp85 -91.95 84.37 5.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.206 0.526 . . . . 0.0 110.969 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.892 HG23 HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -115.76 136.39 53.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.654 178.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -145.56 134.6 22.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.454 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -101.7 108.34 19.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.808 0.337 . . . . 0.0 110.247 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -75.85 106.88 7.67 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.44 2.65 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.374 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -51.61 -38.86 56.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.023 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.63 67.84 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.74 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -35.8 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -168.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.06 -6.0 50.66 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.511 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.83 1.69 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.057 0.456 . . . . 0.0 109.913 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.58 42.9 9.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.004 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 132.79 38.45 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.162 -0.611 . . . . 0.0 110.573 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 m -123.74 133.25 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.405 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.61 103.37 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 96' ' ' LEU . 20.2 tp -86.12 118.07 25.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.46 107.24 19.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.053 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HG ' ' A' ' 108' ' ' LEU . 86.9 mt -115.53 109.39 28.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.757 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 30.0 t80 -80.87 122.89 27.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.903 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 42.7 t30 79.57 75.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.182 0.926 . . . . 0.0 110.791 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.87 140.11 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.878 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.5 p -103.68 163.4 12.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.516 0.674 . . . . 0.0 112.159 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.684 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -69.59 -14.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.219 177.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -75.29 -24.16 57.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.566 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.69 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 42.7 m-20 -103.45 -10.64 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.723 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.833 ' HB2' HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.05 6.63 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.85 -128.68 6.37 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.081 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.52 117.75 30.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.763 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.69 ' HE1' ' HB3' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -87.52 157.91 19.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.38 118.83 32.23 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.619 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.6 t -105.46 116.52 32.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.842 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.603 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 6.2 t -123.89 111.26 28.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.533 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 1.4 m-85 -97.38 123.62 41.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.758 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 12.9 mtpt -132.88 136.47 46.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.544 0.688 . . . . 0.0 111.759 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.3 76.51 1.7 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.684 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.99 -98.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.771 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 -27.4 20.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.485 0.184 . . . . 0.0 111.472 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -75.3 132.55 41.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.424 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 12.6 p90 -151.23 141.08 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 151.46 47.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.639 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.56 51.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.77 137.7 21.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.897 0.379 . . . . 0.0 111.15 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.26 46.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.325 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.441 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -112.56 157.12 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.149 -178.272 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 122.66 45.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.38 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 74.2 t -102.62 113.25 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 3.1 mmmm -97.76 108.24 20.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.841 0.353 . . . . 0.0 110.066 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.833 HG12 ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -76.81 129.46 37.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.397 0.617 . . . . 0.0 111.225 -176.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.452 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ttp . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.607 0.242 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.1 m -60.62 134.53 57.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.578 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.2 24.73 2.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.923 0.868 . . . . 0.0 109.325 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.51 127.56 52.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.649 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.7 -11.52 11.47 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.732 2.288 . . . . 0.0 111.925 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -164.7 147.44 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -143.62 175.38 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.303 -173.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.13 144.36 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.954 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.09 139.31 56.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.731 0.3 . . . . 0.0 110.394 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.37 0.35 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.933 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.26 155.22 42.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.27 -49.4 19.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 66.61 1.77 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.476 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.06 88.11 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.37 2.046 . . . . 0.0 111.791 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 t -75.35 92.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.26 98.83 10.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.153 0.501 . . . . 0.0 110.176 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 113' ' ' VAL . . . -109.37 158.09 18.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.604 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -112.66 129.42 56.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -57.27 125.93 24.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.1 -22.57 22.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.538 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -172.62 41.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.127 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 2.9 p-10 -79.26 125.86 30.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.275 0.559 . . . . 0.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -97.58 123.13 41.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.418 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 112.4 24.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.999 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 45' ' ' LEU . 1.2 mt -96.42 128.71 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 124.71 52.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -130.35 143.4 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.489 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -132.24 131.03 41.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.56 166.14 19.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.536 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -97.51 97.87 4.46 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 85.2 Cg_endo -85.16 130.13 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.779 2.319 . . . . 0.0 113.754 -171.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 16.4 Cg_exo -68.65 -37.55 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.753 2.302 . . . . 0.0 110.744 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 5.3 pt20 -133.91 -172.33 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.876 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.659 ' HG2' ' H ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -69.02 -29.95 68.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.678 0.275 . . . . 0.0 111.339 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 55.49 26.28 8.79 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.426 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.659 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -62.15 -25.44 67.75 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -113.48 18.94 17.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.864 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -88.42 -166.3 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -176.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 1.3 mt-10 -116.66 131.99 56.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.697 0.284 . . . . 0.0 110.678 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 147.46 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.139 0.495 . . . . 0.0 110.384 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.764 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -128.59 117.45 21.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.047 178.123 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.516 ' NE1' ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -126.17 59.35 1.33 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 63' ' ' ARG . 83.2 m-85 -136.6 159.44 41.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.338 0.59 . . . . 0.0 112.422 -164.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HD2' ' HA ' ' A' ' 117' ' ' ASP . 9.7 ttp180 -80.84 149.02 29.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.138 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -133.51 132.17 40.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.449 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.87 134.16 55.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 58.89 -102.07 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.571 0.544 . . . . 0.0 109.641 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -156.45 94.92 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.188 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -129.43 87.37 53.47 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.11 54.73 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.231 2.62 . . . . 0.0 112.112 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.1 -2.86 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.4 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -95.6 128.41 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -176.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 147.48 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.05 0.452 . . . . 0.0 111.067 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.63 112.11 23.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -105.19 122.38 45.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.68 20.01 8.69 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.571 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.43 9.1 76.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.285 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.68 156.14 24.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.46 148.74 21.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.943 0.402 . . . . 0.0 110.352 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.26 156.59 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.653 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -25.38 67.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.71 -25.97 47.92 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.179 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.67 -43.28 17.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.5 tp 39.77 82.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.605 1.19 . . . . 0.0 112.51 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 94' ' ' THR . 29.0 pt -68.52 -1.8 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.212 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -14.91 60.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 173.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -41.31 78.87 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.836 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG12 ' A' ' 91' ' ' VAL . 38.9 m-85 -81.42 -49.55 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 73.22 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.34 1.025 . . . . 0.0 112.482 174.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER 73.35 -125.49 0.04 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.668 175.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HA ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -95.63 96.51 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 -176.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -110.54 114.19 27.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 177.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -145.69 123.56 11.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.568 HD22 ' HD2' ' A' ' 76' ' ' TYR . 12.2 tp -92.59 112.85 24.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.0 110.359 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -74.18 105.48 5.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.6 4.8 50.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.919 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.99 -34.62 57.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.501 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.55 -16.69 65.63 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.945 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -51.32 -38.5 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -167.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.02 -11.14 60.48 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.751 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -116.22 1.15 13.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.52 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.11 34.5 12.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.931 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.639 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -124.55 140.14 53.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.875 0.338 . . . . 0.0 110.613 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.43 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 175.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -125.24 104.55 8.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.242 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 64' ' ' TRP . 5.7 tp -87.84 115.11 25.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 0.0 110.456 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -93.99 107.42 19.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.86 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 108' ' ' LEU . 1.9 mt -122.35 114.38 42.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -72.74 146.12 46.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.159 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 7.0 t30 75.1 89.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.131 0 O-C-N 123.922 0.764 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.432 HG11 ' HB1' ' A' ' 39' ' ' ALA . 4.1 p -107.21 145.11 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 175.48 8.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 41' ' ' LEU . 43.6 t -60.29 -26.34 36.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.282 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -30.2 71.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.474 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 119' ' ' GLY . 15.4 m-20 -93.02 -14.01 27.93 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.05 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.051 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -118.23 -128.62 3.94 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.98 130.4 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.323 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.479 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.5 m-85 -104.28 141.88 35.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.23 120.22 39.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.148 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -98.82 125.11 44.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.403 174.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.764 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 3.6 t -134.32 134.04 55.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 43.0 m-85 -124.61 120.35 31.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.701 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.1 mtpm? -111.16 106.21 15.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.168 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.864 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 49.3 t0 -114.88 114.24 25.24 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.713 0.633 . . . . 0.0 109.754 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.87 -104.06 1.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.962 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -117.4 -10.26 10.74 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.64 154.32 21.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 -176.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.525 ' HD2' HG13 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -143.63 146.95 33.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 0.0 111.413 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.984 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -126.2 160.81 29.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.321 177.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.49 150.85 45.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.522 . . . . 0.0 111.515 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -147.2 132.87 18.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.036 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -89.21 116.33 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.483 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -116.2 134.55 54.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.247 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.87 139.66 30.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.201 0.525 . . . . 0.0 111.895 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.8 t -106.1 132.13 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.568 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -117.54 106.8 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.388 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 41' ' ' LEU . 1.5 mp -73.6 119.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.187 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.055 0.455 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.48 123.41 19.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -0.65 13.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.878 0.847 . . . . 0.0 109.247 -174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -88.45 113.52 55.77 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.255 -1.338 . . . . 0.0 110.769 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.57 7.22 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.988 2.459 . . . . 0.0 111.481 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -146.93 139.35 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.354 -177.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.86 159.3 9.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.999 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.27 134.33 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.945 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 140.88 48.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.542 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.18 -126.36 7.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.518 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.8 177.69 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 mp0 -70.46 -33.9 71.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.127 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.79 75.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.979 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.28 70.37 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.001 2.468 . . . . 0.0 111.36 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.53 106.92 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.182 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -98.75 147.94 24.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -137.3 171.71 14.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.23 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.2 121.0 36.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.091 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.85 128.38 36.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 83.62 -14.54 41.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.764 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.74 -156.84 27.54 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.976 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.99 130.97 35.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.004 0.43 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 110' ' ' ILE . 1.2 tp -110.01 110.36 21.25 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -114.01 114.66 26.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 -178.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 45' ' ' LEU . 1.2 mm? -100.69 128.74 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.362 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.2 121.28 44.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.76 141.07 51.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -134.13 140.82 46.83 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.122 0.487 . . . . 0.0 110.988 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD23 ' CD1' ' A' ' 125' ' ' PHE . 1.2 pp -127.58 161.68 28.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.179 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 1.6 m -82.18 109.05 13.55 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 8.2 Cg_exo -70.53 112.45 3.22 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.255 2.637 . . . . 0.0 114.271 -167.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 52' ' ' SER . 88.9 Cg_endo -90.94 -8.59 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.95 2.434 . . . . 0.0 110.405 168.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -158.41 -172.17 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.426 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -9.11 58.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.75 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 70.63 -1.85 2.44 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.466 0.706 . . . . 0.0 112.877 173.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -65.66 -18.06 65.05 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.047 0.451 . . . . 0.0 111.255 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.64 6.93 22.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.07 155.21 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.311 0.577 . . . . 0.0 112.101 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.026 ' HG2' HD13 ' A' ' 75' ' ' LEU . 11.1 mt-10 -80.02 107.8 13.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.206 172.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.39 140.79 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.361 0.601 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 1.051 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 1.6 ttp180 -131.81 131.63 43.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.302 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.534 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -147.77 57.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HB2' HD21 ' A' ' 67' ' ' ASN . 62.6 m-85 -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.307 -170.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 98.55 7.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 65' ' ' PHE . 1.7 p30 -158.33 144.94 17.46 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.42 161.29 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.413 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.18 56.2 1.78 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 123.487 0.492 . . . . 0.0 110.595 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.93 74.43 5.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.757 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 mt-10 -72.57 -54.29 5.22 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.038 172.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 71' ' ' GLU . 1.5 Cg_endo -85.27 115.2 1.62 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.516 2.144 . . . . 0.0 111.06 172.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 22.9 m-70 -141.39 136.64 31.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.444 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -155.64 151.08 27.03 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -164.688 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.0 111.81 24.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -147.49 153.51 39.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.523 -172.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.64 ' N ' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 64.32 26.06 13.58 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.574 0.546 . . . . 0.0 109.867 175.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.57 73.5 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.963 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -142.51 151.28 41.49 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.115 0.484 . . . . 0.0 111.727 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.71 154.49 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.616 171.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.54 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 23.1 mtp -114.5 -160.04 0.72 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.802 0.334 . . . . 0.0 111.677 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' H ' ' HB3' ' A' ' 82' ' ' MET . 25.7 p90 -72.66 -36.41 67.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.654 ' HA3' ' CE1' ' A' ' 74' ' ' HIS . . . -85.04 -44.05 6.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.504 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 1.6 pm0 -87.45 17.91 4.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.441 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.95 108.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.787 0.804 . . . . 0.0 110.421 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 108' ' ' LEU . 9.3 tt -70.0 -16.73 20.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.744 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -12.84 61.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -60.03 -20.57 58.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.335 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -76.11 0.39 19.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 t 57.16 39.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.419 0.688 . . . . 0.0 112.028 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -168.67 177.56 5.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.864 176.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HG3' ' HB2' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -72.34 141.95 48.79 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.209 0.528 . . . . 0.0 110.813 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.665 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -137.51 141.68 41.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.783 -177.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -136.49 104.25 5.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.776 177.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -78.23 90.28 4.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' A' ' 107' ' ' THR . 20.6 mt -68.81 120.51 14.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.183 0.516 . . . . 0.0 110.894 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 8.99 27.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.858 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.52 -33.69 70.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.47 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.23 -16.66 64.21 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.178 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 57' ' ' ALA . 2.3 tt -54.05 -36.26 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -167.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.92 70.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.104 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.99 2.24 37.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.205 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.01 19.85 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.322 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.66 133.2 53.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.419 0.61 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.99 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 122.237 -0.29 . . . . 0.0 110.27 176.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.539 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.11 107.86 13.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 111.282 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.549 HD13 HD12 ' A' ' 96' ' ' LEU . 45.1 tp -88.33 112.76 23.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.815 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -92.71 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.289 176.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.665 HG12 HG23 ' A' ' 94' ' ' THR . 57.3 mt -116.49 124.63 72.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 1.5 t80 -76.57 124.96 28.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.185 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 54.8 t30 77.04 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.158 0.911 . . . . 0.0 112.053 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 140' ' ' ILE . 11.5 p -133.95 141.52 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.24 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -123.16 174.69 7.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.12 -11.86 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.021 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.64 -24.34 41.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -101.74 -9.97 20.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 140' ' ' ILE . 36.4 t70 -68.46 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.797 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -127.68 -126.54 2.91 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.822 -177.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -77.4 114.8 16.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -174.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -110.31 128.03 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.51 175.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 118.82 37.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.209 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.7 t -105.46 140.3 38.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.635 175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 1.9 t -144.43 132.55 17.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.213 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -120.3 115.45 23.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.336 176.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.619 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.7 mtpm? -130.66 102.26 6.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.845 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -91.74 71.35 5.76 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.56 -107.33 2.29 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.11 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.33 -19.97 27.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.946 0.403 . . . . 0.0 110.429 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' LYS . 21.7 m-85 -68.82 94.37 0.61 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.619 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -120.44 137.81 54.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.2 0.524 . . . . 0.0 111.96 -172.055 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.89 135.2 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.415 171.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -122.7 137.73 54.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.349 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.35 146.95 37.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.219 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 120' ' ' SER . 1.1 tp -123.14 113.21 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.646 0.736 . . . . 0.0 110.452 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 159.71 18.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.273 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.48 129.11 53.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.22 129.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.66 97.82 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.074 0.464 . . . . 0.0 110.863 -177.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 118' ' ' ASP . 33.8 mt -67.85 114.59 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.437 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 121.216 0.423 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 1.1 p90 -157.85 146.88 19.52 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.68 178.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.924 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.44 148.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.816 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 151.84 41.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.764 0.316 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.03 -127.74 9.33 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.56 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.35 178.76 6.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.07 74.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 119.27 84.23 0.89 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.712 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.05 81.62 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.75 2.3 . . . . 0.0 111.002 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -85.25 127.69 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.44 142.3 35.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.46 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.19 172.09 16.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.476 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.69 140.02 51.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.55 133.76 56.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.933 0.397 . . . . 0.0 111.107 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.75 -16.42 8.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.918 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.74 -148.8 15.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.182 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -101.31 130.76 47.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.728 HD13 HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -104.3 110.98 23.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.305 175.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.71 106.11 18.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 0.0 109.89 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 108' ' ' LEU . 1.5 mm? -94.09 128.09 40.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.65 122.12 37.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.541 ' HB3' ' HE2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -126.83 141.12 51.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.461 176.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.627 ' HG3' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -115.15 130.71 56.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -127.79 154.7 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.07 0.462 . . . . 0.0 110.843 -178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -125.15 83.66 60.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.951 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -93.99 164.39 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.511 2.807 . . . . 0.0 112.987 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.83 -14.85 10.99 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.765 2.31 . . . . 0.0 111.875 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -116.5 -172.84 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.115 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.5 ' NE2' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.3 -11.63 48.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 110.432 178.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 68.06 7.72 6.03 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.072 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 1.5 tm0? -58.22 -46.74 85.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.182 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.44 5.08 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.06 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -80.31 166.22 21.55 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -176.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 77' ' ' ARG . 3.1 mt-10 -105.29 142.8 34.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.59 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 64' ' ' TRP . 2.7 tt -137.37 144.49 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.162 0.506 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -127.86 116.76 20.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -130.74 58.1 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -170.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.5 170.51 18.43 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.638 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 117' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.47 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 85' ' ' GLU . 2.4 m170 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.365 0.126 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 61' ' ' GLU . 6.1 tp 176.1 127.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.973 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.12 138.24 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.553 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -137.49 139.62 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -163.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.0 t0 66.82 0.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.437 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.38 4.19 57.37 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 140.92 41.21 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.437 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 169.71 17.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.769 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.923 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 2.6 ttt -132.47 120.89 22.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.966 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.28 -40.57 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.87 80.84 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.93 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -93.96 -25.98 17.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 42.37 68.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.852 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 94' ' ' THR . 6.5 tp -66.06 -12.29 14.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.267 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -13.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -62.77 -35.21 79.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.834 0.349 . . . . 0.0 110.609 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 21.79 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 54.8 -149.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.441 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.46 28.28 4.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.354 0.597 . . . . 0.0 110.645 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -100.49 35.57 2.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.475 -178.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.652 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -120.41 126.12 49.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.922 -175.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -136.33 99.89 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -88.24 100.1 12.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.238 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.11 99.93 0.72 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.885 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.05 -7.65 26.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.159 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -30.83 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.497 0.665 . . . . 0.0 109.99 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.26 -17.87 79.68 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.98 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.517 HG12 ' HB3' ' A' ' 57' ' ' ALA . 3.6 tt -61.03 -29.81 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -171.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.53 -15.6 70.86 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.395 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 -4.58 28.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.944 0.402 . . . . 0.0 109.982 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . 89.83 20.72 42.33 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.945 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.627 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -130.28 132.54 45.96 Favored 'General case' 0 C--O 1.22 -0.477 0 O-C-N 122.507 -0.408 . . . . 0.0 111.11 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.436 HG11 HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -119.66 132.28 69.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 121.763 -0.586 . . . . 0.0 109.75 174.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -125.25 103.17 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 0.0 111.5 -176.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 47' ' ' LEU . 2.0 tp -91.69 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.802 0.334 . . . . 0.0 110.621 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 106.31 18.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -111.14 131.33 62.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -96.3 137.56 35.19 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.904 -176.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 40.4 t30 76.05 74.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.513 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.98 146.97 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.79 168.45 13.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.525 0.202 . . . . 0.0 111.325 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -77.39 -8.15 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.146 0.498 . . . . 0.0 111.643 -173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -35.3 12.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -72.76 -25.4 61.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.53 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HA ' ' HB ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -78.11 24.3 0.25 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.87 -108.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.428 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.87 116.2 23.25 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.393 -0.475 . . . . 0.0 109.898 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -74.37 141.1 45.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.925 178.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.11 105.65 17.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.403 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.7 t -98.68 117.22 32.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.05 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 53.0 t -132.33 124.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.676 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -110.34 135.91 50.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.97 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -123.75 104.8 9.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.444 . . . . 0.0 110.622 178.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.699 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 19.7 t70 -93.07 81.86 4.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.147 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.75 -100.83 0.58 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.694 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -95.75 -10.99 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -93.07 154.92 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.607 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 50.8 p90 -151.26 146.73 26.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.89 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 1.9 mm-40 -139.71 160.37 40.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.885 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG22 ' A' ' 124' ' ' VAL . 2.1 mt-10 -126.46 154.24 43.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -173.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 140.71 14.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.515 HG13 ' H ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -108.48 107.14 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.615 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.3 OUTLIER -95.04 102.03 13.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.055 -176.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.3 116.71 13.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 118' ' ' ASP . 1.3 t -86.53 150.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.164 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.02 112.57 8.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.182 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.33 110.66 11.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.889 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.946 0.311 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.71 149.18 28.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.905 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -143.15 170.63 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.71 HG23 ' HB3' ' A' ' 132' ' ' GLU . 84.9 t -96.88 147.89 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.182 175.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.13 136.6 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.55 78.52 1.16 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.582 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -135.41 115.89 13.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -77.19 -44.77 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.07 111.59 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.716 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.63 62.55 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.53 2.154 . . . . 0.0 110.332 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.36 104.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.953 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 139' ' ' LYS . 1.2 mt -93.99 123.1 37.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.426 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.69 167.15 15.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.634 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.35 139.95 46.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD12 HG21 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -63.06 126.39 27.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.933 0.397 . . . . 0.0 110.621 -177.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 85.98 -9.78 67.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.993 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.76 -164.78 39.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.2 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.74 133.01 48.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.49 115.53 24.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.385 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.3 mt-10 -99.42 112.95 25.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.01 0.433 . . . . 0.0 110.004 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 121' ' ' TYR . 10.3 mt -95.6 128.07 42.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.269 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.8 OUTLIER -123.99 123.05 39.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.36 -179.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.707 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -117.55 140.42 49.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -128.7 134.15 48.39 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.164 0.29 . . . . 0.0 111.062 -173.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.32 164.85 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -80.56 104.94 3.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 7.4 Cg_exo -72.15 114.81 4.09 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.143 2.562 . . . . 0.0 113.551 -170.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 52' ' ' SER . 98.8 Cg_endo -87.89 -13.24 3.96 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 111.067 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -171.5 3.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.478 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.475 ' HG3' ' OE1' ' A' ' 58' ' ' GLN . 4.8 pm0 -68.02 -7.75 31.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.484 0.183 . . . . 0.0 111.479 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 75.51 -33.77 0.24 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HA ' HD13 ' A' ' 101' ' ' ILE . 10.1 pt20 -51.74 -39.79 59.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.413 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -83.93 15.02 3.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.562 -173.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ptm -92.9 160.87 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.733 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 75' ' ' LEU . 71.9 mt-10 -87.2 131.22 34.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -132.26 135.57 57.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.049 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.521 HH11 ' HB2' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -119.15 117.58 29.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.872 172.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.441 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -126.3 63.8 1.25 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' HE1' HG13 ' A' ' 87' ' ' ILE . 89.5 m-85 -148.93 154.71 39.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.611 -170.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.641 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.213 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 61' ' ' GLU . 1.5 tp -113.08 130.81 56.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HE2' ' HD2' ' A' ' 98' ' ' LYS . 52.5 t80 -126.24 152.85 45.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 59' ' ' HIS . 20.8 ttp85 -141.96 143.33 33.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.04 113.2 4.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.328 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 122.45 16.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.401 0.62 . . . . 0.0 111.141 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.99 161.32 30.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.949 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -167.59 163.03 14.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.759 0.314 . . . . 0.0 110.622 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -12.04 61.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.981 0.419 . . . . 0.0 110.63 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.05 -35.87 79.51 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.029 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -76.68 -41.24 46.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.18 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 tp 21.54 72.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 124.754 1.283 . . . . 0.0 112.373 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.923 HG12 ' HB ' ' A' ' 94' ' ' THR . 14.9 tt -58.8 -23.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.235 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -13.72 59.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.956 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.93 -17.98 60.47 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.815 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.59 ' HD2' HG23 ' A' ' 91' ' ' VAL . 13.1 t80 -64.71 -71.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.086 -0.245 . . . . 0.0 110.706 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 ' HD2' ' A' ' 90' ' ' TYR . 97.0 t -134.84 -67.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.675 0.274 . . . . 0.0 110.817 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -168.98 -63.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.197 0.522 . . . . 0.0 110.25 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.745 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -101.0 98.61 9.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.921 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.923 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -130.58 115.05 16.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.536 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -126.7 133.65 50.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.81 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.542 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -102.81 104.53 14.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.97 0.414 . . . . 0.0 110.603 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.52 121.74 25.59 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.756 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -107.87 -4.71 17.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.413 -172.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -62.73 -35.81 80.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 110.959 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.41 -17.79 74.72 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 58' ' ' GLN . 1.2 tt -62.09 -26.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 122.718 -0.283 . . . . 0.0 111.457 -173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.26 -17.37 63.78 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.801 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.63 5.65 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.229 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 89.23 23.66 33.94 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.123 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.5 OUTLIER -128.72 133.62 48.21 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 117.54 0.67 . . . . 0.0 111.475 -178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -115.04 132.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 O-C-N 121.761 -0.587 . . . . 0.0 109.629 175.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -114.12 103.26 10.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.187 0.518 . . . . 0.0 111.512 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.542 HD13 HD12 ' A' ' 96' ' ' LEU . 22.9 tp -93.56 111.22 22.85 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.182 0.515 . . . . 0.0 110.264 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -88.08 107.41 18.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.807 178.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.528 HG13 ' HG ' ' A' ' 108' ' ' LEU . 63.5 mt -110.92 127.3 68.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.922 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.745 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -106.23 143.14 34.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.596 0.236 . . . . 0.0 110.832 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m120 68.35 55.72 0.51 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.636 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.88 152.2 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.39 152.39 39.08 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 112.39 -173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.97 -17.45 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.212 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.47 -38.75 71.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.885 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -96.92 7.74 45.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.226 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.477 ' HA ' HG13 ' A' ' 138' ' ' VAL . 17.2 t70 -55.55 24.88 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 0.0 113.351 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -97.65 -132.66 7.58 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 120.788 -1.195 . . . . 0.0 112.194 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 127.57 43.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.443 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.714 ' CE2' ' HB ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -90.19 161.84 15.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.598 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -103.02 119.06 38.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.623 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -102.34 116.11 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.692 HG22 ' HG3' ' A' ' 133' ' ' GLU . 16.2 t -129.56 117.47 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.265 -176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 17.4 m-30 -107.61 128.68 54.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.8 mtpt -122.55 104.9 9.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 6.2 t70 -91.63 73.94 5.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.525 0.678 . . . . 0.0 109.714 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.29 -83.05 1.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.96 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -116.82 -27.7 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.524 0.202 . . . . 0.0 111.457 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -89.67 125.78 35.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -126.32 150.56 48.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.905 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -132.12 145.38 51.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.877 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.692 ' HG3' HG22 ' A' ' 124' ' ' VAL . 33.9 tt0 -132.35 126.39 33.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.388 . . . . 0.0 110.708 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -129.6 143.72 50.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.333 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -102.39 113.89 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.182 0.515 . . . . 0.0 110.191 176.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.635 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -105.65 147.23 28.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.726 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 150.35 28.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.828 0.347 . . . . 0.0 111.655 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.714 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 14.1 p -122.74 131.28 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.53 ' HB3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.97 103.75 11.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.795 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.607 HG21 HD12 ' A' ' 41' ' ' LEU . 1.4 mp -73.41 124.51 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.444 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.611 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 CA-C-O 121.104 0.377 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -136.45 134.8 38.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.104 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.5 OUTLIER -150.47 161.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.373 0.42 . . . . 0.0 110.175 174.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 51' ' ' LEU . 75.5 t -92.31 145.07 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.491 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.5 t-20 -67.94 162.5 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.85 62.95 2.41 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.294 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 122.78 19.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -83.75 -48.73 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' H ' ' HD3' ' A' ' 36' ' ' PRO . . . 106.55 72.35 0.81 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.397 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HD3' ' H ' ' A' ' 35' ' ' GLY . 5.3 Cg_exo -78.98 72.48 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.753 2.302 . . . . 0.0 110.919 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.89 103.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.74 139.39 33.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.45 171.39 14.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.774 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.62 154.25 28.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -69.6 130.48 42.54 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.451 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.64 8.62 86.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.205 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.97 -158.73 32.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.016 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -102.65 130.21 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.178 0.513 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 113' ' ' VAL . 8.6 tp -116.24 110.6 18.99 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.918 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tt0 -105.96 110.54 22.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 4.7 mt -95.8 128.43 42.67 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.67 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -121.55 125.4 46.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.583 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.3 140.23 50.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.85 130.83 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.103 0.477 . . . . 0.0 111.426 -172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.23 165.56 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.627 -176.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.558 ' H ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -117.54 82.41 15.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.714 169.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 28' ' ' PHE . 97.8 Cg_endo -89.86 141.83 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.027 2.485 . . . . 0.0 113.082 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.27 1.24 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.632 2.221 . . . . 0.0 112.646 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -151.97 -174.44 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.257 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -76.88 -18.55 58.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.272 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 61.45 34.97 17.89 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 170.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -64.6 -36.84 85.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.378 0.608 . . . . 0.0 109.56 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.625 ' HA ' ' OD1' ' A' ' 78' ' ' ASP . 49.9 t-80 -79.92 -2.67 44.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.094 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 3.9 ttm -69.47 141.48 53.97 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.03 0.443 . . . . 0.0 111.396 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CD ' ' HD3' ' A' ' 126' ' ' LYS . 2.7 tt0 -97.81 116.95 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.927 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -116.44 147.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.338 0.589 . . . . 0.0 111.21 -174.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.738 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -128.56 137.22 51.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.241 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.446 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -151.81 42.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 30.6 m-85 -134.18 158.39 43.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.176 -168.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.032 0.444 . . . . 0.0 110.308 177.858 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 1.2 m-70 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.228 0.537 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -161.9 136.22 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.345 -171.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -103.37 109.28 20.85 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.587 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -116.52 130.18 56.6 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.486 -168.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' ' HA ' ' A' ' 59' ' ' HIS . 16.4 t0 58.41 20.22 7.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.353 0.597 . . . . 0.0 111.684 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 22.93 58.25 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.885 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.51 139.18 50.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 110.815 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.81 169.98 17.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.176 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.27 135.11 49.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.924 0.393 . . . . 0.0 110.697 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.5 -2.43 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.073 0.464 . . . . 0.0 110.981 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.46 -18.89 63.22 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -108.83 -40.73 4.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.542 0.21 . . . . 0.0 110.6 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 31.5 mm 65.86 85.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.698 0.761 . . . . 0.0 111.435 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 94' ' ' THR . 2.1 tp -67.8 -20.54 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 0.0 109.692 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -14.02 7.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.696 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -69.44 -22.52 63.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 178.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 91' ' ' VAL . 2.4 m-85 -74.88 -36.93 62.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.504 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.722 HG13 ' HG2' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 65.65 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.796 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.722 ' HG2' HG13 ' A' ' 91' ' ' VAL . 5.9 mm-40 66.25 -151.11 0.22 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.911 0.484 . . . . 0.0 110.416 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.47 109.28 22.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.156 0.503 . . . . 0.0 110.991 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 HD11 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -115.77 95.36 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.524 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 4.7 tp10 -104.63 108.15 19.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.959 0.409 . . . . 0.0 110.675 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -91.96 96.48 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.13 105.33 3.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -102.85 -8.71 20.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.952 -175.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.56 -39.75 61.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.524 ' HA2' ' OE2' ' A' ' 103' ' ' GLU . . . -62.77 -18.66 59.72 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.543 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER -58.61 -25.8 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 117.16 0.48 . . . . 0.0 111.833 -174.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 56' ' ' GLN . . . -63.9 -23.39 67.46 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.561 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.524 ' OE2' ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -105.84 -5.17 19.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.21 42.79 6.12 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.872 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.77 132.6 34.98 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.293 -0.533 . . . . 0.0 110.585 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.573 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 14.0 m -121.67 133.18 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.03 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -120.87 103.46 9.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 64' ' ' TRP . 35.2 tp -92.86 110.25 21.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.476 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -88.95 105.79 17.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.35 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.667 HG12 HG23 ' A' ' 94' ' ' THR . 12.5 mt -112.46 119.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -94.55 140.08 30.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 74.26 67.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.056 0.848 . . . . 0.0 111.134 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -62.02 133.36 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.994 174.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.77 149.44 24.48 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 41' ' ' LEU . 7.9 p -67.59 -22.45 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.717 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -75.03 -37.07 61.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -89.74 2.26 55.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.5 t0 -58.47 27.09 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.94 0.896 . . . . 0.0 112.913 168.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -104.86 -147.43 16.4 Favored Glycine 0 N--CA 1.448 -0.539 0 O-C-N 121.399 -0.813 . . . . 0.0 112.29 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.808 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -100.96 120.3 39.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.7 0.286 . . . . 0.0 110.834 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.81 146.24 35.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 110.894 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 86.4 t60 -99.6 103.45 15.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.336 -177.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 46.7 t -106.0 130.88 53.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.738 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 23.2 t -144.56 137.29 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 17.0 m-85 -115.62 110.97 19.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.611 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -118.01 105.25 11.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 0.0 111.223 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 19.3 t0 -112.77 99.86 8.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 0.0 109.988 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.35 -103.6 2.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.233 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -112.57 -24.6 9.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.463 0.173 . . . . 0.0 111.274 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.74 129.66 36.63 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.788 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 23.5 p90 -137.4 127.77 26.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.283 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -112.34 136.36 51.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.942 177.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -110.1 146.87 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.857 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.508 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 7.1 t-80 -149.16 127.1 11.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.15 110.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.912 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 53.4 m -122.11 111.96 17.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.247 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.6 pt-20 -88.25 150.22 23.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.306 0.574 . . . . 0.0 111.867 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.52 151.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.42 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -122.49 90.83 3.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.923 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.529 HG21 HD12 ' A' ' 41' ' ' LEU . 19.5 mt -76.66 107.32 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.516 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.463 -0.294 0 CA-C-O 121.028 0.345 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.591 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 4.9 p90 -78.58 164.94 24.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.787 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -128.63 173.85 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 111.673 -176.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.615 HG22 ' HE2' ' A' ' 125' ' ' PHE . 82.6 t -89.87 142.26 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.241 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.46 175.62 5.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.709 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.05 -113.47 3.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.772 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.48 176.87 9.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.73 -49.16 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.1 73.03 1.07 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.99 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.16 89.52 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.402 2.068 . . . . 0.0 110.494 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -67.89 129.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -174.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.8 mm? -88.98 128.34 35.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.02 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.71 16.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 128.96 54.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.665 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -62.59 123.91 19.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.73 -9.48 77.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.242 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.85 -171.45 35.73 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.847 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.33 137.35 33.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 tp -111.94 112.92 24.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.926 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -104.78 108.44 19.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.948 177.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.0 OUTLIER -96.61 127.95 43.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.514 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.47 123.87 50.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -121.58 140.73 51.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 1.0 OUTLIER -123.04 131.22 53.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -117.57 164.71 14.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.367 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.53 99.13 2.55 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -83.76 121.1 2.82 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.162 2.575 . . . . 0.0 113.515 -167.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.02 -6.83 13.18 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.465 2.11 . . . . 0.0 110.356 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -165.62 -179.06 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.972 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -72.41 -17.24 61.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.535 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 58.34 30.16 19.18 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.408 0.623 . . . . 0.0 111.098 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -52.31 -58.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.612 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -96.03 26.61 4.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.84 167.68 11.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -97.14 149.97 21.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.685 0.278 . . . . 0.0 110.983 -172.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 146.67 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.408 0.623 . . . . 0.0 112.195 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.661 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mmm-85 -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -143.33 53.49 1.35 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.524 ' HZ ' ' CD1' ' A' ' 76' ' ' TYR . 39.6 m-85 -136.46 154.72 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -166.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HB2' ' CE1' ' A' ' 121' ' ' TYR . 4.2 ttp180 . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.981 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HA ' ' CD ' ' A' ' 85' ' ' GLU . 31.1 m-70 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.96 0.41 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.04 124.83 1.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.587 -172.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CD1' ' HZ ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -108.02 112.4 24.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -119.08 143.96 46.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 68.48 -2.72 1.53 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.319 0.58 . . . . 0.0 110.729 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 9.47 52.11 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.728 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -134.17 167.59 20.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.04 151.9 23.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 164.13 12.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.65 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -22.7 63.81 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.55 -28.64 69.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.478 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.476 ' CD ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -86.85 -42.33 13.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 86' ' ' ILE . 7.5 tp 43.7 90.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.663 1.227 . . . . 0.0 112.61 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 94' ' ' THR . 3.8 tp -65.39 -12.45 13.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.308 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -14.45 60.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.234 0.54 . . . . 0.0 109.78 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.1 -21.51 54.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.173 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -61.86 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 92' ' ' GLU . 2.1 p -169.72 -71.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.285 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 177.85 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 109.887 -177.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' PHE . 5.7 mtm-85 -76.88 105.7 8.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.883 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 87' ' ' ILE . 25.8 m -152.55 107.49 3.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 131.33 55.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.879 0.371 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -99.51 112.81 24.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.868 0.366 . . . . 0.0 110.177 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.41 105.76 10.95 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.954 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 1.78 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.456 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.6 -28.5 69.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 110.2 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.04 -17.46 78.31 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -28.29 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.88 0.34 . . . . 0.0 111.454 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.12 -16.98 67.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.751 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -103.47 -4.26 24.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.516 0.326 . . . . 0.0 110.246 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 92.31 20.13 36.44 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.851 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -129.08 133.0 47.49 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 117.142 0.471 . . . . 0.0 111.511 -178.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.73 132.73 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -120.71 108.71 14.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.613 -177.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 64' ' ' TRP . 11.1 tp -91.96 121.67 33.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.289 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.788 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.405 HG13 ' HG ' ' A' ' 108' ' ' LEU . 38.3 mt -112.59 127.77 69.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.699 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 112' ' ' ASN . 31.4 t80 -83.48 122.61 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 32.6 t30 80.13 119.36 0.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.071 0.857 . . . . 0.0 111.68 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 140' ' ' ILE . 7.1 p -117.9 134.59 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.412 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.5 p -103.78 171.27 7.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 112.007 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -67.06 -14.14 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.499 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 13.7 t0 -81.38 -34.02 31.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' HA ' ' CD ' ' A' ' 66' ' ' ARG . 32.6 m-20 -72.3 -24.84 61.39 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.014 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.56 -3.66 0.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.697 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.69 -132.12 1.71 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.813 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -106.62 127.12 53.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.105 0.479 . . . . 0.0 111.542 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-85 -90.37 148.48 22.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -106.19 113.66 27.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.781 0.324 . . . . 0.0 110.141 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 4.5 t -103.4 116.21 31.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.128 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.661 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 8.8 t -132.31 113.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.615 ' HE2' HG22 ' A' ' 30' ' ' VAL . 34.7 m-85 -93.27 136.09 33.87 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 126' ' ' LYS . 11.8 mtpp -121.01 102.97 8.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 33.9 t70 -99.05 74.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.548 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.15 -96.94 0.34 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.905 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.89 -27.83 17.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.67 0.271 . . . . 0.0 111.601 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB2' ' HD1' ' A' ' 28' ' ' PHE . 2.9 m-85 -90.68 148.46 22.6 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.34 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -146.18 150.34 35.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.46 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.683 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -143.38 132.84 23.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.008 177.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -114.48 121.93 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 109.949 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.05 148.15 50.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -93.29 133.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.153 0.501 . . . . 0.0 110.772 -176.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -128.79 102.38 6.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.63 138.51 38.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 46.0 t -95.48 142.72 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.83 100.78 5.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 113' ' ' VAL . 70.7 mt -81.83 97.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.682 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.56 ' CB ' ' HB3' ' A' ' 130' ' ' PHE . 4.0 Cg_exo . . . . . 0 N--CA 1.459 -0.551 0 N-CA-C 110.991 -0.426 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.765 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 13.4 p90 -140.67 160.55 39.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.75 172.35 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.582 . . . . 0.0 112.123 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.61 147.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.78 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 26.3 t30 -99.2 167.74 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.735 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.16 128.14 45.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.0 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.691 HD11 ' HA ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -112.47 176.62 4.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.752 0.311 . . . . 0.0 110.518 -175.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -73.53 -12.3 60.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.009 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 -132.35 11.02 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.567 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 55.5 Cg_endo -71.5 97.68 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.328 2.018 . . . . 0.0 111.513 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.78 113.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.1 mt -95.59 96.2 8.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.606 -175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -127.4 170.84 12.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.885 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -97.38 145.35 26.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.777 0.322 . . . . 0.0 110.239 -170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 140' ' ' ILE . 0.9 OUTLIER -70.71 142.65 51.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.13 -173.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.16 -8.07 72.44 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.698 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.12 -167.98 35.98 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.237 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.26 134.59 33.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.285 0.564 . . . . 0.0 110.412 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.941 ' HG ' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -106.05 111.0 23.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.289 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 96.89 6.8 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.63 129.22 42.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.879 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -107.49 128.94 54.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.691 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.11 140.26 50.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.699 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -125.96 129.72 49.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.597 0.237 . . . . 0.0 110.758 -175.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.69 165.49 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.564 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.71 83.45 48.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.071 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -95.02 162.73 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.305 2.67 . . . . 0.0 113.107 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -88.44 37.45 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.947 2.431 . . . . 0.0 111.612 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -160.32 177.34 10.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.048 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.88 2.12 55.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.038 0.447 . . . . 0.0 109.817 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 62.28 24.77 14.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -67.81 -24.21 65.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 109.858 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -104.0 17.11 24.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.493 ' HA ' ' HB3' ' A' ' 127' ' ' ASP . 18.6 ttm -76.2 118.95 19.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 110.985 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -78.67 98.88 6.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.464 HD12 HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -111.22 140.48 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 111.336 -172.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.868 ' HB3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.33 118.93 13.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -114.19 63.24 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 81.0 m-85 -136.01 151.28 49.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.604 -168.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.593 HH11 ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.63 175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -146.71 152.24 38.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.693 -175.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.19 128.85 42.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.634 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.564 ' HB3' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.52 128.96 34.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -175.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.6 t70 62.25 15.08 7.25 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.463 0.649 . . . . 0.0 111.269 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 98' ' ' LYS . . . 82.47 20.19 62.61 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.975 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.3 154.27 49.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.025 0.441 . . . . 0.0 111.065 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -132.22 139.03 48.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.916 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -177.8 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -23.81 65.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.58 -53.36 5.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.047 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 75' ' ' LEU . 16.4 pm0 -93.15 15.31 15.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.543 0.337 . . . . 0.0 111.777 -175.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.708 HG23 ' HB2' ' A' ' 89' ' ' LYS . 2.4 tt -42.58 121.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.712 0.768 . . . . 0.0 112.303 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 108' ' ' LEU . 14.3 tt -72.75 -36.42 52.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.792 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -13.97 27.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.708 ' HB2' HG23 ' A' ' 86' ' ' ILE . 4.3 ttpt -71.48 -12.42 61.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.534 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE1' ' HD1' ' A' ' 65' ' ' PHE . 1.3 t80 -58.76 -60.74 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -64.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -161.44 -91.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.921 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -72.1 111.78 7.63 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.52 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -140.91 90.8 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.054 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.01 127.08 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.095 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -97.65 100.5 11.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 110.951 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 9.3 mp -73.08 110.98 7.77 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.758 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HD3' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -101.14 -4.71 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.703 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.63 -29.33 67.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.272 0.558 . . . . 0.0 111.07 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.31 -17.94 77.07 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.829 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.564 HD12 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -59.54 -26.37 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -170.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -21.93 67.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.793 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.62 5.03 26.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 0.0 110.206 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 83.3 31.47 27.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.109 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HG3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -123.78 132.25 53.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.16 0.48 . . . . 0.0 110.89 179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -121.32 132.79 69.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -120.02 105.04 10.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.309 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 96' ' ' LEU . 7.0 tp -94.43 118.18 31.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.353 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 109' ' ' ARG . 5.7 ttt180 -95.14 106.21 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.927 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 94' ' ' THR . 65.4 mt -117.35 130.28 72.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER -91.0 134.53 34.42 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.465 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.8 t30 73.58 81.55 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.098 0.874 . . . . 0.0 112.237 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.941 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 8.4 p -82.09 140.81 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.992 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -117.65 176.51 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.974 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.42 -14.25 18.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.243 0.544 . . . . 0.0 110.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.583 ' HB3' HH21 ' A' ' 66' ' ' ARG . 30.3 t70 -80.58 -24.56 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 4.3 m-20 -86.13 -20.27 28.92 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.698 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.415 ' HB2' HD13 ' A' ' 140' ' ' ILE . 31.2 t0 -63.84 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.069 0.948 . . . . 0.0 112.776 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -153.38 -119.96 0.78 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.944 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 123.41 24.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -125.02 161.26 27.13 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.404 172.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.57 119.68 24.04 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.298 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -105.0 117.61 34.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.229 173.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.868 HG12 ' HB3' ' A' ' 63' ' ' ARG . 5.1 p -124.11 141.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.226 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.765 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -136.13 121.2 18.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.583 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -135.22 110.2 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 60' ' ' MET . 11.1 p-10 -116.8 95.91 5.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.127 0.965 . . . . 0.0 110.983 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.72 -82.92 1.38 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.693 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -118.87 -23.62 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.56 ' HB3' ' CB ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -97.28 141.34 30.5 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -148.26 145.46 28.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -150.26 132.3 15.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.804 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -128.22 121.56 29.69 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 139.83 49.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.192 0.52 . . . . 0.0 111.16 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.85 138.79 20.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.58 175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.79 160.2 37.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -121.13 135.37 55.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.22 -175.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 43.1 t -104.92 142.46 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.64 118.46 24.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.251 0.548 . . . . 0.0 111.137 -177.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.618 HD11 HG22 ' A' ' 113' ' ' VAL . 1.5 mp -82.77 119.29 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.605 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.73 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 CA-C-O 120.912 0.297 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 52' ' ' SER . 1.7 p90 -71.8 137.32 47.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -119.28 178.86 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.247 0.546 . . . . 0.0 112.36 -171.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.761 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 p -90.77 147.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.623 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 15.3 t30 -120.44 130.48 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.96 74.34 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.834 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -78.25 111.24 14.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.5 -24.72 67.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.47 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 136' ' ' THR . . . 69.22 -120.55 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.02 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.21 90.18 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.781 2.321 . . . . 0.0 111.66 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -74.01 117.66 18.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 139' ' ' LYS . 3.9 mt -91.2 134.21 34.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.025 0.44 . . . . 0.0 110.811 -171.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.667 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -136.02 172.56 12.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.107 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.55 133.88 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -64.38 124.69 22.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 -177.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.78 -12.17 36.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.304 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.97 -147.33 22.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.223 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -108.25 153.05 23.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.99 0.424 . . . . 0.0 111.228 -176.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 39' ' ' ALA . 1.4 tp -140.95 113.55 8.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.376 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.852 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -92.95 111.86 23.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 64' ' ' TRP . 3.0 mt -95.91 127.53 42.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.817 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.79 43.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 139.72 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -125.66 137.17 53.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.4 mm? -126.22 164.96 19.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.951 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -111.79 80.98 3.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 99.0 Cg_endo -81.74 142.84 12.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.629 2.219 . . . . 0.0 112.882 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 12.6 Cg_exo -71.6 -26.17 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.958 2.439 . . . . 0.0 111.711 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -129.51 -172.14 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -68.08 -28.66 67.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB1' ' SD ' ' A' ' 60' ' ' MET . . . 63.36 25.51 14.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.619 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -60.66 -33.7 73.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.922 0.392 . . . . 0.0 111.253 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -113.22 28.48 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.636 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 7.8 ptm -80.21 169.34 17.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 111.49 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.843 ' HG2' HD12 ' A' ' 75' ' ' LEU . 3.5 mt-10 -89.68 121.18 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.16 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -114.98 139.47 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.45 . . . . 0.0 110.231 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -133.67 118.04 17.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -132.08 61.1 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.2 147.67 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.266 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 6.6 m170 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.843 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -114.99 151.7 33.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.307 0.575 . . . . 0.0 112.367 -173.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -129.2 109.5 11.2 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' HG3' ' HG3' ' A' ' 61' ' ' GLU . 3.0 ttt-85 -116.31 89.09 3.03 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.165 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.0 t0 52.85 59.7 4.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.018 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.11 7.84 84.71 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.1 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.81 124.32 50.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.543 -0.387 . . . . 0.0 111.316 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -126.56 152.64 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.407 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -118.22 -158.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.85 0.357 . . . . 0.0 111.563 -172.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -41.63 99.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.14 -30.41 31.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.12 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.4 pm0 -112.42 13.77 20.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.509 HG23 ' HD3' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -46.38 112.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.651 0.739 . . . . 0.0 110.257 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -69.05 -12.61 16.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.732 -167.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -13.51 58.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.186 0.517 . . . . 0.0 110.282 173.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -78.92 -16.8 56.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.267 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.44 -33.34 32.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.24 167.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 124.04 0.838 . . . . 0.0 112.213 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 65.01 -105.92 0.13 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.477 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -127.51 120.79 29.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -171.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.15 92.97 2.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.199 175.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.54 116.11 31.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.461 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -102.98 109.35 20.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 107' ' ' THR . 12.7 mt -87.37 106.15 17.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.701 ' HE2' HG21 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -110.73 -3.73 15.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.456 -172.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.29 -12.79 61.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.517 0.675 . . . . 0.0 111.071 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.65 -17.34 70.93 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.43 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.701 HG21 ' HE2' ' A' ' 98' ' ' LYS . 1.7 tt -57.33 -23.27 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.12 -18.99 58.74 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -120.32 7.9 10.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.225 0.536 . . . . 0.0 109.954 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 80.41 43.67 9.25 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.195 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 1.2 mppp? -126.67 133.05 51.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.466 0.633 . . . . 0.0 110.854 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.49 134.7 43.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.572 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.731 ' HB ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -122.54 111.57 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.599 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 96' ' ' LEU . 13.0 tp -103.44 110.83 23.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.852 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -87.33 106.09 17.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.517 176.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.68 129.63 66.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 44' ' ' ASN . 5.4 m-85 -107.06 155.96 19.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.789 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.6 t30 69.61 54.21 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.297 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.56 124.0 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.727 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.617 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 68.5 p -101.88 168.05 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.31 -26.39 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.528 0.68 . . . . 0.0 110.196 176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.25 -28.49 31.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER -72.84 -25.68 61.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.871 175.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.1 t70 -63.13 26.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.358 1.063 . . . . 0.0 113.824 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -100.25 -147.65 21.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.566 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -92.3 107.83 19.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.169 0.509 . . . . 0.0 111.352 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.804 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.5 m-85 -73.92 157.45 36.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -126.84 118.29 24.32 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.343 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 10.3 t -99.51 116.72 32.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 28.9 t -136.34 118.71 20.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.213 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -112.18 128.21 56.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -120.64 117.64 28.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.593 0.235 . . . . 0.0 110.795 -178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.506 ' HB2' ' HE3' ' A' ' 60' ' ' MET . 21.1 t0 -117.47 93.76 4.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.036 0.445 . . . . 0.0 110.469 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.49 -80.21 0.9 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.095 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.82 -29.36 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -102.9 150.03 23.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.596 -174.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 16.6 p90 -145.51 144.76 30.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 3.7 tp10 -111.82 131.39 55.37 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.55 121.18 28.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.651 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.22 134.58 44.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.047 0.451 . . . . 0.0 110.391 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.75 130.98 35.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.237 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -132.88 102.0 5.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.232 -178.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 2.7 mm-40 -73.77 125.61 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.676 0.274 . . . . 0.0 110.849 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 118' ' ' ASP . 9.3 p -88.85 134.38 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -122.89 104.66 9.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.021 0.439 . . . . 0.0 111.795 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 31.2 mt -76.51 96.25 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.177 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.927 ' HB2' ' HB3' ' A' ' 130' ' ' PHE . 30.5 Cg_exo . . . . . 0 CA--C 1.529 0.226 0 CA-C-O 120.914 0.297 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HD1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -154.19 143.83 21.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.888 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -115.47 169.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.366 0.603 . . . . 0.0 111.314 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 125' ' ' PHE . 2.2 t -120.16 120.58 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.265 -174.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -78.48 132.85 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.95 -175.63 14.11 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.521 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 35' ' ' GLY . 0.4 OUTLIER -114.25 178.89 4.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -38.85 76.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.438 . . . . 0.0 109.974 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' H ' HD12 ' A' ' 33' ' ' LEU . . . 74.73 62.39 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.19 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 20.2 Cg_endo -96.22 75.78 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.422 2.748 . . . . 0.0 111.295 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 47' ' ' LEU . 21.8 t -78.41 93.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.159 0.504 . . . . 0.0 110.761 -177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HA ' ' HG3' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -86.67 103.72 15.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.751 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.31 9.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.809 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.52 140.88 37.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD12 HG21 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -64.25 110.52 2.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.593 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.75 7.86 88.11 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.403 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.48 -160.24 28.01 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.378 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -82.85 110.87 18.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.145 0.498 . . . . 0.0 110.305 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HB ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -98.74 123.85 43.22 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.22 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 8.4 mt-10 -126.23 108.7 11.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.149 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -96.3 143.95 26.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.193 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.07 114.63 25.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.065 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -118.59 141.17 48.84 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 146.67 49.89 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.29 145.24 50.86 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.371 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -65.87 108.26 2.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 37.6 Cg_exo -60.7 108.98 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.52 2.814 . . . . 0.0 114.587 -167.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 52' ' ' SER . 71.3 Cg_endo -94.43 -22.27 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.083 2.522 . . . . 0.0 111.602 170.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -156.5 -172.23 3.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.573 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 3.0 pt20 -77.87 -17.36 57.43 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.189 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . 59.01 13.85 3.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.928 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -65.3 -33.28 75.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.073 0.463 . . . . 0.0 110.053 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.91 17.64 19.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.704 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.514 ' HB3' ' O ' ' A' ' 57' ' ' ALA . 3.5 ttm -84.69 142.52 29.82 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.646 ' HG2' ' HA ' ' A' ' 77' ' ' ARG . 19.5 mt-10 -88.65 142.45 27.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.861 HD13 HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -135.22 131.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.255 0.55 . . . . 0.0 111.12 -178.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 75' ' ' LEU . 1.5 ttp180 -110.81 115.39 29.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 49' ' ' CYS . 4.7 t90 -140.64 79.52 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.834 0.35 . . . . 0.0 111.339 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HB3' ' HE2' ' A' ' 90' ' ' TYR . 7.1 m-85 -154.75 169.01 24.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD3' ' HA ' ' A' ' 117' ' ' ASP . 9.4 ttp85 . . . . . 0 N--CA 1.447 -0.612 0 C-N-CA 119.683 -0.807 . . . . 0.0 108.934 168.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.811 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.83 0.348 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.91 143.0 27.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.541 -175.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.1 t80 -95.25 111.15 23.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -112.16 125.58 54.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.878 -171.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 72.26 -10.99 0.84 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.457 0.646 . . . . 0.0 110.948 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 100.74 17.79 22.49 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -168.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.98 138.3 53.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.214 -0.493 . . . . 0.0 109.973 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.86 161.83 20.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.263 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.98 148.67 38.96 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.635 -175.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' O ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -75.72 -16.99 60.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.265 0.555 . . . . 0.0 110.39 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.95 73.81 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.044 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.81 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 1.7 pp20? -105.36 -41.26 5.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.41 0.148 . . . . 0.0 110.666 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 83' ' ' PHE . 48.5 mt 70.1 95.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.843 0.83 . . . . 0.0 111.41 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.811 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 1.8 tt -75.08 -16.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.274 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -12.96 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.704 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -53.73 -28.13 32.43 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.783 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.644 ' HE2' ' HB3' ' A' ' 65' ' ' PHE . 3.1 m-85 -98.06 -33.24 11.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.276 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.63 163.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 124.186 0.929 . . . . 0.0 111.663 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.3 OUTLIER 75.65 -167.12 0.08 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.984 177.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 93' ' ' ARG . 7.8 ttp180 -65.9 112.6 3.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.342 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.912 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -126.33 112.18 15.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.333 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 1.3 pt-20 -137.54 129.73 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.201 0.524 . . . . 0.0 110.629 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.98 107.31 19.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.639 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -74.53 99.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.127 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -96.2 6.25 49.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.522 178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.24 -34.12 63.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.975 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.02 -17.29 65.52 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.962 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.527 HD12 HG13 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -60.41 -21.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.72 61.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.625 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 3.65 20.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.81 31.62 8.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.726 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.46 132.68 53.5 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.673 0.737 . . . . 0.0 111.389 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -125.7 133.79 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 O-C-N 122.161 -0.337 . . . . 0.0 110.515 177.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.98 111.65 19.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 27.4 tp -86.43 113.42 22.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 3.3 mpt_? -98.82 106.77 19.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.929 ' HB ' HD23 ' A' ' 45' ' ' LEU . 14.6 mt -127.45 120.78 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -80.79 127.82 32.95 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 83.26 133.95 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.309 1.006 . . . . 0.0 111.213 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -145.02 139.51 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.304 178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -111.92 172.71 6.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.203 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 p -65.12 -10.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.162 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.91 -50.33 13.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.012 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.717 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -78.11 -9.75 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.784 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -55.0 -22.47 15.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.276 177.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.13 -86.7 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.173 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -145.19 155.86 43.52 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.604 -0.35 . . . . 0.0 111.004 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.552 ' HD1' HG21 ' A' ' 138' ' ' VAL . 1.7 m-85 -103.81 127.51 51.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.451 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 68.6 t60 -76.49 101.67 5.72 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.73 117.32 34.4 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.413 1.071 . . . . 0.0 109.861 -176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.01 116.49 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 0.8 OUTLIER -96.08 112.78 24.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.287 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 2.8 mtpt -119.7 105.0 10.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.95 0.405 . . . . 0.0 110.834 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.37 108.36 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.698 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.18 -102.21 0.7 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.87 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.65 -18.15 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.927 ' HB3' ' HB2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.72 135.96 33.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 110.266 -177.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 1.7 p90 -144.76 151.44 38.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.888 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.5 140.67 43.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 124.82 46.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.322 0.582 . . . . 0.0 110.791 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.38 158.84 42.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.583 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -114.62 112.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.969 0.414 . . . . 0.0 110.427 177.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 120.13 19.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.303 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.06 118.7 13.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.006 0.431 . . . . 0.0 110.731 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.552 HG21 ' HD1' ' A' ' 121' ' ' TYR . 1.8 t -105.38 151.58 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.711 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.37 141.06 37.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.578 HG21 HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -93.71 139.02 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.537 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.473 0.265 0 CA-C-O 121.078 0.366 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -166.19 147.85 6.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.423 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -138.63 169.73 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.554 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 132' ' ' GLU . 54.7 t -90.73 111.88 24.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -87.82 150.17 23.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.44 -156.14 38.7 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.706 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -147.17 137.02 23.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.853 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -96.49 -49.13 5.28 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 55.04 -134.59 47.95 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.85 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 5.6 Cg_exo -80.84 97.97 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.417 2.744 . . . . 0.0 112.81 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.24 119.53 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.991 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -106.16 132.83 51.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.927 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.16 170.91 18.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.081 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.28 131.29 47.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.415 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -71.63 142.22 49.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.022 0.439 . . . . 0.0 110.488 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.1 -29.86 10.5 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.21 -153.51 26.27 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.6 p-10 -110.04 135.72 50.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.502 0.668 . . . . 0.0 111.074 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -97.92 110.9 23.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.304 175.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.754 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -97.15 99.62 11.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.96 127.99 42.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -116.7 119.04 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.612 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -117.06 139.93 50.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.3 132.68 50.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.875 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.454 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -128.48 156.91 42.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.919 175.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -87.52 101.6 2.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 87.2 Cg_endo -86.54 126.45 2.62 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 114.142 -166.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.17 -27.23 13.97 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.372 2.048 . . . . 0.0 110.665 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.635 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 2.8 pt20 -136.21 178.46 7.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HG3' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -71.45 -19.78 62.18 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.59 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.89 19.67 9.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.767 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.55 -30.54 65.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.537 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -113.5 17.2 18.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 5.2 mmt -87.74 -166.61 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.748 0.309 . . . . 0.0 111.26 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.924 ' HB3' HD11 ' A' ' 75' ' ' LEU . 30.9 mt-10 -114.54 136.53 52.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.962 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -132.17 146.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.821 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 10.9 ttt-85 -141.23 115.21 9.18 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.636 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -129.89 90.19 2.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.604 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 77.8 m-85 -143.57 164.18 31.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.068 -172.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 120.962 0.411 . . . . 0.0 109.933 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.654 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 12.0 p-80 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -164.3 152.16 12.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 -174.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.37 115.61 27.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.417 ' HB2' ' HG2' ' A' ' 61' ' ' GLU . 9.4 ttm180 -111.36 123.92 51.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -3.32 2.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.887 0.851 . . . . 0.0 109.828 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.6 25.76 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -120.9 149.87 41.95 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 115.051 -0.575 . . . . 0.0 110.875 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -99.57 169.99 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -158.43 163.23 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.318 . . . . 0.0 110.759 -176.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -13.7 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.35 -47.51 7.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.31 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -72.4 -32.38 66.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.512 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.7 OUTLIER 50.11 59.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.656 1.217 . . . . 0.0 112.407 176.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.755 HD11 HG21 ' A' ' 94' ' ' THR . 16.3 tt -67.11 -1.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.025 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -13.95 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.18 0.514 . . . . 0.0 109.891 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -13.68 62.21 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.053 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 74.6 m-85 -109.75 27.05 9.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 77.2 t 77.78 -75.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.811 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 170.69 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.069 0.462 . . . . 0.0 109.851 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -74.24 70.68 1.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -176.064 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.755 HG21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -131.79 120.54 22.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.046 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 124.8 46.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.471 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 tp -102.88 105.79 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.957 0.408 . . . . 0.0 110.168 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -82.95 117.69 22.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -110.65 10.73 22.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -37.33 83.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.342 0.592 . . . . 0.0 110.068 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.24 79.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.899 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 56' ' ' GLN . 2.0 tt -57.59 -29.72 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.988 0.394 . . . . 0.0 111.657 -172.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.562 ' HA2' ' HG3' ' A' ' 56' ' ' GLN . . . -66.54 -18.3 67.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.129 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 3.95 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.924 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 41.48 6.77 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.621 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -137.77 133.68 34.36 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.292 0.546 . . . . 0.0 111.097 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' SER . 15.9 m -119.36 139.69 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.405 174.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -117.91 104.39 10.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.803 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 tp -93.65 110.23 21.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.754 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 1.5 ttp85 -93.0 106.32 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 94' ' ' THR . 78.0 mt -113.79 106.41 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.147 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -86.83 146.82 26.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 t30 70.0 54.76 0.34 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 123.987 0.804 . . . . 0.0 110.174 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 45' ' ' LEU . 12.2 p -78.29 137.56 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.704 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -120.33 162.01 20.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.926 0.393 . . . . 0.0 111.557 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 9.9 p -68.59 -16.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.439 0.638 . . . . 0.0 110.369 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.24 -33.73 76.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.472 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.93 -12.69 14.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.497 -175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.59 -9.89 1.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.01 -86.2 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.974 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -140.74 118.69 11.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.086 -0.656 . . . . 0.0 111.608 -175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.499 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 10.9 m-85 -93.55 127.95 39.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.601 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 1.9 m-70 -101.26 127.54 47.81 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 48.1 t -106.16 116.81 32.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.109 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.743 ' HB ' HH11 ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.12 130.2 74.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.4 m-85 -108.12 126.26 52.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.962 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -116.82 104.91 11.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.815 0.34 . . . . 0.0 110.305 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 21.8 t70 -111.45 107.0 16.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.946 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.53 -92.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.156 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.51 -20.26 7.85 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -101.65 155.8 17.88 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 -173.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 33.0 p90 -144.67 150.37 37.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.33 133.42 50.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.815 176.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -114.92 121.49 43.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.293 0.568 . . . . 0.0 110.705 -177.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.26 159.15 21.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.757 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.76 108.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.331 0.586 . . . . 0.0 110.875 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.34 102.0 11.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.857 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -80.54 129.96 34.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 45' ' ' LEU . 84.4 t -102.8 146.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 0.0 110.48 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.1 94.39 4.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.742 176.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.686 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -78.09 137.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.963 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.461 -0.409 0 CA-C-O 121.05 0.354 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 125' ' ' PHE . 3.1 p90 -110.77 159.85 17.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.806 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -135.25 179.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.393 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 132' ' ' GLU . 77.6 t -115.57 106.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.89 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -112.33 131.14 55.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.445 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.0 -113.39 0.58 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.908 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.83 161.63 20.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.399 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -83.5 -49.03 9.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.935 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.968 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 139.95 87.02 0.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.579 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -94.6 40.6 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.114 2.542 . . . . 0.0 111.282 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.61 119.78 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.274 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.43 139.33 36.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.627 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -140.63 169.73 17.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.42 144.77 43.31 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 111.81 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.17 84.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.329 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.67 -161.8 30.03 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -99.9 146.9 26.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.389 0.614 . . . . 0.0 111.384 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.8 tp -134.49 119.26 18.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.803 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.97 110.34 22.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 107' ' ' THR . 0.9 OUTLIER -94.36 127.24 40.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 122.83 47.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.527 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.698 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.64 141.22 48.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.423 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -106.78 141.43 38.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.077 0.465 . . . . 0.0 110.634 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -125.24 136.9 54.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 -176.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 m -97.95 87.64 0.55 Allowed Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 93.5 Cg_endo -91.2 133.05 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.002 2.468 . . . . 0.0 114.365 -165.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.43 4.14 5.19 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.167 2.578 . . . . 0.0 110.488 168.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' HB3' ' H ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -140.45 -176.35 4.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.194 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -89.62 -6.72 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 71.57 -3.35 2.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.662 174.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 3.4 mt-30 -61.99 -28.17 69.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.25 16.63 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.08 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.7 170.72 9.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.392 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.86 130.65 56.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -127.4 147.05 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.351 0.596 . . . . 0.0 111.275 -177.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 116.64 22.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -126.38 64.33 1.25 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 74' ' ' HIS . 82.3 m-85 -142.24 152.18 42.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.727 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.68 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.188 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.35 126.37 0.42 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.297 0.373 . . . . 0.0 110.33 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.08 128.16 41.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.69 138.26 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.23 -170.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 64.09 21.21 12.5 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.611 0.719 . . . . 0.0 110.061 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.54 17.1 72.41 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 168.64 17.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.141 0.496 . . . . 0.0 111.029 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.32 153.52 18.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.324 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 mtt -135.84 153.35 51.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -5.46 29.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.854 0.359 . . . . 0.0 111.062 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.97 -15.75 69.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.093 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.579 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -118.79 -39.83 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.523 0.201 . . . . 0.0 110.49 178.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 mt 53.92 85.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 111.954 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.68 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 3.5 tt -65.44 -28.57 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.576 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -14.58 52.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.511 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HD2' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -86.76 -14.05 43.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.862 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.2 -52.0 18.53 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 92' ' ' GLU . 4.2 p -178.34 175.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.952 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -85.77 150.27 24.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER 63.74 64.78 0.76 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.827 -175.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.577 HG23 HG12 ' A' ' 110' ' ' ILE . 1.2 m -120.87 106.78 11.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.89 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -117.4 118.39 32.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD22 HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -87.57 98.06 11.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mt -72.07 109.2 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.657 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 20.2 mtmt -108.11 14.0 25.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.655 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -20.65 66.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.493 0.663 . . . . 0.0 110.512 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.83 -17.21 66.09 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.473 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 57' ' ' ALA . 1.9 tt -51.9 -38.42 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 -19.9 69.46 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.373 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.67 22.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.93 45.02 8.63 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.69 133.08 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.185 -0.597 . . . . 0.0 110.642 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.91 132.25 70.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.151 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -123.53 104.19 8.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.588 HD13 HD22 ' A' ' 96' ' ' LEU . 7.1 tp -88.7 111.89 22.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.26 0.553 . . . . 0.0 110.286 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -90.51 106.49 18.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.739 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 94' ' ' THR . 43.0 mt -114.15 116.57 52.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.777 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 13.3 m-85 -88.77 146.32 25.08 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.815 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.53 62.98 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.911 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.578 HG21 ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -65.97 141.54 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.949 175.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.96 167.42 15.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.949 0.404 . . . . 0.0 111.803 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.614 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -70.56 -13.06 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.396 0.617 . . . . 0.0 110.192 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -73.19 -23.61 60.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.94 171.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.91 -11.27 15.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.763 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -62.04 -5.34 2.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.434 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.09 -133.91 1.46 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.658 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.36 124.98 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.191 0.52 . . . . 0.0 111.281 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.84 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 3.3 m-85 -88.22 135.44 33.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.92 119.83 39.27 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.96 0.409 . . . . 0.0 110.02 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.7 t -104.05 118.34 36.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.341 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 133' ' ' GLU . 3.5 t -131.11 128.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.206 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.698 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 29.3 m-85 -116.21 137.3 52.26 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 131' ' ' TYR . 4.3 ptmt -140.61 120.97 13.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.126 0.489 . . . . 0.0 110.918 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -132.48 133.87 44.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.8 -107.55 1.98 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.312 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -120.21 -6.16 9.91 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.71 141.78 35.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 0.0 111.01 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 126' ' ' LYS . 52.8 p90 -134.46 154.33 51.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.806 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -133.41 147.27 51.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.031 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HG2' HG13 ' A' ' 124' ' ' VAL . 28.5 mt-10 -121.35 149.91 42.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.291 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 138.94 18.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.131 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mm -98.62 128.69 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.968 HG23 ' HA3' ' A' ' 35' ' ' GLY . 63.0 m -124.43 109.12 12.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.685 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.98 134.3 37.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.29 124.23 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.147 0.498 . . . . 0.0 110.106 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -98.7 90.7 4.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.56 119.77 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.345 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.46 -0.498 0 N-CA-C 111.16 -0.361 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -167.49 145.22 4.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.69 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.7 pt -132.02 176.83 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.799 0.333 . . . . 0.0 110.663 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 51' ' ' LEU . 37.1 t -102.97 113.85 40.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.782 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -94.66 131.83 40.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.163 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.45 -172.16 15.24 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.8 148.66 22.68 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.679 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.15 -47.25 13.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.48 116.88 4.26 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.286 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.91 91.93 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.331 2.02 . . . . 0.0 111.189 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -69.49 100.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.67 113.32 25.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.926 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -125.98 171.52 10.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.289 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.1 m -122.12 143.88 49.27 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD12 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.72 135.93 57.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -174.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.09 89.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.861 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.2 168.02 17.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.73 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.1 p-10 -79.84 122.68 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.19 0.519 . . . . 0.0 110.512 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.675 HD11 HG11 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -90.39 111.21 22.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.079 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 1.8 mp0 -94.3 105.73 17.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 45' ' ' LEU . 2.0 mm? -96.07 128.46 42.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.45 123.62 49.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.701 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.83 140.26 53.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.884 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -130.53 140.71 50.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -127.84 158.61 37.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.9 m -90.47 98.87 1.65 Allowed Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 10.2 Cg_endo -88.26 125.25 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.371 2.714 . . . . 0.0 114.006 -167.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 73.0 Cg_endo -81.11 -17.81 9.08 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 110.837 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' OE1' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -120.32 -171.66 2.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.112 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -89.89 -10.92 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 0.0 110.165 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HA ' ' HG2' ' A' ' 60' ' ' MET . . . 66.16 -1.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -57.25 -42.18 81.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.156 0.503 . . . . 0.0 110.915 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -99.92 26.11 6.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -92.17 175.9 6.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.735 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 41.8 mt-10 -113.64 129.88 56.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.802 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -125.61 129.17 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.349 0.595 . . . . 0.0 111.216 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 20.4 mtp180 -114.45 117.75 31.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.322 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -125.69 60.3 1.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 87' ' ' ILE . 62.8 m-85 -139.59 152.35 46.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.74 0.781 . . . . 0.0 112.859 -166.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.167 168.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 65.5 m170 . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 61' ' ' GLU . 1.9 pt? -163.76 143.41 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 0.0 112.009 -170.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.06 129.27 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.041 175.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -131.41 132.24 44.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.337 -175.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.2 t0 58.22 21.59 8.28 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.609 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.52 14.66 81.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.174 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 147.24 45.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.79 0.328 . . . . 0.0 110.688 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.556 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.0 p30 -118.49 169.68 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.88 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.25 152.99 50.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.09 -17.27 63.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.88 84.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.232 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 1.7 pp20? -117.63 -38.32 3.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.7 tp 39.06 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.046 1.339 . . . . 0.0 113.82 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG21 ' HE1' ' A' ' 76' ' ' TYR . 14.2 tt -56.91 -31.27 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.67 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -12.28 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.194 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.25 -30.94 68.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.701 0.286 . . . . 0.0 110.549 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -71.5 -59.03 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 94' ' ' THR . 1.2 p -159.62 153.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.112 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -56.26 -47.43 78.59 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -175.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -90.71 77.04 6.38 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.34 0.591 . . . . 0.0 110.887 -177.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.528 HG23 HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.45 94.6 4.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.794 177.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.65 120.96 42.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -175.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -99.55 106.97 19.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.111 0.482 . . . . 0.0 110.835 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mp -77.24 109.3 11.0 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.503 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.53 -13.02 16.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.657 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -19.81 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 110.964 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.16 66.27 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.653 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.96 -27.97 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.66 -25.45 72.87 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.499 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.46 -2.53 57.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.109 0.48 . . . . 0.0 109.921 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 85.82 19.84 57.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.353 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 50' ' ' GLN . 6.9 mptt -123.52 132.15 53.83 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.065 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.38 133.62 68.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 3.8 m -119.94 112.95 19.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 96' ' ' LEU . 11.4 tp -100.17 117.28 34.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.806 0.336 . . . . 0.0 110.271 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 18.7 mtt180 -94.77 106.87 18.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.631 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.598 HD12 HD23 ' A' ' 47' ' ' LEU . 21.6 mt -111.79 107.08 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -71.72 123.05 21.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.7 t30 81.1 108.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.042 0.839 . . . . 0.0 111.429 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.89 146.68 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.434 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.412 ' HB ' ' OD1' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -113.17 151.66 30.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 111.985 -175.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -72.49 -14.13 16.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.582 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' OD1' ' HB ' ' A' ' 114' ' ' THR . 5.4 p-10 -91.76 -19.1 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.933 0.397 . . . . 0.0 110.335 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.534 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.1 OUTLIER -110.36 2.94 19.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB2' HD13 ' A' ' 140' ' ' ILE . 4.7 p-10 -62.81 25.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -80.68 -159.05 20.34 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.334 -174.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -87.04 111.83 21.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.883 0.373 . . . . 0.0 110.686 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.773 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-30 -68.52 146.0 53.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.333 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.11 114.31 28.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 0.0 110.427 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -100.18 117.73 35.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.529 177.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 63' ' ' ARG . 47.1 t -118.02 109.04 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.116 0.484 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 134' ' ' HIS . 1.1 m-85 -93.73 115.52 27.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.1 mtpm? -109.11 104.89 14.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.729 0.3 . . . . 0.0 110.325 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.791 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 23.7 t0 -118.39 136.53 53.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.588 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.82 -111.73 2.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -113.15 3.05 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 110.816 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 171.23 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.904 0.383 . . . . 0.0 111.353 -174.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 4.0 p90 -148.45 147.93 29.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -122.75 142.8 50.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.6 121.01 39.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 0.0 110.482 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.54 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.55 137.37 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.829 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.38 107.42 22.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 34' ' ' GLU . 1.4 m -103.96 105.46 15.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 1.1 mm-40 -67.58 122.43 18.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.491 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 45' ' ' LEU . 4.0 t -91.85 147.77 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.98 115.49 17.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.2 mp -91.94 126.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.173 -176.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo . . . . . 0 C--O 1.233 0.227 0 N-CA-C 113.376 0.491 . . . . 0.0 113.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -133.71 146.42 50.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.435 -174.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.966 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.2 pt -148.56 167.76 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.036 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 132' ' ' GLU . 39.4 t -91.75 140.82 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.663 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -130.79 179.18 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.0 111.108 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.61 -133.45 11.36 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.78 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.96 176.65 5.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.59 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.318 0.386 . . . . 0.0 110.183 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.931 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 134.06 80.66 0.15 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.017 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.83 57.0 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.01 2.474 . . . . 0.0 111.566 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -82.14 100.85 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.267 -176.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.31 101.32 13.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.393 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.46 169.5 8.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.722 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -120.59 138.06 54.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.79 0.329 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -66.08 130.52 43.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -176.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.24 -5.04 84.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.485 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.97 -168.27 27.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.903 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.58 113.54 19.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' HB ' ' A' ' 110' ' ' ILE . 5.3 tp -85.85 114.89 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.82 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 3.7 mt-10 -110.38 117.42 33.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 0.7 OUTLIER -108.39 128.53 54.85 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.458 ' C ' ' HH2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -116.21 119.89 37.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -178.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.774 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -117.76 140.36 49.78 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.793 ' HG3' ' HD2' ' A' ' 105' ' ' LYS . 1.9 mp0 -115.86 135.75 53.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.294 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.698 HD23 ' HA2' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -127.35 153.16 46.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.636 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.74 100.36 5.28 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.7 Cg_endo -88.95 116.09 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.913 2.408 . . . . 0.0 113.584 -170.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.7 -13.84 12.99 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.44 2.094 . . . . 0.0 110.917 171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' ' CE ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -134.27 -174.19 3.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.727 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 58' ' ' GLN . 25.8 pt20 -74.96 -22.41 58.58 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.963 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 64.75 10.29 5.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.963 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.493 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -68.26 -11.29 59.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -117.47 15.68 14.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.293 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.664 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -82.88 155.28 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.079 0.466 . . . . 0.0 111.722 -172.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.968 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 2.1 mp0 -84.05 151.57 24.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -134.16 137.86 51.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.911 0.862 . . . . 0.0 111.316 -178.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -132.16 116.68 17.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.482 173.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.774 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -144.09 98.05 3.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.181 0.515 . . . . 0.0 110.286 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.604 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.365 0.126 . . . . 0.0 111.12 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.889 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.97 150.35 44.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -173.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.611 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 21.6 t80 -117.64 139.64 50.73 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.641 ' HG2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -117.83 147.48 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.177 -174.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -63.9 104.55 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.114 0.483 . . . . 0.0 110.083 177.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 7.71 55.98 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.115 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.641 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -143.26 122.69 13.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.455 0.645 . . . . 0.0 111.241 176.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -110.89 136.98 49.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.425 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -145.59 147.86 32.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.324 -174.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.453 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -71.16 -3.24 18.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 174.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.36 44.89 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.184 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -64.66 -34.43 78.28 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 89' ' ' LYS . 1.1 tt 44.66 51.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.625 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.487 HD11 HG21 ' A' ' 94' ' ' THR . 3.2 tt -65.83 -17.86 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.647 173.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -15.29 62.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.472 174.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.68 -27.62 40.77 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.302 0.572 . . . . 0.0 109.575 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -75.45 -62.65 1.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 111' ' ' PHE . 9.0 p 172.41 136.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.285 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 55.67 2.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.429 0.633 . . . . 0.0 110.158 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.65 66.92 1.39 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.487 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -122.11 151.39 40.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.079 -172.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -137.23 117.14 13.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.307 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 108' ' ' LEU . 15.7 tp -100.82 101.23 12.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -70.34 99.63 1.59 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.729 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -103.69 1.47 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.261 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -24.83 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.261 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.78 -17.02 64.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.41 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 tt -53.51 -37.66 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.98 -15.19 69.11 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.17 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.8 -4.7 21.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.858 0.361 . . . . 0.0 110.244 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.698 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 92.41 31.27 9.05 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -133.51 133.6 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.152 0.476 . . . . 0.0 111.444 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.61 134.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 O-C-N 122.244 -0.285 . . . . 0.0 110.258 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -122.22 114.06 20.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.256 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 96' ' ' LEU . 24.1 tp -94.45 115.5 27.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 4.9 ttp180 -100.01 107.05 18.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.646 ' HB ' HD23 ' A' ' 45' ' ' LEU . 48.2 mt -110.37 118.7 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' HG11 ' A' ' 91' ' ' VAL . 11.0 t80 -75.91 128.3 34.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.059 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 26.4 t30 72.18 84.97 0.12 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.801 0.688 . . . . 0.0 111.758 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 p -89.53 142.06 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.447 HG22 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -124.72 171.34 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.9 0.381 . . . . 0.0 111.676 -178.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -23.12 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -171.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.93 -25.84 60.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.514 0.673 . . . . 0.0 109.894 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.447 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . 1.7 m-20 -101.27 -4.07 27.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.422 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -57.96 -11.85 2.77 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.782 175.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.42 -146.73 0.48 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 121.725 0.625 . . . . 0.0 114.578 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -90.11 136.18 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 111.611 -175.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -105.29 123.4 47.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.277 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -84.62 113.73 21.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.894 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 41.9 t -99.73 117.57 34.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 14.8 t -135.07 118.46 24.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.11 143.41 30.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.968 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.85 118.64 27.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -115.03 85.34 2.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.763 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.73 -90.15 0.16 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.94 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.97 -24.47 13.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.79 25.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 110.786 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.07 143.49 38.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.54 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.966 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 7.0 mm-40 -127.45 132.94 49.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 3.7 pt-20 -123.03 142.66 50.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.423 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -136.84 146.55 45.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.656 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.6 mt -97.02 107.99 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.932 0.396 . . . . 0.0 110.374 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.931 HG23 ' HA3' ' A' ' 35' ' ' GLY . 31.5 m -111.01 100.51 9.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.426 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -84.04 135.14 34.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -88.16 150.73 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.044 0.449 . . . . 0.0 110.637 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.84 101.25 7.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 118' ' ' ASP . 35.9 mm -74.34 108.42 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.872 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.233 0.256 0 N-CA-C 112.908 0.311 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -101.49 146.98 26.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.61 179.21 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.292 0.568 . . . . 0.0 112.257 -170.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -90.65 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.935 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -105.96 129.75 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.09 -110.24 1.25 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 123.572 0.545 . . . . 0.0 112.149 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 33' ' ' LEU . 4.3 mt -146.76 149.86 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 -46.92 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.37 123.13 1.97 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.793 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.63 73.16 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.852 2.368 . . . . 0.0 110.456 172.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.66 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.11 114.97 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.02 -174.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.81 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.754 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.27 173.08 12.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.965 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -112.32 147.17 36.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -73.15 152.08 41.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.48 -7.07 82.0 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.68 179.63 22.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.181 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -79.82 109.58 14.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 110.325 178.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.727 HD13 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -86.99 109.75 19.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.203 178.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.694 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.4 mt-10 -94.25 96.06 9.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.727 HD21 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -104.98 129.51 53.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.775 -175.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -118.07 138.84 51.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 m -117.78 140.2 50.01 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.39 131.85 56.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 110.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -125.4 159.32 32.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.5 -177.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.2 86.5 6.38 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.3 Cg_endo -88.39 153.54 6.6 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.806 2.338 . . . . 0.0 112.55 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 7.2 Cg_exo -73.55 -28.04 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.767 2.311 . . . . 0.0 111.742 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.83 -172.49 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -69.4 -8.27 45.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.137 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 60.74 29.41 18.99 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.107 0.563 . . . . 0.0 112.276 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.49 -42.55 78.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.449 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -101.27 25.0 8.72 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 111.347 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 16.2 ttm -68.88 131.84 45.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.162 0.506 . . . . 0.0 111.457 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -88.05 143.89 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.7 HG21 HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -134.95 148.96 28.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.84 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 3.2 ttp85 -128.74 115.64 18.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.623 ' CZ2' HD22 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -126.65 87.7 2.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -153.61 148.57 26.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.899 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HD3' ' HB2' ' A' ' 117' ' ' ASP . 41.9 ttt-85 . . . . . 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 165.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.636 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -138.77 144.35 39.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.659 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' HE2' HD13 ' A' ' 87' ' ' ILE . 2.7 t80 -100.57 115.11 29.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.52 121.32 44.85 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.085 -168.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.8 t70 64.94 14.16 9.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.148 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.777 ' HA2' HD22 ' A' ' 96' ' ' LEU . . . 89.82 14.05 60.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.741 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -129.05 148.71 51.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 139.02 50.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.934 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.585 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -105.48 -172.89 2.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -75.53 -9.22 58.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.867 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -55.28 3.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.789 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 82' ' ' MET . 6.9 pm0 -74.77 -37.82 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 122.716 0.406 . . . . 0.0 110.446 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.0 tp 43.44 97.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.643 1.177 . . . . 0.0 113.421 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.728 HD13 ' HE2' ' A' ' 76' ' ' TYR . 2.5 tp -62.89 -18.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.167 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -14.22 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.665 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -66.14 -29.67 70.01 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.045 177.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.68 -71.2 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.512 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.99 141.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.01 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.802 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -161.12 65.77 0.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.72 119.16 25.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.223 -174.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.12 99.97 7.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.699 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.777 HD22 ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -86.08 111.39 20.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.186 0.517 . . . . 0.0 110.488 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.2 mp -81.72 112.94 19.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.912 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.05 1.85 56.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.094 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.31 -33.59 63.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.332 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.19 -16.9 65.98 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.814 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -31.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.48 -25.4 66.97 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.435 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.2 13.68 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.979 0.419 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.34 43.66 12.53 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.477 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -129.82 133.19 46.79 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.279 -0.542 . . . . 0.0 110.784 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 62' ' ' ILE . 14.3 m -121.96 132.96 69.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.721 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -116.4 102.86 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.727 178.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.644 HD13 HD12 ' A' ' 96' ' ' LEU . 4.6 tp -96.05 111.52 23.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.098 0.475 . . . . 0.0 110.195 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.694 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -86.42 106.26 17.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.542 174.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.455 HG13 ' HG ' ' A' ' 108' ' ' LEU . 50.0 mt -112.54 112.76 41.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 59.6 t80 -80.14 129.76 34.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 35.5 t30 76.23 79.6 0.09 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.914 0.759 . . . . 0.0 111.76 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 41' ' ' LEU . 10.2 p -84.96 149.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 168.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.25 165.52 14.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.964 0.411 . . . . 0.0 111.964 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.3 -28.95 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.13 -43.27 87.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.552 ' HB2' ' HD3' ' A' ' 66' ' ' ARG . 3.6 p-10 -104.17 4.09 33.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.616 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -62.5 -10.38 11.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 176.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.7 -118.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.931 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.2 124.97 35.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.257 0.551 . . . . 0.0 111.765 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 136' ' ' THR . 50.2 p90 -110.92 164.77 12.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.774 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 113.33 24.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.3 t -104.92 122.37 45.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.84 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 97.8 t -131.95 139.24 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.047 -175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 23.2 m-85 -119.31 140.5 50.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -130.75 105.04 7.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.653 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 43.0 t0 -98.5 74.37 2.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.39 -93.36 0.89 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.3 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -97.79 -27.97 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.742 0.306 . . . . 0.0 111.714 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -96.81 143.18 27.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.922 0.391 . . . . 0.0 110.4 -177.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.738 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -138.02 142.77 40.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.395 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.44 131.91 54.1 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HA ' HG22 ' A' ' 124' ' ' VAL . 8.8 mt-10 -114.36 119.92 38.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 132.19 55.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.158 0.504 . . . . 0.0 111.12 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.452 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -103.5 107.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.576 175.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -120.52 160.66 22.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 139.51 53.83 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.226 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -83.0 150.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -112.58 90.89 3.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mp -80.76 123.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.918 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 N--CA 1.454 -0.824 0 CA-C-O 120.976 0.323 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HE1' ' HA ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -74.83 140.45 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -122.07 168.12 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -170.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 134' ' ' HIS . 67.0 t -91.35 132.46 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.188 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.46 132.25 55.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.72 -107.31 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.749 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.43 168.39 21.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -175.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -48.63 7.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 111.82 2.53 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.927 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.57 86.87 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.569 2.179 . . . . 0.0 111.355 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -72.28 101.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.323 -176.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -87.22 119.72 27.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 171.82 13.8 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.003 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -98.67 133.98 42.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.3 123.42 17.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.85 0.357 . . . . 0.0 111.034 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 94.44 1.22 64.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.04 -174.42 33.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.214 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' HB2' ' HD1' ' A' ' 111' ' ' PHE . 10.3 t30 -93.88 119.8 33.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.36 . . . . 0.0 110.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.499 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -98.23 122.23 41.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.867 -177.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -97.17 101.68 13.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.683 174.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.499 ' HG ' HD22 ' A' ' 45' ' ' LEU . 1.1 mp -96.58 127.25 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.49 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -117.63 130.18 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.74 140.19 50.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 30' ' ' VAL . 8.0 tt0 -110.99 131.34 55.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.138 0.494 . . . . 0.0 110.604 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.24 154.88 44.31 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.376 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -87.27 101.24 2.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.9 Cg_endo -76.41 114.31 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.751 2.3 . . . . 0.0 113.74 -170.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.9 -21.05 9.88 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.44 2.094 . . . . 0.0 110.602 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -171.66 2.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -18.06 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 56.99 32.32 21.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.261 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.59 -33.81 74.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.722 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -93.39 9.61 35.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 146.68 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.314 0.578 . . . . 0.0 111.39 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -92.68 102.63 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.78 130.01 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.689 0.757 . . . . 0.0 111.255 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.577 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 8.1 ttm180 -113.94 117.1 30.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.681 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.602 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -125.86 55.43 1.45 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.81 167.42 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.324 0.583 . . . . 0.0 112.192 -164.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' CD ' ' HB3' ' A' ' 117' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.24 174.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.86 143.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.556 0.535 . . . . 0.0 110.7 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.21 114.8 28.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.168 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.445 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -97.76 120.51 38.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -176.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t70 67.44 14.03 9.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.85 0.833 . . . . 0.0 109.969 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.44 70.72 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.595 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -122.99 151.68 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -101.01 169.32 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.264 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.705 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 2.8 ptt? -140.06 161.33 37.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.79 -27.71 69.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.28 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.17 -5.61 89.04 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.648 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -111.24 -40.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.6 OUTLIER 37.58 80.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.249 1.02 . . . . 0.0 112.929 177.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 76' ' ' TYR . 14.8 tt -64.04 -19.79 25.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.125 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -13.73 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.552 175.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -66.27 -29.84 70.15 Favored 'General case' 0 CA--C 1.524 -0.037 0 CA-C-O 121.019 0.438 . . . . 0.0 110.234 178.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -52.87 7.99 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.44 HG12 HG23 ' A' ' 94' ' ' THR . 7.3 p 176.4 159.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.317 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -79.34 -25.01 42.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -80.53 66.44 6.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.559 173.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.18 89.27 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.66 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -104.87 112.33 25.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.111 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -89.91 101.77 14.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 178.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -75.08 107.21 7.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 1.66 49.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.791 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.23 -29.19 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.16 -16.9 70.76 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.0 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 tp -55.54 -25.53 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.5 -21.12 70.42 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.903 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.26 13.33 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.316 0.579 . . . . 0.0 109.581 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.36 27.13 66.4 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.758 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.87 132.04 56.65 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.968 -0.724 . . . . 0.0 110.84 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.05 131.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -124.08 103.81 8.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.284 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' HG13 ' A' ' 110' ' ' ILE . 9.0 tp -94.86 117.63 30.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.93 0.395 . . . . 0.0 110.336 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.797 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -96.22 107.48 19.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.566 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 94' ' ' THR . 53.3 mt -116.28 121.4 67.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' HD1' ' HB2' ' A' ' 44' ' ' ASN . 22.0 t80 -83.17 130.99 35.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.448 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 56.7 t30 71.78 84.38 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.162 174.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.08 131.92 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.018 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.19 177.24 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.94 -29.95 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -171.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -40.62 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.338 0.59 . . . . 0.0 110.276 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' ' CD ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.47 -7.9 55.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.277 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -63.88 -21.75 66.6 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.81 177.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.07 -110.05 0.08 OUTLIER Glycine 0 C--O 1.243 0.674 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.928 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.72 120.4 25.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.127 -0.536 . . . . 0.0 111.671 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.21 137.36 44.3 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -105.33 115.7 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -105.98 116.27 31.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.121 175.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 85.6 t -134.64 121.54 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.505 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.2 m-85 -111.22 113.39 25.85 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 104.37 9.73 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.546 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -105.28 89.34 3.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.21 -82.55 0.13 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.012 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.31 8.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.07 140.22 34.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 40.2 p90 -147.61 142.9 27.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.408 . . . . 0.0 111.06 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.675 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.99 137.8 41.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.745 176.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 124' ' ' VAL . 4.6 mt-10 -122.12 121.26 36.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.954 0.407 . . . . 0.0 110.436 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -119.36 144.88 46.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.43 108.27 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.602 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -97.07 160.29 14.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.45 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -127.47 135.64 50.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.291 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 23.9 t -98.37 147.1 7.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HB2' ' HA ' ' A' ' 38' ' ' LEU . 1.3 mtpt -120.88 90.22 3.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -75.0 133.66 31.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.223 0.535 . . . . 0.0 109.886 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.84 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 N--CA 1.446 -1.266 0 CA-C-O 120.72 0.217 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -156.63 165.18 37.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.875 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pt -134.75 165.66 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.887 0.375 . . . . 0.0 110.547 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.898 HG23 ' HB3' ' A' ' 132' ' ' GLU . 95.4 t -91.05 127.27 43.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.411 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.18 179.56 4.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.45 -133.9 11.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.07 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -111.42 172.84 6.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 35' ' ' GLY . 1.8 pm0 -69.0 -29.49 67.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 109.39 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.871 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 117.38 72.68 0.46 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.363 173.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.95 52.74 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.497 2.131 . . . . 0.0 111.101 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 138' ' ' VAL . 2.3 m -78.57 104.51 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.499 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.55 137.77 32.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -133.76 170.69 15.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.616 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -119.57 138.32 53.28 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.735 -178.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.33 111.08 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.15 8.53 87.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.013 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 40' ' ' SER . . . -103.92 -147.55 17.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.98 143.78 41.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 39' ' ' ALA . 10.3 tp -127.76 118.94 24.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.175 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -101.39 107.01 18.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.154 178.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -96.75 127.71 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 123.75 39.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.01 0.433 . . . . 0.0 111.103 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.25 50.06 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.82 160.01 18.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.249 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.502 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -127.64 148.71 50.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.035 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 89.67 0.31 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 162.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 14.3 Cg_exo -67.81 115.21 3.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 2.729 . . . . 0.0 114.248 -162.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.27 -32.98 2.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.874 2.383 . . . . 0.0 110.129 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -146.34 -172.78 4.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.344 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.32 -21.89 59.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 55.57 24.54 7.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -42.42 90.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.189 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.11 5.32 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -80.22 174.94 11.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -169.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.148 ' HB3' HD11 ' A' ' 75' ' ' LEU . 48.7 mt-10 -106.24 143.63 34.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.448 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.517 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -118.89 134.04 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 168.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -149.54 59.69 1.01 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -137.89 152.37 48.96 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.715 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HE ' ' HA3' ' A' ' 119' ' ' GLY . 11.4 tpt85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.732 0.777 . . . . 0.0 109.375 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 1.038 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.148 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -149.22 143.6 26.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.475 -169.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.76 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.6 t80 -94.44 114.63 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.217 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.671 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.75 163.71 35.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.322 -0.151 . . . . 0.0 110.845 -173.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t0 68.69 6.93 5.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.669 0.747 . . . . 0.0 109.93 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.76 -6.15 62.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.439 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 pttp -144.69 179.79 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.081 0.467 . . . . 0.0 111.266 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.9 168.09 19.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.717 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.654 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -134.0 143.27 48.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.797 0.332 . . . . 0.0 111.242 -175.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.36 -23.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 0.0 110.941 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.95 -32.57 77.49 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.399 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 2.0 pp20? -95.2 -30.06 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.5 OUTLIER 47.6 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.676 1.19 . . . . 0.0 113.667 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 8.5 tp -77.8 -7.93 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.123 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -13.45 7.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.713 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -69.56 -26.83 64.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.523 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -72.36 0.32 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -154.51 -174.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.829 -178.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -92.04 -23.45 19.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.848 0.356 . . . . 0.0 110.302 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.881 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -106.97 88.94 2.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.301 0.572 . . . . 0.0 111.268 -178.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.504 HG22 HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -116.46 95.61 5.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.292 173.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 23.3 tt0 -103.1 98.93 8.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.621 -171.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.821 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -100.4 117.73 35.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.118 0.485 . . . . 0.0 110.932 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -89.96 109.54 20.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.194 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.14 -10.47 14.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.633 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -17.97 65.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.145 -177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.93 80.33 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.178 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.674 HD11 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 tt -57.56 -29.04 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 122.707 0.403 . . . . 0.0 111.709 -174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.88 64.04 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.658 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.13 4.7 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.166 0.507 . . . . 0.0 110.211 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.08 42.17 8.96 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.711 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 132.64 40.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.818 0.309 . . . . 0.0 110.538 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.79 132.33 59.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.253 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 46' ' ' GLU . 1.2 m -123.02 124.46 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.461 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.821 HD13 HD12 ' A' ' 96' ' ' LEU . 40.8 tp -112.11 111.9 23.13 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -96.03 105.95 18.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.81 132.09 51.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.881 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 1.5 m-85 -95.99 143.44 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.0 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HB3' HG11 ' A' ' 91' ' ' VAL . 49.4 t30 67.15 84.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -95.12 128.67 46.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.007 178.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.9 p -96.84 175.52 6.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.04 -16.8 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.602 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.43 -44.81 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.516 ' HB2' HG12 ' A' ' 113' ' ' VAL . 41.0 m-20 -65.8 -25.19 67.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.602 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.733 ' HB2' HD13 ' A' ' 140' ' ' ILE . 17.8 t70 -55.36 -17.42 4.83 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA3' ' HE ' ' A' ' 66' ' ' ARG . . . -71.82 -156.96 2.84 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.11 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -78.29 105.94 9.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.923 0.392 . . . . 0.0 111.729 -176.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -73.97 144.45 45.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 114.02 27.19 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.474 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 51.2 t -97.38 117.06 30.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.517 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 10.6 t -131.6 105.11 9.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.674 ' HZ ' HD11 ' A' ' 101' ' ' ILE . 21.8 t80 -97.82 139.2 34.03 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.186 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.0 mtpt -122.12 104.58 9.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.219 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 17.6 t0 -106.71 138.4 42.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.447 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.86 -110.61 1.76 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.96 11.52 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 159.7 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 4.9 p90 -140.67 153.43 45.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.88 0.372 . . . . 0.0 111.17 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.898 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -142.45 157.35 44.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.592 178.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -133.38 154.44 50.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.242 0.544 . . . . 0.0 112.22 -172.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.86 124.55 14.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.167 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.94 108.95 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.433 . . . . 0.0 110.247 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.871 HG23 ' HA3' ' A' ' 35' ' ' GLY . 99.0 m -122.29 102.34 8.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.745 -176.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 5.3 pt-20 -82.84 141.96 31.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.463 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 37' ' ' VAL . 89.6 t -86.82 151.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -113.63 92.29 3.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 174.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -71.75 120.33 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 139' ' ' LYS . 2.3 t . . . . . 0 C--O 1.251 1.164 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.572 -174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 CA-C-O 120.656 0.19 . . . . 0.0 111.909 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -105.43 158.0 16.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 177.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.63 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.5 pt -129.25 167.93 23.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' HB3' ' A' ' 132' ' ' GLU . 44.3 t -91.1 144.7 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.83 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.09 161.31 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.604 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -171.15 28.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.536 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.21 176.85 4.86 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -49.8 73.73 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.158 0.286 . . . . 0.0 110.829 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.56 81.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.518 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.82 89.93 0.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.575 2.183 . . . . 0.0 111.061 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -68.55 124.78 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.409 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -88.77 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.014 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.41 170.58 9.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -120.98 145.07 48.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 119.04 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.074 0.464 . . . . 0.0 110.586 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 90.76 -7.33 81.41 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.322 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.11 -176.35 49.04 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.528 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -87.61 115.65 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -108.12 118.65 37.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.407 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.91 112.24 24.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.372 177.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.6 128.1 42.19 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.28 128.5 52.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 140.49 52.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.82 145.26 45.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.48 -178.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 28' ' ' PHE . 4.6 mt -117.75 164.37 15.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.71 85.36 0.55 Allowed Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 165.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 11.7 Cg_exo -68.39 119.2 6.21 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.233 2.622 . . . . 0.0 113.929 -162.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 -31.95 4.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.757 2.304 . . . . 0.0 110.098 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.99 -172.64 3.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.667 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -71.23 -15.93 62.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 59.46 17.05 5.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -64.3 -22.56 66.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.126 0.489 . . . . 0.0 111.22 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -115.14 24.18 11.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.318 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.677 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -86.55 169.9 12.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -178.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 12.0 tt0 -101.79 123.68 46.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.089 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.37 137.7 45.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.399 0.619 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.681 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 8.0 mtt180 -134.41 116.95 15.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.806 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.753 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -136.85 73.48 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -177.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -149.28 169.69 20.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.184 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-O 121.309 0.576 . . . . 0.0 110.993 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 82' ' ' MET . 0.1 OUTLIER -161.68 113.72 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -143.42 109.58 5.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 159.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.3 122.68 26.85 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.037 -0.414 . . . . 0.0 111.447 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 56.57 41.01 29.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.151 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.08 24.89 65.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.857 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.1 tptt -145.6 129.63 17.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.836 0.351 . . . . 0.0 111.049 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.26 163.36 17.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.798 ' HB2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -123.34 161.92 23.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.709 ' HA ' HG13 ' A' ' 86' ' ' ILE . 23.9 m-85 -62.24 -20.79 64.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.081 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.49 99.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.246 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OE1' ' HA ' ' A' ' 74' ' ' HIS . 3.9 tp10 -104.15 -43.19 5.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.709 HG13 ' HA ' ' A' ' 83' ' ' PHE . 6.2 mt 61.09 109.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 122.037 0.922 . . . . 0.0 112.294 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 94' ' ' THR . 8.2 tp -72.38 -19.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.165 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -14.29 49.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.377 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -72.29 -26.09 61.84 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.403 0.621 . . . . 0.0 109.666 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 29.4 m-85 -92.23 -65.33 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.215 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.558 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p 166.73 153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.2 60.25 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.288 177.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 1.1 mmp_? -145.98 60.69 1.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.7 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -125.46 164.5 20.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.105 -174.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.51 135.76 13.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.588 173.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 4.2 tp -108.26 94.29 4.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.809 0.338 . . . . 0.0 110.108 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -70.45 108.76 4.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 109.707 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -107.07 6.59 29.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 -176.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.11 -25.91 68.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.012 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.0 -16.8 66.63 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.266 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.496 HD13 ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -53.79 -28.23 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.88 -26.71 67.47 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.072 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.53 15.31 19.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 109.857 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.584 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 76.83 43.2 18.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.462 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.489 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.275 0.537 . . . . 0.0 110.603 176.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' A' ' 125' ' ' PHE . 15.4 m -131.05 139.51 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -126.96 106.43 9.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 96' ' ' LEU . 13.9 tp -90.27 107.59 19.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.146 0.498 . . . . 0.0 110.121 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -84.79 107.43 16.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.552 178.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.5 mt -116.88 111.35 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.838 0.351 . . . . 0.0 110.498 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 23.9 t80 -81.44 137.04 35.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.546 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 53.9 t30 77.9 75.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.917 0.761 . . . . 0.0 111.71 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.88 148.73 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -113.1 164.58 13.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.207 0.527 . . . . 0.0 112.118 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 7.7 p -66.69 -25.35 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.078 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 5.0 t70 -73.57 -34.22 65.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 175.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -78.79 -19.28 52.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.497 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.615 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -54.69 -15.96 2.19 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.633 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.52 -130.98 0.98 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.726 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -94.95 121.4 36.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.073 0.463 . . . . 0.0 111.61 -177.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.3 m-85 -87.68 142.97 27.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.565 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.75 118.76 35.21 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.186 0.517 . . . . 0.0 111.026 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 37.1 t -100.45 120.67 40.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.195 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.19 121.09 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CD1' HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.68 137.23 52.28 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.33 -178.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.947 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 20.4 mtpt -121.29 111.71 17.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.677 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 14.8 t70 -101.91 111.84 24.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.99 -105.93 1.69 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.035 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.03 -7.92 9.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 28' ' ' PHE . 3.2 p90 -100.23 148.82 24.21 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.417 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.947 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 4.0 p90 -133.74 151.99 51.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.273 0.559 . . . . 0.0 112.017 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.765 ' HB3' HG23 ' A' ' 30' ' ' VAL . 1.6 mm-40 -128.89 156.83 43.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.8 174.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -133.53 142.57 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.392 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -129.09 133.65 47.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.056 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.98 107.91 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.81 0.338 . . . . 0.0 110.498 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.562 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 51.7 m -117.68 118.3 31.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.624 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -77.7 134.85 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.61 149.86 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -114.02 96.08 5.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.761 0.315 . . . . 0.0 110.745 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.1 mp -76.3 118.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.492 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 130' ' ' PHE . 13.0 Cg_exo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.96 0.316 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.642 ' HZ ' ' HB3' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -143.65 141.69 30.68 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 HG22 ' HG3' ' A' ' 132' ' ' GLU . 1.1 pp -139.09 178.38 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 110.956 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 134' ' ' HIS . 71.9 t -106.49 145.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.422 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.44 144.2 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.802 0.334 . . . . 0.0 110.452 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.62 60.95 4.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.736 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -135.79 109.74 8.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 4.3 mp0 -77.25 -49.13 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.8 91.4 0.17 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.52 95.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.553 2.835 . . . . 0.0 112.987 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.73 97.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.998 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.8 101.76 13.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.417 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 45' ' ' LEU . . . -111.21 170.81 7.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.633 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.0 m -130.56 141.36 50.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 128.08 35.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.31 -23.89 22.22 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.65 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.3 174.67 52.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.7 138.9 39.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -118.1 122.11 42.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.942 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.643 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 6.4 mt-10 -102.52 108.02 19.18 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 HD12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -95.3 128.38 42.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.328 -176.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.22 129.59 55.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.746 -174.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -138.26 140.11 39.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 131.52 52.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.922 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -111.35 165.0 12.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.367 -173.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -124.92 72.26 63.05 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.398 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 92.9 Cg_endo -91.3 155.88 3.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.215 2.61 . . . . 0.0 113.207 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 35.4 Cg_endo -92.55 14.51 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.413 2.742 . . . . 0.0 112.108 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -137.09 -173.03 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.725 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.24 -16.77 34.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.217 175.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 60.72 13.14 4.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.99 174.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.693 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 4.1 tm0? -56.34 -40.78 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 3.0 p80 -115.51 21.96 13.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.031 0.443 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -74.07 -173.52 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -177.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 77' ' ' ARG . 1.3 tt0 -103.81 118.21 36.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.965 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -127.3 123.89 62.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.0 111.92 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 123' ' ' CYS . 7.8 ttt85 -102.25 132.72 48.02 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.469 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -144.89 59.56 1.31 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -142.95 157.98 44.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.352 0.596 . . . . 0.0 111.864 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 165.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 2.0 m80 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -164.84 149.81 9.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.574 -173.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' A' ' 62' ' ' ILE . 29.5 t80 -95.95 118.32 32.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.725 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.664 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -132.12 137.71 47.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.113 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 59' ' ' HIS . 4.2 m-20 63.07 17.03 9.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.288 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 15.24 70.43 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.481 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -136.59 143.16 43.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 0.0 110.527 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 8.8 p-10 -85.88 137.78 32.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.74 155.91 24.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.042 -176.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -40.21 80.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.215 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.6 0.91 79.93 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.79 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -105.54 -43.18 5.01 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.595 -0.356 . . . . 0.0 110.22 178.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 27.67 84.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.461 1.101 . . . . 0.0 113.019 -178.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 94' ' ' THR . 16.1 tt -62.65 -11.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.557 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -12.34 58.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -13.9 14.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -78.37 7.37 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.13 -0.356 . . . . 0.0 110.751 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.0 33.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.332 0.653 . . . . 0.0 111.657 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -170.71 -164.16 0.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 178.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -79.46 143.02 35.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -139.62 104.04 4.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.953 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -114.88 108.21 16.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.532 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.72 109.8 18.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.945 0.403 . . . . 0.0 110.846 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.6 105.65 11.06 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -102.13 9.94 39.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.88 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -27.09 67.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.522 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.72 -16.75 65.11 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.172 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -33.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -170.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.55 -11.02 67.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.073 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 6.05 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.16 26.55 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.55 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.18 133.08 38.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.384 -0.48 . . . . 0.0 110.796 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.11 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.855 0.359 . . . . 0.0 110.557 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -126.19 105.92 9.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.151 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' HG ' HG13 ' A' ' 110' ' ' ILE . 13.8 tp -90.78 118.13 29.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.643 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -86.88 106.61 17.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.691 175.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.639 HD12 HD23 ' A' ' 47' ' ' LEU . 56.4 mt -111.37 121.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.516 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -82.25 136.03 35.14 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.5 t30 68.59 91.66 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.431 0.634 . . . . 0.0 111.621 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.7 p -79.5 120.71 31.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.4 150.3 24.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.736 -176.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.95 -22.57 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.23 -35.96 58.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.214 0.53 . . . . 0.0 109.818 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.09 5.52 46.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.73 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.34 -4.27 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.916 176.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -134.42 0.52 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.0 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -102.17 127.86 48.91 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.343 -0.504 . . . . 0.0 111.032 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.843 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 40.7 m-85 -82.93 151.94 25.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.07 110.41 18.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.783 0.325 . . . . 0.0 111.034 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.5 OUTLIER -98.6 117.15 32.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 133' ' ' GLU . 8.0 t -118.6 107.36 21.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.642 ' HB3' ' HZ ' ' A' ' 28' ' ' PHE . 2.7 t80 -99.26 133.67 43.22 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.777 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -121.53 110.82 16.49 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.12 72.05 5.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.97 -96.82 1.6 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.178 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.33 -27.32 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 111.311 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.509 ' HB2' ' HD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -94.48 143.31 26.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 52.4 p90 -146.88 151.08 36.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.49 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.648 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -147.53 143.68 27.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.685 ' HB3' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -112.71 144.96 41.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.145 0.498 . . . . 0.0 110.753 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 30' ' ' VAL . 52.0 t-80 -129.82 138.83 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.61 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -104.06 107.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.5 m -99.7 107.76 19.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.438 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -75.71 122.73 24.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 -178.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -96.18 150.71 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 110.82 12.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.302 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 113' ' ' VAL . 8.9 mt -76.77 102.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 110.436 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.461 -0.411 0 CA-C-O 120.909 0.295 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -153.71 136.66 15.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.1 pt -144.53 165.8 12.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.617 0.723 . . . . 0.0 112.062 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.556 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.0 t -97.6 149.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.182 171.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -67.07 150.59 48.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.85 63.41 3.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.264 -0.493 . . . . 0.0 113.344 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 tp -139.51 132.4 29.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -85.9 -31.7 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.262 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.59 90.51 0.8 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.807 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.16 80.55 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.808 2.339 . . . . 0.0 110.97 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.53 92.42 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -89.39 110.09 20.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.773 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.19 171.97 8.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.137 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.05 133.55 36.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 140' ' ' ILE . 3.1 tp -66.62 111.69 3.77 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.944 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.6 11.49 74.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.819 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.38 -152.01 9.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.919 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -87.45 134.25 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.413 . . . . 0.0 111.112 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -119.93 115.44 23.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.519 176.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.5 mt-10 -108.19 110.08 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 110.748 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.69 129.22 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.346 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.26 122.16 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.888 0.375 . . . . 0.0 110.632 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.66 140.02 50.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -120.1 130.1 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.109 0.481 . . . . 0.0 110.131 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.7 mm? -117.72 165.22 13.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.047 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.49 71.6 26.77 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 94.6 Cg_endo -89.48 154.61 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.013 2.475 . . . . 0.0 113.322 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.6 Cg_exo -70.44 -25.54 25.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.003 2.469 . . . . 0.0 111.964 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.21 -173.26 3.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.939 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -22.51 42.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 54.22 32.97 17.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -32.0 66.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.791 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -115.46 28.96 8.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.866 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.935 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -91.73 -165.6 1.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.289 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.8 126.66 53.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 110.745 -178.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.466 HD13 HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -126.49 146.57 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.243 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.632 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 10.0 ttm180 -132.52 117.37 17.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.527 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -131.36 58.34 1.73 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CE1' HG13 ' A' ' 87' ' ' ILE . 59.4 m-85 -139.38 150.66 45.57 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.676 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -178.69 151.55 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.228 0.537 . . . . 0.0 111.472 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.35 117.52 30.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -127.46 143.1 51.24 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.784 -172.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.62 17.51 10.62 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.827 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.5 83.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.057 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -139.66 177.15 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 111.285 -178.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -95.41 170.07 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.112 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.52 138.96 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.945 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.84 -4.7 36.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.649 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.62 -16.42 70.84 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.781 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.633 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -111.94 -40.96 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.244 -177.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.633 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 76.6 mt 49.15 87.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 112.235 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -74.22 -6.46 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -14.84 27.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 173.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -21.85 64.1 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.899 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.0 t80 -85.58 -69.05 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -162.63 145.69 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.228 173.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -72.53 -7.86 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.348 0.594 . . . . 0.0 110.206 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.721 ' HA ' HH11 ' A' ' 93' ' ' ARG . 2.3 mmm180 -97.19 69.32 2.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.158 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.673 HG21 HD12 ' A' ' 87' ' ' ILE . 21.3 m -131.41 103.97 6.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.634 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.75 106.93 17.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.611 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 108' ' ' LEU . 1.1 tp -91.17 100.62 13.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.878 0.37 . . . . 0.0 110.708 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.478 HD12 ' HB ' ' A' ' 107' ' ' THR . 30.3 mt -77.07 117.39 18.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.21 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.42 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 6.8 mtmm -108.12 15.4 24.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.645 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.81 -33.67 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.648 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.33 -16.68 70.87 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.037 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -29.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -21.35 59.62 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.155 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -117.21 4.1 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.759 0.314 . . . . 0.0 110.469 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.15 35.06 11.4 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.022 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.3 55.65 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.177 -0.602 . . . . 0.0 110.712 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.466 HG11 HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -128.34 132.89 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.853 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.478 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.29 110.48 16.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.805 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 96' ' ' LEU . 5.4 tp -98.41 119.56 37.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.794 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 2.6 mpp_? -96.12 106.71 18.93 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.483 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.605 ' HB ' HD23 ' A' ' 45' ' ' LEU . 69.1 mt -117.61 124.19 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.818 0.342 . . . . 0.0 110.132 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -94.19 132.12 39.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.858 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.478 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 36.9 t-20 75.54 80.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.024 0.827 . . . . 0.0 112.287 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.895 HG21 HD22 ' A' ' 45' ' ' LEU . 41.3 t -107.85 139.5 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.864 172.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.448 ' HA ' HD12 ' A' ' 41' ' ' LEU . 6.1 p -116.02 -173.71 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -24.6 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -168.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.29 -48.09 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.05 0.452 . . . . 0.0 110.534 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.407 ' OD2' HG13 ' A' ' 113' ' ' VAL . 7.2 p-10 -85.01 -6.61 59.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.626 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -68.92 -3.59 13.33 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 175.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.31 -99.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.0 -0.619 . . . . 0.0 114.066 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.09 128.01 41.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 111.21 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -90.48 151.5 21.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.307 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.86 108.72 20.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.036 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -101.11 117.91 35.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.329 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 23.1 t -134.03 131.92 55.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -122.43 122.67 39.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.19 104.45 11.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 110.312 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.935 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 58.0 t0 -92.74 83.39 4.83 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.9 -97.55 0.82 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.617 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.44 -5.19 13.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.588 0.232 . . . . 0.0 111.568 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.87 110.06 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.12 141.1 43.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.522 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.583 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -121.02 154.41 36.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 176.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -135.19 128.62 32.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.04 135.47 32.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.451 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.15 127.2 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.237 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.527 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -105.46 134.71 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.145 -176.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -92.41 115.85 28.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.61 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 16.3 t -96.29 141.64 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -131.13 95.42 3.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -73.47 127.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.175 0.512 . . . . 0.0 109.702 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.033 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 N--CA 1.46 -0.474 0 CA-C-O 120.969 0.32 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.478 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -86.71 170.4 11.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.44 168.21 24.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.291 0.567 . . . . 0.0 111.789 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.67 148.59 11.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.375 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -93.31 160.75 14.68 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.08 43.71 2.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.581 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 tp -133.95 94.2 3.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.202 0.525 . . . . 0.0 110.051 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -102.24 -24.34 13.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.573 175.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 93.64 1.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.013 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 68.37 3.85 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.761 2.308 . . . . 0.0 110.118 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 130.04 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.719 -169.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -97.52 91.61 5.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.927 174.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.68 151.89 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.375 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.74 121.49 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -63.39 118.76 8.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 96.8 -2.74 62.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.181 -177.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.73 -165.27 24.28 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.324 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.45 115.97 22.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 tp -100.97 112.47 24.93 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.096 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.98 108.42 19.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.069 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.1 mt -95.94 128.76 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -122.23 122.27 38.74 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.044 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.17 140.13 50.24 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.4 131.32 56.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -126.44 157.05 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.06 -178.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.26 83.2 51.95 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.22 156.64 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.086 2.524 . . . . 0.0 112.843 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 97.5 Cg_endo -87.5 20.36 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.98 2.453 . . . . 0.0 112.091 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.49 -172.96 3.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.734 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -72.09 -19.11 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.127 0.267 . . . . 0.0 111.681 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 59.62 24.78 13.61 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.197 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -59.09 -40.85 86.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -89.09 18.7 4.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.379 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -49.65 132.54 21.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.229 0.538 . . . . 0.0 112.413 -175.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 75' ' ' LEU . 37.6 tt0 -96.0 101.02 12.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG12 ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -117.3 137.0 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.163 0.506 . . . . 0.0 111.521 -171.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.603 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -114.25 117.02 29.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.465 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -127.42 59.57 1.43 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.91 171.7 14.82 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.881 -165.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.688 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.129 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -110.49 133.95 52.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.925 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 110.71 19.92 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 172.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -116.64 113.64 22.95 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.578 -174.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 t0 64.71 12.1 7.34 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.776 0.672 . . . . 0.0 111.166 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 2.76 58.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.919 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 133.27 47.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.962 0.41 . . . . 0.0 110.853 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -125.11 157.74 35.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.414 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 -172.8 2.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.709 0.29 . . . . 0.0 110.508 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -6.44 56.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.887 0.375 . . . . 0.0 111.575 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.88 -53.35 3.55 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.208 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.8 pm0 -90.65 12.94 17.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.904 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' A' ' 89' ' ' LYS . 3.1 tt -36.89 114.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.235 0 O-C-N 124.619 1.2 . . . . 0.0 110.903 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.558 HG12 HG21 ' A' ' 94' ' ' THR . 11.4 tt -71.77 -18.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.21 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -15.14 63.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 0.0 110.106 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.757 ' HB2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -81.58 -18.0 46.34 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.423 0.63 . . . . 0.0 109.556 177.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -82.19 -55.72 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.092 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.892 HG12 HG23 ' A' ' 94' ' ' THR . 0.3 OUTLIER -161.13 155.2 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.148 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.65 -58.08 10.13 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.2 0.312 . . . . 0.0 111.735 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.757 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 6.7 tpp85 -91.95 84.37 5.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.206 0.526 . . . . 0.0 110.969 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.892 HG23 HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -115.76 136.39 53.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.654 178.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -145.56 134.6 22.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.454 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -101.7 108.34 19.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.808 0.337 . . . . 0.0 110.247 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -75.85 106.88 7.67 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.44 2.65 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.374 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -51.61 -38.86 56.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.023 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.63 67.84 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.74 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -35.8 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -168.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.06 -6.0 50.66 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.511 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.83 1.69 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.057 0.456 . . . . 0.0 109.913 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.58 42.9 9.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.004 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 132.79 38.45 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.162 -0.611 . . . . 0.0 110.573 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 m -123.74 133.25 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.405 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.61 103.37 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 96' ' ' LEU . 20.2 tp -86.12 118.07 25.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.46 107.24 19.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.053 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HG ' ' A' ' 108' ' ' LEU . 86.9 mt -115.53 109.39 28.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.757 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 30.0 t80 -80.87 122.89 27.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.903 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 42.7 t30 79.57 75.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.182 0.926 . . . . 0.0 110.791 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.87 140.11 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.878 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.5 p -103.68 163.4 12.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.516 0.674 . . . . 0.0 112.159 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.684 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -69.59 -14.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.219 177.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -75.29 -24.16 57.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.566 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.69 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 42.7 m-20 -103.45 -10.64 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.723 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.833 ' HB2' HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.05 6.63 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.85 -128.68 6.37 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.081 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.52 117.75 30.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.763 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.69 ' HE1' ' HB3' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -87.52 157.91 19.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.38 118.83 32.23 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.619 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.6 t -105.46 116.52 32.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.842 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.603 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 6.2 t -123.89 111.26 28.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.533 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 1.4 m-85 -97.38 123.62 41.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.758 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 12.9 mtpt -132.88 136.47 46.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.544 0.688 . . . . 0.0 111.759 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.3 76.51 1.7 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.684 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.99 -98.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.771 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 -27.4 20.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.485 0.184 . . . . 0.0 111.472 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -75.3 132.55 41.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.424 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 12.6 p90 -151.23 141.08 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 151.46 47.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.639 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.56 51.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.77 137.7 21.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.897 0.379 . . . . 0.0 111.15 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.26 46.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.325 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.441 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -112.56 157.12 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.149 -178.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 122.66 45.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.38 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 74.2 t -102.62 113.25 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 139' ' ' LYS . 3.1 mmmm -97.76 108.24 20.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.841 0.353 . . . . 0.0 110.066 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.833 HG12 ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -76.81 129.46 37.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.397 0.617 . . . . 0.0 111.225 -176.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.452 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--O 1.233 0.257 0 CA-C-O 121.236 0.431 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -164.7 147.44 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -143.62 175.38 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.303 -173.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.13 144.36 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.954 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.09 139.31 56.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.731 0.3 . . . . 0.0 110.394 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.37 0.35 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.933 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.26 155.22 42.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.27 -49.4 19.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 66.61 1.77 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.476 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.06 88.11 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.37 2.046 . . . . 0.0 111.791 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 t -75.35 92.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.26 98.83 10.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.153 0.501 . . . . 0.0 110.176 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 113' ' ' VAL . . . -109.37 158.09 18.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.604 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -112.66 129.42 56.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -57.27 125.93 24.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.1 -22.57 22.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.538 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -172.62 41.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.127 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 2.9 p-10 -79.26 125.86 30.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.275 0.559 . . . . 0.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -97.58 123.13 41.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.418 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 112.4 24.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.999 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 45' ' ' LEU . 1.2 mt -96.42 128.71 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 124.71 52.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -130.35 143.4 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.489 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -132.24 131.03 41.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.56 166.14 19.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.536 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -97.51 97.87 4.46 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 85.2 Cg_endo -85.16 130.13 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.779 2.319 . . . . 0.0 113.754 -171.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 16.4 Cg_exo -68.65 -37.55 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.753 2.302 . . . . 0.0 110.744 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 5.3 pt20 -133.91 -172.33 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.876 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.659 ' HG2' ' H ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -69.02 -29.95 68.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.678 0.275 . . . . 0.0 111.339 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 55.49 26.28 8.79 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.426 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.659 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -62.15 -25.44 67.75 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -113.48 18.94 17.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.864 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -88.42 -166.3 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -176.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 1.3 mt-10 -116.66 131.99 56.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.697 0.284 . . . . 0.0 110.678 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 147.46 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.139 0.495 . . . . 0.0 110.384 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.764 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -128.59 117.45 21.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.047 178.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.516 ' NE1' ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -126.17 59.35 1.33 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 63' ' ' ARG . 83.2 m-85 -136.6 159.44 41.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.338 0.59 . . . . 0.0 112.422 -164.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HD2' ' HA ' ' A' ' 117' ' ' ASP . 9.7 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.138 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.658 ' HD2' ' HA ' ' A' ' 85' ' ' GLU . 1.8 m170 . . . . . 0 N--CA 1.456 -0.175 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 147.48 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.05 0.452 . . . . 0.0 111.067 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.63 112.11 23.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -105.19 122.38 45.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.68 20.01 8.69 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.571 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.43 9.1 76.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.285 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.68 156.14 24.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.46 148.74 21.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.943 0.402 . . . . 0.0 110.352 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.26 156.59 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.653 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -25.38 67.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.71 -25.97 47.92 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.179 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.658 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -82.67 -43.28 17.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.5 tp 39.77 82.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.605 1.19 . . . . 0.0 112.51 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 94' ' ' THR . 29.0 pt -68.52 -1.8 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.212 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -14.91 60.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 173.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -41.31 78.87 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.836 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG12 ' A' ' 91' ' ' VAL . 38.9 m-85 -81.42 -49.55 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 73.22 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.34 1.025 . . . . 0.0 112.482 174.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER 73.35 -125.49 0.04 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.668 175.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HA ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -95.63 96.51 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 -176.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -110.54 114.19 27.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 177.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -145.69 123.56 11.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.568 HD22 ' HD2' ' A' ' 76' ' ' TYR . 12.2 tp -92.59 112.85 24.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.0 110.359 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -74.18 105.48 5.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.6 4.8 50.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.919 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.99 -34.62 57.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.501 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.55 -16.69 65.63 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.945 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -51.32 -38.5 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -167.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.02 -11.14 60.48 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.751 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -116.22 1.15 13.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.52 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.11 34.5 12.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.931 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.639 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -124.55 140.14 53.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.875 0.338 . . . . 0.0 110.613 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.43 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 175.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -125.24 104.55 8.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.242 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 64' ' ' TRP . 5.7 tp -87.84 115.11 25.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 0.0 110.456 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -93.99 107.42 19.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.86 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 108' ' ' LEU . 1.9 mt -122.35 114.38 42.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -72.74 146.12 46.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.159 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 7.0 t30 75.1 89.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.131 0 O-C-N 123.922 0.764 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.432 HG11 ' HB1' ' A' ' 39' ' ' ALA . 4.1 p -107.21 145.11 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 175.48 8.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 41' ' ' LEU . 43.6 t -60.29 -26.34 36.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.282 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -30.2 71.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.474 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 119' ' ' GLY . 15.4 m-20 -93.02 -14.01 27.93 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.05 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.051 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -118.23 -128.62 3.94 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.98 130.4 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.323 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.479 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.5 m-85 -104.28 141.88 35.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.23 120.22 39.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.148 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -98.82 125.11 44.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.403 174.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.764 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 3.6 t -134.32 134.04 55.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 43.0 m-85 -124.61 120.35 31.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.701 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.1 mtpm? -111.16 106.21 15.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.168 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.864 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 49.3 t0 -114.88 114.24 25.24 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.713 0.633 . . . . 0.0 109.754 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.87 -104.06 1.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.962 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -117.4 -10.26 10.74 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.64 154.32 21.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 -176.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.525 ' HD2' HG13 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -143.63 146.95 33.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 0.0 111.413 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.984 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -126.2 160.81 29.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.321 177.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.49 150.85 45.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.522 . . . . 0.0 111.515 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -147.2 132.87 18.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.036 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -89.21 116.33 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.483 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -116.2 134.55 54.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.247 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.87 139.66 30.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.201 0.525 . . . . 0.0 111.895 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.8 t -106.1 132.13 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.568 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -117.54 106.8 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.388 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 41' ' ' LEU . 1.5 mp -73.6 119.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.187 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 CA-C-O 121.539 0.558 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -146.93 139.35 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.354 -177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.86 159.3 9.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.999 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.27 134.33 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.945 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 140.88 48.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.542 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.18 -126.36 7.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.518 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.8 177.69 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 mp0 -70.46 -33.9 71.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.127 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.79 75.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.979 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.28 70.37 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.001 2.468 . . . . 0.0 111.36 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.53 106.92 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.182 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -98.75 147.94 24.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -137.3 171.71 14.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.23 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.2 121.0 36.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.091 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.85 128.38 36.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 83.62 -14.54 41.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.764 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.74 -156.84 27.54 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.976 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.99 130.97 35.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.004 0.43 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 110' ' ' ILE . 1.2 tp -110.01 110.36 21.25 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -114.01 114.66 26.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 -178.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 45' ' ' LEU . 1.2 mm? -100.69 128.74 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.362 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.2 121.28 44.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.76 141.07 51.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -134.13 140.82 46.83 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.122 0.487 . . . . 0.0 110.988 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD23 ' CD1' ' A' ' 125' ' ' PHE . 1.2 pp -127.58 161.68 28.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.179 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 1.6 m -82.18 109.05 13.55 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 8.2 Cg_exo -70.53 112.45 3.22 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.255 2.637 . . . . 0.0 114.271 -167.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 52' ' ' SER . 88.9 Cg_endo -90.94 -8.59 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.95 2.434 . . . . 0.0 110.405 168.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -158.41 -172.17 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.426 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -9.11 58.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.75 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 70.63 -1.85 2.44 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.466 0.706 . . . . 0.0 112.877 173.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -65.66 -18.06 65.05 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.047 0.451 . . . . 0.0 111.255 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.64 6.93 22.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.07 155.21 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.311 0.577 . . . . 0.0 112.101 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.026 ' HG2' HD13 ' A' ' 75' ' ' LEU . 11.1 mt-10 -80.02 107.8 13.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.206 172.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.39 140.79 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.361 0.601 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 1.051 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 1.6 ttp180 -131.81 131.63 43.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.302 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.534 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -147.77 57.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.307 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 22.9 m-70 . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -155.64 151.08 27.03 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -164.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.0 111.81 24.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -147.49 153.51 39.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.523 -172.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.64 ' N ' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 64.32 26.06 13.58 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.574 0.546 . . . . 0.0 109.867 175.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.57 73.5 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.963 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -142.51 151.28 41.49 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.115 0.484 . . . . 0.0 111.727 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.71 154.49 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.616 171.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.54 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 23.1 mtp -114.5 -160.04 0.72 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.802 0.334 . . . . 0.0 111.677 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' H ' ' HB3' ' A' ' 82' ' ' MET . 25.7 p90 -72.66 -36.41 67.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.654 ' HA3' ' CE1' ' A' ' 74' ' ' HIS . . . -85.04 -44.05 6.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.504 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 1.6 pm0 -87.45 17.91 4.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.441 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.95 108.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.787 0.804 . . . . 0.0 110.421 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 108' ' ' LEU . 9.3 tt -70.0 -16.73 20.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.744 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -12.84 61.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -60.03 -20.57 58.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.335 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -76.11 0.39 19.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 t 57.16 39.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.419 0.688 . . . . 0.0 112.028 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -168.67 177.56 5.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.864 176.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HG3' ' HB2' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -72.34 141.95 48.79 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.209 0.528 . . . . 0.0 110.813 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.665 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -137.51 141.68 41.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.783 -177.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -136.49 104.25 5.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.776 177.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -78.23 90.28 4.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' A' ' 107' ' ' THR . 20.6 mt -68.81 120.51 14.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.183 0.516 . . . . 0.0 110.894 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 8.99 27.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.858 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.52 -33.69 70.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.47 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.23 -16.66 64.21 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.178 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 57' ' ' ALA . 2.3 tt -54.05 -36.26 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -167.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.92 70.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.104 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.99 2.24 37.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.205 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.01 19.85 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.322 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.66 133.2 53.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.419 0.61 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.99 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 122.237 -0.29 . . . . 0.0 110.27 176.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.539 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.11 107.86 13.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 111.282 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.549 HD13 HD12 ' A' ' 96' ' ' LEU . 45.1 tp -88.33 112.76 23.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.815 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -92.71 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.289 176.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.665 HG12 HG23 ' A' ' 94' ' ' THR . 57.3 mt -116.49 124.63 72.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 1.5 t80 -76.57 124.96 28.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.185 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 54.8 t30 77.04 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.158 0.911 . . . . 0.0 112.053 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 140' ' ' ILE . 11.5 p -133.95 141.52 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.24 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -123.16 174.69 7.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.12 -11.86 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.021 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.64 -24.34 41.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -101.74 -9.97 20.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 140' ' ' ILE . 36.4 t70 -68.46 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.797 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -127.68 -126.54 2.91 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.822 -177.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -77.4 114.8 16.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -174.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -110.31 128.03 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.51 175.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 118.82 37.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.209 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.7 t -105.46 140.3 38.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.635 175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 1.9 t -144.43 132.55 17.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.213 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -120.3 115.45 23.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.336 176.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.619 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.7 mtpm? -130.66 102.26 6.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.845 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -91.74 71.35 5.76 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.56 -107.33 2.29 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.11 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.33 -19.97 27.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.946 0.403 . . . . 0.0 110.429 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' LYS . 21.7 m-85 -68.82 94.37 0.61 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.619 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -120.44 137.81 54.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.2 0.524 . . . . 0.0 111.96 -172.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.89 135.2 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.415 171.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -122.7 137.73 54.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.349 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.35 146.95 37.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.219 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 120' ' ' SER . 1.1 tp -123.14 113.21 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.646 0.736 . . . . 0.0 110.452 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 159.71 18.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.273 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.48 129.11 53.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.22 129.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.66 97.82 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.074 0.464 . . . . 0.0 110.863 -177.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 118' ' ' ASP . 33.8 mt -67.85 114.59 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.437 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.029 0.442 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.09 101.1 5.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.555 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.6 OUTLIER -126.5 21.62 7.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.466 0.65 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.62 105.67 38.68 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.721 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 25' ' ' SER . 9.1 Cg_exo -72.2 -71.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.807 2.338 . . . . 0.0 111.426 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.789 ' HB2' ' HA ' ' A' ' 53' ' ' PRO . 1.1 p90 -157.85 146.88 19.52 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.68 178.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.268 0.556 . . . . 0.0 111.924 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.44 148.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.816 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 151.84 41.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.764 0.316 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.03 -127.74 9.33 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.56 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.35 178.76 6.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.07 74.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 119.27 84.23 0.89 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.712 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.05 81.62 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.75 2.3 . . . . 0.0 111.002 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -85.25 127.69 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.44 142.3 35.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.46 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.19 172.09 16.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.476 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.69 140.02 51.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.55 133.76 56.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.933 0.397 . . . . 0.0 111.107 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.75 -16.42 8.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.918 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.74 -148.8 15.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.182 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -101.31 130.76 47.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.728 HD13 HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -104.3 110.98 23.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.305 175.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.71 106.11 18.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 0.0 109.89 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 108' ' ' LEU . 1.5 mm? -94.09 128.09 40.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.65 122.12 37.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 111.142 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.541 ' HB3' ' HE2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -126.83 141.12 51.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.461 176.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.627 ' HG3' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -115.15 130.71 56.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -127.79 154.7 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.07 0.462 . . . . 0.0 110.843 -178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -125.15 83.66 60.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.951 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -93.99 164.39 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.511 2.807 . . . . 0.0 112.987 -176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.83 -14.85 10.99 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.765 2.31 . . . . 0.0 111.875 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -116.5 -172.84 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.115 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.5 ' NE2' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.3 -11.63 48.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 110.432 178.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 68.06 7.72 6.03 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.072 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 1.5 tm0? -58.22 -46.74 85.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.182 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.44 5.08 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.06 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -80.31 166.22 21.55 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -176.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 77' ' ' ARG . 3.1 mt-10 -105.29 142.8 34.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.59 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 64' ' ' TRP . 2.7 tt -137.37 144.49 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.162 0.506 . . . . 0.0 111.234 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -127.86 116.76 20.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -130.74 58.1 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -170.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 1.3 m-85 -149.5 170.51 18.43 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.638 -170.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -132.94 126.79 32.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.47 176.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.46 164.6 37.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -98.94 127.12 44.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -174.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 51.1 m-85 77.97 146.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.993 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.29 86.78 4.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.046 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.748 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -148.89 -57.39 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.548 172.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 55.5 Cg_endo -95.64 161.34 1.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.527 2.151 . . . . 0.0 110.998 170.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 65' ' ' PHE . 70.0 t 63.83 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.787 0.803 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 85' ' ' GLU . 2.4 m170 -122.61 -58.59 1.67 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.787 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 61' ' ' GLU . 6.1 tp 176.1 127.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.973 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.12 138.24 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.553 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -137.49 139.62 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -163.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.0 t0 66.82 0.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.437 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.38 4.19 57.37 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 140.92 41.21 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.437 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 169.71 17.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.769 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.923 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 2.6 ttt -132.47 120.89 22.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.966 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.28 -40.57 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.87 80.84 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.93 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -93.96 -25.98 17.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 42.37 68.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.852 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 94' ' ' THR . 6.5 tp -66.06 -12.29 14.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.267 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -13.04 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -62.77 -35.21 79.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.834 0.349 . . . . 0.0 110.609 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 21.79 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 54.8 -149.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.441 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.46 28.28 4.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.354 0.597 . . . . 0.0 110.645 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -100.49 35.57 2.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.475 -178.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.652 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -120.41 126.12 49.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.922 -175.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -136.33 99.89 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -88.24 100.1 12.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.238 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.11 99.93 0.72 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.885 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.05 -7.65 26.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.159 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -30.83 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.497 0.665 . . . . 0.0 109.99 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.26 -17.87 79.68 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.98 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.517 HG12 ' HB3' ' A' ' 57' ' ' ALA . 3.6 tt -61.03 -29.81 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -171.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.53 -15.6 70.86 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.395 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 -4.58 28.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.944 0.402 . . . . 0.0 109.982 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . 89.83 20.72 42.33 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.945 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.627 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -130.28 132.54 45.96 Favored 'General case' 0 C--O 1.22 -0.477 0 O-C-N 122.507 -0.408 . . . . 0.0 111.11 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.436 HG11 HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -119.66 132.28 69.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 121.763 -0.586 . . . . 0.0 109.75 174.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -125.25 103.17 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 0.0 111.5 -176.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.835 HD23 HD23 ' A' ' 47' ' ' LEU . 2.0 tp -91.69 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.802 0.334 . . . . 0.0 110.621 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 106.31 18.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -111.14 131.33 62.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -96.3 137.56 35.19 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.904 -176.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 40.4 t30 76.05 74.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.513 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.98 146.97 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.79 168.45 13.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.525 0.202 . . . . 0.0 111.325 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -77.39 -8.15 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.146 0.498 . . . . 0.0 111.643 -173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -35.3 12.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -72.76 -25.4 61.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.53 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HA ' ' HB ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -78.11 24.3 0.25 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.87 -108.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.428 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.87 116.2 23.25 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.393 -0.475 . . . . 0.0 109.898 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -74.37 141.1 45.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.925 178.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.11 105.65 17.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 0.0 110.403 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.7 t -98.68 117.22 32.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.05 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 53.0 t -132.33 124.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.676 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -110.34 135.91 50.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.97 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -123.75 104.8 9.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.444 . . . . 0.0 110.622 178.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.699 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 19.7 t70 -93.07 81.86 4.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.147 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.75 -100.83 0.58 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.694 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -95.75 -10.99 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -93.07 154.92 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.607 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 50.8 p90 -151.26 146.73 26.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.89 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 1.9 mm-40 -139.71 160.37 40.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.885 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG22 ' A' ' 124' ' ' VAL . 2.1 mt-10 -126.46 154.24 43.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -173.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 140.71 14.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.515 HG13 ' H ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -108.48 107.14 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 178.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.615 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.3 OUTLIER -95.04 102.03 13.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.055 -176.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.3 116.71 13.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 118' ' ' ASP . 1.3 t -86.53 150.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.164 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.02 112.57 8.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.182 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.33 110.66 11.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.889 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 121.025 0.441 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -0.77 51.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.058 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.35 -35.59 71.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -108.16 98.95 29.06 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.381 169.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.5 -76.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.89 2.394 . . . . 0.0 112.7 -173.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.71 149.18 28.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.905 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -143.15 170.63 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 0.0 110.844 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.71 HG23 ' HB3' ' A' ' 132' ' ' GLU . 84.9 t -96.88 147.89 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.182 175.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.13 136.6 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.55 78.52 1.16 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.582 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -135.41 115.89 13.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -77.19 -44.77 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.07 111.59 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.716 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.63 62.55 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.53 2.154 . . . . 0.0 110.332 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.36 104.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.953 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 139' ' ' LYS . 1.2 mt -93.99 123.1 37.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.426 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.69 167.15 15.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.634 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.35 139.95 46.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD12 HG21 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -63.06 126.39 27.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.933 0.397 . . . . 0.0 110.621 -177.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 85.98 -9.78 67.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.993 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.76 -164.78 39.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.2 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.74 133.01 48.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.49 115.53 24.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.385 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.3 mt-10 -99.42 112.95 25.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.01 0.433 . . . . 0.0 110.004 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 121' ' ' TYR . 10.3 mt -95.6 128.07 42.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.269 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.8 OUTLIER -123.99 123.05 39.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.36 -179.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.707 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -117.55 140.42 49.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -128.7 134.15 48.39 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.164 0.29 . . . . 0.0 111.062 -173.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.32 164.85 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -80.56 104.94 3.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 7.4 Cg_exo -72.15 114.81 4.09 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.143 2.562 . . . . 0.0 113.551 -170.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 52' ' ' SER . 98.8 Cg_endo -87.89 -13.24 3.96 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 111.067 170.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -171.5 3.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.478 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' HG3' ' OE1' ' A' ' 58' ' ' GLN . 4.8 pm0 -68.02 -7.75 31.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.484 0.183 . . . . 0.0 111.479 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 75.51 -33.77 0.24 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 169.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HA ' HD13 ' A' ' 101' ' ' ILE . 10.1 pt20 -51.74 -39.79 59.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -83.93 15.02 3.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.562 -173.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ptm -92.9 160.87 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.733 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 75' ' ' LEU . 71.9 mt-10 -87.2 131.22 34.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -132.26 135.57 57.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.405 0.621 . . . . 0.0 112.049 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.521 HH11 ' HB2' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -119.15 117.58 29.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.872 172.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.441 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -126.3 63.8 1.25 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -177.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' HE1' HG13 ' A' ' 87' ' ' ILE . 89.5 m-85 -148.93 154.71 39.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.611 -170.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.641 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.68 170.65 11.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.213 174.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -132.81 122.23 24.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.257 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.406 ' H ' ' HB2' ' A' ' 71' ' ' GLU . 13.2 tp -142.25 131.32 23.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.399 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HB3' ' H ' ' A' ' 70' ' ' THR . 0.2 OUTLIER 60.51 -103.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.915 175.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -117.84 34.48 5.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.746 0.308 . . . . 0.0 111.262 -176.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -60.12 113.19 6.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.799 177.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 8.5 Cg_exo -72.35 -178.28 3.21 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.007 2.471 . . . . 0.0 112.663 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.2 89.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -80.26 81.89 6.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 61' ' ' GLU . 1.5 tp -113.08 130.81 56.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HE2' ' HD2' ' A' ' 98' ' ' LYS . 52.5 t80 -126.24 152.85 45.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 59' ' ' HIS . 20.8 ttp85 -141.96 143.33 33.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.04 113.2 4.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.45 -6.49 59.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.328 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 122.45 16.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.401 0.62 . . . . 0.0 111.141 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.99 161.32 30.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.949 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -167.59 163.03 14.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.759 0.314 . . . . 0.0 110.622 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -12.04 61.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.981 0.419 . . . . 0.0 110.63 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.05 -35.87 79.51 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.029 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -76.68 -41.24 46.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.18 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 tp 21.54 72.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 124.754 1.283 . . . . 0.0 112.373 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.923 HG12 ' HB ' ' A' ' 94' ' ' THR . 14.9 tt -58.8 -23.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.235 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -13.72 59.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.956 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.93 -17.98 60.47 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.815 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.59 ' HD2' HG23 ' A' ' 91' ' ' VAL . 13.1 t80 -64.71 -71.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.086 -0.245 . . . . 0.0 110.706 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 ' HD2' ' A' ' 90' ' ' TYR . 97.0 t -134.84 -67.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.675 0.274 . . . . 0.0 110.817 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -168.98 -63.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.197 0.522 . . . . 0.0 110.25 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.745 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -101.0 98.61 9.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.921 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.923 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -130.58 115.05 16.23 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.536 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -126.7 133.65 50.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.81 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.542 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -102.81 104.53 14.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.97 0.414 . . . . 0.0 110.603 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.52 121.74 25.59 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.756 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -107.87 -4.71 17.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.413 -172.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -62.73 -35.81 80.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 110.959 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.41 -17.79 74.72 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 58' ' ' GLN . 1.2 tt -62.09 -26.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 122.718 -0.283 . . . . 0.0 111.457 -173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.26 -17.37 63.78 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.801 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.63 5.65 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.229 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 89.23 23.66 33.94 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.123 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.5 OUTLIER -128.72 133.62 48.21 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 117.54 0.67 . . . . 0.0 111.475 -178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -115.04 132.43 64.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 O-C-N 121.761 -0.587 . . . . 0.0 109.629 175.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -114.12 103.26 10.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.187 0.518 . . . . 0.0 111.512 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.542 HD13 HD12 ' A' ' 96' ' ' LEU . 22.9 tp -93.56 111.22 22.85 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.182 0.515 . . . . 0.0 110.264 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -88.08 107.41 18.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.807 178.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.528 HG13 ' HG ' ' A' ' 108' ' ' LEU . 63.5 mt -110.92 127.3 68.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.922 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.745 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -106.23 143.14 34.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.596 0.236 . . . . 0.0 110.832 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m120 68.35 55.72 0.51 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.636 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.88 152.2 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.4 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.39 152.39 39.08 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 112.39 -173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.97 -17.45 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.212 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.47 -38.75 71.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.885 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -96.92 7.74 45.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.226 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.477 ' HA ' HG13 ' A' ' 138' ' ' VAL . 17.2 t70 -55.55 24.88 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.405 1.082 . . . . 0.0 113.351 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -97.65 -132.66 7.58 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 120.788 -1.195 . . . . 0.0 112.194 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 127.57 43.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.443 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.714 ' CE2' ' HB ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -90.19 161.84 15.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.598 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -103.02 119.06 38.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.623 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -102.34 116.11 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.692 HG22 ' HG3' ' A' ' 133' ' ' GLU . 16.2 t -129.56 117.47 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.265 -176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 17.4 m-30 -107.61 128.68 54.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.8 mtpt -122.55 104.9 9.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 6.2 t70 -91.63 73.94 5.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.525 0.678 . . . . 0.0 109.714 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.29 -83.05 1.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.96 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -116.82 -27.7 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.524 0.202 . . . . 0.0 111.457 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -89.67 125.78 35.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -126.32 150.56 48.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.905 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -132.12 145.38 51.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.877 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.692 ' HG3' HG22 ' A' ' 124' ' ' VAL . 33.9 tt0 -132.35 126.39 33.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.916 0.388 . . . . 0.0 110.708 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -129.6 143.72 50.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.333 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -102.39 113.89 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.182 0.515 . . . . 0.0 110.191 176.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.635 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -105.65 147.23 28.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.726 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 150.35 28.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.828 0.347 . . . . 0.0 111.655 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.714 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 14.1 p -122.74 131.28 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.53 ' HB3' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -111.97 103.75 11.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.795 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.607 HG21 HD12 ' A' ' 41' ' ' LEU . 1.4 mp -73.41 124.51 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.444 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.611 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.781 0.324 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 74.54 10.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.187 0.517 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 m -128.13 -45.31 1.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.185 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -69.86 112.01 10.93 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.508 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.03 -16.63 11.11 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.459 2.106 . . . . 0.0 112.177 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -136.45 134.8 38.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.104 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.5 OUTLIER -150.47 161.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.373 0.42 . . . . 0.0 110.175 174.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 51' ' ' LEU . 75.5 t -92.31 145.07 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.491 175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.5 t-20 -67.94 162.5 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.85 62.95 2.41 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.294 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 122.78 19.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -83.75 -48.73 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' H ' ' HD3' ' A' ' 36' ' ' PRO . . . 106.55 72.35 0.81 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.397 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HD3' ' H ' ' A' ' 35' ' ' GLY . 5.3 Cg_exo -78.98 72.48 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.753 2.302 . . . . 0.0 110.919 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.89 103.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mp -97.74 139.39 33.69 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.45 171.39 14.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.774 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.62 154.25 28.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -69.6 130.48 42.54 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.451 -176.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.64 8.62 86.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.205 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.97 -158.73 32.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.016 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -102.65 130.21 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.178 0.513 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 113' ' ' VAL . 8.6 tp -116.24 110.6 18.99 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.918 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tt0 -105.96 110.54 22.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.049 0.452 . . . . 0.0 109.989 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 4.7 mt -95.8 128.43 42.67 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.67 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -121.55 125.4 46.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.583 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.3 140.23 50.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.85 130.83 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.103 0.477 . . . . 0.0 111.426 -172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.23 165.56 20.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.627 -176.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.558 ' H ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -117.54 82.41 15.59 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.714 169.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 28' ' ' PHE . 97.8 Cg_endo -89.86 141.83 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.027 2.485 . . . . 0.0 113.082 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.27 1.24 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.632 2.221 . . . . 0.0 112.646 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -151.97 -174.44 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.257 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -76.88 -18.55 58.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.272 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 61.45 34.97 17.89 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 170.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -64.6 -36.84 85.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.378 0.608 . . . . 0.0 109.56 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.625 ' HA ' ' OD1' ' A' ' 78' ' ' ASP . 49.9 t-80 -79.92 -2.67 44.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.094 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 3.9 ttm -69.47 141.48 53.97 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.03 0.443 . . . . 0.0 111.396 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CD ' ' HD3' ' A' ' 126' ' ' LYS . 2.7 tt0 -97.81 116.95 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.927 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -116.44 147.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.338 0.589 . . . . 0.0 111.21 -174.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.738 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -128.56 137.22 51.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.241 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.446 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -151.81 42.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 30.6 m-85 -134.18 158.39 43.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.176 -168.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.57 124.91 51.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.032 0.444 . . . . 0.0 110.308 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.4 154.05 26.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.345 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -64.85 109.77 2.19 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.293 0.37 . . . . 0.0 110.792 -178.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 60.37 67.52 0.84 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.972 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.34 57.87 4.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.351 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' CB ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -79.64 -60.43 0.52 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -178.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 71' ' ' GLU . 26.2 Cg_endo -92.6 -49.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.076 1.851 . . . . 0.0 113.198 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.78 163.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.89 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 1.2 m-70 73.15 97.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.994 0.918 . . . . 0.0 110.739 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -161.9 136.22 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.345 -171.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -103.37 109.28 20.85 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.587 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -116.52 130.18 56.6 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.486 -168.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' ' HA ' ' A' ' 59' ' ' HIS . 16.4 t0 58.41 20.22 7.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.353 0.597 . . . . 0.0 111.684 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.15 22.93 58.25 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.885 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.51 139.18 50.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 110.815 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.81 169.98 17.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.176 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.27 135.11 49.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.924 0.393 . . . . 0.0 110.697 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.5 -2.43 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.073 0.464 . . . . 0.0 110.981 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.46 -18.89 63.22 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -108.83 -40.73 4.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.542 0.21 . . . . 0.0 110.6 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 31.5 mm 65.86 85.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.698 0.761 . . . . 0.0 111.435 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 94' ' ' THR . 2.1 tp -67.8 -20.54 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 0.0 109.692 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.89 -14.02 7.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.696 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -69.44 -22.52 63.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 178.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 91' ' ' VAL . 2.4 m-85 -74.88 -36.93 62.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.504 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG13 ' HG2' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 65.65 178.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.796 178.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.722 ' HG2' HG13 ' A' ' 91' ' ' VAL . 5.9 mm-40 66.25 -151.11 0.22 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.911 0.484 . . . . 0.0 110.416 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.47 109.28 22.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.156 0.503 . . . . 0.0 110.991 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 HD11 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -115.77 95.36 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.524 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 4.7 tp10 -104.63 108.15 19.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.959 0.409 . . . . 0.0 110.675 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -91.96 96.48 10.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.13 105.33 3.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -102.85 -8.71 20.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.952 -175.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.56 -39.75 61.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.524 ' HA2' ' OE2' ' A' ' 103' ' ' GLU . . . -62.77 -18.66 59.72 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.543 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER -58.61 -25.8 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 117.16 0.48 . . . . 0.0 111.833 -174.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 56' ' ' GLN . . . -63.9 -23.39 67.46 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.561 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.524 ' OE2' ' HA2' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -105.84 -5.17 19.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.21 42.79 6.12 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.872 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.77 132.6 34.98 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.293 -0.533 . . . . 0.0 110.585 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.573 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 14.0 m -121.67 133.18 68.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.03 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -120.87 103.46 9.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 64' ' ' TRP . 35.2 tp -92.86 110.25 21.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.476 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -88.95 105.79 17.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.35 176.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.667 HG12 HG23 ' A' ' 94' ' ' THR . 12.5 mt -112.46 119.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -94.55 140.08 30.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 74.26 67.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.056 0.848 . . . . 0.0 111.134 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -62.02 133.36 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.994 174.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.77 149.44 24.48 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 41' ' ' LEU . 7.9 p -67.59 -22.45 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.717 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -75.03 -37.07 61.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -89.74 2.26 55.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.5 t0 -58.47 27.09 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.94 0.896 . . . . 0.0 112.913 168.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -104.86 -147.43 16.4 Favored Glycine 0 N--CA 1.448 -0.539 0 O-C-N 121.399 -0.813 . . . . 0.0 112.29 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.808 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -100.96 120.3 39.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.7 0.286 . . . . 0.0 110.834 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.81 146.24 35.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 110.894 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 86.4 t60 -99.6 103.45 15.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.336 -177.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 46.7 t -106.0 130.88 53.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.203 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.738 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 23.2 t -144.56 137.29 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 17.0 m-85 -115.62 110.97 19.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.611 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -118.01 105.25 11.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 0.0 111.223 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 19.3 t0 -112.77 99.86 8.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 0.0 109.988 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.35 -103.6 2.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.233 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -112.57 -24.6 9.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.463 0.173 . . . . 0.0 111.274 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.74 129.66 36.63 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.788 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 23.5 p90 -137.4 127.77 26.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.283 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -112.34 136.36 51.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.942 177.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -110.1 146.87 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.857 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.508 ' HE1' ' HA ' ' A' ' 34' ' ' GLU . 7.1 t-80 -149.16 127.1 11.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.15 110.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.912 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 53.4 m -122.11 111.96 17.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.247 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.6 pt-20 -88.25 150.22 23.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.306 0.574 . . . . 0.0 111.867 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.52 151.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.42 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -122.49 90.83 3.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.923 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.529 HG21 HD12 ' A' ' 41' ' ' LEU . 19.5 mt -76.66 107.32 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.516 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.88 48.54 0.84 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.109 0.481 . . . . 0.0 111.689 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -157.79 63.14 0.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 4.1 tt0 -129.73 122.71 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.393 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 12.2 Cg_exo -70.99 160.63 48.76 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.891 2.394 . . . . 0.0 112.154 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.591 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 4.9 p90 -78.58 164.94 24.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.787 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -128.63 173.85 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 111.673 -176.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.615 HG22 ' HE2' ' A' ' 125' ' ' PHE . 82.6 t -89.87 142.26 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.241 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.46 175.62 5.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.709 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.05 -113.47 3.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.772 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.48 176.87 9.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -67.73 -49.16 64.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.1 73.03 1.07 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.99 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.16 89.52 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.402 2.068 . . . . 0.0 110.494 171.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -67.89 129.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -174.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.8 mm? -88.98 128.34 35.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.02 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.71 16.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 128.96 54.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.665 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -62.59 123.91 19.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.73 -9.48 77.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.242 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.85 -171.45 35.73 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.847 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.33 137.35 33.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 tp -111.94 112.92 24.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.926 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -104.78 108.44 19.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.948 177.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.0 OUTLIER -96.61 127.95 43.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.514 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.47 123.87 50.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -121.58 140.73 51.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 1.0 OUTLIER -123.04 131.22 53.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -117.57 164.71 14.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.367 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.53 99.13 2.55 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 170.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -83.76 121.1 2.82 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.162 2.575 . . . . 0.0 113.515 -167.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.02 -6.83 13.18 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.465 2.11 . . . . 0.0 110.356 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -165.62 -179.06 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.972 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -72.41 -17.24 61.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.535 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 58.34 30.16 19.18 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.408 0.623 . . . . 0.0 111.098 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -52.31 -58.43 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.612 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -96.03 26.61 4.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.84 167.68 11.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -97.14 149.97 21.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.685 0.278 . . . . 0.0 110.983 -172.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 146.67 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.408 0.623 . . . . 0.0 112.195 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.661 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mmm-85 -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -143.33 53.49 1.35 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.524 ' HZ ' ' CD1' ' A' ' 76' ' ' TYR . 39.6 m-85 -136.46 154.72 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -166.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HB2' ' CE1' ' A' ' 121' ' ' TYR . 4.2 ttp180 -80.38 110.72 16.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.981 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -149.45 108.5 3.9 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.478 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.8 pt? -70.32 145.58 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.156 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER 62.96 -152.34 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.603 0.564 . . . . 0.0 110.211 -174.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.1 m -129.41 89.63 2.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 111.187 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.5 mm-40 -113.62 142.21 27.29 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 9.8 Cg_exo -71.72 43.61 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.393 2.728 . . . . 0.0 113.905 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -117.2 158.65 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HA ' ' CD ' ' A' ' 85' ' ' GLU . 31.1 m-70 69.57 107.48 0.06 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.636 0.585 . . . . 0.0 110.468 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.04 124.83 1.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.587 -172.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CD1' ' HZ ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -108.02 112.4 24.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -119.08 143.96 46.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.1 t70 68.48 -2.72 1.53 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.319 0.58 . . . . 0.0 110.729 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 9.47 52.11 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.728 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -134.17 167.59 20.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.04 151.9 23.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.418 . . . . 0.0 110.4 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 164.13 12.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.65 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -22.7 63.81 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.55 -28.64 69.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.478 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' CD ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -86.85 -42.33 13.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 86' ' ' ILE . 7.5 tp 43.7 90.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.663 1.227 . . . . 0.0 112.61 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 94' ' ' THR . 3.8 tp -65.39 -12.45 13.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.308 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -14.45 60.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.234 0.54 . . . . 0.0 109.78 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -77.1 -21.51 54.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.173 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -61.86 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 92' ' ' GLU . 2.1 p -169.72 -71.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.285 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER 177.85 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 109.887 -177.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' PHE . 5.7 mtm-85 -76.88 105.7 8.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.883 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 87' ' ' ILE . 25.8 m -152.55 107.49 3.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 131.33 55.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.879 0.371 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -99.51 112.81 24.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.868 0.366 . . . . 0.0 110.177 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.41 105.76 10.95 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.954 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.32 1.78 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.456 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.6 -28.5 69.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 110.2 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.04 -17.46 78.31 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -28.29 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.88 0.34 . . . . 0.0 111.454 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.12 -16.98 67.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.751 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -103.47 -4.26 24.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.516 0.326 . . . . 0.0 110.246 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 92.31 20.13 36.44 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.851 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -129.08 133.0 47.49 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 117.142 0.471 . . . . 0.0 111.511 -178.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.73 132.73 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -120.71 108.71 14.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.613 -177.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 64' ' ' TRP . 11.1 tp -91.96 121.67 33.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.289 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.788 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.405 HG13 ' HG ' ' A' ' 108' ' ' LEU . 38.3 mt -112.59 127.77 69.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.699 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 112' ' ' ASN . 31.4 t80 -83.48 122.61 28.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 32.6 t30 80.13 119.36 0.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.071 0.857 . . . . 0.0 111.68 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 140' ' ' ILE . 7.1 p -117.9 134.59 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.412 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.5 p -103.78 171.27 7.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 112.007 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -67.06 -14.14 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.499 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 13.7 t0 -81.38 -34.02 31.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' HA ' ' CD ' ' A' ' 66' ' ' ARG . 32.6 m-20 -72.3 -24.84 61.39 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.014 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.56 -3.66 0.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.697 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.69 -132.12 1.71 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.813 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -106.62 127.12 53.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.105 0.479 . . . . 0.0 111.542 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-85 -90.37 148.48 22.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -106.19 113.66 27.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.781 0.324 . . . . 0.0 110.141 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 4.5 t -103.4 116.21 31.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.128 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.661 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 8.8 t -132.31 113.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.615 ' HE2' HG22 ' A' ' 30' ' ' VAL . 34.7 m-85 -93.27 136.09 33.87 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 126' ' ' LYS . 11.8 mtpp -121.01 102.97 8.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 60' ' ' MET . 33.9 t70 -99.05 74.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.548 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.15 -96.94 0.34 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.905 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.89 -27.83 17.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.67 0.271 . . . . 0.0 111.601 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.405 ' HB2' ' HD1' ' A' ' 28' ' ' PHE . 2.9 m-85 -90.68 148.46 22.6 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.34 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -146.18 150.34 35.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.46 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.683 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -143.38 132.84 23.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.008 177.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -114.48 121.93 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 109.949 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.05 148.15 50.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -93.29 133.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.153 0.501 . . . . 0.0 110.772 -176.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -128.79 102.38 6.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.63 138.51 38.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 46.0 t -95.48 142.72 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.83 100.78 5.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.768 0.318 . . . . 0.0 110.744 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 113' ' ' VAL . 70.7 mt -81.83 97.43 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.682 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.92 61.81 6.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.243 0.544 . . . . 0.0 111.089 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -89.2 40.22 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -140.54 114.56 7.37 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.314 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.56 ' CB ' ' HB3' ' A' ' 130' ' ' PHE . 4.0 Cg_exo -77.2 -88.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.761 2.308 . . . . 0.0 110.991 173.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.765 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 13.4 p90 -140.67 160.55 39.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.75 172.35 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.582 . . . . 0.0 112.123 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.61 147.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.78 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 26.3 t30 -99.2 167.74 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.735 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.16 128.14 45.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.0 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.691 HD11 ' HA ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -112.47 176.62 4.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.752 0.311 . . . . 0.0 110.518 -175.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -73.53 -12.3 60.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.009 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.3 -132.35 11.02 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.567 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 55.5 Cg_endo -71.5 97.68 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.328 2.018 . . . . 0.0 111.513 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.78 113.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.502 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 1.1 mt -95.59 96.2 8.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.606 -175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -127.4 170.84 12.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.885 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -97.38 145.35 26.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.777 0.322 . . . . 0.0 110.239 -170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 140' ' ' ILE . 0.9 OUTLIER -70.71 142.65 51.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.13 -173.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.16 -8.07 72.44 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.698 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.12 -167.98 35.98 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.237 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.26 134.59 33.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.285 0.564 . . . . 0.0 110.412 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.941 ' HG ' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -106.05 111.0 23.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.289 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 96.89 6.8 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.63 129.22 42.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.879 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -107.49 128.94 54.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.848 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.691 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.11 140.26 50.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.699 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -125.96 129.72 49.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.597 0.237 . . . . 0.0 110.758 -175.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.69 165.49 21.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.564 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.71 83.45 48.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.071 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -95.02 162.73 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.305 2.67 . . . . 0.0 113.107 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -88.44 37.45 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.947 2.431 . . . . 0.0 111.612 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -160.32 177.34 10.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.048 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.88 2.12 55.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.038 0.447 . . . . 0.0 109.817 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 62.28 24.77 14.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -67.81 -24.21 65.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 109.858 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -104.0 17.11 24.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.493 ' HA ' ' HB3' ' A' ' 127' ' ' ASP . 18.6 ttm -76.2 118.95 19.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 110.985 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -78.67 98.88 6.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.464 HD12 HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -111.22 140.48 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 111.336 -172.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.868 ' HB3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.33 118.93 13.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 177.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -114.19 63.24 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 81.0 m-85 -136.01 151.28 49.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.604 -168.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.593 HH11 ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -87.83 141.87 28.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.63 175.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.425 ' HB2' HH12 ' A' ' 63' ' ' ARG . 0.4 OUTLIER -164.64 107.43 0.88 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.77 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -73.44 134.05 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 168.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 5.8 t80 64.51 91.14 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -162.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.17 102.09 0.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.699 -170.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.567 ' HB3' HG12 ' A' ' 73' ' ' VAL . 20.3 mm-40 -104.67 121.5 46.75 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.627 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.92 1.37 8.7 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.831 2.354 . . . . 0.0 112.494 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.567 HG12 ' HB3' ' A' ' 71' ' ' GLU . 13.4 p -79.78 50.29 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 122.334 1.064 . . . . 0.0 110.847 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -171.16 65.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.778 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -146.71 152.24 38.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.693 -175.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.19 128.85 42.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.634 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.564 ' HB3' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.52 128.96 34.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -175.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.6 t70 62.25 15.08 7.25 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.463 0.649 . . . . 0.0 111.269 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 98' ' ' LYS . . . 82.47 20.19 62.61 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.975 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.3 154.27 49.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.025 0.441 . . . . 0.0 111.065 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -132.22 139.03 48.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.916 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -177.8 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -23.81 65.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.58 -53.36 5.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.047 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 75' ' ' LEU . 16.4 pm0 -93.15 15.31 15.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.543 0.337 . . . . 0.0 111.777 -175.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.708 HG23 ' HB2' ' A' ' 89' ' ' LYS . 2.4 tt -42.58 121.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.712 0.768 . . . . 0.0 112.303 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 108' ' ' LEU . 14.3 tt -72.75 -36.42 52.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.792 -173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -13.97 27.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.708 ' HB2' HG23 ' A' ' 86' ' ' ILE . 4.3 ttpt -71.48 -12.42 61.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.534 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE1' ' HD1' ' A' ' 65' ' ' PHE . 1.3 t80 -58.76 -60.74 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -64.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 110.323 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -161.44 -91.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.921 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -72.1 111.78 7.63 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.52 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -140.91 90.8 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.054 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.01 127.08 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.095 -174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -97.65 100.5 11.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 110.951 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 9.3 mp -73.08 110.98 7.77 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.758 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HD3' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -101.14 -4.71 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.703 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.63 -29.33 67.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.272 0.558 . . . . 0.0 111.07 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.31 -17.94 77.07 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.829 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.564 HD12 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -59.54 -26.37 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -170.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -21.93 67.83 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.793 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.62 5.03 26.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 0.0 110.206 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 83.3 31.47 27.97 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.109 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.699 ' HG3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -123.78 132.25 53.76 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 117.16 0.48 . . . . 0.0 110.89 179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -121.32 132.79 69.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -120.02 105.04 10.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.309 -177.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 96' ' ' LEU . 7.0 tp -94.43 118.18 31.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.353 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 109' ' ' ARG . 5.7 ttt180 -95.14 106.21 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.927 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 94' ' ' THR . 65.4 mt -117.35 130.28 72.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER -91.0 134.53 34.42 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.465 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.8 t30 73.58 81.55 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.098 0.874 . . . . 0.0 112.237 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.941 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 8.4 p -82.09 140.81 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.992 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -117.65 176.51 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.974 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.42 -14.25 18.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.243 0.544 . . . . 0.0 110.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.583 ' HB3' HH21 ' A' ' 66' ' ' ARG . 30.3 t70 -80.58 -24.56 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 138' ' ' VAL . 4.3 m-20 -86.13 -20.27 28.92 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.698 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.415 ' HB2' HD13 ' A' ' 140' ' ' ILE . 31.2 t0 -63.84 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.069 0.948 . . . . 0.0 112.776 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -153.38 -119.96 0.78 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.944 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 123.41 24.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -125.02 161.26 27.13 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.404 172.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.57 119.68 24.04 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.298 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -105.0 117.61 34.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.229 173.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.868 HG12 ' HB3' ' A' ' 63' ' ' ARG . 5.1 p -124.11 141.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.226 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.765 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -136.13 121.2 18.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.583 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -135.22 110.2 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 60' ' ' MET . 11.1 p-10 -116.8 95.91 5.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.127 0.965 . . . . 0.0 110.983 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.72 -82.92 1.38 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.693 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -118.87 -23.62 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.56 ' HB3' ' CB ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -97.28 141.34 30.5 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -148.26 145.46 28.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -150.26 132.3 15.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.804 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -128.22 121.56 29.69 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 139.83 49.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.192 0.52 . . . . 0.0 111.16 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.85 138.79 20.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.58 175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.79 160.2 37.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -121.13 135.37 55.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.22 -175.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 117' ' ' ASP . 43.1 t -104.92 142.46 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -126.64 118.46 24.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.251 0.548 . . . . 0.0 111.137 -177.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.618 HD11 HG22 ' A' ' 113' ' ' VAL . 1.5 mp -82.77 119.29 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.605 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.73 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.91 75.42 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.562 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.5 m -151.85 33.61 0.54 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -61.81 132.41 93.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.934 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.6 Cg_exo -71.03 -175.76 1.58 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 52' ' ' SER . 1.7 p90 -71.8 137.32 47.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -119.28 178.86 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.247 0.546 . . . . 0.0 112.36 -171.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.761 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 p -90.77 147.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.623 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 15.3 t30 -120.44 130.48 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.96 74.34 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.834 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -78.25 111.24 14.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.5 -24.72 67.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.47 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 136' ' ' THR . . . 69.22 -120.55 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.02 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.21 90.18 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.781 2.321 . . . . 0.0 111.66 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -74.01 117.66 18.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 139' ' ' LYS . 3.9 mt -91.2 134.21 34.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.025 0.44 . . . . 0.0 110.811 -171.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.667 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -136.02 172.56 12.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.107 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.55 133.88 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -64.38 124.69 22.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 -177.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.78 -12.17 36.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.304 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.97 -147.33 22.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.223 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -108.25 153.05 23.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.99 0.424 . . . . 0.0 111.228 -176.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 39' ' ' ALA . 1.4 tp -140.95 113.55 8.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.376 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.852 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -92.95 111.86 23.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 64' ' ' TRP . 3.0 mt -95.91 127.53 42.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.817 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.79 43.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.286 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 139.72 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -125.66 137.17 53.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.4 mm? -126.22 164.96 19.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.951 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -111.79 80.98 3.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 99.0 Cg_endo -81.74 142.84 12.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.629 2.219 . . . . 0.0 112.882 -173.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 12.6 Cg_exo -71.6 -26.17 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.958 2.439 . . . . 0.0 111.711 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -129.51 -172.14 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -68.08 -28.66 67.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB1' ' SD ' ' A' ' 60' ' ' MET . . . 63.36 25.51 14.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.619 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -60.66 -33.7 73.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.922 0.392 . . . . 0.0 111.253 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -113.22 28.48 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.636 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 7.8 ptm -80.21 169.34 17.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 111.49 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.843 ' HG2' HD12 ' A' ' 75' ' ' LEU . 3.5 mt-10 -89.68 121.18 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.16 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -114.98 139.47 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.45 . . . . 0.0 110.231 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -133.67 118.04 17.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -132.08 61.1 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.2 147.67 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.266 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -72.05 139.48 48.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 177.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -133.99 114.58 13.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -132.47 93.48 3.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 63.03 18.74 11.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.819 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.31 151.12 19.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.936 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.756 ' HG2' ' HD2' ' A' ' 72' ' ' PRO . 2.5 tt0 -63.16 147.87 93.91 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 171.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.756 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 45.7 Cg_endo -70.98 44.14 0.51 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.753 2.302 . . . . 0.0 112.887 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 71' ' ' GLU . 4.2 t -105.91 72.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 6.6 m170 -151.16 70.94 0.99 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.248 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.843 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -114.99 151.7 33.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.307 0.575 . . . . 0.0 112.367 -173.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -129.2 109.5 11.2 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' HG3' ' HG3' ' A' ' 61' ' ' GLU . 3.0 ttt-85 -116.31 89.09 3.03 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.165 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.0 t0 52.85 59.7 4.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.018 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.11 7.84 84.71 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.1 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.81 124.32 50.41 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.543 -0.387 . . . . 0.0 111.316 179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -126.56 152.64 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.407 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -118.22 -158.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.85 0.357 . . . . 0.0 111.563 -172.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -41.63 99.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.14 -30.41 31.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.12 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.4 pm0 -112.42 13.77 20.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.509 HG23 ' HD3' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -46.38 112.55 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.651 0.739 . . . . 0.0 110.257 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -69.05 -12.61 16.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.732 -167.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -13.51 58.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.186 0.517 . . . . 0.0 110.282 173.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -78.92 -16.8 56.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.267 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.44 -33.34 32.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.24 167.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 124.04 0.838 . . . . 0.0 112.213 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 65.01 -105.92 0.13 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.477 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -127.51 120.79 29.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.959 0.409 . . . . 0.0 111.211 -171.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.15 92.97 2.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.199 175.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.54 116.11 31.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.461 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -102.98 109.35 20.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 107' ' ' THR . 12.7 mt -87.37 106.15 17.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.701 ' HE2' HG21 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -110.73 -3.73 15.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.456 -172.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.29 -12.79 61.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.517 0.675 . . . . 0.0 111.071 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.65 -17.34 70.93 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.43 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.701 HG21 ' HE2' ' A' ' 98' ' ' LYS . 1.7 tt -57.33 -23.27 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.12 -18.99 58.74 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.992 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -120.32 7.9 10.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.225 0.536 . . . . 0.0 109.954 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 80.41 43.67 9.25 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.195 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 1.2 mppp? -126.67 133.05 51.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.466 0.633 . . . . 0.0 110.854 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.49 134.7 43.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.349 . . . . 0.0 110.572 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.731 ' HB ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -122.54 111.57 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.599 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 96' ' ' LEU . 13.0 tp -103.44 110.83 23.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.852 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -87.33 106.09 17.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.517 176.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.68 129.63 66.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 44' ' ' ASN . 5.4 m-85 -107.06 155.96 19.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.789 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.6 t30 69.61 54.21 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.297 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.56 124.0 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.727 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.617 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 68.5 p -101.88 168.05 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.31 -26.39 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.528 0.68 . . . . 0.0 110.196 176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.25 -28.49 31.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER -72.84 -25.68 61.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.871 175.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 140' ' ' ILE . 25.1 t70 -63.13 26.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.358 1.063 . . . . 0.0 113.824 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -100.25 -147.65 21.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.566 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -92.3 107.83 19.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.169 0.509 . . . . 0.0 111.352 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.804 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 2.5 m-85 -73.92 157.45 36.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -126.84 118.29 24.32 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.343 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 10.3 t -99.51 116.72 32.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 28.9 t -136.34 118.71 20.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.213 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -112.18 128.21 56.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -120.64 117.64 28.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.593 0.235 . . . . 0.0 110.795 -178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.506 ' HB2' ' HE3' ' A' ' 60' ' ' MET . 21.1 t0 -117.47 93.76 4.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.036 0.445 . . . . 0.0 110.469 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.49 -80.21 0.9 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.095 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.82 -29.36 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -102.9 150.03 23.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.596 -174.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 16.6 p90 -145.51 144.76 30.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 3.7 tp10 -111.82 131.39 55.37 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.55 121.18 28.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.651 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.22 134.58 44.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.047 0.451 . . . . 0.0 110.391 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.75 130.98 35.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.237 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -132.88 102.0 5.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.232 -178.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 2.7 mm-40 -73.77 125.61 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.676 0.274 . . . . 0.0 110.849 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 118' ' ' ASP . 9.3 p -88.85 134.38 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -122.89 104.66 9.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.021 0.439 . . . . 0.0 111.795 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 31.2 mt -76.51 96.25 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.177 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.747 0.308 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.85 147.91 48.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.331 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -125.7 14.68 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.062 0.934 . . . . 0.0 108.719 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 32.5 mp0 -100.06 125.4 40.1 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.147 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.927 ' HB2' ' HB3' ' A' ' 130' ' ' PHE . 30.5 Cg_exo -61.88 -31.94 85.1 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.708 2.272 . . . . 0.0 112.677 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HD1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -154.19 143.83 21.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.888 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -115.47 169.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.366 0.603 . . . . 0.0 111.314 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 125' ' ' PHE . 2.2 t -120.16 120.58 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.265 -174.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -78.48 132.85 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.95 -175.63 14.11 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.521 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 35' ' ' GLY . 0.4 OUTLIER -114.25 178.89 4.12 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -38.85 76.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.438 . . . . 0.0 109.974 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' H ' HD12 ' A' ' 33' ' ' LEU . . . 74.73 62.39 2.85 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.19 174.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 20.2 Cg_endo -96.22 75.78 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.422 2.748 . . . . 0.0 111.295 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 47' ' ' LEU . 21.8 t -78.41 93.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.159 0.504 . . . . 0.0 110.761 -177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HA ' ' HG3' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -86.67 103.72 15.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.751 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.31 9.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.809 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.52 140.88 37.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD12 HG21 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -64.25 110.52 2.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.593 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.75 7.86 88.11 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.403 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.48 -160.24 28.01 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.378 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -82.85 110.87 18.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.145 0.498 . . . . 0.0 110.305 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HB ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -98.74 123.85 43.22 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.22 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 8.4 mt-10 -126.23 108.7 11.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.149 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -96.3 143.95 26.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.193 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.07 114.63 25.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.065 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -118.59 141.17 48.84 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.54 146.67 49.89 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.29 145.24 50.86 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.371 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -65.87 108.26 2.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 37.6 Cg_exo -60.7 108.98 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.52 2.814 . . . . 0.0 114.587 -167.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 52' ' ' SER . 71.3 Cg_endo -94.43 -22.27 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.083 2.522 . . . . 0.0 111.602 170.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -156.5 -172.23 3.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.573 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 3.0 pt20 -77.87 -17.36 57.43 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.189 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 60' ' ' MET . . . 59.01 13.85 3.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.928 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -65.3 -33.28 75.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.073 0.463 . . . . 0.0 110.053 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.91 17.64 19.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.704 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.514 ' HB3' ' O ' ' A' ' 57' ' ' ALA . 3.5 ttm -84.69 142.52 29.82 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.646 ' HG2' ' HA ' ' A' ' 77' ' ' ARG . 19.5 mt-10 -88.65 142.45 27.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.861 HD13 HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -135.22 131.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.255 0.55 . . . . 0.0 111.12 -178.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 75' ' ' LEU . 1.5 ttp180 -110.81 115.39 29.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 49' ' ' CYS . 4.7 t90 -140.64 79.52 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.834 0.35 . . . . 0.0 111.339 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HB3' ' HE2' ' A' ' 90' ' ' TYR . 7.1 m-85 -154.75 169.01 24.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD3' ' HA ' ' A' ' 117' ' ' ASP . 9.4 ttp85 -96.67 93.76 6.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.683 -0.807 . . . . 0.0 108.934 168.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -163.83 107.18 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.73 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 mp -104.23 84.93 2.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 110.206 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -107.58 153.42 22.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.24 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -30.03 67.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.16 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.732 ' HB2' HG23 ' A' ' 73' ' ' VAL . 2.1 mp0 -97.85 163.1 20.17 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.26 40.64 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.057 2.505 . . . . 0.0 112.479 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.732 HG23 ' HB2' ' A' ' 71' ' ' GLU . 23.4 t -75.74 144.25 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.16 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.811 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER 65.64 81.5 0.2 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 123.873 0.733 . . . . 0.0 110.794 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.91 143.0 27.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.541 -175.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.1 t80 -95.25 111.15 23.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -112.16 125.58 54.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.878 -171.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 72.26 -10.99 0.84 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.457 0.646 . . . . 0.0 110.948 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 100.74 17.79 22.49 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -168.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.98 138.3 53.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.214 -0.493 . . . . 0.0 109.973 175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.86 161.83 20.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.263 172.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.98 148.67 38.96 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.635 -175.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' O ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -75.72 -16.99 60.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.265 0.555 . . . . 0.0 110.39 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.95 73.81 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.044 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.81 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 1.7 pp20? -105.36 -41.26 5.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.41 0.148 . . . . 0.0 110.666 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 83' ' ' PHE . 48.5 mt 70.1 95.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.843 0.83 . . . . 0.0 111.41 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.811 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 1.8 tt -75.08 -16.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.274 174.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -12.96 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.704 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -53.73 -28.13 32.43 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.783 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.644 ' HE2' ' HB3' ' A' ' 65' ' ' PHE . 3.1 m-85 -98.06 -33.24 11.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.276 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.63 163.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 124.186 0.929 . . . . 0.0 111.663 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.3 OUTLIER 75.65 -167.12 0.08 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.984 177.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 93' ' ' ARG . 7.8 ttp180 -65.9 112.6 3.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.342 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.912 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -126.33 112.18 15.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.333 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 1.3 pt-20 -137.54 129.73 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.201 0.524 . . . . 0.0 110.629 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.98 107.31 19.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.639 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -74.53 99.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.127 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HD2' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -96.2 6.25 49.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.522 178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.24 -34.12 63.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.975 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.02 -17.29 65.52 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.962 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.527 HD12 HG13 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -60.41 -21.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.72 61.83 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.625 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 3.65 20.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.81 31.62 8.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.726 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.46 132.68 53.5 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.673 0.737 . . . . 0.0 111.389 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG13 HD12 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -125.7 133.79 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 O-C-N 122.161 -0.337 . . . . 0.0 110.515 177.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.98 111.65 19.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 27.4 tp -86.43 113.42 22.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 3.3 mpt_? -98.82 106.77 19.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.929 ' HB ' HD23 ' A' ' 45' ' ' LEU . 14.6 mt -127.45 120.78 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -80.79 127.82 32.95 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 83.26 133.95 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.309 1.006 . . . . 0.0 111.213 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -145.02 139.51 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.304 178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -111.92 172.71 6.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.203 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 2.9 p -65.12 -10.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.162 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.91 -50.33 13.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.012 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.717 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -78.11 -9.75 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.784 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -55.0 -22.47 15.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.276 177.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.13 -86.7 0.17 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.173 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -145.19 155.86 43.52 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.604 -0.35 . . . . 0.0 111.004 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.552 ' HD1' HG21 ' A' ' 138' ' ' VAL . 1.7 m-85 -103.81 127.51 51.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.451 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 68.6 t60 -76.49 101.67 5.72 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.73 117.32 34.4 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.413 1.071 . . . . 0.0 109.861 -176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.01 116.49 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 0.8 OUTLIER -96.08 112.78 24.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.287 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 2.8 mtpt -119.7 105.0 10.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.95 0.405 . . . . 0.0 110.834 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.37 108.36 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.698 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.18 -102.21 0.7 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.87 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.65 -18.15 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.927 ' HB3' ' HB2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.72 135.96 33.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.127 0.489 . . . . 0.0 110.266 -177.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 1.7 p90 -144.76 151.44 38.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.888 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.5 140.67 43.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 124.82 46.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.322 0.582 . . . . 0.0 110.791 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.38 158.84 42.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.583 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -114.62 112.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.969 0.414 . . . . 0.0 110.427 177.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 120.13 19.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.303 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.06 118.7 13.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.006 0.431 . . . . 0.0 110.731 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.552 HG21 ' HD1' ' A' ' 121' ' ' TYR . 1.8 t -105.38 151.58 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.711 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HG3' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.37 141.06 37.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 171.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.578 HG21 HD12 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -93.71 139.02 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -177.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.537 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.478 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -68.63 121.62 16.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.6 m -146.09 20.71 1.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 0.0 109.787 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -76.55 118.19 69.85 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.088 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.43 -9.19 24.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.069 2.513 . . . . 0.0 112.482 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -166.19 147.85 6.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.423 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -138.63 169.73 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.554 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 132' ' ' GLU . 54.7 t -90.73 111.88 24.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -87.82 150.17 23.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.44 -156.14 38.7 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.706 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -147.17 137.02 23.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.853 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -96.49 -49.13 5.28 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 55.04 -134.59 47.95 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.85 173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 5.6 Cg_exo -80.84 97.97 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.417 2.744 . . . . 0.0 112.81 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.24 119.53 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.991 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -106.16 132.83 51.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.927 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.16 170.91 18.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.081 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.28 131.29 47.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.415 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -71.63 142.22 49.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.022 0.439 . . . . 0.0 110.488 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.1 -29.86 10.5 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.21 -153.51 26.27 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.6 p-10 -110.04 135.72 50.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.502 0.668 . . . . 0.0 111.074 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.733 HD12 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -97.92 110.9 23.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.304 175.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.754 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -97.15 99.62 11.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.96 127.99 42.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -116.7 119.04 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.612 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.4 OUTLIER -117.06 139.93 50.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.3 132.68 50.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.875 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.454 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -128.48 156.91 42.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.919 175.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -87.52 101.6 2.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 87.2 Cg_endo -86.54 126.45 2.62 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 114.142 -166.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.17 -27.23 13.97 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.372 2.048 . . . . 0.0 110.665 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.635 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 2.8 pt20 -136.21 178.46 7.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HG3' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -71.45 -19.78 62.18 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.59 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.89 19.67 9.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.767 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.55 -30.54 65.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.537 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -113.5 17.2 18.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 5.2 mmt -87.74 -166.61 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.748 0.309 . . . . 0.0 111.26 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.924 ' HB3' HD11 ' A' ' 75' ' ' LEU . 30.9 mt-10 -114.54 136.53 52.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.962 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -132.17 146.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.821 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 10.9 ttt-85 -141.23 115.21 9.18 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.636 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -129.89 90.19 2.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' HD2' ' HG3' ' A' ' 63' ' ' ARG . 77.8 m-85 -143.57 164.18 31.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.068 -172.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 136.88 56.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.962 0.411 . . . . 0.0 109.933 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.73 106.35 8.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -160.46 129.73 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.163 -177.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 67.44 -83.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.696 0.622 . . . . 0.0 111.492 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.11 44.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.24 82.53 47.14 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.22 -173.05 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.048 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 48.6 t -64.17 102.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.654 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 12.0 p-80 -141.97 102.61 4.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -164.3 152.16 12.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 -174.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.37 115.61 27.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.417 ' HB2' ' HG2' ' A' ' 61' ' ' GLU . 9.4 ttm180 -111.36 123.92 51.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -3.32 2.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.887 0.851 . . . . 0.0 109.828 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.6 25.76 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -120.9 149.87 41.95 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 115.051 -0.575 . . . . 0.0 110.875 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -99.57 169.99 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -158.43 163.23 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.318 . . . . 0.0 110.759 -176.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -13.7 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.35 -47.51 7.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.31 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -72.4 -32.38 66.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.512 -178.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.7 OUTLIER 50.11 59.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.656 1.217 . . . . 0.0 112.407 176.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.755 HD11 HG21 ' A' ' 94' ' ' THR . 16.3 tt -67.11 -1.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.025 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -13.95 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.18 0.514 . . . . 0.0 109.891 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -13.68 62.21 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.053 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 74.6 m-85 -109.75 27.05 9.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 77.2 t 77.78 -75.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.811 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 170.69 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.069 0.462 . . . . 0.0 109.851 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -74.24 70.68 1.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -176.064 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.755 HG21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -131.79 120.54 22.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.046 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 124.8 46.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.471 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.7 tp -102.88 105.79 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.957 0.408 . . . . 0.0 110.168 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -82.95 117.69 22.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -110.65 10.73 22.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.294 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -37.33 83.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.342 0.592 . . . . 0.0 110.068 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.24 79.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.899 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 56' ' ' GLN . 2.0 tt -57.59 -29.72 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.988 0.394 . . . . 0.0 111.657 -172.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.562 ' HA2' ' HG3' ' A' ' 56' ' ' GLN . . . -66.54 -18.3 67.7 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.129 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 3.95 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.924 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 41.48 6.77 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.621 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -137.77 133.68 34.36 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.292 0.546 . . . . 0.0 111.097 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' SER . 15.9 m -119.36 139.69 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.405 174.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -117.91 104.39 10.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.803 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 tp -93.65 110.23 21.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.443 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.754 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 1.5 ttp85 -93.0 106.32 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 94' ' ' THR . 78.0 mt -113.79 106.41 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.147 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -86.83 146.82 26.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 t30 70.0 54.76 0.34 Allowed 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 123.987 0.804 . . . . 0.0 110.174 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD12 ' A' ' 45' ' ' LEU . 12.2 p -78.29 137.56 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.704 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.3 p -120.33 162.01 20.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.926 0.393 . . . . 0.0 111.557 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 9.9 p -68.59 -16.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.439 0.638 . . . . 0.0 110.369 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.24 -33.73 76.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.472 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.93 -12.69 14.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.497 -175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.59 -9.89 1.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.01 -86.2 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.974 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -140.74 118.69 11.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.086 -0.656 . . . . 0.0 111.608 -175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.499 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 10.9 m-85 -93.55 127.95 39.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.601 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 1.9 m-70 -101.26 127.54 47.81 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 48.1 t -106.16 116.81 32.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.109 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.743 ' HB ' HH11 ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.12 130.2 74.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.4 m-85 -108.12 126.26 52.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.962 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -116.82 104.91 11.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.815 0.34 . . . . 0.0 110.305 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 21.8 t70 -111.45 107.0 16.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.946 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.53 -92.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.156 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.51 -20.26 7.85 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -101.65 155.8 17.88 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 -173.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 33.0 p90 -144.67 150.37 37.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.33 133.42 50.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.815 176.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -114.92 121.49 43.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.293 0.568 . . . . 0.0 110.705 -177.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.26 159.15 21.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.757 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.76 108.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.331 0.586 . . . . 0.0 110.875 -175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.34 102.0 11.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.857 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -80.54 129.96 34.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 45' ' ' LEU . 84.4 t -102.8 146.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 0.0 110.48 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -122.1 94.39 4.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.742 176.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.686 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -78.09 137.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 177.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.963 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 tmm? . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.472 -0.195 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 m 59.85 -92.5 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.634 0.584 . . . . 0.0 112.011 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.03 41.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.418 0.627 . . . . 0.0 109.365 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.73 134.83 92.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.583 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.06 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.136 2.557 . . . . 0.0 112.407 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 125' ' ' PHE . 3.1 p90 -110.77 159.85 17.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.806 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -135.25 179.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.393 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 132' ' ' GLU . 77.6 t -115.57 106.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.89 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -112.33 131.14 55.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.445 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.0 -113.39 0.58 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.908 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.83 161.63 20.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.399 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -83.5 -49.03 9.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.935 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.968 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 139.95 87.02 0.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.579 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -94.6 40.6 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.114 2.542 . . . . 0.0 111.282 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.61 119.78 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.274 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.43 139.33 36.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.627 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -140.63 169.73 17.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.42 144.77 43.31 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 111.81 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.17 84.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.329 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.67 -161.8 30.03 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -99.9 146.9 26.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.389 0.614 . . . . 0.0 111.384 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.8 tp -134.49 119.26 18.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.803 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.97 110.34 22.46 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 107' ' ' THR . 0.9 OUTLIER -94.36 127.24 40.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 122.83 47.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.527 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.698 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.64 141.22 48.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.423 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -106.78 141.43 38.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.077 0.465 . . . . 0.0 110.634 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -125.24 136.9 54.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 -176.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 m -97.95 87.64 0.55 Allowed Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 93.5 Cg_endo -91.2 133.05 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.002 2.468 . . . . 0.0 114.365 -165.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.43 4.14 5.19 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.167 2.578 . . . . 0.0 110.488 168.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' HB3' ' H ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -140.45 -176.35 4.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.194 -176.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -89.62 -6.72 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 71.57 -3.35 2.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.662 174.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 3.4 mt-30 -61.99 -28.17 69.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.316 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.25 16.63 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.08 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.7 170.72 9.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.392 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.86 130.65 56.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -127.4 147.05 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.351 0.596 . . . . 0.0 111.275 -177.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 116.64 22.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -126.38 64.33 1.25 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 74' ' ' HIS . 82.3 m-85 -142.24 152.18 42.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.727 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.42 143.78 57.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 -177.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 9.7 t30 -120.47 108.15 13.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.024 0.44 . . . . 0.0 111.358 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 mp -108.63 -177.01 3.2 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -78.6 60.23 2.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.216 0.531 . . . . 0.0 110.256 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 -176.01 4.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.303 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 71' ' ' GLU . 3.7 mm-40 -69.19 120.89 79.66 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.253 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 6.2 Cg_exo -79.19 66.14 8.8 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.886 2.391 . . . . 0.0 111.576 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -93.02 78.6 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.922 0.868 . . . . 0.0 110.678 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.68 ' HE1' ' HA ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -170.41 136.61 1.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.503 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.35 126.37 0.42 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.297 0.373 . . . . 0.0 110.33 -175.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.08 128.16 41.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.69 138.26 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.23 -170.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 64.09 21.21 12.5 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.611 0.719 . . . . 0.0 110.061 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.54 17.1 72.41 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 168.64 17.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.141 0.496 . . . . 0.0 111.029 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.32 153.52 18.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.324 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 mtt -135.84 153.35 51.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -5.46 29.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.854 0.359 . . . . 0.0 111.062 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.97 -15.75 69.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.093 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.579 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -118.79 -39.83 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.523 0.201 . . . . 0.0 110.49 178.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 mt 53.92 85.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 111.954 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.68 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 3.5 tt -65.44 -28.57 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.576 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -14.58 52.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.511 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HD2' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -86.76 -14.05 43.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.862 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.2 -52.0 18.53 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 92' ' ' GLU . 4.2 p -178.34 175.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.952 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -85.77 150.27 24.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 173.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER 63.74 64.78 0.76 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.827 -175.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.577 HG23 HG12 ' A' ' 110' ' ' ILE . 1.2 m -120.87 106.78 11.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.89 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -117.4 118.39 32.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD22 HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -87.57 98.06 11.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mt -72.07 109.2 5.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.657 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 20.2 mtmt -108.11 14.0 25.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.655 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -20.65 66.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.493 0.663 . . . . 0.0 110.512 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.83 -17.21 66.09 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.473 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 57' ' ' ALA . 1.9 tt -51.9 -38.42 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -170.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 -19.9 69.46 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.373 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.67 22.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.93 45.02 8.63 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.69 133.08 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.185 -0.597 . . . . 0.0 110.642 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.91 132.25 70.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.151 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -123.53 104.19 8.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -177.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.588 HD13 HD22 ' A' ' 96' ' ' LEU . 7.1 tp -88.7 111.89 22.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.26 0.553 . . . . 0.0 110.286 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -90.51 106.49 18.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.739 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 94' ' ' THR . 43.0 mt -114.15 116.57 52.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.777 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 13.3 m-85 -88.77 146.32 25.08 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.815 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 t30 69.53 62.98 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.911 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.578 HG21 ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -65.97 141.54 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.949 175.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.96 167.42 15.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.949 0.404 . . . . 0.0 111.803 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.614 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -70.56 -13.06 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.396 0.617 . . . . 0.0 110.192 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB3' ' NH2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -73.19 -23.61 60.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.94 171.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.91 -11.27 15.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.763 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -62.04 -5.34 2.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.434 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.09 -133.91 1.46 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.658 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.36 124.98 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.191 0.52 . . . . 0.0 111.281 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.84 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 3.3 m-85 -88.22 135.44 33.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.644 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -100.92 119.83 39.27 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.96 0.409 . . . . 0.0 110.02 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.7 t -104.05 118.34 36.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.341 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 133' ' ' GLU . 3.5 t -131.11 128.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.206 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.698 ' HZ ' ' HB3' ' A' ' 49' ' ' CYS . 29.3 m-85 -116.21 137.3 52.26 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 131' ' ' TYR . 4.3 ptmt -140.61 120.97 13.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.126 0.489 . . . . 0.0 110.918 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -132.48 133.87 44.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.8 -107.55 1.98 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.312 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -120.21 -6.16 9.91 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.71 141.78 35.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 0.0 111.01 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 126' ' ' LYS . 52.8 p90 -134.46 154.33 51.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.806 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -133.41 147.27 51.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.031 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HG2' HG13 ' A' ' 124' ' ' VAL . 28.5 mt-10 -121.35 149.91 42.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.291 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 138.94 18.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.131 175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mm -98.62 128.69 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.968 HG23 ' HA3' ' A' ' 35' ' ' GLY . 63.0 m -124.43 109.12 12.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.685 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.98 134.3 37.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.29 124.23 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.147 0.498 . . . . 0.0 110.106 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -98.7 90.7 4.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.56 119.77 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.345 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 tpp . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.64 109.38 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 110.287 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -147.16 36.14 0.91 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.687 0.755 . . . . 0.0 109.406 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -94.14 117.12 67.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.145 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.2 -80.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.079 1.853 . . . . 0.0 111.16 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -167.49 145.22 4.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.69 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.7 pt -132.02 176.83 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.799 0.333 . . . . 0.0 110.663 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 51' ' ' LEU . 37.1 t -102.97 113.85 40.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.782 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -94.66 131.83 40.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.163 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.45 -172.16 15.24 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.8 148.66 22.68 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.679 ' HB2' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.15 -47.25 13.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.48 116.88 4.26 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.286 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.91 91.93 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.331 2.02 . . . . 0.0 111.189 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -69.49 100.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.67 113.32 25.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.926 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -125.98 171.52 10.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.289 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.1 m -122.12 143.88 49.27 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD12 ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -59.72 135.93 57.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -174.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.09 89.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.861 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.2 168.02 17.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.73 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 1.1 p-10 -79.84 122.68 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.19 0.519 . . . . 0.0 110.512 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.675 HD11 HG11 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -90.39 111.21 22.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.079 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 1.8 mp0 -94.3 105.73 17.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 45' ' ' LEU . 2.0 mm? -96.07 128.46 42.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.45 123.62 49.88 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.701 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.83 140.26 53.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.884 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -130.53 140.71 50.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -127.84 158.61 37.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.9 m -90.47 98.87 1.65 Allowed Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 10.2 Cg_endo -88.26 125.25 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.371 2.714 . . . . 0.0 114.006 -167.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 73.0 Cg_endo -81.11 -17.81 9.08 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 110.837 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' OE1' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -120.32 -171.66 2.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.112 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -89.89 -10.92 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 0.0 110.165 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HA ' ' HG2' ' A' ' 60' ' ' MET . . . 66.16 -1.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -57.25 -42.18 81.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.156 0.503 . . . . 0.0 110.915 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -99.92 26.11 6.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -92.17 175.9 6.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.735 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 41.8 mt-10 -113.64 129.88 56.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.802 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -125.61 129.17 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.349 0.595 . . . . 0.0 111.216 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 20.4 mtp180 -114.45 117.75 31.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.322 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -125.69 60.3 1.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 87' ' ' ILE . 62.8 m-85 -139.59 152.35 46.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.74 0.781 . . . . 0.0 112.859 -166.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -148.51 126.22 11.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.167 168.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -152.2 156.44 39.77 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.85 138.16 43.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -81.74 66.72 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.33 0.586 . . . . 0.0 111.46 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.17 -58.93 1.96 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -154.6 83.74 3.97 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.465 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.28 170.34 18.72 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.726 2.284 . . . . 0.0 113.201 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.591 ' CG1' ' HA ' ' A' ' 87' ' ' ILE . 2.0 t -68.72 154.72 8.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.464 175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 65.5 m170 -104.0 -86.63 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.859 -171.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 61' ' ' GLU . 1.9 pt? -163.76 143.41 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 0.0 112.009 -170.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.06 129.27 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.041 175.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -131.41 132.24 44.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.337 -175.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.2 t0 58.22 21.59 8.28 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.609 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.52 14.66 81.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.174 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 147.24 45.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.79 0.328 . . . . 0.0 110.688 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.556 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.0 p30 -118.49 169.68 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.88 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.25 152.99 50.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.09 -17.27 63.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.88 84.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.232 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 1.7 pp20? -117.63 -38.32 3.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.7 tp 39.06 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.046 1.339 . . . . 0.0 113.82 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.591 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 14.2 tt -56.91 -31.27 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.67 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -12.28 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.194 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.25 -30.94 68.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.701 0.286 . . . . 0.0 110.549 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -71.5 -59.03 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 94' ' ' THR . 1.2 p -159.62 153.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.112 177.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -56.26 -47.43 78.59 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -175.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -90.71 77.04 6.38 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.34 0.591 . . . . 0.0 110.887 -177.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.528 HG23 HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.45 94.6 4.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.794 177.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.65 120.96 42.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.649 -175.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -99.55 106.97 19.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.111 0.482 . . . . 0.0 110.835 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 4.8 mp -77.24 109.3 11.0 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.503 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.53 -13.02 16.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.657 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -19.81 63.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 110.964 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.16 66.27 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.653 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.96 -27.97 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.66 -25.45 72.87 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.499 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.46 -2.53 57.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.109 0.48 . . . . 0.0 109.921 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 50' ' ' GLN . . . 85.82 19.84 57.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.353 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 50' ' ' GLN . 6.9 mptt -123.52 132.15 53.83 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.065 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.38 133.62 68.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 3.8 m -119.94 112.95 19.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.345 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 96' ' ' LEU . 11.4 tp -100.17 117.28 34.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.806 0.336 . . . . 0.0 110.271 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 18.7 mtt180 -94.77 106.87 18.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.631 176.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.598 HD12 HD23 ' A' ' 47' ' ' LEU . 21.6 mt -111.79 107.08 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -71.72 123.05 21.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.7 t30 81.1 108.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.042 0.839 . . . . 0.0 111.429 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.89 146.68 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.434 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.412 ' HB ' ' OD1' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -113.17 151.66 30.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 111.985 -175.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' HD12 ' A' ' 41' ' ' LEU . 2.9 p -72.49 -14.13 16.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.582 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' OD1' ' HB ' ' A' ' 114' ' ' THR . 5.4 p-10 -91.76 -19.1 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.933 0.397 . . . . 0.0 110.335 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.534 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.1 OUTLIER -110.36 2.94 19.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB2' HD13 ' A' ' 140' ' ' ILE . 4.7 p-10 -62.81 25.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -80.68 -159.05 20.34 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.334 -174.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -87.04 111.83 21.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.883 0.373 . . . . 0.0 110.686 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.773 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 2.4 m-30 -68.52 146.0 53.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.333 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.11 114.31 28.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 0.0 110.427 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -100.18 117.73 35.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.529 177.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 63' ' ' ARG . 47.1 t -118.02 109.04 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.116 0.484 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 134' ' ' HIS . 1.1 m-85 -93.73 115.52 27.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.1 mtpm? -109.11 104.89 14.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.729 0.3 . . . . 0.0 110.325 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.791 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 23.7 t0 -118.39 136.53 53.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.588 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.82 -111.73 2.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -113.15 3.05 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 110.816 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.53 171.23 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.904 0.383 . . . . 0.0 111.353 -174.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 4.0 p90 -148.45 147.93 29.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -122.75 142.8 50.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.6 121.01 39.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 0.0 110.482 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.54 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.55 137.37 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.829 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.38 107.42 22.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.194 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 34' ' ' GLU . 1.4 m -103.96 105.46 15.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 1.1 mm-40 -67.58 122.43 18.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.491 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 45' ' ' LEU . 4.0 t -91.85 147.77 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.98 115.49 17.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.2 mp -91.94 126.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.173 -176.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.715 0.293 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 m 57.6 27.57 14.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.19 9.87 4.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -74.69 134.6 75.51 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.038 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 19.1 Cg_exo -66.05 -62.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.976 2.451 . . . . 0.0 113.376 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -133.71 146.42 50.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.435 -174.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.966 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.2 pt -148.56 167.76 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.036 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 132' ' ' GLU . 39.4 t -91.75 140.82 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.663 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -130.79 179.18 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.0 111.108 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.61 -133.45 11.36 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.78 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.96 176.65 5.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.59 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.318 0.386 . . . . 0.0 110.183 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.931 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 134.06 80.66 0.15 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.017 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.83 57.0 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.01 2.474 . . . . 0.0 111.566 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -82.14 100.85 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.267 -176.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.31 101.32 13.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.393 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.46 169.5 8.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.722 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -120.59 138.06 54.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.79 0.329 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -66.08 130.52 43.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.766 -176.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.24 -5.04 84.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.485 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.97 -168.27 27.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.903 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -81.58 113.54 19.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' HB ' ' A' ' 110' ' ' ILE . 5.3 tp -85.85 114.89 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.82 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 3.7 mt-10 -110.38 117.42 33.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 0.7 OUTLIER -108.39 128.53 54.85 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.458 ' C ' ' HH2' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -116.21 119.89 37.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -178.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.774 ' HB2' ' CZ3' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -117.76 140.36 49.78 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.793 ' HG3' ' HD2' ' A' ' 105' ' ' LYS . 1.9 mp0 -115.86 135.75 53.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.294 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.698 HD23 ' HA2' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -127.35 153.16 46.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.636 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.74 100.36 5.28 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.7 Cg_endo -88.95 116.09 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.913 2.408 . . . . 0.0 113.584 -170.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.7 -13.84 12.99 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.44 2.094 . . . . 0.0 110.917 171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' ' CE ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -134.27 -174.19 3.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.727 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 58' ' ' GLN . 25.8 pt20 -74.96 -22.41 58.58 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.963 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 64.75 10.29 5.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.963 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.493 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -68.26 -11.29 59.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -117.47 15.68 14.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.293 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.664 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -82.88 155.28 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.079 0.466 . . . . 0.0 111.722 -172.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.968 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 2.1 mp0 -84.05 151.57 24.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -134.16 137.86 51.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.911 0.862 . . . . 0.0 111.316 -178.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -132.16 116.68 17.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.482 173.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.774 ' CZ3' ' HB2' ' A' ' 49' ' ' CYS . 2.1 t90 -144.09 98.05 3.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.181 0.515 . . . . 0.0 110.286 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.604 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.45 170.76 6.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.03 117.01 31.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.568 ' HG ' ' OE2' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -119.24 -164.5 1.06 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.762 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -100.31 37.07 1.74 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.284 0.564 . . . . 0.0 110.876 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.03 64.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.706 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 35.5 mm-40 -91.5 -37.65 0.37 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -170.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.706 ' HD2' ' N ' ' A' ' 71' ' ' GLU . 91.9 Cg_exo -17.99 -78.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 125.209 3.939 . . . . 0.0 115.523 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.452 HG22 ' HA3' ' A' ' 84' ' ' GLY . 3.2 p -100.57 119.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -159.12 37.85 0.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.12 -175.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.889 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.97 150.35 44.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -173.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.611 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 21.6 t80 -117.64 139.64 50.73 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.641 ' HG2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -117.83 147.48 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.177 -174.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -63.9 104.55 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.114 0.483 . . . . 0.0 110.083 177.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 7.71 55.98 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.115 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.641 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -143.26 122.69 13.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.455 0.645 . . . . 0.0 111.241 176.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -110.89 136.98 49.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.425 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -145.59 147.86 32.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.324 -174.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.453 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -71.16 -3.24 18.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 174.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' HA3' HG22 ' A' ' 73' ' ' VAL . . . -68.51 -49.36 44.89 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.184 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -64.66 -34.43 78.28 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 89' ' ' LYS . 1.1 tt 44.66 51.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.625 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.487 HD11 HG21 ' A' ' 94' ' ' THR . 3.2 tt -65.83 -17.86 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.647 173.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -15.29 62.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.472 174.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.68 -27.62 40.77 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.302 0.572 . . . . 0.0 109.575 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -75.45 -62.65 1.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 111' ' ' PHE . 9.0 p 172.41 136.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.285 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.31 55.67 2.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.429 0.633 . . . . 0.0 110.158 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.65 66.92 1.39 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.487 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -122.11 151.39 40.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.079 -172.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -137.23 117.14 13.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.307 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 108' ' ' LEU . 15.7 tp -100.82 101.23 12.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.868 0.366 . . . . 0.0 110.307 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -70.34 99.63 1.59 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.729 178.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -103.69 1.47 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.261 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -24.83 65.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.547 0.689 . . . . 0.0 110.261 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.78 -17.02 64.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.41 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 tt -53.51 -37.66 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.98 -15.19 69.11 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.17 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.8 -4.7 21.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.858 0.361 . . . . 0.0 110.244 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.698 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 92.41 31.27 9.05 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -133.51 133.6 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.152 0.476 . . . . 0.0 111.444 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.61 134.02 62.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 O-C-N 122.244 -0.285 . . . . 0.0 110.258 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -122.22 114.06 20.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.256 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.624 HD13 HD13 ' A' ' 96' ' ' LEU . 24.1 tp -94.45 115.5 27.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.553 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 4.9 ttp180 -100.01 107.05 18.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.646 ' HB ' HD23 ' A' ' 45' ' ' LEU . 48.2 mt -110.37 118.7 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' HG11 ' A' ' 91' ' ' VAL . 11.0 t80 -75.91 128.3 34.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.059 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 26.4 t30 72.18 84.97 0.12 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.801 0.688 . . . . 0.0 111.758 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 p -89.53 142.06 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.447 HG22 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -124.72 171.34 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.9 0.381 . . . . 0.0 111.676 -178.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -23.12 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -171.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.93 -25.84 60.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.514 0.673 . . . . 0.0 109.894 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.447 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . 1.7 m-20 -101.27 -4.07 27.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.422 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -57.96 -11.85 2.77 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.782 175.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.42 -146.73 0.48 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 121.725 0.625 . . . . 0.0 114.578 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -90.11 136.18 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 111.611 -175.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -105.29 123.4 47.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.277 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -84.62 113.73 21.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.894 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 41.9 t -99.73 117.57 34.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 14.8 t -135.07 118.46 24.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.173 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.514 ' CE2' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.11 143.41 30.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.968 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -123.85 118.64 27.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 0.0 111.11 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -115.03 85.34 2.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.763 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.73 -90.15 0.16 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.94 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.97 -24.47 13.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.79 25.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 110.786 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.07 143.49 38.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.54 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.966 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 7.0 mm-40 -127.45 132.94 49.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 3.7 pt-20 -123.03 142.66 50.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.423 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -136.84 146.55 45.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.656 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.6 mt -97.02 107.99 20.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.932 0.396 . . . . 0.0 110.374 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.931 HG23 ' HA3' ' A' ' 35' ' ' GLY . 31.5 m -111.01 100.51 9.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.426 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -84.04 135.14 34.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -88.16 150.73 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.044 0.449 . . . . 0.0 110.637 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.84 101.25 7.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 118' ' ' ASP . 35.9 mm -74.34 108.42 5.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.872 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.61 106.86 14.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 0.0 110.277 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.98 4.28 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.747 0.784 . . . . 0.0 109.102 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -105.55 101.89 34.63 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.953 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.38 -37.47 4.34 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.75 2.3 . . . . 0.0 112.908 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -101.49 146.98 26.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.61 179.21 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.292 0.568 . . . . 0.0 112.257 -170.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -90.65 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.935 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -105.96 129.75 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.09 -110.24 1.25 Allowed Glycine 0 C--N 1.334 0.456 0 O-C-N 123.572 0.545 . . . . 0.0 112.149 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 33' ' ' LEU . 4.3 mt -146.76 149.86 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 -46.92 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.37 123.13 1.97 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.793 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.63 73.16 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.852 2.368 . . . . 0.0 110.456 172.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.66 HG21 HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.11 114.97 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.02 -174.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.81 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.754 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -145.27 173.08 12.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.965 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -112.32 147.17 36.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -73.15 152.08 41.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.48 -7.07 82.0 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.68 179.63 22.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.181 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -79.82 109.58 14.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 110.325 178.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.727 HD13 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -86.99 109.75 19.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.203 178.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.694 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.4 mt-10 -94.25 96.06 9.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.727 HD21 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -104.98 129.51 53.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.775 -175.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -118.07 138.84 51.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.889 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 m -117.78 140.2 50.01 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.39 131.85 56.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 110.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -125.4 159.32 32.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.5 -177.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.2 86.5 6.38 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 172.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.3 Cg_endo -88.39 153.54 6.6 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.806 2.338 . . . . 0.0 112.55 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 7.2 Cg_exo -73.55 -28.04 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.767 2.311 . . . . 0.0 111.742 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.83 -172.49 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -69.4 -8.27 45.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.137 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 60.74 29.41 18.99 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.107 0.563 . . . . 0.0 112.276 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.49 -42.55 78.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.449 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -101.27 25.0 8.72 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 111.347 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 16.2 ttm -68.88 131.84 45.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.162 0.506 . . . . 0.0 111.457 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -88.05 143.89 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.7 HG21 HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -134.95 148.96 28.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.84 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 3.2 ttp85 -128.74 115.64 18.3 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.623 ' CZ2' HD22 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -126.65 87.7 2.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -153.61 148.57 26.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.899 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HD3' ' HB2' ' A' ' 117' ' ' ASP . 41.9 ttt-85 -88.72 94.92 10.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 165.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.47 129.32 51.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.066 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.52 132.86 38.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.948 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 74.86 148.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.242 0.964 . . . . 0.0 110.999 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.43 109.62 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.707 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.55 103.22 51.22 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.951 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.98 -9.5 25.2 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.216 2.611 . . . . 0.0 112.651 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.57 0.49 8.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.683 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -109.14 80.71 1.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.077 -178.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -138.77 144.35 39.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.659 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' HE2' HD13 ' A' ' 87' ' ' ILE . 2.7 t80 -100.57 115.11 29.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.52 121.32 44.85 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.085 -168.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.8 t70 64.94 14.16 9.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.148 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.777 ' HA2' HD22 ' A' ' 96' ' ' LEU . . . 89.82 14.05 60.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.741 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -129.05 148.71 51.02 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 139.02 50.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.934 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.585 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -105.48 -172.89 2.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.524 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -75.53 -9.22 58.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.867 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -55.28 3.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.789 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 82' ' ' MET . 6.9 pm0 -74.77 -37.82 62.34 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 122.716 0.406 . . . . 0.0 110.446 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.0 tp 43.44 97.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.643 1.177 . . . . 0.0 113.421 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.728 HD13 ' HE2' ' A' ' 76' ' ' TYR . 2.5 tp -62.89 -18.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.167 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -14.22 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.665 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -66.14 -29.67 70.01 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.045 177.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.68 -71.2 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.512 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.99 141.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.01 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.356 0.598 . . . . 0.0 110.802 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -161.12 65.77 0.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.72 119.16 25.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.223 -174.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.12 99.97 7.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.699 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.777 HD22 ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -86.08 111.39 20.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.186 0.517 . . . . 0.0 110.488 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.2 mp -81.72 112.94 19.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.912 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.05 1.85 56.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.094 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.31 -33.59 63.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.332 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.19 -16.9 65.98 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.814 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -31.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.48 -25.4 66.97 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.435 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.2 13.68 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.979 0.419 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.34 43.66 12.53 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.477 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -129.82 133.19 46.79 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.279 -0.542 . . . . 0.0 110.784 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 62' ' ' ILE . 14.3 m -121.96 132.96 69.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.721 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -116.4 102.86 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.727 178.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.644 HD13 HD12 ' A' ' 96' ' ' LEU . 4.6 tp -96.05 111.52 23.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.098 0.475 . . . . 0.0 110.195 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.694 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -86.42 106.26 17.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.542 174.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.455 HG13 ' HG ' ' A' ' 108' ' ' LEU . 50.0 mt -112.54 112.76 41.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 59.6 t80 -80.14 129.76 34.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 35.5 t30 76.23 79.6 0.09 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.914 0.759 . . . . 0.0 111.76 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 41' ' ' LEU . 10.2 p -84.96 149.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 168.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.25 165.52 14.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.964 0.411 . . . . 0.0 111.964 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.3 -28.95 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.13 -43.27 87.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.552 ' HB2' ' HD3' ' A' ' 66' ' ' ARG . 3.6 p-10 -104.17 4.09 33.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.616 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -62.5 -10.38 11.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 176.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.7 -118.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.931 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.2 124.97 35.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.257 0.551 . . . . 0.0 111.765 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 136' ' ' THR . 50.2 p90 -110.92 164.77 12.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.774 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 113.33 24.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.3 t -104.92 122.37 45.67 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.84 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 97.8 t -131.95 139.24 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.047 -175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 23.2 m-85 -119.31 140.5 50.2 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -130.75 105.04 7.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.653 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' A' ' 130' ' ' PHE . 43.0 t0 -98.5 74.37 2.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.39 -93.36 0.89 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.3 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -97.79 -27.97 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.742 0.306 . . . . 0.0 111.714 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -96.81 143.18 27.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.922 0.391 . . . . 0.0 110.4 -177.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.738 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -138.02 142.77 40.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.395 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.44 131.91 54.1 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HA ' HG22 ' A' ' 124' ' ' VAL . 8.8 mt-10 -114.36 119.92 38.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 132.19 55.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.158 0.504 . . . . 0.0 111.12 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.452 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -103.5 107.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.576 175.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -120.52 160.66 22.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 139.51 53.83 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.226 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -83.0 150.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -112.58 90.89 3.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mp -80.76 123.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.918 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.458 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.341 0.115 . . . . 0.0 110.887 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -103.01 91.4 4.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.51 -179.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -151.49 33.55 0.56 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.445 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -72.15 117.19 56.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.382 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.08 -178.54 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.949 2.433 . . . . 0.0 112.301 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HE1' ' HA ' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -74.83 140.45 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.675 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.0 OUTLIER -122.07 168.12 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -170.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 134' ' ' HIS . 67.0 t -91.35 132.46 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.188 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.46 132.25 55.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.72 -107.31 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.749 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.43 168.39 21.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -175.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -48.63 7.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 111.82 2.53 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.927 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.57 86.87 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.569 2.179 . . . . 0.0 111.355 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -72.28 101.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.323 -176.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -87.22 119.72 27.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 171.82 13.8 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.003 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -98.67 133.98 42.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.3 123.42 17.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.85 0.357 . . . . 0.0 111.034 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 94.44 1.22 64.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.04 -174.42 33.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.214 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' HB2' ' HD1' ' A' ' 111' ' ' PHE . 10.3 t30 -93.88 119.8 33.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.857 0.36 . . . . 0.0 110.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.499 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -98.23 122.23 41.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.867 -177.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -97.17 101.68 13.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.683 174.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.499 ' HG ' HD22 ' A' ' 45' ' ' LEU . 1.1 mp -96.58 127.25 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.49 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -117.63 130.18 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.74 140.19 50.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 30' ' ' VAL . 8.0 tt0 -110.99 131.34 55.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.138 0.494 . . . . 0.0 110.604 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.24 154.88 44.31 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.376 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -87.27 101.24 2.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 170.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 72.9 Cg_endo -76.41 114.31 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.751 2.3 . . . . 0.0 113.74 -170.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.9 -21.05 9.88 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.44 2.094 . . . . 0.0 110.602 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -171.66 2.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.83 -18.06 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 56.99 32.32 21.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.261 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.59 -33.81 74.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.722 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -93.39 9.61 35.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 146.68 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.314 0.578 . . . . 0.0 111.39 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -92.68 102.63 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.78 130.01 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.689 0.757 . . . . 0.0 111.255 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.577 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 8.1 ttm180 -113.94 117.1 30.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.681 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.602 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -125.86 55.43 1.45 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.81 167.42 21.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.324 0.583 . . . . 0.0 112.192 -164.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' CD ' ' HB3' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -112.3 144.16 42.18 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.24 174.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.16 152.6 35.33 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.52 ' HB3' ' H ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -142.95 -141.47 0.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.859 -175.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.52 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -64.96 71.81 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -172.02 -101.25 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.373 173.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.431 ' H ' ' HB ' ' A' ' 70' ' ' THR . 8.2 mm-40 -153.25 158.27 32.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.87 56.21 3.52 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.748 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.4 t -98.78 89.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.94 124.78 0.44 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.677 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.86 143.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.556 0.535 . . . . 0.0 110.7 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CE1' HD12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -100.21 114.8 28.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.168 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.445 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -97.76 120.51 38.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -176.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t70 67.44 14.03 9.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.85 0.833 . . . . 0.0 109.969 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.44 70.72 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.595 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -122.99 151.68 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -101.01 169.32 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.264 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.705 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 2.8 ptt? -140.06 161.33 37.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.79 -27.71 69.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.28 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.17 -5.61 89.04 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.648 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -111.24 -40.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.6 OUTLIER 37.58 80.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.249 1.02 . . . . 0.0 112.929 177.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 76' ' ' TYR . 14.8 tt -64.04 -19.79 25.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.125 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -13.73 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.552 175.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -66.27 -29.84 70.15 Favored 'General case' 0 CA--C 1.524 -0.037 0 CA-C-O 121.019 0.438 . . . . 0.0 110.234 178.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -52.87 7.99 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.44 HG12 HG23 ' A' ' 94' ' ' THR . 7.3 p 176.4 159.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.317 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -79.34 -25.01 42.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -80.53 66.44 6.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.559 173.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.18 89.27 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.66 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -104.87 112.33 25.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.111 -175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -89.91 101.77 14.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 178.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -75.08 107.21 7.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 1.66 49.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.791 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.23 -29.19 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.16 -16.9 70.76 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.0 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 tp -55.54 -25.53 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.5 -21.12 70.42 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.903 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.26 13.33 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.316 0.579 . . . . 0.0 109.581 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.36 27.13 66.4 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.758 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.87 132.04 56.65 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.968 -0.724 . . . . 0.0 110.84 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.05 131.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -124.08 103.81 8.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.284 -176.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' HG13 ' A' ' 110' ' ' ILE . 9.0 tp -94.86 117.63 30.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.93 0.395 . . . . 0.0 110.336 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.797 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -96.22 107.48 19.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.566 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 94' ' ' THR . 53.3 mt -116.28 121.4 67.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' HD1' ' HB2' ' A' ' 44' ' ' ASN . 22.0 t80 -83.17 130.99 35.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.448 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 56.7 t30 71.78 84.38 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.162 174.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.08 131.92 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.018 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.19 177.24 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.94 -29.95 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -171.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -40.62 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.338 0.59 . . . . 0.0 110.276 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' ' CD ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.47 -7.9 55.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.277 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -63.88 -21.75 66.6 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.81 177.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.07 -110.05 0.08 OUTLIER Glycine 0 C--O 1.243 0.674 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.928 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.72 120.4 25.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.127 -0.536 . . . . 0.0 111.671 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.21 137.36 44.3 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -105.33 115.7 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -105.98 116.27 31.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.121 175.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 85.6 t -134.64 121.54 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.505 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 1.2 m-85 -111.22 113.39 25.85 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 104.37 9.73 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.546 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -105.28 89.34 3.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.21 -82.55 0.13 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.012 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.31 8.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.07 140.22 34.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 40.2 p90 -147.61 142.9 27.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.408 . . . . 0.0 111.06 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.675 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.99 137.8 41.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.745 176.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG2' HG13 ' A' ' 124' ' ' VAL . 4.6 mt-10 -122.12 121.26 36.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.954 0.407 . . . . 0.0 110.436 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -119.36 144.88 46.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -99.43 108.27 22.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.602 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -97.07 160.29 14.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.45 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -127.47 135.64 50.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.291 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 23.9 t -98.37 147.1 7.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HB2' ' HA ' ' A' ' 38' ' ' LEU . 1.3 mtpt -120.88 90.22 3.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -75.0 133.66 31.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.223 0.535 . . . . 0.0 109.886 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.84 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.648 0.261 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.22 61.63 3.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.414 0.626 . . . . 0.0 110.099 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.43 17.92 20.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.377 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 25.0 tt0 -70.78 114.08 23.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.195 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 27.0 Cg_endo -90.5 -94.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.977 2.451 . . . . 0.0 112.157 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -156.63 165.18 37.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.875 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.1 pt -134.75 165.66 30.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.887 0.375 . . . . 0.0 110.547 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.898 HG23 ' HB3' ' A' ' 132' ' ' GLU . 95.4 t -91.05 127.27 43.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.411 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.18 179.56 4.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.45 -133.9 11.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.07 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -111.42 172.84 6.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 35' ' ' GLY . 1.8 pm0 -69.0 -29.49 67.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 109.39 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.871 ' HA3' HG23 ' A' ' 136' ' ' THR . . . 117.38 72.68 0.46 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.363 173.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.95 52.74 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.497 2.131 . . . . 0.0 111.101 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 138' ' ' VAL . 2.3 m -78.57 104.51 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.499 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.55 137.77 32.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.71 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -133.76 170.69 15.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.616 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -119.57 138.32 53.28 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.735 -178.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.33 111.08 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.15 8.53 87.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.013 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' HA3' ' HB2' ' A' ' 40' ' ' SER . . . -103.92 -147.55 17.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.98 143.78 41.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 39' ' ' ALA . 10.3 tp -127.76 118.94 24.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.175 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -101.39 107.01 18.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.154 178.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -96.75 127.71 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 123.75 39.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.01 0.433 . . . . 0.0 111.103 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.25 50.06 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.82 160.01 18.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.249 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.502 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -127.64 148.71 50.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.035 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 89.67 0.31 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 162.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 51' ' ' LEU . 14.3 Cg_exo -67.81 115.21 3.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 2.729 . . . . 0.0 114.248 -162.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.27 -32.98 2.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.874 2.383 . . . . 0.0 110.129 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -146.34 -172.78 4.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.344 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.32 -21.89 59.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 55.57 24.54 7.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -42.42 90.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.189 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.11 5.32 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -80.22 174.94 11.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -169.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.148 ' HB3' HD11 ' A' ' 75' ' ' LEU . 48.7 mt-10 -106.24 143.63 34.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.53 -171.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.448 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.517 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -118.89 134.04 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 168.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -149.54 59.69 1.01 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -137.89 152.37 48.96 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.715 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HE ' ' HA3' ' A' ' 119' ' ' GLY . 11.4 tpt85 -89.89 95.09 10.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.732 0.777 . . . . 0.0 109.375 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.62 125.93 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.483 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.92 144.87 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.775 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 75.16 4.08 4.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.103 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.98 149.37 27.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.423 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.33 155.93 78.15 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.023 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.46 29.31 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.272 2.648 . . . . 0.0 113.754 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.8 50.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.399 0.619 . . . . 0.0 109.665 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 1.038 ' HA ' ' HB2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -161.56 82.09 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.117 179.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.148 HD11 ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -149.22 143.6 26.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.475 -169.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.76 ' HB3' HG23 ' A' ' 62' ' ' ILE . 4.6 t80 -94.44 114.63 26.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.217 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.671 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -147.75 163.71 35.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.322 -0.151 . . . . 0.0 110.845 -173.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t0 68.69 6.93 5.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.669 0.747 . . . . 0.0 109.93 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.76 -6.15 62.39 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.439 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 pttp -144.69 179.79 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.081 0.467 . . . . 0.0 111.266 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.9 168.09 19.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.717 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.654 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -134.0 143.27 48.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.797 0.332 . . . . 0.0 111.242 -175.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.36 -23.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 0.0 110.941 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.95 -32.57 77.49 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.399 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 74' ' ' HIS . 2.0 pp20? -95.2 -30.06 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.5 OUTLIER 47.6 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.676 1.19 . . . . 0.0 113.667 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 74' ' ' HIS . 8.5 tp -77.8 -7.93 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.123 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -13.45 7.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.713 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -69.56 -26.83 64.68 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.523 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -72.36 0.32 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -154.51 -174.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.829 -178.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -92.04 -23.45 19.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.848 0.356 . . . . 0.0 110.302 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.881 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -106.97 88.94 2.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.301 0.572 . . . . 0.0 111.268 -178.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.504 HG22 HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -116.46 95.61 5.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.292 173.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 109' ' ' ARG . 23.3 tt0 -103.1 98.93 8.79 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.621 -171.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.821 HD12 HD13 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -100.4 117.73 35.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.118 0.485 . . . . 0.0 110.932 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -89.96 109.54 20.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.194 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.14 -10.47 14.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.633 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -17.97 65.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.145 -177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.93 80.33 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.178 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.674 HD11 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 tt -57.56 -29.04 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 122.707 0.403 . . . . 0.0 111.709 -174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.88 64.04 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.658 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.13 4.7 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.166 0.507 . . . . 0.0 110.211 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.08 42.17 8.96 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.711 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 132.64 40.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.818 0.309 . . . . 0.0 110.538 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.79 132.33 59.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.253 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 46' ' ' GLU . 1.2 m -123.02 124.46 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.461 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.821 HD13 HD12 ' A' ' 96' ' ' LEU . 40.8 tp -112.11 111.9 23.13 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -96.03 105.95 18.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.81 132.09 51.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.881 ' HB2' ' HB3' ' A' ' 93' ' ' ARG . 1.5 m-85 -95.99 143.44 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.0 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HB3' HG11 ' A' ' 91' ' ' VAL . 49.4 t30 67.15 84.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -95.12 128.67 46.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.007 178.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.9 p -96.84 175.52 6.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.04 -16.8 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.602 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.43 -44.81 20.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.516 ' HB2' HG12 ' A' ' 113' ' ' VAL . 41.0 m-20 -65.8 -25.19 67.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.602 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.733 ' HB2' HD13 ' A' ' 140' ' ' ILE . 17.8 t70 -55.36 -17.42 4.83 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA3' ' HE ' ' A' ' 66' ' ' ARG . . . -71.82 -156.96 2.84 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.11 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -78.29 105.94 9.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.923 0.392 . . . . 0.0 111.729 -176.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -73.97 144.45 45.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 114.02 27.19 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.474 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 51.2 t -97.38 117.06 30.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.517 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 10.6 t -131.6 105.11 9.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.674 ' HZ ' HD11 ' A' ' 101' ' ' ILE . 21.8 t80 -97.82 139.2 34.03 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.186 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 6.0 mtpt -122.12 104.58 9.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.219 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 17.6 t0 -106.71 138.4 42.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.447 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.86 -110.61 1.76 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -120.96 11.52 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 159.7 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.807 0.337 . . . . 0.0 110.465 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 4.9 p90 -140.67 153.43 45.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.88 0.372 . . . . 0.0 111.17 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.898 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -142.45 157.35 44.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.592 178.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -133.38 154.44 50.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.242 0.544 . . . . 0.0 112.22 -172.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.86 124.55 14.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.167 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.94 108.95 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.433 . . . . 0.0 110.247 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.871 HG23 ' HA3' ' A' ' 35' ' ' GLY . 99.0 m -122.29 102.34 8.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.745 -176.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 5.3 pt-20 -82.84 141.96 31.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.34 . . . . 0.0 110.463 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 37' ' ' VAL . 89.6 t -86.82 151.18 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -113.63 92.29 3.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 174.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -71.75 120.33 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 139' ' ' LYS . 2.3 t . . . . . 0 C--O 1.251 1.164 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.572 -174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.512 0.196 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.3 112.25 5.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.999 0.428 . . . . 0.0 110.42 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.27 27.57 9.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.905 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.86 120.77 63.6 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -86.85 -131.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.768 2.312 . . . . 0.0 111.909 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -105.43 158.0 16.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 177.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.63 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 1.5 pt -129.25 167.93 23.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' HB3' ' A' ' 132' ' ' GLU . 44.3 t -91.1 144.7 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.83 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.09 161.31 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.604 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -171.15 28.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.536 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.21 176.85 4.86 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -49.8 73.73 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.158 0.286 . . . . 0.0 110.829 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.56 81.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.518 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.82 89.93 0.43 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.575 2.183 . . . . 0.0 111.061 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -68.55 124.78 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.409 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -88.77 105.59 17.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.014 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.41 170.58 9.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -120.98 145.07 48.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.57 119.04 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.074 0.464 . . . . 0.0 110.586 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 112' ' ' ASN . . . 90.76 -7.33 81.41 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.322 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.11 -176.35 49.04 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.528 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -87.61 115.65 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -108.12 118.65 37.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.407 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.91 112.24 24.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.372 177.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.6 128.1 42.19 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.28 128.5 52.42 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 140.49 52.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.82 145.26 45.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.48 -178.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 ' HE2' ' A' ' 28' ' ' PHE . 4.6 mt -117.75 164.37 15.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.71 85.36 0.55 Allowed Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 165.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 11.7 Cg_exo -68.39 119.2 6.21 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.233 2.622 . . . . 0.0 113.929 -162.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 -31.95 4.75 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.757 2.304 . . . . 0.0 110.098 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.99 -172.64 3.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.667 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -71.23 -15.93 62.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 59.46 17.05 5.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -64.3 -22.56 66.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.126 0.489 . . . . 0.0 111.22 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -115.14 24.18 11.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.318 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.677 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -86.55 169.9 12.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -178.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 12.0 tt0 -101.79 123.68 46.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.089 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.37 137.7 45.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.399 0.619 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.681 ' HB3' ' CD2' ' A' ' 74' ' ' HIS . 8.0 mtt180 -134.41 116.95 15.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.806 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.753 ' HZ3' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -136.85 73.48 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -177.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -149.28 169.69 20.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.184 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -94.3 95.94 9.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.309 0.576 . . . . 0.0 110.993 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -158.28 111.12 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mp -138.09 152.86 49.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.807 0.337 . . . . 0.0 111.726 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 74.11 -71.6 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.42 168.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -62.91 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -171.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.755 ' HB3' HG23 ' A' ' 73' ' ' VAL . 5.9 mt-10 -130.21 145.23 56.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.809 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.44 21.95 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.067 2.511 . . . . 0.0 112.48 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.755 HG23 ' HB3' ' A' ' 71' ' ' GLU . 2.9 t -69.03 128.83 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.515 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -175.32 131.22 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 82' ' ' MET . 0.1 OUTLIER -161.68 113.72 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -143.42 109.58 5.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 159.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.3 122.68 26.85 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.037 -0.414 . . . . 0.0 111.447 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 56.57 41.01 29.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.151 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.08 24.89 65.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.857 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.1 tptt -145.6 129.63 17.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.836 0.351 . . . . 0.0 111.049 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.26 163.36 17.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 172.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.798 ' HB2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -123.34 161.92 23.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.709 ' HA ' HG13 ' A' ' 86' ' ' ILE . 23.9 m-85 -62.24 -20.79 64.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.081 -173.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.49 99.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.246 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OE1' ' HA ' ' A' ' 74' ' ' HIS . 3.9 tp10 -104.15 -43.19 5.31 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.709 HG13 ' HA ' ' A' ' 83' ' ' PHE . 6.2 mt 61.09 109.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 122.037 0.922 . . . . 0.0 112.294 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 94' ' ' THR . 8.2 tp -72.38 -19.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.165 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -14.29 49.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.377 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -72.29 -26.09 61.84 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.403 0.621 . . . . 0.0 109.666 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 29.4 m-85 -92.23 -65.33 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.215 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.558 ' HB ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p 166.73 153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.2 60.25 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.288 177.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 1.1 mmp_? -145.98 60.69 1.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.7 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -125.46 164.5 20.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.105 -174.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.51 135.76 13.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.588 173.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 108' ' ' LEU . 4.2 tp -108.26 94.29 4.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.809 0.338 . . . . 0.0 110.108 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -70.45 108.76 4.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 109.707 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -107.07 6.59 29.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 -176.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.11 -25.91 68.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.012 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.0 -16.8 66.63 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.266 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.496 HD13 ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -53.79 -28.23 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.88 -26.71 67.47 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.072 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.53 15.31 19.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 109.857 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.584 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 76.83 43.2 18.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.462 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.489 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.0 OUTLIER -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.275 0.537 . . . . 0.0 110.603 176.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' A' ' 125' ' ' PHE . 15.4 m -131.05 139.51 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.6 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -126.96 106.43 9.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.797 179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 96' ' ' LEU . 13.9 tp -90.27 107.59 19.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.146 0.498 . . . . 0.0 110.121 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -84.79 107.43 16.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.552 178.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.5 mt -116.88 111.35 34.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.838 0.351 . . . . 0.0 110.498 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 23.9 t80 -81.44 137.04 35.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.546 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 53.9 t30 77.9 75.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.917 0.761 . . . . 0.0 111.71 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.88 148.73 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -113.1 164.58 13.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.207 0.527 . . . . 0.0 112.118 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 118' ' ' ASP . 7.7 p -66.69 -25.35 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.078 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 5.0 t70 -73.57 -34.22 65.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 175.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -78.79 -19.28 52.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.497 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.615 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -54.69 -15.96 2.19 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.633 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.52 -130.98 0.98 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.726 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -94.95 121.4 36.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.073 0.463 . . . . 0.0 111.61 -177.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.3 m-85 -87.68 142.97 27.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.565 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.75 118.76 35.21 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.186 0.517 . . . . 0.0 111.026 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 37.1 t -100.45 120.67 40.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.195 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.19 121.09 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.625 ' CD1' HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.68 137.23 52.28 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.33 -178.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.947 ' HG2' ' HB3' ' A' ' 131' ' ' TYR . 20.4 mtpt -121.29 111.71 17.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.677 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 14.8 t70 -101.91 111.84 24.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.99 -105.93 1.69 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.035 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.03 -7.92 9.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.666 ' HD1' ' HD1' ' A' ' 28' ' ' PHE . 3.2 p90 -100.23 148.82 24.21 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.417 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.947 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 4.0 p90 -133.74 151.99 51.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.273 0.559 . . . . 0.0 112.017 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.765 ' HB3' HG23 ' A' ' 30' ' ' VAL . 1.6 mm-40 -128.89 156.83 43.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.8 174.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -133.53 142.57 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.656 0.741 . . . . 0.0 112.392 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -129.09 133.65 47.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.056 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.98 107.91 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.81 0.338 . . . . 0.0 110.498 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.562 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 51.7 m -117.68 118.3 31.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.624 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -77.7 134.85 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.61 149.86 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -114.02 96.08 5.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.761 0.315 . . . . 0.0 110.745 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 118' ' ' ASP . 1.1 mp -76.3 118.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.492 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.13 55.69 1.87 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.672 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.67 11.27 3.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.407 0.622 . . . . 0.0 110.124 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.4 OUTLIER -87.17 148.5 45.11 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.622 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 13.0 Cg_exo -71.17 -15.0 31.96 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.074 2.516 . . . . 0.0 112.034 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.642 ' HZ ' ' HB3' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -143.65 141.69 30.68 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 HG22 ' HG3' ' A' ' 132' ' ' GLU . 1.1 pp -139.09 178.38 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 110.956 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 134' ' ' HIS . 71.9 t -106.49 145.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.422 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.44 144.2 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.802 0.334 . . . . 0.0 110.452 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.62 60.95 4.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.736 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -135.79 109.74 8.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HA ' ' HE1' ' A' ' 134' ' ' HIS . 4.3 mp0 -77.25 -49.13 15.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.8 91.4 0.17 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.52 95.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.553 2.835 . . . . 0.0 112.987 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.73 97.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.998 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.8 101.76 13.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.417 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 45' ' ' LEU . . . -111.21 170.81 7.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.633 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.0 m -130.56 141.36 50.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 128.08 35.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.31 -23.89 22.22 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.65 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.3 174.67 52.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.7 138.9 39.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 HG21 ' A' ' 138' ' ' VAL . 0.3 OUTLIER -118.1 122.11 42.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.942 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.643 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 6.4 mt-10 -102.52 108.02 19.18 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 HD12 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -95.3 128.38 42.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.328 -176.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.22 129.59 55.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.746 -174.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -138.26 140.11 39.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 131.52 52.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.922 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -111.35 165.0 12.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.367 -173.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -124.92 72.26 63.05 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.398 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 92.9 Cg_endo -91.3 155.88 3.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.215 2.61 . . . . 0.0 113.207 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 35.4 Cg_endo -92.55 14.51 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.413 2.742 . . . . 0.0 112.108 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -137.09 -173.03 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.725 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -87.24 -16.77 34.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.217 175.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HA ' ' SD ' ' A' ' 60' ' ' MET . . . 60.72 13.14 4.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.99 174.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.693 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 4.1 tm0? -56.34 -40.78 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 78' ' ' ASP . 3.0 p80 -115.51 21.96 13.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.031 0.443 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -74.07 -173.52 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -177.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 77' ' ' ARG . 1.3 tt0 -103.81 118.21 36.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.965 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -127.3 123.89 62.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.0 111.92 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 123' ' ' CYS . 7.8 ttt85 -102.25 132.72 48.02 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.469 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -144.89 59.56 1.31 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -142.95 157.98 44.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.352 0.596 . . . . 0.0 111.864 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -141.29 109.79 5.97 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 165.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -165.28 107.43 0.8 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.669 -1.151 . . . . 0.0 107.922 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 113.69 25.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.185 0.517 . . . . 0.0 112.246 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.93 -155.57 0.15 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.922 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.4 63.86 2.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 111.903 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 53.72 70.14 1.9 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.24 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 73' ' ' VAL . 6.0 Cg_exo -77.73 -98.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.921 2.414 . . . . 0.0 111.357 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.438 ' H ' ' HB2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -64.15 143.95 15.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 173.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 85' ' ' GLU . 2.0 m80 -120.64 -86.26 0.65 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -164.84 149.81 9.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.574 -173.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' A' ' 62' ' ' ILE . 29.5 t80 -95.95 118.32 32.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.725 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.664 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -132.12 137.71 47.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.113 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 59' ' ' HIS . 4.2 m-20 63.07 17.03 9.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.288 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 15.24 70.43 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.481 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -136.59 143.16 43.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 0.0 110.527 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 8.8 p-10 -85.88 137.78 32.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.74 155.91 24.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.042 -176.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -40.21 80.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.215 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.6 0.91 79.93 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.79 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -105.54 -43.18 5.01 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.595 -0.356 . . . . 0.0 110.22 178.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 27.67 84.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.461 1.101 . . . . 0.0 113.019 -178.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 94' ' ' THR . 16.1 tt -62.65 -11.34 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.557 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -12.34 58.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -13.9 14.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -78.37 7.37 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.13 -0.356 . . . . 0.0 110.751 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.0 33.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.332 0.653 . . . . 0.0 111.657 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -170.71 -164.16 0.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 178.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -79.46 143.02 35.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -139.62 104.04 4.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.953 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -114.88 108.21 16.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.532 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.72 109.8 18.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.945 0.403 . . . . 0.0 110.846 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.6 105.65 11.06 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -102.13 9.94 39.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.88 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -27.09 67.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.522 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.72 -16.75 65.11 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.172 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -33.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -170.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.55 -11.02 67.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.073 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 6.05 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.23 43.16 26.55 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.55 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.18 133.08 38.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.384 -0.48 . . . . 0.0 110.796 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.11 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.855 0.359 . . . . 0.0 110.557 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -126.19 105.92 9.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.151 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' HG ' HG13 ' A' ' 110' ' ' ILE . 13.8 tp -90.78 118.13 29.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.643 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -86.88 106.61 17.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.691 175.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.639 HD12 HD23 ' A' ' 47' ' ' LEU . 56.4 mt -111.37 121.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.516 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -82.25 136.03 35.14 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.5 t30 68.59 91.66 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.431 0.634 . . . . 0.0 111.621 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.7 p -79.5 120.71 31.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.4 150.3 24.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.736 -176.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.95 -22.57 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.23 -35.96 58.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.214 0.53 . . . . 0.0 109.818 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.09 5.52 46.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.73 -177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.34 -4.27 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.916 176.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -134.42 0.52 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.0 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -102.17 127.86 48.91 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.343 -0.504 . . . . 0.0 111.032 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.843 ' HA ' ' HB3' ' A' ' 66' ' ' ARG . 40.7 m-85 -82.93 151.94 25.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.07 110.41 18.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.783 0.325 . . . . 0.0 111.034 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.5 OUTLIER -98.6 117.15 32.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 133' ' ' GLU . 8.0 t -118.6 107.36 21.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.642 ' HB3' ' HZ ' ' A' ' 28' ' ' PHE . 2.7 t80 -99.26 133.67 43.22 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.777 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -121.53 110.82 16.49 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.12 72.05 5.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.97 -96.82 1.6 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.178 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.33 -27.32 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.825 0.345 . . . . 0.0 111.311 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.509 ' HB2' ' HD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -94.48 143.31 26.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 52.4 p90 -146.88 151.08 36.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.49 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.648 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -147.53 143.68 27.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.685 ' HB3' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -112.71 144.96 41.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.145 0.498 . . . . 0.0 110.753 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 30' ' ' VAL . 52.0 t-80 -129.82 138.83 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.61 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -104.06 107.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 4.5 m -99.7 107.76 19.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.438 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -75.71 122.73 24.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 -178.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -96.18 150.71 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 110.82 12.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.302 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.661 HD11 HG22 ' A' ' 113' ' ' VAL . 8.9 mt -76.77 102.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 110.436 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m 51.83 72.87 0.35 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.712 0.633 . . . . 0.0 111.073 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -26.82 7.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.021 0.439 . . . . 0.0 110.545 -172.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -106.38 116.45 59.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.752 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.14 -3.24 9.57 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.935 2.423 . . . . 0.0 112.552 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -153.71 136.66 15.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 3.1 pt -144.53 165.8 12.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.617 0.723 . . . . 0.0 112.062 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.556 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.0 t -97.6 149.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.182 171.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -67.07 150.59 48.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.85 63.41 3.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.264 -0.493 . . . . 0.0 113.344 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 tp -139.51 132.4 29.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -85.9 -31.7 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.262 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.59 90.51 0.8 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.807 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.16 80.55 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.808 2.339 . . . . 0.0 110.97 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.53 92.42 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -89.39 110.09 20.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.773 176.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.19 171.97 8.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.137 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.05 133.55 36.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 140' ' ' ILE . 3.1 tp -66.62 111.69 3.77 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.944 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 85.6 11.49 74.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.819 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.38 -152.01 9.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.919 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -87.45 134.25 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.413 . . . . 0.0 111.112 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -119.93 115.44 23.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.519 176.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 2.5 mt-10 -108.19 110.08 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 110.748 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -96.69 129.22 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.346 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.26 122.16 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.888 0.375 . . . . 0.0 110.632 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.66 140.02 50.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -120.1 130.1 54.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.109 0.481 . . . . 0.0 110.131 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 30' ' ' VAL . 3.7 mm? -117.72 165.22 13.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.047 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.49 71.6 26.77 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 94.6 Cg_endo -89.48 154.61 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.013 2.475 . . . . 0.0 113.322 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.6 Cg_exo -70.44 -25.54 25.36 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.003 2.469 . . . . 0.0 111.964 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.21 -173.26 3.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.939 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -22.51 42.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . 54.22 32.97 17.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -32.0 66.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.791 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -115.46 28.96 8.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.866 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.935 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -91.73 -165.6 1.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.289 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG2' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.8 126.66 53.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 110.745 -178.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.466 HD13 HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -126.49 146.57 32.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.243 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.632 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 10.0 ttm180 -132.52 117.37 17.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.527 ' HH2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -131.36 58.34 1.73 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CE1' HG13 ' A' ' 87' ' ' ILE . 59.4 m-85 -139.38 150.66 45.57 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.676 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -70.06 96.6 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.662 HD21 ' HB2' ' A' ' 71' ' ' GLU . 11.5 t-20 -129.95 125.34 35.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.31 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -84.53 129.92 34.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.753 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 65.42 -108.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.655 0.597 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -153.47 114.21 4.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.805 0.336 . . . . 0.0 110.577 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.662 ' HB2' HD21 ' A' ' 67' ' ' ASN . 1.1 mt-10 -114.12 123.89 31.85 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 71' ' ' GLU . 25.6 Cg_exo -62.56 -44.32 18.24 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.968 2.445 . . . . 0.0 113.382 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.48 72.33 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.631 -172.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.5 105.71 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.599 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -178.69 151.55 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.228 0.537 . . . . 0.0 111.472 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HE2' ' HD3' ' A' ' 98' ' ' LYS . 2.6 t80 -95.35 117.52 30.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -127.46 143.1 51.24 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.784 -172.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.62 17.51 10.62 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.827 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.19 13.5 83.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.057 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -139.66 177.15 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 111.285 -178.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -95.41 170.07 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.112 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.52 138.96 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.945 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.84 -4.7 36.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.649 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.62 -16.42 70.84 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.781 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.633 ' HG3' ' N ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -111.94 -40.96 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.244 -177.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.633 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 76.6 mt 49.15 87.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 112.235 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -74.22 -6.46 8.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -14.84 27.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 173.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -21.85 64.1 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.899 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.0 t80 -85.58 -69.05 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -162.63 145.69 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.228 173.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -72.53 -7.86 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.348 0.594 . . . . 0.0 110.206 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.721 ' HA ' HH11 ' A' ' 93' ' ' ARG . 2.3 mmm180 -97.19 69.32 2.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.158 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.673 HG21 HD12 ' A' ' 87' ' ' ILE . 21.3 m -131.41 103.97 6.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.634 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.75 106.93 17.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.611 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 108' ' ' LEU . 1.1 tp -91.17 100.62 13.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.878 0.37 . . . . 0.0 110.708 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 HD12 ' HB ' ' A' ' 107' ' ' THR . 30.3 mt -77.07 117.39 18.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.21 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.42 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 6.8 mtmm -108.12 15.4 24.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.645 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.81 -33.67 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.648 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.33 -16.68 70.87 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.037 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.61 -29.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -21.35 59.62 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.155 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -117.21 4.1 12.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.759 0.314 . . . . 0.0 110.469 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.15 35.06 11.4 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.022 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 133.3 55.65 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.177 -0.602 . . . . 0.0 110.712 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.466 HG11 HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -128.34 132.89 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.853 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.478 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.29 110.48 16.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.805 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 96' ' ' LEU . 5.4 tp -98.41 119.56 37.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.794 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 2.6 mpp_? -96.12 106.71 18.93 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.483 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.605 ' HB ' HD23 ' A' ' 45' ' ' LEU . 69.1 mt -117.61 124.19 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.818 0.342 . . . . 0.0 110.132 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -94.19 132.12 39.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.858 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.478 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 36.9 t-20 75.54 80.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.024 0.827 . . . . 0.0 112.287 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.895 HG21 HD22 ' A' ' 45' ' ' LEU . 41.3 t -107.85 139.5 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.864 172.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.448 ' HA ' HD12 ' A' ' 41' ' ' LEU . 6.1 p -116.02 -173.71 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -24.6 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -168.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.29 -48.09 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.05 0.452 . . . . 0.0 110.534 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.407 ' OD2' HG13 ' A' ' 113' ' ' VAL . 7.2 p-10 -85.01 -6.61 59.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.626 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -68.92 -3.59 13.33 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 175.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.31 -99.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.0 -0.619 . . . . 0.0 114.066 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.09 128.01 41.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 111.21 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -90.48 151.5 21.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.307 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.86 108.72 20.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.036 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.4 t -101.11 117.91 35.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.329 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 23.1 t -134.03 131.92 55.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -122.43 122.67 39.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.19 104.45 11.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.991 0.424 . . . . 0.0 110.312 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.935 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 58.0 t0 -92.74 83.39 4.83 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.9 -97.55 0.82 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.617 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -113.44 -5.19 13.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.588 0.232 . . . . 0.0 111.568 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.87 110.06 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.12 141.1 43.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.522 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.583 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -121.02 154.41 36.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 176.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -135.19 128.62 32.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.04 135.47 32.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.451 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.15 127.2 48.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.237 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.527 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -105.46 134.71 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.145 -176.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -92.41 115.85 28.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.61 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 118' ' ' ASP . 16.3 t -96.29 141.64 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -131.13 95.42 3.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -73.47 127.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.175 0.512 . . . . 0.0 109.702 177.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.033 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.5 ' HG3' ' OG ' ' A' ' 25' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.58 65.46 6.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.28 0.562 . . . . 0.0 111.208 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.5 ' OG ' ' HG3' ' A' ' 23' ' ' MET . 1.0 OUTLIER -130.29 19.44 5.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -103.6 130.02 24.29 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.304 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 4.0 Cg_exo -75.31 -166.83 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.1 2.534 . . . . 0.0 111.843 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.478 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -86.71 170.4 11.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.44 168.21 24.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.291 0.567 . . . . 0.0 111.789 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.67 148.59 11.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.375 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -93.31 160.75 14.68 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.08 43.71 2.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.581 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 tp -133.95 94.2 3.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.202 0.525 . . . . 0.0 110.051 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -102.24 -24.34 13.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.573 175.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.48 93.64 1.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.013 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 68.37 3.85 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.761 2.308 . . . . 0.0 110.118 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 130.04 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.719 -169.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -97.52 91.61 5.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.927 174.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.68 151.89 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.375 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.74 121.49 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.538 ' HB2' HG23 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -63.39 118.76 8.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.938 0.399 . . . . 0.0 110.743 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 96.8 -2.74 62.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.181 -177.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.73 -165.27 24.28 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.324 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.45 115.97 22.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 0.0 110.661 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 tp -100.97 112.47 24.93 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.096 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.98 108.42 19.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.069 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 107' ' ' THR . 1.1 mt -95.94 128.76 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -122.23 122.27 38.74 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.044 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -118.17 140.13 50.24 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.4 131.32 56.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -126.44 157.05 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.06 -178.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.26 83.2 51.95 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.22 156.64 5.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.086 2.524 . . . . 0.0 112.843 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 97.5 Cg_endo -87.5 20.36 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.98 2.453 . . . . 0.0 112.091 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.49 -172.96 3.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.734 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -72.09 -19.11 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.127 0.267 . . . . 0.0 111.681 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 60' ' ' MET . . . 59.62 24.78 13.61 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.197 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -59.09 -40.85 86.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -89.09 18.7 4.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.379 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -49.65 132.54 21.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.229 0.538 . . . . 0.0 112.413 -175.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 75' ' ' LEU . 37.6 tt0 -96.0 101.02 12.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG12 ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -117.3 137.0 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.163 0.506 . . . . 0.0 111.521 -171.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.603 ' HG3' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -114.25 117.02 29.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.465 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -127.42 59.57 1.43 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.91 171.7 14.82 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.881 -165.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.59 164.15 12.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.688 164.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -159.81 155.36 25.67 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.695 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.1 mt -95.63 109.02 21.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.884 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.2 m-85 74.52 172.34 0.28 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 124.002 0.814 . . . . 0.0 111.099 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.04 92.63 5.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.087 0.47 . . . . 0.0 112.106 -176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.512 ' HB3' HG12 ' A' ' 73' ' ' VAL . 1.1 tm-20 -138.01 115.52 9.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.253 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 61.4 Cg_endo -73.82 45.08 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.82 2.346 . . . . 0.0 112.456 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 71' ' ' GLU . 12.2 p -108.22 49.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 122.151 0.977 . . . . 0.0 110.35 -177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -155.95 60.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.912 177.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -110.49 133.95 52.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.925 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 110.71 19.92 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 172.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -116.64 113.64 22.95 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.578 -174.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 t0 64.71 12.1 7.34 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.776 0.672 . . . . 0.0 111.166 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.09 2.76 58.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.919 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 133.27 47.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.962 0.41 . . . . 0.0 110.853 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -125.11 157.74 35.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.414 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 -172.8 2.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.709 0.29 . . . . 0.0 110.508 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -6.44 56.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.887 0.375 . . . . 0.0 111.575 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.88 -53.35 3.55 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.208 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 74' ' ' HIS . 1.8 pm0 -90.65 12.94 17.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.904 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' A' ' 89' ' ' LYS . 3.1 tt -36.89 114.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.235 0 O-C-N 124.619 1.2 . . . . 0.0 110.903 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.558 HG12 HG21 ' A' ' 94' ' ' THR . 11.4 tt -71.77 -18.77 19.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.21 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -15.14 63.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 0.0 110.106 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.757 ' HB2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -81.58 -18.0 46.34 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.423 0.63 . . . . 0.0 109.556 177.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -82.19 -55.72 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.092 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.892 HG12 HG23 ' A' ' 94' ' ' THR . 0.3 OUTLIER -161.13 155.2 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.148 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.65 -58.08 10.13 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.2 0.312 . . . . 0.0 111.735 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.757 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 6.7 tpp85 -91.95 84.37 5.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.206 0.526 . . . . 0.0 110.969 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.892 HG23 HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -115.76 136.39 53.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.654 178.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -145.56 134.6 22.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.454 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -101.7 108.34 19.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.808 0.337 . . . . 0.0 110.247 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -75.85 106.88 7.67 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.44 2.65 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.374 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -51.61 -38.86 56.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.023 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.66 -16.63 67.84 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.74 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -35.8 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -168.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.06 -6.0 50.66 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.511 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.83 1.69 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.057 0.456 . . . . 0.0 109.913 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.58 42.9 9.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.004 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 132.79 38.45 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.162 -0.611 . . . . 0.0 110.573 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' HZ ' ' A' ' 125' ' ' PHE . 5.9 m -123.74 133.25 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.405 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.61 103.37 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 96' ' ' LEU . 20.2 tp -86.12 118.07 25.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.46 107.24 19.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.053 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HG ' ' A' ' 108' ' ' LEU . 86.9 mt -115.53 109.39 28.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.757 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 30.0 t80 -80.87 122.89 27.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.903 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 42.7 t30 79.57 75.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.182 0.926 . . . . 0.0 110.791 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.87 140.11 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.878 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.5 p -103.68 163.4 12.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.516 0.674 . . . . 0.0 112.159 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.684 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -69.59 -14.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.219 177.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -75.29 -24.16 57.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.566 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.69 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 42.7 m-20 -103.45 -10.64 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.723 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.833 ' HB2' HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -61.05 6.63 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.85 -128.68 6.37 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.081 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.52 117.75 30.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.763 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.69 ' HE1' ' HB3' ' A' ' 117' ' ' ASP . 0.6 OUTLIER -87.52 157.91 19.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.38 118.83 32.23 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.619 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 5.6 t -105.46 116.52 32.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.842 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.603 ' HB ' ' HG3' ' A' ' 63' ' ' ARG . 6.2 t -123.89 111.26 28.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.533 ' HZ ' HG22 ' A' ' 106' ' ' VAL . 1.4 m-85 -97.38 123.62 41.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.758 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 12.9 mtpt -132.88 136.47 46.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.544 0.688 . . . . 0.0 111.759 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.3 76.51 1.7 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.684 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.99 -98.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.771 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 -27.4 20.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.485 0.184 . . . . 0.0 111.472 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -75.3 132.55 41.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.424 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 12.6 p90 -151.23 141.08 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 151.46 47.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.639 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.56 51.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.824 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.77 137.7 21.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.897 0.379 . . . . 0.0 111.15 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.26 46.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.325 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.441 HG21 ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -112.56 157.12 21.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.149 -178.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 122.66 45.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.38 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 74.2 t -102.62 113.25 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 139' ' ' LYS . 3.1 mmmm -97.76 108.24 20.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.841 0.353 . . . . 0.0 110.066 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.833 HG12 ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -76.81 129.46 37.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.397 0.617 . . . . 0.0 111.225 -176.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.452 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ttp . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.607 0.242 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.1 m -60.62 134.53 57.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.578 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.2 24.73 2.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.923 0.868 . . . . 0.0 109.325 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.51 127.56 52.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.649 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.7 -11.52 11.47 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.732 2.288 . . . . 0.0 111.925 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -164.7 147.44 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 0.2 OUTLIER -143.62 175.38 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.303 -173.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -91.13 144.36 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.954 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.09 139.31 56.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.731 0.3 . . . . 0.0 110.394 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.37 0.35 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.933 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.26 155.22 42.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.27 -49.4 19.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 66.61 1.77 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.476 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.06 88.11 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.37 2.046 . . . . 0.0 111.791 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 t -75.35 92.19 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.26 98.83 10.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.153 0.501 . . . . 0.0 110.176 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 113' ' ' VAL . . . -109.37 158.09 18.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.604 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -112.66 129.42 56.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -57.27 125.93 24.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 -174.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.1 -22.57 22.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.538 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -172.62 41.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.127 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 2.9 p-10 -79.26 125.86 30.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.275 0.559 . . . . 0.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -97.58 123.13 41.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.418 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 112.4 24.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.999 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.503 HD11 HD21 ' A' ' 45' ' ' LEU . 1.2 mt -96.42 128.71 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 124.71 52.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' HB3' ' HZ ' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -130.35 143.4 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.489 ' HG2' ' HG3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -132.24 131.03 41.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.544 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.56 166.14 19.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.536 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -97.51 97.87 4.46 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 85.2 Cg_endo -85.16 130.13 3.97 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.779 2.319 . . . . 0.0 113.754 -171.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HD2' ' OD2' ' A' ' 127' ' ' ASP . 16.4 Cg_exo -68.65 -37.55 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.753 2.302 . . . . 0.0 110.744 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 5.3 pt20 -133.91 -172.33 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.876 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.659 ' HG2' ' H ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -69.02 -29.95 68.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.678 0.275 . . . . 0.0 111.339 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 55.49 26.28 8.79 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.426 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.659 ' H ' ' HG2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -62.15 -25.44 67.75 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -113.48 18.94 17.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.864 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -88.42 -166.3 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -176.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 126' ' ' LYS . 1.3 mt-10 -116.66 131.99 56.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.697 0.284 . . . . 0.0 110.678 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 147.46 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.139 0.495 . . . . 0.0 110.384 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.764 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -128.59 117.45 21.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.047 178.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.516 ' NE1' ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -126.17 59.35 1.33 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 63' ' ' ARG . 83.2 m-85 -136.6 159.44 41.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.338 0.59 . . . . 0.0 112.422 -164.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HD2' ' HA ' ' A' ' 117' ' ' ASP . 9.7 ttp180 -80.84 149.02 29.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.138 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -133.51 132.17 40.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.449 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.87 134.16 55.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 58.89 -102.07 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.571 0.544 . . . . 0.0 109.641 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -156.45 94.92 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.188 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -129.43 87.37 53.47 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.11 54.73 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.231 2.62 . . . . 0.0 112.112 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.1 -2.86 9.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.658 ' HD2' ' HA ' ' A' ' 85' ' ' GLU . 1.8 m170 -95.6 128.41 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 147.48 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.05 0.452 . . . . 0.0 111.067 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.63 112.11 23.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -105.19 122.38 45.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.68 20.01 8.69 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.571 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.43 9.1 76.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.285 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.68 156.14 24.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.46 148.74 21.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.943 0.402 . . . . 0.0 110.352 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.26 156.59 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.653 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -25.38 67.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.71 -25.97 47.92 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.179 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.658 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 0.7 OUTLIER -82.67 -43.28 17.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.5 tp 39.77 82.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.605 1.19 . . . . 0.0 112.51 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 94' ' ' THR . 29.0 pt -68.52 -1.8 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.212 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -14.91 60.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 173.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.14 -41.31 78.87 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.836 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG12 ' A' ' 91' ' ' VAL . 38.9 m-85 -81.42 -49.55 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER 73.22 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.34 1.025 . . . . 0.0 112.482 174.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.4 OUTLIER 73.35 -125.49 0.04 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.668 175.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HA ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -95.63 96.51 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 -176.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -110.54 114.19 27.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 177.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -145.69 123.56 11.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.568 HD22 ' HD2' ' A' ' 76' ' ' TYR . 12.2 tp -92.59 112.85 24.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.0 110.359 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -74.18 105.48 5.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.6 4.8 50.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.919 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.99 -34.62 57.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.501 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 105' ' ' LYS . . . -84.55 -16.69 65.63 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.945 -176.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG21 ' HG2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -51.32 -38.5 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -167.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.02 -11.14 60.48 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.751 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -116.22 1.15 13.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.52 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.11 34.5 12.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.931 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.639 ' HB2' ' HA3' ' A' ' 100' ' ' GLY . 0.1 OUTLIER -124.55 140.14 53.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.875 0.338 . . . . 0.0 110.613 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.43 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 175.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -125.24 104.55 8.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.242 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 64' ' ' TRP . 5.7 tp -87.84 115.11 25.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 0.0 110.456 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -93.99 107.42 19.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.86 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 108' ' ' LEU . 1.9 mt -122.35 114.38 42.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -72.74 146.12 46.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.159 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 7.0 t30 75.1 89.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.131 0 O-C-N 123.922 0.764 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.432 HG11 ' HB1' ' A' ' 39' ' ' ALA . 4.1 p -107.21 145.11 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 175.48 8.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 41' ' ' LEU . 43.6 t -60.29 -26.34 36.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.282 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -30.2 71.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.474 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 119' ' ' GLY . 15.4 m-20 -93.02 -14.01 27.93 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.05 25.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.051 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -118.23 -128.62 3.94 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.98 130.4 53.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.323 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.479 ' HB3' ' HZ3' ' A' ' 64' ' ' TRP . 1.5 m-85 -104.28 141.88 35.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.23 120.22 39.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.148 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -98.82 125.11 44.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.403 174.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.764 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 3.6 t -134.32 134.04 55.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 28' ' ' PHE . 43.0 m-85 -124.61 120.35 31.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.701 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.1 mtpm? -111.16 106.21 15.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.168 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.864 ' HA ' ' HG3' ' A' ' 60' ' ' MET . 49.3 t0 -114.88 114.24 25.24 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.713 0.633 . . . . 0.0 109.754 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.87 -104.06 1.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.962 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -117.4 -10.26 10.74 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.64 154.32 21.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 -176.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.525 ' HD2' HG13 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -143.63 146.95 33.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 0.0 111.413 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.984 ' HG3' ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -126.2 160.81 29.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.321 177.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.49 150.85 45.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.522 . . . . 0.0 111.515 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -147.2 132.87 18.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.036 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -89.21 116.33 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.483 ' HB ' ' HH2' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -116.2 134.55 54.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.247 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.87 139.66 30.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.201 0.525 . . . . 0.0 111.895 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.8 t -106.1 132.13 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.568 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -117.54 106.8 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.388 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 41' ' ' LEU . 1.5 mp -73.6 119.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.187 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.055 0.455 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.48 123.41 19.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -0.65 13.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.878 0.847 . . . . 0.0 109.247 -174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -88.45 113.52 55.77 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.255 -1.338 . . . . 0.0 110.769 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -89.57 7.22 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.988 2.459 . . . . 0.0 111.481 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -146.93 139.35 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.354 -177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.86 159.3 9.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.999 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.27 134.33 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.945 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 140.88 48.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.542 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.18 -126.36 7.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.518 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.8 177.69 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 mp0 -70.46 -33.9 71.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.127 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.79 75.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.979 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.28 70.37 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.001 2.468 . . . . 0.0 111.36 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.53 106.92 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.182 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -98.75 147.94 24.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -137.3 171.71 14.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.23 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.2 121.0 36.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.091 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.85 128.38 36.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 -176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 112' ' ' ASN . . . 83.62 -14.54 41.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.764 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.74 -156.84 27.54 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.976 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.99 130.97 35.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.004 0.43 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 110' ' ' ILE . 1.2 tp -110.01 110.36 21.25 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -114.01 114.66 26.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 -178.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 45' ' ' LEU . 1.2 mm? -100.69 128.74 46.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.362 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.2 121.28 44.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.76 141.07 51.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -134.13 140.82 46.83 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.122 0.487 . . . . 0.0 110.988 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD23 ' CD1' ' A' ' 125' ' ' PHE . 1.2 pp -127.58 161.68 28.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.179 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 1.6 m -82.18 109.05 13.55 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 8.2 Cg_exo -70.53 112.45 3.22 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.255 2.637 . . . . 0.0 114.271 -167.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 52' ' ' SER . 88.9 Cg_endo -90.94 -8.59 3.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.95 2.434 . . . . 0.0 110.405 168.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -158.41 -172.17 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.426 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -9.11 58.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.75 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . . . 70.63 -1.85 2.44 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.466 0.706 . . . . 0.0 112.877 173.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -65.66 -18.06 65.05 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.047 0.451 . . . . 0.0 111.255 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.64 6.93 22.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.07 155.21 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.311 0.577 . . . . 0.0 112.101 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.026 ' HG2' HD13 ' A' ' 75' ' ' LEU . 11.1 mt-10 -80.02 107.8 13.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.206 172.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.39 140.79 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.361 0.601 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 1.051 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 1.6 ttp180 -131.81 131.63 43.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.302 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.534 ' HA ' ' CE3' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -147.77 57.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HB2' HD21 ' A' ' 67' ' ' ASN . 62.6 m-85 -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.307 -170.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 98.55 7.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 65' ' ' PHE . 1.7 p30 -158.33 144.94 17.46 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.968 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.42 161.29 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.413 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.18 56.2 1.78 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 123.487 0.492 . . . . 0.0 110.595 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.93 74.43 5.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.757 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 mt-10 -72.57 -54.29 5.22 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.038 172.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 71' ' ' GLU . 1.5 Cg_endo -85.27 115.2 1.62 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.516 2.144 . . . . 0.0 111.06 172.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . 22.9 m-70 -141.39 136.64 31.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.444 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 ' HG2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -155.64 151.08 27.03 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -164.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.0 111.81 24.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -147.49 153.51 39.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.523 -172.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.64 ' N ' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER 64.32 26.06 13.58 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.574 0.546 . . . . 0.0 109.867 175.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.57 73.5 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.963 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -142.51 151.28 41.49 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.115 0.484 . . . . 0.0 111.727 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.71 154.49 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.616 171.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.54 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 23.1 mtp -114.5 -160.04 0.72 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.802 0.334 . . . . 0.0 111.677 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' H ' ' HB3' ' A' ' 82' ' ' MET . 25.7 p90 -72.66 -36.41 67.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.654 ' HA3' ' CE1' ' A' ' 74' ' ' HIS . . . -85.04 -44.05 6.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.504 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 1.6 pm0 -87.45 17.91 4.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.441 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.95 108.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.787 0.804 . . . . 0.0 110.421 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 108' ' ' LEU . 9.3 tt -70.0 -16.73 20.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.744 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -12.84 61.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -60.03 -20.57 58.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.335 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -76.11 0.39 19.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 t 57.16 39.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.419 0.688 . . . . 0.0 112.028 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -168.67 177.56 5.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.864 176.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HG3' ' HB2' ' A' ' 111' ' ' PHE . 0.9 OUTLIER -72.34 141.95 48.79 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.209 0.528 . . . . 0.0 110.813 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.665 HG23 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -137.51 141.68 41.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.783 -177.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -136.49 104.25 5.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.776 177.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 108' ' ' LEU . 0.8 OUTLIER -78.23 90.28 4.32 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' A' ' 107' ' ' THR . 20.6 mt -68.81 120.51 14.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.183 0.516 . . . . 0.0 110.894 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 8.99 27.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.858 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.52 -33.69 70.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.47 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.23 -16.66 64.21 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.178 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 57' ' ' ALA . 2.3 tt -54.05 -36.26 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -167.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.92 70.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.104 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.99 2.24 37.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.205 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.01 19.85 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.322 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.66 133.2 53.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.419 0.61 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.99 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 122.237 -0.29 . . . . 0.0 110.27 176.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.539 ' HB ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -121.11 107.86 13.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.042 0.449 . . . . 0.0 111.282 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.549 HD13 HD12 ' A' ' 96' ' ' LEU . 45.1 tp -88.33 112.76 23.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.815 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -92.71 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.289 176.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.665 HG12 HG23 ' A' ' 94' ' ' THR . 57.3 mt -116.49 124.63 72.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 1.5 t80 -76.57 124.96 28.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.185 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 42' ' ' GLY . 54.8 t30 77.04 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.158 0.911 . . . . 0.0 112.053 176.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 140' ' ' ILE . 11.5 p -133.95 141.52 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.24 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -123.16 174.69 7.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.12 -11.86 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.021 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.64 -24.34 41.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -101.74 -9.97 20.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 140' ' ' ILE . 36.4 t70 -68.46 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.797 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 117' ' ' ASP . . . -127.68 -126.54 2.91 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.822 -177.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -77.4 114.8 16.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -174.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 64' ' ' TRP . 0.2 OUTLIER -110.31 128.03 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.51 175.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 118.82 37.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.209 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.7 t -105.46 140.3 38.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.635 175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 63' ' ' ARG . 1.9 t -144.43 132.55 17.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.213 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -120.3 115.45 23.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.336 176.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.619 ' HG2' ' HB2' ' A' ' 131' ' ' TYR . 4.7 mtpm? -130.66 102.26 6.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.845 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -91.74 71.35 5.76 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.56 -107.33 2.29 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.11 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.33 -19.97 27.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.946 0.403 . . . . 0.0 110.429 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' LYS . 21.7 m-85 -68.82 94.37 0.61 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.619 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -120.44 137.81 54.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.2 0.524 . . . . 0.0 111.96 -172.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.89 135.2 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.415 171.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -122.7 137.73 54.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.349 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.35 146.95 37.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.219 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 120' ' ' SER . 1.1 tp -123.14 113.21 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.646 0.736 . . . . 0.0 110.452 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 159.71 18.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.273 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.48 129.11 53.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.22 129.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -117.66 97.82 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.074 0.464 . . . . 0.0 110.863 -177.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 118' ' ' ASP . 33.8 mt -67.85 114.59 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.437 -175.195 . . . . . . . . 2 2 . 1 stop_ save_